1	Journal	NNP	O	Journal	_	0	SENT_1	[p1l41t81r128b109],
2	of	IN	O	of	_	0	SENT_1	[p1l138t81r164b103],
3	the	DT	O	the	det	5	SENT_1	[p1l171t81r207b103],
4	American	NNP	ORGANIZATION	American	nn	5	SENT_1	[p1l217t81r333b103],
5	College	NNP	ORGANIZATION	College	prep_of	1	SENT_1	[p1l344t81r432b111],
6	of	IN	ORGANIZATION	of	_	0	SENT_1	[p1l443t81r470b103],
7	Cardiology	NNP	ORGANIZATION	Cardiology	nn	8	SENT_1	[p1l477t81r607b111],
8	Vol	NNP	ORGANIZATION	Vol	prep_of	1	SENT_1	[p1l1869t81r1916b103],
9	.	.	O	.	_	0	SENT_1	[p1l1869t81r1916b103],

1	51	CD	NUMBER	51	_	0	SENT_2	[p1l1928t81r1963b108],
2	,	,	O	,	_	0	SENT_2	[p1l1928t81r1963b108],
3	No.	NN	O	no.	appos	1	SENT_2	[p1l1974t81r2017b103],
4	4	CD	NUMBER	4	num	3	SENT_2	[p1l2029t82r2049b108],
5	,	,	O	,	_	0	SENT_2	[p1l2029t82r2049b108],
6	2008	CD	DATE	2008	num	7	SENT_2	[p1l2061t82r2117b104],
7	©	CD	DATE	©	appos	1	SENT_2	[p1l44t114r66b137],
8	2008	CD	DATE	2008	dep	29	SENT_2	[p1l77t116r134b137],
9	by	IN	O	by	_	0	SENT_2	[p1l145t115r173b144],
10	the	DT	O	the	det	12	SENT_2	[p1l183t115r219b137],
11	American	NNP	ORGANIZATION	American	nn	12	SENT_2	[p1l229t114r344b137],
12	College	NNP	ORGANIZATION	College	prep_by	8	SENT_2	[p1l356t114r444b144],
13	of	IN	ORGANIZATION	of	_	0	SENT_2	[p1l455t114r481b137],
14	Cardiology	NNP	ORGANIZATION	Cardiology	nn	16	SENT_2	[p1l489t114r619b144],
15	Foundation	NNP	ORGANIZATION	Foundation	nn	16	SENT_2	[p1l628t114r765b137],
16	ISSN	NNP	ORGANIZATION	ISSN	prep_of	12	SENT_2	[p1l1785t114r1850b137],
17	0735-1097/08	CD	DURATION	0735-1097/08	num	16	SENT_2	[p1l1861t114r2118b138],
18	/	:	O	/	punct	19	SENT_2	[p1l1861t114r2118b138],
19	$	$	MONEY	$	dep	12	SENT_2	[p1l1861t114r2118b138],
20	34.00	CD	MONEY	34.00	num	19	SENT_2	[p1l1861t114r2118b138],
21	Published	VBN	O	publish	partmod	19	SENT_2	[p1l44t148r159b170],
22	by	IN	O	by	_	0	SENT_2	[p1l169t148r197b177],
23	Elsevier	NNP	ORGANIZATION	Elsevier	nn	24	SENT_2	[p1l207t148r300b170],
24	Inc.	NNP	ORGANIZATION	Inc.	agent	21	SENT_2	[p1l309t148r353b170],
25	doi	FW	O	doi	dep	24	SENT_2	[p1l1758t148r2118b177],
26	:10.1016	CD	NUMBER	:10.1016	dep	25	SENT_2	[p1l1758t148r2118b177],
27	/	:	O	/	punct	19	SENT_2	[p1l1758t148r2118b177],
28	j.	NN	O	j.	nn	29	SENT_2	[p1l1758t148r2118b177],
29	jacc	NN	O	jacc	rcmod	7	SENT_2	[p1l1758t148r2118b177],
30	.2007.10.017	CD	NUMBER	.2007.10.017	dep	29	SENT_2	[p1l1758t148r2118b177],

1	Polymorphism	NN	O	polymorphism	_	0	SENT_3	[p1l122t356r564b425],
2	in	IN	O	in	_	0	SENT_3	[p1l596t356r649b413],
3	KIF6	NNP	O	KIF6	nn	4	SENT_3	[p1l682t355r830b414],
4	Gene	NNP	O	Gene	prep_in	1	SENT_3	[p1l853t355r1010b414],
5	and	CC	O	and	_	0	SENT_3	[p1l1038t356r1151b414],
6	Benefit	NNP	O	Benefit	prep_in	1	SENT_3	[p1l1184t355r1406b414],
7	From	IN	O	from	dep	1	SENT_3	[p1l122t455r278b513],
8	Statins	NNPS	O	Statins	pobj	7	SENT_3	[p1l307t454r528b513],
9	After	IN	O	after	dep	1	SENT_3	[p1l554t454r711b513],
10	Acute	JJ	O	acute	amod	12	SENT_3	[p1l736t455r916b513],
11	Coronary	JJ	O	coronary	amod	12	SENT_3	[p1l944t454r1230b524],
12	Syndromes	NNS	O	syndrome	pobj	9	SENT_3	[p1l1256t454r1603b524],

1	Results	NNS	O	result	_	0	SENT_4	[p1l121t569r286b613],
2	From	IN	O	from	_	0	SENT_4	[p1l309t570r437b613],
3	the	DT	O	the	det	5	SENT_4	[p1l459t569r532b613],
4	PROVE	NNP	O	PROVE	nn	5	SENT_4	[p1l554t569r756b613],
5	IT-TIMI	NN	O	it-timus	prep_from	1	SENT_4	[p1l778t568r1003b612],
6	22	CD	NUMBER	22	num	7	SENT_4	[p1l1025t571r1081b613],
7	Study	NN	O	study	dep	1	SENT_4	[p1l1106t569r1240b628],

1	Olga	NNP	PERSON	Olga	dep	107	SENT_5	[p1l120t695r209b741],
2	A.	NNP	PERSON	A.	dep	107	SENT_5	[p1l224t694r267b729],
3	Iakoubova	NNP	PERSON	Iakoubova	dep	107	SENT_5	[p1l286t695r486b737],
4	,	,	O	,	_	0	SENT_5	[p1l286t695r486b737],
5	MD	NNP	O	MD	dep	107	SENT_5	[p1l503t695r595b737],
6	,	,	O	,	_	0	SENT_5	[p1l503t695r595b737],
7	PHD	NNP	O	PHD	dep	107	SENT_5	[p1l613t695r732b737],
8	,	,	O	,	_	0	SENT_5	[p1l613t695r732b737],
9	*	CD	NUMBER	*	dep	107	SENT_5	[p1l613t695r732b737],
10	Marc	NNP	PERSON	Marc	dep	107	SENT_5	[p1l748t695r847b729],
11	S.	NNP	PERSON	S.	dep	107	SENT_5	[p1l865t695r896b729],
12	Sabatine	NNP	PERSON	Sabatine	dep	107	SENT_5	[p1l917t695r1082b737],
13	,	,	O	,	_	0	SENT_5	[p1l917t695r1082b737],
14	MD	NNP	O	MD	dep	107	SENT_5	[p1l1099t695r1191b737],
15	,	,	O	,	_	0	SENT_5	[p1l1099t695r1191b737],
16	MPH	NNP	O	MPH	dep	107	SENT_5	[p1l1208t695r1330b737],
17	,	,	O	,	_	0	SENT_5	[p1l1208t695r1330b737],
18	FACC	NNP	O	FACC	dep	107	SENT_5	[p1l1348t694r1511b737],
19	,	,	O	,	_	0	SENT_5	[p1l1348t694r1511b737],
20	'	''	O	'	_	0	SENT_5	[p1l1348t694r1511b737],
21	l	NN	O	l	dep	107	SENT_5	[p1l1348t694r1511b737],
22	‘	CD	NUMBER	‘	dep	107	SENT_5	[p1l1348t694r1511b737],
23	Charles	NNP	PERSON	Charles	dep	107	SENT_5	[p1l1529t695r1667b729],
24	M.	NNP	PERSON	M.	dep	107	SENT_5	[p1l1684t695r1738b729],
25	Rowland	NNP	PERSON	Rowland	dep	107	SENT_5	[p1l1758t695r1931b737],
26	,	,	O	,	_	0	SENT_5	[p1l1758t695r1931b737],
27	MS	NN	O	m	dep	107	SENT_5	[p1l1949t695r2045b737],
28	,	,	O	,	_	0	SENT_5	[p1l1949t695r2045b737],
29	*	CD	NUMBER	*	dep	107	SENT_5	[p1l1949t695r2045b737],
30	Carmen	NNP	PERSON	Carmen	dep	107	SENT_5	[p1l120t751r268b785],
31	H.	NNP	PERSON	H.	dep	107	SENT_5	[p1l285t751r332b785],
32	Tong	NNP	PERSON	Tong	dep	107	SENT_5	[p1l349t750r461b797],
33	,	,	O	,	_	0	SENT_5	[p1l349t750r461b797],
34	BS	NNP	O	BS	dep	107	SENT_5	[p1l479t751r560b793],
35	,	,	O	,	_	0	SENT_5	[p1l479t751r560b793],
36	*	NNP	O	*	dep	107	SENT_5	[p1l479t751r560b793],
37	Joseph	NNP	PERSON	Joseph	dep	107	SENT_5	[p1l572t751r697b797],
38	^	NNP	O	^	dep	107	SENT_5	[p1l709t751r737b795],
39	*	NNP	O	*	dep	107	SENT_5	[p1l709t751r737b795],
40	Catanese	NNP	O	Catanese	dep	107	SENT_5	[p1l757t751r932b793],
41	,	,	O	,	_	0	SENT_5	[p1l757t751r932b793],
42	BS	NNP	O	BS	dep	107	SENT_5	[p1l951t751r1031b793],
43	,	,	O	,	_	0	SENT_5	[p1l951t751r1031b793],
44	*	CD	NUMBER	*	dep	107	SENT_5	[p1l951t751r1031b793],
45	Koustubh	NNP	PERSON	Koustubh	dep	107	SENT_5	[p1l1049t751r1227b785],
46	Ranade	NNP	PERSON	Ranade	dep	107	SENT_5	[p1l1245t751r1391b793],
47	,	,	O	,	_	0	SENT_5	[p1l1245t751r1391b793],
48	PHD	NNP	O	PHD	dep	107	SENT_5	[p1l1410t751r1536b793],
49	,	,	O	,	_	0	SENT_5	[p1l1410t751r1536b793],
50	:	:	O	:	_	0	SENT_5	[p1l1410t751r1536b793],
51	l	NN	O	l	dep	107	SENT_5	[p1l1410t751r1536b793],
52	:	:	O	:	_	0	SENT_5	[p1l1410t751r1536b793],
53	Katy	NNP	PERSON	Katy	dep	107	SENT_5	[p1l1555t751r1640b797],
54	L.	NNP	PERSON	L.	dep	107	SENT_5	[p1l1656t751r1693b785],
55	Simonsen	NNP	PERSON	Simonsen	dep	107	SENT_5	[p1l1714t751r1903b793],
56	,	,	O	,	_	0	SENT_5	[p1l1714t751r1903b793],
57	PHD	NNP	O	PHD	dep	107	SENT_5	[p1l1921t751r2047b793],
58	,	,	O	,	_	0	SENT_5	[p1l1921t751r2047b793],
59	:	:	O	:	_	0	SENT_5	[p1l1921t751r2047b793],
60	lI	NNP	O	lI	dep	107	SENT_5	[p1l1921t751r2047b793],
61	Todd	NNP	PERSON	Todd	dep	107	SENT_5	[p1l118t806r221b841],
62	G.	NNP	PERSON	G.	dep	107	SENT_5	[p1l238t807r282b841],
63	Kirchgessner	NNP	PERSON	Kirchgessner	dep	107	SENT_5	[p1l303t807r548b853],
64	,	,	O	,	_	0	SENT_5	[p1l303t807r548b853],
65	PHD	NNP	O	PHD	dep	107	SENT_5	[p1l567t807r693b849],
66	,	,	O	,	_	0	SENT_5	[p1l567t807r693b849],
67	:	:	O	:	_	0	SENT_5	[p1l567t807r693b849],
68	l2	NN	O	l2	dep	107	SENT_5	[p1l567t807r693b849],
69	Christopher	NNP	PERSON	Christopher	dep	107	SENT_5	[p1l711t807r933b853],
70	P.	NNP	PERSON	P.	dep	107	SENT_5	[p1l949t807r985b841],
71	Cannon	NNP	PERSON	Cannon	dep	107	SENT_5	[p1l1005t807r1162b849],
72	,	,	O	,	_	0	SENT_5	[p1l1005t807r1162b849],
73	MD	NNP	O	MD	dep	107	SENT_5	[p1l1180t807r1271b849],
74	,	,	O	,	_	0	SENT_5	[p1l1180t807r1271b849],
75	FACC	NNP	O	FACC	dep	107	SENT_5	[p1l1290t806r1452b849],
76	,	,	O	,	_	0	SENT_5	[p1l1290t806r1452b849],
77	'	''	O	'	_	0	SENT_5	[p1l1290t806r1452b849],
78	l	NN	O	l	dep	107	SENT_5	[p1l1290t806r1452b849],
79	James	NNP	PERSON	James	dep	107	SENT_5	[p1l1465t807r1575b851],
80	PQ	NNP	PERSON	PQ	dep	107	SENT_5	[p1l1588t807r1615b851],
81	*	NNP	PERSON	*	dep	107	SENT_5	[p1l1588t807r1615b851],
82	Devlin	NNP	PERSON	Devlin	dep	107	SENT_5	[p1l1635t807r1768b849],
83	,	,	O	,	_	0	SENT_5	[p1l1635t807r1768b849],
84	PHD	NNP	O	PHD	dep	107	SENT_5	[p1l1787t807r1905b849],
85	,	,	O	,	_	0	SENT_5	[p1l1787t807r1905b849],
86	*	NNP	O	*	dep	107	SENT_5	[p1l1787t807r1905b849],
87	Eugene	NNP	PERSON	Eugene	dep	107	SENT_5	[p1l120t863r258b909],
88	Braunwald	NNP	PERSON	Braunwald	dep	107	SENT_5	[p1l275t863r483b905],
89	,	,	O	,	_	0	SENT_5	[p1l275t863r483b905],
90	MD	NNP	O	MD	dep	107	SENT_5	[p1l501t863r592b905],
91	,	,	O	,	_	0	SENT_5	[p1l501t863r592b905],
92	MACC1	NN	O	macc1	dep	107	SENT_5	[p1l610t862r779b903],
93	‘	NN	O	‘	dep	107	SENT_5	[p1l610t862r779b903],
94	ﬂlameda	NN	O	ﬂlameda	dep	107	SENT_5	[p1l115t920r278b958],
95	,	,	O	,	_	0	SENT_5	[p1l115t920r278b958],
96	Calzfornia	NN	LOCATION	calzfornium	dep	107	SENT_5	[p1l302t920r490b965],
97	;	:	O	;	_	0	SENT_5	[p1l302t920r490b965],
98	Boston	NNP	LOCATION	Boston	dep	107	SENT_5	[p1l506t920r630b958],
99	,	,	O	,	_	0	SENT_5	[p1l506t920r630b958],
100	Masmc/Jusetts	NNP	O	Masmc/Jusetts	dep	107	SENT_5	[p1l648t920r901b958],
101	,	,	O	,	_	0	SENT_5	[p1l648t920r901b958],
102	‘	NN	O	‘	dep	107	SENT_5	[p1l648t920r901b958],
103	and	CC	O	and	dep	107	SENT_5	[p1l918t920r987b952],
104	Princeton	NNP	ORGANIZATION	Princeton	dep	107	SENT_5	[p1l999t920r1172b957],
105	,	,	O	,	_	0	SENT_5	[p1l999t920r1172b957],
106	New	NNP	LOCATION	New	dep	107	SENT_5	[p1l1191t920r1275b952],
107	jersey	NN	LOCATION	jersey	_	0	SENT_5	[p1l1284t920r1388b965],

1	Objectives	NNS	O	objective	_	0	SENT_6	[p1l194t1051r368b1084],
2	We	PRP	O	we	nsubj	3	SENT_6	[p1l494t1055r539b1078],
3	explored	VBD	O	explore	rcmod	1	SENT_6	[p1l551t1055r670b1083],
4	whether	IN	O	whether	complm	15	SENT_6	[p1l682t1055r798b1078],
5	the	DT	O	the	det	6	SENT_6	[p1l808t1055r853b1078],
6	benefit	NN	O	benefit	nsubj	15	SENT_6	[p1l866t1054r963b1078],
7	of	IN	O	of	_	0	SENT_6	[p1l974t1054r1001b1078],
8	intensive	JJ	O	intensive	prep_of	6	SENT_6	[p1l1013t1055r1138b1078],
9	versus	CC	O	versus	prep	8	SENT_6	[p1l1149t1060r1239b1078],
10	moderate	JJ	O	moderate	amod	12	SENT_6	[p1l1252t1055r1388b1078],
11	statin	NN	O	statin	nn	12	SENT_6	[p1l1399t1055r1478b1078],
12	therapy	NN	O	therapy	dep	9	SENT_6	[p1l1490t1055r1597b1083],
13	would	MD	O	would	aux	15	SENT_6	[p1l1607t1055r1690b1078],
14	be	VB	O	be	cop	15	SENT_6	[p1l1703t1055r1736b1078],
15	greater	JJR	O	greater	ccomp	3	SENT_6	[p1l1747t1056r1849b1083],
16	in	IN	O	in	_	0	SENT_6	[p1l1861t1055r1883b1077],
17	carriers	NNS	O	carrier	prep_in	15	SENT_6	[p1l1896t1055r2002b1078],
18	of	IN	O	of	_	0	SENT_6	[p1l2013t1054r2040b1078],
19	KIF6	NN	O	kif6	prep_of	17	SENT_6	[p1l2051t1054r2116b1078],

1	719Arg	NN	O	719arg	_	0	SENT_7	[p1l495t1097r601b1126],
2	than	IN	O	than	dep	1	SENT_7	[p1l610t1097r673b1120],
3	in	IN	O	in	_	0	SENT_7	[p1l687t1097r709b1120],
4	noncarriers	NNS	O	noncarrier	prep_in	2	SENT_7	[p1l722t1097r888b1120],
5	.	.	O	.	_	0	SENT_7	[p1l722t1097r888b1120],

1	Background	NN	O	background	nsubjpass	19	SENT_8	[p1l195t1138r393b1171],
2	The	DT	O	the	det	4	SENT_8	[p1l493t1141r544b1165],
3	719Arg	NN	O	719arg	nn	4	SENT_8	[p1l556t1141r662b1170],
4	variant	NN	O	variant	dep	1	SENT_8	[p1l672t1141r770b1165],
5	of	IN	O	of	_	0	SENT_8	[p1l781t1141r808b1165],
6	Trp719Arg	NN	O	trp719arg	nn	9	SENT_8	[p1l817t1141r970b1170],
7	(	CD	NUMBER	(	num	9	SENT_8	[p1l981t1141r1130b1170],
8	rs20455	NN	O	rs20455	nn	9	SENT_8	[p1l981t1141r1130b1170],
9	)	NN	O	)	prep_of	4	SENT_8	[p1l981t1141r1130b1170],
10	,	,	O	,	_	0	SENT_8	[p1l981t1141r1130b1170],
11	a	DT	O	a	det	12	SENT_8	[p1l1143t1147r1158b1165],
12	polymorphism	NN	O	polymorphism	appos	1	SENT_8	[p1l1172t1141r1372b1170],
13	in	IN	O	in	_	0	SENT_8	[p1l1386t1141r1408b1164],
14	kinesin-like	JJ	O	kinesin-like	amod	15	SENT_8	[p1l1421t1141r1581b1165],
15	protein	NN	O	protein	prep_in	12	SENT_8	[p1l1594t1141r1691b1170],
16	6	CD	NUMBER	6	dep	12	SENT_8	[p1l1704t1141r1728b1169],
17	,	,	O	,	_	0	SENT_8	[p1l1704t1141r1728b1169],
18	is	VBZ	O	be	auxpass	19	SENT_8	[p1l1742t1141r1763b1165],
19	associated	VBN	O	associate	_	0	SENT_8	[p1l1774t1141r1925b1165],
20	with	IN	O	with	_	0	SENT_8	[p1l1937t1141r1994b1165],
21	greater	JJR	O	greater	amod	22	SENT_8	[p1l2007t1142r2109b1170],
22	risk	NN	O	risk	prep_with	19	SENT_8	[p1l495t1185r545b1208],
23	of	IN	O	of	_	0	SENT_8	[p1l556t1185r583b1208],
24	coronary	JJ	O	coronary	amod	25	SENT_8	[p1l594t1190r716b1214],
25	events	NNS	O	event	prep_of	22	SENT_8	[p1l727t1186r819b1208],
26	and	CC	O	and	_	0	SENT_8	[p1l830t1185r882b1208],
27	greater	JJR	O	greater	amod	28	SENT_8	[p1l894t1186r996b1214],
28	benefit	NN	O	benefit	prep_of	22	SENT_8	[p1l1008t1185r1105b1208],
29	from	IN	O	from	_	0	SENT_8	[p1l1115t1185r1181b1208],
30	pravastatin	NN	O	pravastatin	prep_from	19	SENT_8	[p1l1195t1185r1352b1214],
31	versus	CC	O	versus	prep	30	SENT_8	[p1l1363t1190r1454b1208],
32	placebo	NN	O	placebo	dep	31	SENT_8	[p1l1467t1185r1584b1214],
33	.	.	O	.	_	0	SENT_8	[p1l1467t1185r1584b1214],

1	Methods	NNS	O	method	_	0	SENT_9	[p1l195t1225r339b1251],
2	We	PRP	O	we	nsubj	31	SENT_9	[p1l494t1228r539b1251],
3	genotyped	VBD	O	genotype	rcmod	1	SENT_9	[p1l550t1228r697b1257],
4	1,778	CD	NUMBER	1,778	num	8	SENT_9	[p1l710t1228r794b1256],
5	acute	JJ	O	acute	amod	8	SENT_9	[p1l806t1230r884b1251],
6	coronary	JJ	O	coronary	amod	8	SENT_9	[p1l895t1234r1018b1257],
7	syndrome	NN	O	syndrome	nn	8	SENT_9	[p1l1028t1228r1168b1257],
8	patients	NNS	O	patient	dobj	3	SENT_9	[p1l1180t1228r1294b1257],
9	within	IN	O	within	_	0	SENT_9	[p1l1305t1228r1389b1251],
10	the	DT	O	the	det	12	SENT_9	[p1l1401t1228r1446b1251],
11	PROVE	NNP	O	PROVE	nn	12	SENT_9	[p1l1458t1228r1554b1251],
12	IT-TIMI	NN	O	it-timus	prep_within	3	SENT_9	[p1l1567t1228r1656b1251],
13	22	CD	NUMBER	22	number	14	SENT_9	[p1l1669t1228r1706b1251],
14	(	CD	NUMBER	(	num	15	SENT_9	[p1l1718t1228r1888b1257],
15	Pravastatin	NN	O	pravastatin	dep	12	SENT_9	[p1l1718t1228r1888b1257],
16	or	CC	O	or	_	0	SENT_9	[p1l1900t1234r1928b1251],
17	Atorvastatin	NNP	O	Atorvastatin	nn	18	SENT_9	[p1l1938t1228r2109b1251],
18	Evaluation	NN	O	evaluation	prep_within	3	SENT_9	[p1l495t1272r641b1296],
19	and	CC	O	and	_	0	SENT_9	[p1l653t1272r704b1296],
20	Infection	NN	O	infection	nn	21	SENT_9	[p1l718t1272r839b1296],
21	Therapy	NN	O	therapy	conj_and	18	SENT_9	[p1l851t1272r971b1301],
22	:	:	O	:	_	0	SENT_9	[p1l851t1272r971b1301],
23	Thrombolysis	NNP	O	Thrombolysis	dep	18	SENT_9	[p1l982t1272r1170b1301],
24	in	IN	O	in	_	0	SENT_9	[p1l1182t1272r1205b1295],
25	Myocardial	JJ	O	myocardial	amod	26	SENT_9	[p1l1218t1272r1370b1301],
26	Infarction	NN	O	infarction	prep_in	23	SENT_9	[p1l1384t1272r1517b1296],
27	22	CD	NUMBER	22	num	29	SENT_9	[p1l1529t1272r1577b1301],
28	)	NN	O	)	nn	29	SENT_9	[p1l1529t1272r1577b1301],
29	trial	NN	O	trial	dep	23	SENT_9	[p1l1588t1272r1641b1296],
30	and	CC	O	and	_	0	SENT_9	[p1l1654t1272r1705b1296],
31	investigated	VBD	O	investigate	rcmod	1	SENT_9	[p1l1719t1272r1889b1301],
32	different	JJ	O	different	amod	33	SENT_9	[p1l1901t1272r2022b1296],
33	intensities	NNS	O	intensity	dobj	31	SENT_9	[p1l2034t1272r2113b1296, p1l493t1316r568b1339],
34	of	IN	O	of	_	0	SENT_9	[p1l579t1315r606b1339],
35	statin	NN	O	statin	nn	36	SENT_9	[p1l616t1316r694b1339],
36	therapy	NN	O	therapy	prep_of	33	SENT_9	[p1l706t1316r814b1344],
37	in	IN	O	in	_	0	SENT_9	[p1l826t1316r848b1338],
38	carriers	NNS	O	carrier	prep_in	31	SENT_9	[p1l861t1316r966b1339],
39	of	IN	O	of	_	0	SENT_9	[p1l978t1315r1005b1339],
40	719Arg	NN	O	719arg	prep_of	38	SENT_9	[p1l1016t1315r1122b1344],
41	and	CC	O	and	_	0	SENT_9	[p1l1132t1316r1183b1339],
42	in	IN	O	in	_	0	SENT_9	[p1l1197t1316r1219b1338],
43	noncarriers	NNS	O	noncarrier	prep_in	31	SENT_9	[p1l1233t1316r1391b1339],
44	using	VBG	O	use	partmod	43	SENT_9	[p1l1404t1316r1478b1344],
45	cox	NN	O	cox	dobj	44	SENT_9	[p1l1489t1315r1540b1339],
46	proportional	JJ	O	proportional	amod	48	SENT_9	[p1l1551t1316r1721b1344],
47	hazards	NNS	O	hazard	nn	48	SENT_9	[p1l1735t1316r1845b1339],
48	models	NNS	O	model	dep	1	SENT_9	[p1l1857t1316r1960b1339],
49	that	WDT	O	that	nsubj	50	SENT_9	[p1l1970t1316r2027b1339],
50	adjusted	VBN	O	adjust	rcmod	48	SENT_9	[p1l2038t1316r2081b1339, p1l491t1358r579b1388],
51	for	IN	O	for	_	0	SENT_9	[p1l590t1358r629b1382],
52	traditional	JJ	O	traditional	amod	54	SENT_9	[p1l640t1358r784b1382],
53	risk	NN	O	risk	nn	54	SENT_9	[p1l798t1358r847b1382],
54	factors	NNS	O	factor	prep_for	50	SENT_9	[p1l857t1358r962b1382],
55	.	.	O	.	_	0	SENT_9	[p1l857t1358r962b1382],

1	Results	NNS	O	result	nsubj	2	SENT_10	[p1l195t1399r319b1426],
2	Benefit	VBP	O	benefit	dep	14	SENT_10	[p1l495t1402r595b1426],
3	from	IN	O	from	_	0	SENT_10	[p1l605t1402r671b1426],
4	intensive	JJ	O	intensive	prep_from	2	SENT_10	[p1l685t1402r817b1430],
5	,	,	O	,	_	0	SENT_10	[p1l685t1402r817b1430],
6	compared	VBN	O	compare	_	0	SENT_10	[p1l830t1402r971b1431],
7	with	IN	O	with	prepc_compared_with	2	SENT_10	[p1l983t1402r1041b1426],
8	moderate	JJ	O	moderate	amod	11	SENT_10	[p1l1055t1402r1199b1430],
9	,	,	O	,	_	0	SENT_10	[p1l1055t1402r1199b1430],
10	statin	JJ	O	statin	amod	11	SENT_10	[p1l1210t1402r1289b1426],
11	therapy	NN	O	therapy	pobj	2	SENT_10	[p1l1301t1402r1408b1431],
12	was	VBD	O	be	cop	14	SENT_10	[p1l1418t1408r1474b1426],
13	significantly	RB	O	significantly	advmod	14	SENT_10	[p1l1484t1402r1654b1431],
14	greater	JJR	O	greater	_	0	SENT_10	[p1l1664t1403r1767b1431],
15	in	IN	O	in	_	0	SENT_10	[p1l1779t1402r1801b1425],
16	the	DT	O	the	det	18	SENT_10	[p1l1813t1402r1858b1426],
17	59	CD	PERCENT	59	num	18	SENT_10	[p1l1869t1402r1932b1426],
18	%	NN	PERCENT	%	prep_in	14	SENT_10	[p1l1869t1402r1932b1426],
19	of	IN	O	of	_	0	SENT_10	[p1l1944t1402r1971b1426],
20	the	DT	O	the	det	21	SENT_10	[p1l1981t1402r2026b1426],
21	cohort	NN	O	cohort	prep_of	18	SENT_10	[p1l494t1447r583b1470],
22	who	WP	O	who	nsubj	24	SENT_10	[p1l594t1447r652b1470],
23	were	VBD	O	be	cop	24	SENT_10	[p1l663t1452r730b1470],
24	carriers	NNS	O	carrier	rcmod	21	SENT_10	[p1l742t1447r848b1470],
25	(	CD	NUMBER	(	num	26	SENT_10	[p1l859t1447r963b1475],
26	hazard	NN	O	hazard	dep	24	SENT_10	[p1l859t1447r963b1475],
27	ratio	NN	O	ratio	nn	30	SENT_10	[p1l977t1447r1040b1470],
28	[	CD	NUMBER	[	num	30	SENT_10	[p1l1052t1447r1111b1475],
29	HR	NN	DURATION	hr	nn	30	SENT_10	[p1l1052t1447r1111b1475],
30	]	NN	O	]	dep	40	SENT_10	[p1l1052t1447r1111b1475],
31	0.59	CD	NUMBER	0.59	dep	30	SENT_10	[p1l1124t1446r1197b1474],
32	,	,	O	,	_	0	SENT_10	[p1l1124t1446r1197b1474],
33	95	CD	PERCENT	95	number	34	SENT_10	[p1l1209t1446r1272b1470],
34	%	NN	PERCENT	%	amod	36	SENT_10	[p1l1209t1446r1272b1470],
35	confidence	NN	O	confidence	nn	36	SENT_10	[p1l1284t1446r1437b1470],
36	interval	NN	O	interval	appos	31	SENT_10	[p1l1450t1447r1552b1470],
37	[	CD	NUMBER	[	num	38	SENT_10	[p1l1566t1446r1610b1475],
38	CI	NN	O	ci	dep	40	SENT_10	[p1l1566t1446r1610b1475],
39	]	CD	NUMBER	]	num	40	SENT_10	[p1l1566t1446r1610b1475],
40	0.45	CD	NUMBER	0.45	dep	24	SENT_10	[p1l1623t1446r1688b1470],
41	to	TO	O	to	_	0	SENT_10	[p1l1699t1448r1726b1470],
42	0.77	CD	NUMBER	0.77	num	43	SENT_10	[p1l1738t1446r1813b1475],
43	)	CD	NUMBER	)	prep_to	40	SENT_10	[p1l1738t1446r1813b1475],
44	than	IN	O	than	advmod	14	SENT_10	[p1l1824t1447r1887b1470],
45	in	IN	O	in	_	0	SENT_10	[p1l1900t1447r1922b1470],
46	those	DT	O	those	prep_in	44	SENT_10	[p1l1934t1447r2012b1470],
47	who	WP	O	who	nsubj	49	SENT_10	[p1l2023t1447r2081b1470],
48	were	VBD	O	be	cop	49	SENT_10	[p1l494t1496r562b1513],
49	noncarriers	NNS	O	noncarrier	rcmod	46	SENT_10	[p1l574t1490r733b1513],
50	(	CD	NUMBER	(	num	51	SENT_10	[p1l744t1490r795b1519],
51	HR	NN	DURATION	hr	dep	49	SENT_10	[p1l744t1490r795b1519],
52	0.94	CD	NUMBER	0.94	nsubj	14	SENT_10	[p1l807t1490r879b1518],
53	,	,	O	,	_	0	SENT_10	[p1l807t1490r879b1518],
54	95	CD	PERCENT	95	number	55	SENT_10	[p1l891t1490r954b1513],
55	%	NN	PERCENT	%	amod	56	SENT_10	[p1l891t1490r954b1513],
56	Cl	NN	O	cl	appos	52	SENT_10	[p1l966t1490r991b1513],
57	0.70	CD	NUMBER	0.70	num	59	SENT_10	[p1l1004t1490r1069b1513],
58	to	TO	O	to	dep	59	SENT_10	[p1l1080t1492r1107b1513],
59	1.27	CD	NUMBER	1.27	dep	56	SENT_10	[p1l1119t1490r1191b1518],
60	;	:	O	;	_	0	SENT_10	[p1l1119t1490r1191b1518],
61	p	NN	O	p	dep	56	SENT_10	[p1l1204t1496r1219b1519],
62	=	JJ	O	=	amod	61	SENT_10	[p1l1234t1498r1254b1506],
63	0.018	CD	NUMBER	0.018	tmod	62	SENT_10	[p1l1268t1490r1353b1513],
64	for	IN	O	for	_	0	SENT_10	[p1l1364t1490r1403b1513],
65	interaction	NN	O	interaction	prep_for	62	SENT_10	[p1l1414t1490r1564b1513],
66	between	IN	O	between	_	0	SENT_10	[p1l1578t1490r1696b1513],
67	719Arg	NNP	O	719Arg	nn	69	SENT_10	[p1l1709t1490r1815b1519],
68	carrier	NN	O	carrier	nn	69	SENT_10	[p1l1825t1490r1917b1513],
69	status	NN	O	status	prep_between	65	SENT_10	[p1l1927t1492r2014b1513],
70	and	CC	O	and	_	0	SENT_10	[p1l2025t1490r2076b1513],
71	treatment	NN	O	treatment	nn	72	SENT_10	[p1l494t1534r653b1563],
72	)	NN	O	)	conj_and	69	SENT_10	[p1l494t1534r653b1563],
73	.	.	O	.	_	0	SENT_10	[p1l494t1534r653b1563],

1	Absolute	JJ	O	absolute	amod	3	SENT_11	[p1l665t1534r789b1558],
2	risk	NN	O	risk	nn	3	SENT_11	[p1l801t1534r851b1558],
3	reduction	NN	O	reduction	nsubj	6	SENT_11	[p1l863t1534r994b1558],
4	was	VBD	O	be	cop	6	SENT_11	[p1l1006t1540r1061b1558],
5	10.0	CD	PERCENT	10.0	num	6	SENT_11	[p1l1073t1534r1163b1558],
6	%	NN	PERCENT	%	_	0	SENT_11	[p1l1073t1534r1163b1558],
7	in	IN	O	in	_	0	SENT_11	[p1l1176t1534r1198b1557],
8	carriers	NNS	O	carrier	prep_in	6	SENT_11	[p1l1211t1534r1316b1558],
9	versus	CC	O	versus	prep	8	SENT_11	[p1l1327t1540r1418b1558],
10	0.8	CD	PERCENT	0.8	num	11	SENT_11	[p1l1429t1534r1500b1558],
11	%	NN	PERCENT	%	dep	9	SENT_11	[p1l1429t1534r1500b1558],
12	in	IN	O	in	_	0	SENT_11	[p1l1513t1534r1535b1557],
13	noncarriers	NNS	O	noncarrier	prep_in	11	SENT_11	[p1l1549t1534r1714b1558],
14	.	.	O	.	_	0	SENT_11	[p1l1549t1534r1714b1558],

1	The	DT	O	the	det	2	SENT_12	[p1l1725t1534r1776b1558],
2	benefit	NN	O	benefit	nsubj	9	SENT_12	[p1l1789t1534r1886b1558],
3	of	IN	O	of	_	0	SENT_12	[p1l1897t1534r1924b1558],
4	intensive	JJ	O	intensive	amod	5	SENT_12	[p1l1936t1534r2061b1558],
5	therapy	NN	O	therapy	prep_of	2	SENT_12	[p1l494t1578r601b1607],
6	in	IN	O	in	_	0	SENT_12	[p1l613t1578r635b1601],
7	carriers	NNS	O	carrier	prep_in	5	SENT_12	[p1l648t1578r754b1601],
8	was	VBD	O	be	cop	9	SENT_12	[p1l764t1584r820b1601],
9	significant	JJ	O	significant	_	0	SENT_12	[p1l830t1578r976b1607],
10	as	IN	O	as	_	0	SENT_12	[p1l988t1584r1019b1601],
11	early	JJ	O	early	prep_as	9	SENT_12	[p1l1031t1578r1099b1607],
12	as	IN	O	as	_	0	SENT_12	[p1l1110t1584r1141b1601],
13	day	NN	DURATION	day	prep_as	9	SENT_12	[p1l1152t1578r1202b1607],
14	30	CD	NUMBER	30	num	13	SENT_12	[p1l1213t1578r1250b1601],
15	of	IN	O	of	_	0	SENT_12	[p1l1262t1578r1288b1601],
16	therapy	NN	O	therapy	prep_of	13	SENT_12	[p1l1299t1578r1413b1607],
17	.	.	O	.	_	0	SENT_12	[p1l1299t1578r1413b1607],

1	Carriers	NNS	O	carrier	nsubj	6	SENT_13	[p1l1425t1578r1535b1601],
2	and	CC	O	and	_	0	SENT_13	[p1l1546t1578r1597b1601],
3	noncarriers	NNS	O	noncarrier	conj_and	1	SENT_13	[p1l1611t1578r1769b1601],
4	did	VBD	O	do	aux	6	SENT_13	[p1l1781t1578r1822b1601],
5	not	RB	O	not	neg	6	SENT_13	[p1l1835t1579r1879b1601],
6	differ	VB	O	differ	_	0	SENT_13	[p1l1890t1578r1965b1601],
7	in	IN	O	in	_	0	SENT_13	[p1l1977t1578r1999b1601],
8	ontreatment	JJ	O	ontreatment	amod	11	SENT_13	[p1l2012t1584r2055b1601, p1l494t1623r636b1644],
9	low-density	JJ	O	low-density	amod	11	SENT_13	[p1l648t1621r805b1650],
10	lipoprotein	NN	O	lipoprotein	nn	11	SENT_13	[p1l817t1621r966b1650],
11	cholesterol	NN	O	cholesterol	prep_in	6	SENT_13	[p1l979t1621r1141b1649],
12	,	,	O	,	_	0	SENT_13	[p1l979t1621r1141b1649],
13	triglyceride	NN	O	triglyceride	prep_in	6	SENT_13	[p1l1153t1621r1317b1650],
14	,	,	O	,	_	0	SENT_13	[p1l1153t1621r1317b1650],
15	or	CC	O	or	_	0	SENT_13	[p1l1329t1627r1357b1644],
16	C-reactive	JJ	MISC	c-reactive	amod	17	SENT_13	[p1l1368t1621r1507b1644],
17	protein	NN	O	protein	prep_in	6	SENT_13	[p1l1519t1621r1616b1650],
18	(	CD	NUMBER	(	num	21	SENT_13	[p1l1629t1621r1708b1650],
19	CRP	NN	O	crp	nn	21	SENT_13	[p1l1629t1621r1708b1650],
20	)	NN	O	)	nn	21	SENT_13	[p1l1629t1621r1708b1650],
21	levels	NNS	O	level	dep	17	SENT_13	[p1l1721t1621r1806b1644],
22	.	.	O	.	_	0	SENT_13	[p1l1721t1621r1806b1644],

1	Conclusions	NNS	O	conclusion	nn	2	SENT_14	[p1l194t1661r395b1688],
2	Carriers	NNS	O	carrier	nsubj	5	SENT_14	[p1l494t1664r604b1688],
3	of	IN	O	of	_	0	SENT_14	[p1l615t1664r642b1688],
4	719Arg	NN	O	719arg	prep_of	2	SENT_14	[p1l653t1664r759b1693],
5	receive	VBP	O	receive	_	0	SENT_14	[p1l771t1665r870b1688],
6	significantly	RB	O	significantly	advmod	7	SENT_14	[p1l881t1664r1050b1693],
7	greater	JJR	O	greater	amod	8	SENT_14	[p1l1061t1666r1163b1693],
8	benefit	NN	O	benefit	dobj	5	SENT_14	[p1l1175t1664r1272b1688],
9	from	IN	O	from	_	0	SENT_14	[p1l1282t1664r1348b1688],
10	intensive	JJ	O	intensive	amod	12	SENT_14	[p1l1362t1665r1487b1688],
11	statin	NN	O	statin	nn	12	SENT_14	[p1l1498t1665r1577b1688],
12	therapy	NN	O	therapy	prep_from	5	SENT_14	[p1l1589t1665r1696b1693],
13	than	IN	O	than	_	0	SENT_14	[p1l1706t1665r1769b1688],
14	do	VB	O	do	dep	19	SENT_14	[p1l1781t1665r1815b1688],
15	noncarriers	NNS	O	noncarrier	dobj	14	SENT_14	[p1l1827t1665r1993b1692],
16	,	,	O	,	_	0	SENT_14	[p1l1827t1665r1993b1692],
17	a	DT	O	a	det	19	SENT_14	[p1l2006t1670r2021b1688],
18	superior	JJ	O	superior	amod	19	SENT_14	[p1l2032t1670r2109b1693, p1l495t1708r541b1731],
19	benefit	NN	O	benefit	prep_than	12	SENT_14	[p1l553t1708r650b1731],
20	that	WDT	O	that	nsubj	21	SENT_14	[p1l660t1708r717b1731],
21	appears	VBZ	O	appear	rcmod	19	SENT_14	[p1l728t1713r842b1737],
22	to	TO	O	to	aux	24	SENT_14	[p1l853t1709r880b1731],
23	be	VB	O	be	cop	24	SENT_14	[p1l893t1708r925b1731],
24	due	JJ	O	due	xcomp	21	SENT_14	[p1l937t1708r988b1731],
25	to	TO	O	to	_	0	SENT_14	[p1l999t1709r1026b1731],
26	a	DT	O	a	det	27	SENT_14	[p1l1038t1714r1053b1731],
27	mechanism	NN	O	mechanism	prep_to	24	SENT_14	[p1l1066t1708r1231b1731],
28	distinct	JJ	O	distinct	amod	27	SENT_14	[p1l1243t1708r1346b1731],
29	from	IN	O	from	_	0	SENT_14	[p1l1357t1708r1423b1731],
30	lipid	NN	O	lipid	nn	33	SENT_14	[p1l1437t1708r1493b1737],
31	or	CC	O	or	_	0	SENT_14	[p1l1506t1713r1533b1731],
32	CRP	NN	O	crp	conj_or	30	SENT_14	[p1l1544t1708r1603b1731],
33	lowering	NN	O	lowering	prep_from	28	SENT_14	[p1l1615t1708r1741b1737],
34	.	.	O	.	_	0	SENT_14	[p1l1615t1708r1741b1737],

1	Functional	JJ	O	functional	amod	2	SENT_15	[p1l1754t1708r1899b1731],
2	studies	NNS	O	study	nsubjpass	8	SENT_15	[p1l1911t1708r2013b1731],
3	of	IN	O	of	_	0	SENT_15	[p1l2024t1708r2051b1731],
4	the	DT	O	the	det	6	SENT_15	[p1l2062t1708r2106b1731],
5	KIF6	NN	O	kif6	nn	6	SENT_15	[p1l494t1751r559b1775],
6	kinesin	NN	O	kinesin	prep_of	2	SENT_15	[p1l571t1751r669b1774],
7	are	VBP	O	be	auxpass	8	SENT_15	[p1l682t1757r727b1774],
8	warranted	VBN	O	warrant	_	0	SENT_15	[p1l738t1751r889b1779],
9	,	,	O	,	_	0	SENT_15	[p1l738t1751r889b1779],
10	given	VBN	O	give	prep	8	SENT_15	[p1l901t1751r974b1780],
11	the	DT	O	the	det	13	SENT_15	[p1l986t1751r1031b1774],
12	consistent	JJ	O	consistent	amod	13	SENT_15	[p1l1043t1751r1188b1774],
13	association	NN	O	association	npadvmod	18	SENT_15	[p1l1199t1751r1359b1774],
14	of	IN	O	of	_	0	SENT_15	[p1l1371t1751r1398b1774],
15	Trp719Arg	NN	O	trp719arg	prep_of	13	SENT_15	[p1l1408t1751r1560b1780],
16	with	IN	O	with	_	0	SENT_15	[p1l1570t1751r1628b1774],
17	risk	NN	O	risk	prep_with	15	SENT_15	[p1l1642t1751r1692b1774],
18	of	IN	O	of	pcomp	10	SENT_15	[p1l1702t1751r1729b1774],
19	coronary	JJ	O	coronary	amod	20	SENT_15	[p1l1740t1757r1863b1780],
20	events	NNS	O	event	pobj	18	SENT_15	[p1l1874t1753r1966b1774],
21	and	CC	O	and	_	0	SENT_15	[p1l1977t1751r2028b1774],
22	statin	NN	O	statin	nn	23	SENT_15	[p1l2040t1753r2092b1774, p1l494t1795r528b1819],
23	benefit	NN	O	benefit	pobj	18	SENT_15	[p1l542t1795r646b1819],
24	.	.	O	.	_	0	SENT_15	[p1l542t1795r646b1819],

1	(	NN	O	(	nn	2	SENT_16	[p1l688t1795r708b1824],
2	J	NN	O	j	nsubj	5	SENT_16	[p1l688t1795r708b1824],
3	Am	VBP	O	be	cop	5	SENT_16	[p1l720t1795r767b1818],
4	Coll	NNP	O	Coll	nn	5	SENT_16	[p1l779t1795r830b1819],
5	Cardiol	NNP	O	Cardiol	_	0	SENT_16	[p1l842t1795r940b1819],
6	2008	CD	DATE	2008	dep	5	SENT_16	[p1l952t1795r1209b1824],
7	;	:	O	;	_	0	SENT_16	[p1l952t1795r1209b1824],
8	51:449	CD	NUMBER	51:449	number	9	SENT_16	[p1l952t1795r1209b1824],
9	—	CD	NUMBER	—	dep	5	SENT_16	[p1l952t1795r1209b1824],
10	55	CD	NUMBER	55	num	11	SENT_16	[p1l952t1795r1209b1824],
11	)	NN	O	)	dep	9	SENT_16	[p1l952t1795r1209b1824],
12	©	CD	NUMBER	©	num	13	SENT_16	[p1l1220t1795r1244b1819],
13	2008	CD	DATE	2008	dep	5	SENT_16	[p1l1255t1795r1331b1819],
14	by	IN	O	by	dep	13	SENT_16	[p1l1344t1795r1374b1824],
15	the	DT	O	the	det	17	SENT_16	[p1l1384t1795r1429b1819],
16	American	NNP	ORGANIZATION	American	nn	17	SENT_16	[p1l1440t1795r1575b1819],
17	College	NNP	ORGANIZATION	College	pobj	14	SENT_16	[p1l1588t1795r1691b1824],
18	of	IN	ORGANIZATION	of	dep	13	SENT_16	[p1l1703t1795r1730b1819],
19	Cardiology	NNP	ORGANIZATION	Cardiology	nn	20	SENT_16	[p1l1741t1795r1890b1824],
20	Foundation	NNP	ORGANIZATION	Foundation	pobj	18	SENT_16	[p1l1902t1795r2059b1819],

1	Differential	JJ	O	differential	amod	2	SENT_17	[p1l13t2094r401b2156],
2	risk	NN	O	risk	nsubjpass	20	SENT_17	[p1l454t2094r579b2156],
3	of	IN	O	of	_	0	SENT_17	[p1l631t2094r707b2156],
4	disease	NN	O	disease	nn	7	SENT_17	[p1l751t2094r982b2156],
5	and	CC	O	and	_	0	SENT_17	[p1l1040t2094r1161b2156],
6	differential	JJ	O	differential	nn	7	SENT_17	[p1l1216t2094r1579b2156],
7	response	NN	O	response	prep_of	2	SENT_17	[p1l1632t2118r1920b2178],
8	to	TO	O	to	_	0	SENT_17	[p1l1977t2110r2041b2156],
9	treatment	NN	O	treatment	prep_to	7	SENT_17	[p1l12t2211r342b2257],
10	due	JJ	O	due	_	0	SENT_17	[p1l366t2195r484b2257],
11	to	TO	O	to	_	0	SENT_17	[p1l509t2211r574b2257],
12	the	DT	O	the	det	14	SENT_17	[p1l600t2195r705b2257],
13	genetic	JJ	O	genetic	amod	14	SENT_17	[p1l729t2198r970b2279],
14	diversity	NN	O	diversity	prep_due_to	9	SENT_17	[p1l995t2195r1280b2279],
15	of	IN	O	of	_	0	SENT_17	[p1l1301t2195r1377b2257],
16	patient	NN	O	patient	nn	17	SENT_17	[p1l1389t2198r1626b2280],
17	populations	NNS	O	population	prep_of	14	SENT_17	[p1l1648t2195r2041b2280],
18	has	VBZ	O	have	aux	20	SENT_17	[p1l12t2297r119b2359],
19	been	VBN	O	be	auxpass	20	SENT_17	[p1l151t2297r310b2359],
20	reported	VBN	O	report	_	0	SENT_17	[p1l341t2296r625b2381],
21	for	IN	O	for	mark	28	SENT_17	[p1l656t2296r752b2359],
22	a	DT	O	a	det	23	SENT_17	[p1l784t2321r816b2359],
23	number	NN	O	number	nsubj	28	SENT_17	[p1l848t2297r1109b2359],
24	of	IN	O	of	_	0	SENT_17	[p1l1140t2296r1216b2359],
25	diseases	NNS	O	disease	prep_of	23	SENT_17	[p1l1237t2296r1497b2359],
26	and	CC	O	and	_	0	SENT_17	[p1l1532t2296r1653b2359],
27	treatments	NNS	O	treatment	prep_of	23	SENT_17	[p1l1684t2313r2041b2359],
28	(	VBP	O	(	advcl	20	SENT_17	[p1l15t2395r209b2473],
29	1-3	CD	NUMBER	1-3	num	30	SENT_17	[p1l15t2395r209b2473],
30	)	CD	NUMBER	)	dobj	28	SENT_17	[p1l15t2395r209b2473],
31	.	.	O	.	_	0	SENT_17	[p1l15t2395r209b2473],

1	If	IN	O	if	_	0	SENT_18	[p1l253t2397r320b2459],
2	the	DT	O	the	det	4	SENT_18	[p1l348t2397r453b2459],
3	genetic	JJ	O	genetic	amod	4	SENT_18	[p1l493t2400r734b2481],
4	Variants	NNS	O	variant	dep	1	SENT_18	[p1l770t2400r1031b2459],
5	responsible	JJ	O	responsible	amod	4	SENT_18	[p1l1073t2397r1448b2481],
6	for	IN	O	for	_	0	SENT_18	[p1l1489t2397r1585b2459],
7	these	DT	O	these	det	8	SENT_18	[p1l1623t2397r1794b2459],
8	differSee	NN	O	differsee	prep_for	4	SENT_18	[p1l1836t2397r2040b2459, p1l835t2604r933b2655],

1	page	NN	O	page	_	0	SENT_19	[p1l959t2617r1086b2664],
2	456	CD	NUMBER	456	num	1	SENT_19	[p1l1110t2605r1218b2655],

1	ences	NNS	O	ence	nsubjpass	3	SENT_20	[p1l13t2829r190b2867],
2	were	VBD	O	be	auxpass	3	SENT_20	[p1l224t2828r382b2867],
3	known	VBN	O	know	_	0	SENT_20	[p1l419t2804r667b2881],
4	,	,	O	,	_	0	SENT_20	[p1l419t2804r667b2881],
5	such	JJ	O	such	amod	6	SENT_20	[p1l707t2805r856b2867],
6	variants	NNS	O	variant	nsubj	8	SENT_20	[p1l888t2807r1150b2867],
7	could	MD	O	could	aux	8	SENT_20	[p1l1188t2804r1370b2867],
8	facilitate	VB	O	facilitate	dep	3	SENT_20	[p1l1405t2804r1692b2867],
9	personalized	JJ	O	personalized	amod	10	SENT_20	[p1l1727t2804r2040b2889, p1l12t2905r149b2967],
10	medicine	NN	O	medicine	dobj	8	SENT_20	[p1l171t2905r476b2967],
11	by	IN	O	by	_	0	SENT_20	[p1l497t2905r579b2989],
12	identifying	VBG	O	identify	prepc_by	8	SENT_20	[p1l597t2905r965b2989],
13	those	DT	O	those	dobj	12	SENT_20	[p1l986t2905r1162b2967],
14	at	IN	O	at	_	0	SENT_20	[p1l1187t2921r1247b2967],
15	elevated	JJ	O	elevated	amod	16	SENT_20	[p1l1268t2905r1538b2967],
16	risk	NN	O	risk	prep_at	12	SENT_20	[p1l1559t2905r1684b2967],
17	of	IN	O	of	_	0	SENT_20	[p1l1703t2905r1779b2967],
18	disease	NN	O	disease	prep_of	16	SENT_20	[p1l1790t2905r2040b2981],
19	,	,	O	,	_	0	SENT_20	[p1l1790t2905r2040b2981],

1	From	IN	O	from	dep	11	SENT_21	[p1l12t3230r142b3274],
2	*	CD	NUMBER	*	num	5	SENT_21	[p1l165t3230r352b3284],
3	Celera	NNP	ORGANIZATION	Celera	nn	5	SENT_21	[p1l165t3230r352b3284],
4	,	,	O	,	_	0	SENT_21	[p1l165t3230r352b3284],
5	Alameda	NNP	LOCATION	Alameda	pobj	1	SENT_21	[p1l375t3229r602b3284],
6	,	,	O	,	_	0	SENT_21	[p1l375t3229r602b3284],
7	California	NNP	LOCATION	California	appos	5	SENT_21	[p1l628t3230r879b3284],
8	;	:	O	;	_	0	SENT_21	[p1l628t3230r879b3284],
9	TTIMI	NNP	ORGANIZATION	TTIMI	nn	11	SENT_21	[p1l904t3229r1074b3281],
10	Study	NNP	ORGANIZATION	Study	nn	11	SENT_21	[p1l1101t3230r1237b3289],
11	Group	NNP	ORGANIZATION	Group	_	0	SENT_21	[p1l1259t3230r1427b3289],
12	,	,	O	,	_	0	SENT_21	[p1l1259t3230r1427b3289],
13	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	14	SENT_21	[p1l1454t3230r1805b3274],
14	Division	NNP	ORGANIZATION	Division	appos	11	SENT_21	[p1l1827t3231r2041b3284],
15	,	,	O	,	_	0	SENT_21	[p1l1827t3231r2041b3284],
16	Brigham	NNP	ORGANIZATION	Brigham	poss	20	SENT_21	[p1l12t3303r218b3362],
17	&	CC	ORGANIZATION	&	_	0	SENT_21	[p1l235t3303r522b3347],
18	Women	NNP	ORGANIZATION	Women	conj_and	16	SENT_21	[p1l235t3303r522b3347],
19	’s	POS	ORGANIZATION	’s	_	0	SENT_21	[p1l235t3303r522b3347],
20	Hospital	NNP	ORGANIZATION	Hospital	appos	11	SENT_21	[p1l540t3303r757b3362],
21	,	,	O	,	_	0	SENT_21	[p1l540t3303r757b3362],
22	Harvard	NNP	ORGANIZATION	Harvard	nn	24	SENT_21	[p1l775t3303r972b3347],
23	Medical	NNP	ORGANIZATION	Medical	nn	24	SENT_21	[p1l986t3303r1181b3347],
24	School	NNP	ORGANIZATION	School	appos	20	SENT_21	[p1l1198t3303r1370b3357],
25	,	,	O	,	_	0	SENT_21	[p1l1198t3303r1370b3357],
26	Boston	NNP	LOCATION	Boston	nn	28	SENT_21	[p1l1387t3304r1568b3357],
27	,	,	O	,	_	0	SENT_21	[p1l1387t3304r1568b3357],
28	Massachusetts	NNP	LOCATION	Massachusetts	appos	20	SENT_21	[p1l1585t3303r1940b3357],
29	;	:	O	;	_	0	SENT_21	[p1l1585t3303r1940b3357],
30	and	CC	O	and	_	0	SENT_21	[p1l1959t3303r2043b3347],
31	the	DT	O	the	det	32	SENT_21	[p1l12t3376r85b3420],
32	Il	NN	O	il	conj_and	20	SENT_21	[p1l124t3376r518b3427],
33	:	:	O	:	_	0	SENT_21	[p1l124t3376r518b3427],
34	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	36	SENT_21	[p1l124t3376r518b3427],
35	Research	NNP	ORGANIZATION	Research	nn	36	SENT_21	[p1l557t3376r768b3420],
36	Institute	NNP	ORGANIZATION	Institute	dep	20	SENT_21	[p1l805t3377r1019b3430],
37	,	,	O	,	_	0	SENT_21	[p1l805t3377r1019b3430],
38	Bristol	NNP	LOCATION	Bristol	appos	36	SENT_21	[p1l1059t3376r1390b3435],
39	.	.	O	.	_	0	SENT_21	[p1l1059t3376r1390b3435],

1	—	NN	O	—	_	0	SENT_22	[p1l1059t3376r1390b3435],
2	.	.	O	.	_	0	SENT_22	[p1l1059t3376r1390b3435],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_23	[p1l1059t3376r1390b3435],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_23	[p1l1431t3376r1608b3435],
3	,	,	O	,	_	0	SENT_23	[p1l1431t3376r1608b3435],
4	Princeton	NNP	ORGANIZATION	Princeton	appos	2	SENT_23	[p1l1649t3376r1892b3430],
5	,	,	O	,	_	0	SENT_23	[p1l1649t3376r1892b3430],
6	New	NNP	LOCATION	New	nn	7	SENT_23	[p1l1932t3376r2045b3420],
7	Jersey	NNP	LOCATION	Jersey	appos	4	SENT_23	[p1l6t3450r159b3508],
8	.	.	O	.	_	0	SENT_23	[p1l6t3450r159b3508],

1	Supported	VBN	O	support	_	0	SENT_24	[p1l198t3449r442b3508],
2	by	IN	O	by	_	0	SENT_24	[p1l474t3449r532b3508],
3	research	NN	O	research	nn	4	SENT_24	[p1l563t3449r755b3493],
4	grants	NNS	O	grant	prep_by	1	SENT_24	[p1l788t3460r931b3508],
5	from	IN	O	from	_	0	SENT_24	[p1l966t3449r1079b3493],
6	Bristol	NNP	LOCATION	Bristol	prep_from	1	SENT_24	[p1l1114t3449r1445b3508],
7	.	.	O	.	_	0	SENT_24	[p1l1114t3449r1445b3508],

1	—	NN	O	—	_	0	SENT_25	[p1l1114t3449r1445b3508],
2	.	.	O	.	_	0	SENT_25	[p1l1114t3449r1445b3508],

1	Myers	NNP	ORGANIZATION	Myers	nn	5	SENT_26	[p1l1114t3449r1445b3508],
2	Squibb	NNP	ORGANIZATION	Squibb	nn	5	SENT_26	[p1l1482t3449r1645b3508],
3	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	5	SENT_26	[p1l1680t3449r2044b3493],
4	Research	NNP	ORGANIZATION	Research	nn	5	SENT_26	[p1l13t3522r225b3566],
5	Institute	NNP	ORGANIZATION	Institute	_	0	SENT_26	[p1l257t3523r457b3566],
6	(	NN	O	(	dep	5	SENT_26	[p1l492t3521r555b3575],
7	to	TO	O	to	_	0	SENT_26	[p1l492t3521r555b3575],
8	Drs.	NNP	O	Drs.	nn	9	SENT_26	[p1l589t3523r688b3566],
9	Braunwald	NNP	PERSON	Braunwald	prep_to	6	SENT_26	[p1l724t3522r980b3566],
10	and	CC	O	and	_	0	SENT_26	[p1l1013t3522r1098b3566],
11	Cannon	NNP	O	Cannon	nn	12	SENT_26	[p1l1132t3521r1354b3575],
12	)	NNP	O	)	prep_to	6	SENT_26	[p1l1132t3521r1354b3575],
13	.	.	O	.	_	0	SENT_26	[p1l1132t3521r1354b3575],

1	Genotyping	NN	O	genotyping	nsubjpass	6	SENT_27	[p1l1391t3522r1674b3581],
2	and	CC	O	and	_	0	SENT_27	[p1l1707t3522r1792b3566],
3	statistical	JJ	O	statistical	amod	4	SENT_27	[p1l1825t3522r2044b3566],
4	analysis	NN	O	analysis	conj_and	1	SENT_27	[p1l13t3595r190b3654],
5	was	VBD	O	be	auxpass	6	SENT_27	[p1l210t3612r297b3639],
6	funded	VBN	O	fund	_	0	SENT_27	[p1l319t3595r485b3639],
7	by	IN	O	by	_	0	SENT_27	[p1l505t3595r562b3654],
8	Celera	NNP	ORGANIZATION	Celera	agent	6	SENT_27	[p1l583t3595r747b3639],
9	.	.	O	.	_	0	SENT_27	[p1l583t3595r747b3639],

1	Manuscript	NN	O	manuscript	nsubj	2	SENT_28	[p1l70t3669r346b3727],
2	received	VBD	O	receive	_	0	SENT_28	[p1l366t3668r557b3712],
3	August	NNP	DATE	August	tmod	2	SENT_28	[p1l576t3667r750b3727],
4	13	CD	DATE	13	num	3	SENT_28	[p1l773t3670r840b3722],
5	,	,	DATE	,	_	0	SENT_28	[p1l773t3670r840b3722],
6	2007	CD	DATE	2007	num	3	SENT_28	[p1l862t3669r993b3722],
7	;	:	O	;	_	0	SENT_28	[p1l862t3669r993b3722],
8	revised	VBN	O	revise	amod	9	SENT_28	[p1l1016t3668r1179b3712],
9	manuscript	NN	O	manuscript	dobj	2	SENT_28	[p1l1200t3670r1464b3727],
10	received	VBD	O	receive	rcmod	9	SENT_28	[p1l1484t3668r1675b3712],
11	September	NNP	DATE	September	tmod	10	SENT_28	[p1l1699t3668r1951b3727],
12	28	CD	DATE	28	num	11	SENT_28	[p1l1970t3670r2041b3722],
13	,	,	O	,	_	0	SENT_28	[p1l1970t3670r2041b3722],

1	2007	CD	DATE	2007	_	0	SENT_29	[p1l11t3742r141b3795],
2	,	,	O	,	_	0	SENT_29	[p1l11t3742r141b3795],
3	accepted	VBN	O	accept	partmod	1	SENT_29	[p1l166t3741r368b3800],
4	October	NNP	DATE	October	tmod	3	SENT_29	[p1l391t3741r586b3785],
5	22	CD	DATE	22	num	4	SENT_29	[p1l605t3743r677b3795],
6	,	,	DATE	,	_	0	SENT_29	[p1l605t3743r677b3795],
7	2007	CD	DATE	2007	num	4	SENT_29	[p1l699t3742r829b3786],
8	.	.	O	.	_	0	SENT_29	[p1l699t3742r829b3786],

1	those	DT	O	those	_	0	SENT_30	[p2l53t306r235b370],
2	likely	JJ	O	likely	amod	4	SENT_30	[p2l259t306r446b393],
3	to	TO	O	to	dep	4	SENT_30	[p2l466t322r533b370],
4	beneﬁt	JJ	O	beneﬁt	amod	1	SENT_30	[p2l556t306r796b370],
5	from	IN	O	from	_	0	SENT_30	[p2l818t306r984b370],
6	a	DT	O	a	det	8	SENT_30	[p2l1010t331r1044b370],
7	particular	JJ	O	particular	amod	8	SENT_30	[p2l1065t306r1396b393],
8	therapy	NN	O	therapy	prep_from	4	SENT_30	[p2l1418t306r1695b393],
9	,	,	O	,	_	0	SENT_30	[p2l1418t306r1695b393],
10	or	CC	O	or	_	0	SENT_30	[p2l1723t331r1793b370],
11	those	DT	O	those	dep	12	SENT_30	[p2l1815t306r1997b370],
12	less	RBR	O	less	amod	1	SENT_30	[p2l2021t306r2138b370],
13	likely	JJ	O	likely	dep	1	SENT_30	[p2l52t413r240b500],
14	to	TO	O	to	aux	15	SENT_30	[p2l268t430r335b478],
15	beneﬁt	VB	O	beneﬁt	xcomp	13	SENT_30	[p2l366t413r607b478],
16	(	CD	NUMBER	(	number	17	SENT_30	[p2l640t411r818b492],
17	4,5	CD	NUMBER	4,5	num	18	SENT_30	[p2l640t411r818b492],
18	)	NN	O	)	dobj	15	SENT_30	[p2l640t411r818b492],
19	.	.	O	.	_	0	SENT_30	[p2l640t411r818b492],

1	To	TO	O	to	_	0	SENT_31	[p2l137t519r240b586],
2	that	DT	O	that	det	3	SENT_31	[p2l301t521r440b586],
3	end	NN	O	end	prep_to	8	SENT_31	[p2l498t521r642b600],
4	,	,	O	,	_	0	SENT_31	[p2l498t521r642b600],
5	we	PRP	O	we	nsubj	8	SENT_31	[p2l701t547r797b586],
6	have	VBP	O	have	aux	8	SENT_31	[p2l858t521r1013b586],
7	previously	RB	DATE	previously	advmod	8	SENT_31	[p2l1072t521r1426b609],
8	reported	VBN	O	report	_	0	SENT_31	[p2l1482t521r1775b609],
9	that	IN	O	that	complm	26	SENT_31	[p2l1834t521r1972b586],
10	the	DT	O	the	det	12	SENT_31	[p2l2030t521r2138b586],
11	Trp719Arg	NN	O	trp719arg	nn	12	SENT_31	[p2l51t628r441b717],
12	polymorphism	NN	O	polymorphism	nsubjpass	26	SENT_31	[p2l468t630r954b717],
13	in	IN	O	in	_	0	SENT_31	[p2l984t633r1049b693],
14	kinesin	NN	O	kinesin	prep_in	12	SENT_31	[p2l1079t630r1467b694],
15	—	CD	NUMBER	—	num	14	SENT_31	[p2l1079t630r1467b694],
16	like	IN	O	like	_	0	SENT_31	[p2l1079t630r1467b694],
17	protein	NN	O	protein	nn	19	SENT_31	[p2l1497t633r1736b717],
18	6	CD	NUMBER	6	num	19	SENT_31	[p2l1768t633r1804b694],
19	(	NN	O	(	prep_like	14	SENT_31	[p2l1839t628r2141b708],
20	encoded	VBN	O	encode	partmod	19	SENT_31	[p2l1839t628r2141b708],
21	by	IN	O	by	_	0	SENT_31	[p2l51t738r134b825],
22	KIF	NN	ORGANIZATION	kif	nn	24	SENT_31	[p2l153t741r303b801],
23	6	CD	NUMBER	6	num	24	SENT_31	[p2l298t735r358b816],
24	)	NN	O	)	agent	20	SENT_31	[p2l298t735r358b816],
25	is	VBZ	O	be	auxpass	26	SENT_31	[p2l386t740r434b802],
26	associated	VBN	O	associate	ccomp	8	SENT_31	[p2l461t737r791b802],
27	with	IN	O	with	_	0	SENT_31	[p2l811t737r964b802],
28	a	DT	O	a	det	30	SENT_31	[p2l990t763r1024b802],
29	greater	JJR	O	greater	amod	30	SENT_31	[p2l1046t754r1276b825],
30	risk	NN	O	risk	prep_with	26	SENT_31	[p2l1299t738r1422b802],
31	of	IN	O	of	_	0	SENT_31	[p2l1444t737r1520b802],
32	coronary	JJ	O	coronary	amod	33	SENT_31	[p2l1534t762r1825b825],
33	events	NNS	O	event	prep_of	30	SENT_31	[p2l1847t754r2049b802],
34	in	IN	O	in	_	0	SENT_31	[p2l2075t740r2140b801],
35	the	DT	O	the	det	37	SENT_31	[p2l53t845r158b910],
36	placebo	NN	O	placebo	nn	37	SENT_31	[p2l194t845r444b933],
37	arms	NNS	O	arm	prep_in	26	SENT_31	[p2l484t870r640b910],
38	of	IN	O	of	_	0	SENT_31	[p2l680t845r756b910],
39	the	DT	O	the	det	42	SENT_31	[p2l780t845r885b910],
40	CARE	NNP	O	CARE	nn	42	SENT_31	[p2l924t844r1163b910],
41	(	CD	NUMBER	(	num	42	SENT_31	[p2l1204t843r1615b924],
42	Cholesterol	NNP	O	Cholesterol	prep_of	37	SENT_31	[p2l1204t843r1615b924],
43	and	CC	O	and	_	0	SENT_31	[p2l1651t845r1773b910],
44	Recurrent	NNP	O	Recurrent	nn	46	SENT_31	[p2l1811t846r2142b910],
45	Events	NNS	O	event	nn	46	SENT_31	[p2l55t952r305b1032],
46	)	NN	O	)	prep_of	37	SENT_31	[p2l55t952r305b1032],
47	and	CC	O	and	_	0	SENT_31	[p2l346t954r467b1018],
48	WOSCOPS	NN	O	woscop	nn	50	SENT_31	[p2l498t954r933b1019],
49	(	CD	NUMBER	(	num	50	SENT_31	[p2l974t952r1179b1032],
50	VVest	NN	O	vvest	conj_and	37	SENT_31	[p2l974t952r1179b1032],
51	of	IN	O	of	_	0	SENT_31	[p2l1214t954r1290b1018],
52	Scotland	NNP	LOCATION	Scotland	nn	57	SENT_31	[p2l1317t954r1605b1018],
53	Coronary	NNP	O	Coronary	nn	57	SENT_31	[p2l1642t954r1961b1041],
54	Prevention	NNP	O	Prevention	nn	57	SENT_31	[p2l1994t955r2137b1018, p2l50t1064r302b1126],
55	Study	NNP	O	Study	nn	57	SENT_31	[p2l325t1059r538b1149],
56	)	NN	O	)	nn	57	SENT_31	[p2l325t1059r538b1149],
57	trials	NNS	O	trial	prep_of	50	SENT_31	[p2l561t1061r736b1126],
58	.	.	O	.	_	0	SENT_31	[p2l561t1061r736b1126],

1	The	DT	O	the	det	4	SENT_32	[p2l758t1060r898b1126],
2	KIF	NN	ORGANIZATION	kif	nn	4	SENT_32	[p2l918t1065r1068b1125],
3	6	CD	NUMBER	6	num	4	SENT_32	[p2l1063t1068r1099b1126],
4	kinesin	NN	O	kinesin	nsubj	7	SENT_32	[p2l1119t1062r1356b1126],
5	is	VBZ	O	be	cop	7	SENT_32	[p2l1376t1064r1423b1126],
6	a	DT	O	a	det	7	SENT_32	[p2l1447t1087r1480b1126],
7	member	NN	O	member	_	0	SENT_32	[p2l1500t1062r1777b1126],
8	of	IN	O	of	_	0	SENT_32	[p2l1796t1061r1872b1126],
9	a	DT	O	a	det	10	SENT_32	[p2l1882t1087r1915b1126],
10	family	NN	O	family	prep_of	7	SENT_32	[p2l1934t1061r2144b1149],
11	of	IN	O	of	_	0	SENT_32	[p2l54t1169r130b1234],
12	molecular	JJ	O	molecular	amod	13	SENT_32	[p2l171t1169r497b1234],
13	motors	NNS	O	motor	prep_of	10	SENT_32	[p2l548t1186r779b1234],
14	involved	VBN	O	involve	partmod	13	SENT_32	[p2l833t1169r1111b1234],
15	in	IN	O	in	_	0	SENT_32	[p2l1162t1172r1227b1233],
16	intracellular	JJ	O	intracellular	amod	17	SENT_32	[p2l1279t1169r1672b1234],
17	transport	NN	O	transport	prep_in	14	SENT_32	[p2l1722t1186r2024b1256],
18	of	IN	O	of	_	0	SENT_32	[p2l2075t1169r2152b1234],
19	protein	NN	O	protein	nn	20	SENT_32	[p2l52t1281r292b1365],
20	complexes	NNS	O	complex	prep_of	17	SENT_32	[p2l317t1278r677b1365],
21	,	,	O	,	_	0	SENT_32	[p2l317t1278r677b1365],
22	membrane	NN	O	membrane	nn	23	SENT_32	[p2l705t1278r1059b1342],
23	organelles	NNS	O	organelle	prep_of	17	SENT_32	[p2l1085t1278r1432b1365],
24	,	,	O	,	_	0	SENT_32	[p2l1085t1278r1432b1365],
25	and	CC	O	and	_	0	SENT_32	[p2l1461t1278r1582b1342],
26	messenger	NN	O	messenger	nn	28	SENT_32	[p2l1607t1303r1952b1365],
27	ribonucleic	JJ	O	ribonucleic	amod	28	SENT_32	[p2l1975t1278r2137b1342, p2l54t1385r285b1450],
28	acid	NN	O	acid	conj_and	20	SENT_32	[p2l316t1385r448b1450],
29	along	IN	O	along	_	0	SENT_32	[p2l479t1385r660b1472],
30	microtubules	NNS	O	microtubule	prep_along	14	SENT_32	[p2l690t1385r1118b1450],
31	(	CD	NUMBER	(	number	32	SENT_32	[p2l1152t1383r1322b1464],
32	6,7	CD	NUMBER	6,7	num	33	SENT_32	[p2l1152t1383r1322b1464],
33	)	NN	O	)	dep	14	SENT_32	[p2l1152t1383r1322b1464],
34	.	.	O	.	_	0	SENT_32	[p2l1152t1383r1322b1464],

1	Carriers	NNS	O	carrier	nsubj	10	SENT_33	[p2l1359t1385r1622b1450],
2	of	IN	O	of	_	0	SENT_33	[p2l1655t1385r1731b1450],
3	the	DT	O	the	det	5	SENT_33	[p2l1749t1385r1854b1450],
4	719Arg	NNP	O	719Arg	nn	5	SENT_33	[p2l1886t1384r2142b1472],
5	allele	NN	O	allele	prep_of	1	SENT_33	[p2l55t1493r219b1557],
6	of	IN	O	of	_	0	SENT_33	[p2l251t1493r328b1557],
7	the	DT	O	the	det	9	SENT_33	[p2l346t1493r450b1557],
8	KIF6	NN	O	kif6	nn	9	SENT_33	[p2l480t1496r662b1558],
9	kinesin	NN	O	kinesin	prep_of	5	SENT_33	[p2l692t1493r929b1557],
10	had	VBD	O	have	dep	14	SENT_33	[p2l960t1493r1083b1557],
11	a	DT	O	a	det	13	SENT_33	[p2l1114t1518r1148b1557],
12	50	CD	PERCENT	50	number	13	SENT_33	[p2l1177t1493r1323b1558],
13	%	NN	PERCENT	%	dobj	10	SENT_33	[p2l1177t1493r1323b1558],
14	increased	VBD	O	increase	_	0	SENT_33	[p2l1354t1493r1660b1557],
15	risk	NN	O	risk	dobj	14	SENT_33	[p2l1689t1493r1813b1557],
16	of	IN	O	of	_	0	SENT_33	[p2l1840t1493r1916b1557],
17	events	NNS	O	event	prep_of	15	SENT_33	[p2l1936t1510r2138b1558],
18	compared	VBN	O	compare	_	0	SENT_33	[p2l54t1601r382b1689],
19	with	IN	O	with	prepc_compared_with	14	SENT_33	[p2l419t1601r572b1666],
20	noncarriers	JJ	O	noncarriers	amod	21	SENT_33	[p2l615t1604r981b1666],
21	@a	NN	O	@a	pobj	14	SENT_33	[p2l1027t1599r1134b1680],
22	}	CD	NUMBER	}	number	23	SENT_33	[p2l1027t1599r1134b1680],
23	*	CD	NUMBER	*	nsubj	14	SENT_33	[p2l1027t1599r1134b1680],
24	The	DT	O	the	det	26	SENT_33	[p2l1177t1600r1318b1666],
25	719Arg	NN	O	719arg	nn	26	SENT_33	[p2l1362t1600r1617b1689],
26	allele	NN	O	allele	nsubjpass	30	SENT_33	[p2l1659t1601r1822b1666],
27	has	VBZ	O	have	aux	30	SENT_33	[p2l1865t1601r1971b1666],
28	also	RB	O	also	advmod	30	SENT_33	[p2l2016t1601r2139b1666],
29	been	VBN	O	be	auxpass	30	SENT_33	[p2l51t1709r209b1774],
30	associated	VBN	O	associate	rcmod	23	SENT_33	[p2l240t1709r569b1774],
31	with	IN	O	with	_	0	SENT_33	[p2l594t1709r747b1774],
32	risk	NN	O	risk	prep_with	30	SENT_33	[p2l775t1709r898b1774],
33	of	IN	O	of	_	0	SENT_33	[p2l924t1709r1000b1774],
34	coronary	JJ	O	coronary	amod	39	SENT_33	[p2l1018t1734r1309b1796],
35	heart	NN	O	heart	nn	39	SENT_33	[p2l1334t1709r1504b1774],
36	disease	NN	O	disease	nn	39	SENT_33	[p2l1532t1709r1759b1774],
37	(	CD	NUMBER	(	num	39	SENT_33	[p2l1792t1707r2043b1788],
38	CHD	NN	O	chd	nn	39	SENT_33	[p2l1792t1707r2043b1788],
39	)	NN	O	)	prep_of	32	SENT_33	[p2l1792t1707r2043b1788],
40	in	IN	O	in	_	0	SENT_33	[p2l2075t1712r2140b1773],
41	the	DT	O	the	det	45	SENT_33	[p2l53t1818r158b1882],
42	ARIC	NNP	O	ARIC	nn	45	SENT_33	[p2l199t1816r414b1882],
43	(	CD	NUMBER	(	num	45	SENT_33	[p2l461t1816r990b1896],
44	Atherosclerosis	NNP	O	Atherosclerosis	nn	45	SENT_33	[p2l461t1816r990b1896],
45	Risk	NN	O	risk	prep_in	39	SENT_33	[p2l1038t1818r1189b1882],
46	in	IN	O	in	_	0	SENT_33	[p2l1228t1821r1292b1881],
47	Communities	NNS	O	community	prep_in	30	SENT_33	[p2l1338t1816r1820b1896],
48	)	CD	NUMBER	)	num	49	SENT_33	[p2l1338t1816r1820b1896],
49	study	NN	O	study	dep	47	SENT_33	[p2l1868t1818r2060b1905],
50	,	,	O	,	_	0	SENT_33	[p2l1868t1818r2060b1905],
51	a	DT	O	a	det	53	SENT_33	[p2l2108t1843r2141b1882],
52	large	JJ	O	large	amod	53	SENT_33	[p2l52t1925r204b2012],
53	prospective	JJ	O	prospective	appos	49	SENT_33	[p2l228t1928r599b2013],
54	,	,	O	,	_	0	SENT_33	[p2l228t1928r599b2013],
55	population	NN	O	population	appos	49	SENT_33	[p2l625t1925r1178b2013],
56	—	CD	NUMBER	—	num	55	SENT_33	[p2l625t1925r1178b2013],
57	based	VBN	O	base	partmod	55	SENT_33	[p2l625t1925r1178b2013],
58	study	NN	O	study	dep	57	SENT_33	[p2l1203t1925r1375b2012],
59	of	IN	O	of	_	0	SENT_33	[p2l1396t1925r1471b1990],
60	over	IN	O	over	advmod	69	SENT_33	[p2l1484t1950r1619b1990],
61	15,000	CD	NUMBER	15,000	num	63	SENT_33	[p2l1646t1925r1860b2004],
62	middleaged	JJ	O	middleaged	amod	63	SENT_33	[p2l1886t1925r2137b1990, p2l55t2033r202b2120],
63	Americans	NNS	MISC	american	pobj	60	SENT_33	[p2l223t2031r568b2097],
64	with	IN	O	with	_	0	SENT_33	[p2l591t2033r739b2098],
65	long	JJ	O	long	amod	68	SENT_33	[p2l762t2033r1086b2120],
66	—	JJ	O	—	amod	68	SENT_33	[p2l762t2033r1086b2120],
67	term	NN	O	term	nn	68	SENT_33	[p2l762t2033r1086b2120],
68	folloW	NN	O	follow	prep_with	60	SENT_33	[p2l1111t2033r1420b2120],
69	—	CD	NUMBER	—	prep_of	58	SENT_33	[p2l1111t2033r1420b2120],
70	up	RP	O	up	prt	57	SENT_33	[p2l1111t2033r1420b2120],
71	(	CD	NUMBER	(	number	72	SENT_33	[p2l1450t2031r1553b2112],
72	9	CD	NUMBER	9	num	73	SENT_33	[p2l1450t2031r1553b2112],
73	)	NN	O	)	dep	57	SENT_33	[p2l1450t2031r1553b2112],
74	,	,	O	,	_	0	SENT_33	[p2l1450t2031r1553b2112],
75	and	CC	O	and	_	0	SENT_33	[p2l1582t2033r1700b2097],
76	in	IN	O	in	prep_in	30	SENT_33	[p2l1724t2036r1787b2097],
77	the	DT	O	the	det	78	SENT_33	[p2l1811t2033r1912b2097],
78	WHS	NN	O	wh	pobj	76	SENT_33	[p2l1933t2033r2137b2098],
79	450	CD	NUMBER	450	num	80	SENT_33	[p2l9t2133r122b2185],
80	Iakoubova	NNP	O	Iakoubova	dep	78	SENT_33	[p2l331t2133r617b2185],
81	et	FW	O	et	nn	82	SENT_33	[p2l640t2136r698b2185],
82	al.	FW	O	al.	dep	47	SENT_33	[p2l713t2134r779b2185],
83	.	.	O	.	_	0	SENT_33	[p2l713t2134r779b2185],

1	KIFG	NN	O	kifg	nn	2	SENT_34	[p2l331t2220r465b2273],
2	Trp719Arg	NN	O	trp719arg	_	0	SENT_34	[p2l478t2220r787b2283],
3	in	IN	O	in	_	0	SENT_34	[p2l806t2221r853b2272],
4	the	DT	O	the	det	6	SENT_34	[p2l873t2221r964b2273],
5	PROVE	NNP	O	PROVE	nn	6	SENT_34	[p2l985t2220r1175b2273],
6	IT-TIMI	NN	O	it-timus	prep_in	2	SENT_34	[p2l1196t2221r1392b2272],
7	22	CD	NUMBER	22	num	8	SENT_34	[p2l1415t2220r1488b2272],
8	Trial	NN	O	trial	dep	2	SENT_34	[p2l1506t2221r1633b2273],

1	(	NN	O	(	nn	2	SENT_35	[p2l965t2440r1303b2522],
2	VVomen	NN	O	vvoman	poss	6	SENT_35	[p2l965t2440r1303b2522],
3	’s	POS	O	’s	_	0	SENT_35	[p2l965t2440r1303b2522],
4	Health	NNP	O	Health	nn	6	SENT_35	[p2l1352t2442r1580b2508],
5	Study	NNP	O	Study	nn	6	SENT_35	[p2l1629t2440r1858b2531],
6	)	NNP	O	)	nsubj	24	SENT_35	[p2l1629t2440r1858b2531],
7	,	,	O	,	_	0	SENT_35	[p2l1629t2440r1858b2531],
8	a	DT	O	a	det	9	SENT_35	[p2l1907t2468r1942b2508],
9	large	JJ	O	large	appos	6	SENT_35	[p2l1985t2442r2139b2531],
10	and	CC	O	and	_	0	SENT_35	[p2l82t2564r191b2614],
11	Acronyms	NNS	MISC	acronym	appos	6	SENT_35	[p2l219t2565r529b2625],
12	prospective	JJ	O	prospective	amod	9	SENT_35	[p2l960t2552r1339b2638],
13	,	,	O	,	_	0	SENT_35	[p2l960t2552r1339b2638],
14	population	NN	O	population	appos	6	SENT_35	[p2l1372t2549r1937b2638],
15	—	CD	NUMBER	—	num	14	SENT_35	[p2l1372t2549r1937b2638],
16	based	VBN	O	base	partmod	14	SENT_35	[p2l1372t2549r1937b2638],
17	study	NN	O	study	dobj	16	SENT_35	[p2l1969t2549r2145b2638],
18	of	IN	O	of	_	0	SENT_35	[p2l962t2655r1039b2721],
19	over	IN	O	over	quantmod	20	SENT_35	[p2l1072t2681r1210b2721],
20	25,000	CD	NUMBER	25,000	prep_of	17	SENT_35	[p2l1251t2655r1476b2736],
21	apparently	RB	O	apparently	advmod	16	SENT_35	[p2l1523t2655r1863b2744],
22	healthy	JJ	O	healthy	amod	23	SENT_35	[p2l1903t2655r2144b2744],
23	Women	NNS	O	woman	dep	6	SENT_35	[p2l958t2788r1206b2828],
24	(	VBP	O	(	_	0	SENT_35	[p2l1235t2760r1380b2842],
25	10	CD	NUMBER	10	number	26	SENT_35	[p2l1235t2760r1380b2842],
26	)	CD	NUMBER	)	dobj	24	SENT_35	[p2l1235t2760r1380b2842],
27	.	.	O	.	_	0	SENT_35	[p2l1235t2760r1380b2842],

1	In	IN	O	in	_	0	SENT_36	[p2l1050t2870r1126b2934],
2	addition	NN	O	addition	_	0	SENT_36	[p2l1162t2869r1443b2934],
3	to	TO	O	to	_	0	SENT_36	[p2l1478t2886r1544b2934],
4	a	DT	O	a	det	6	SENT_36	[p2l1582t2895r1617b2934],
5	greater	JJR	O	greater	amod	6	SENT_36	[p2l1649t2886r1884b2958],
6	risk	NN	O	risk	prep_in_addition_to	18	SENT_36	[p2l1917t2869r2042b2934],
7	of	IN	O	of	_	0	SENT_36	[p2l2075t2869r2152b2934],
8	coronary	JJ	O	coronary	amod	9	SENT_36	[p2l963t3001r1247b3064],
9	events	NNS	O	event	prep_of	6	SENT_36	[p2l1264t2993r1480b3056],
10	,	,	O	,	_	0	SENT_36	[p2l1264t2993r1480b3056],
11	carriers	NNS	O	carrier	appos	9	SENT_36	[p2l1504t2979r1732b3041],
12	of	IN	O	of	_	0	SENT_36	[p2l1755t2975r1832b3041],
13	the	DT	O	the	det	14	SENT_36	[p2l1839t2975r1943b3041],
14	KIF	NN	ORGANIZATION	kif	prep_of	11	SENT_36	[p2l1963t2979r2112b3041],
15	6	CD	NUMBER	6	num	17	SENT_36	[p2l2106t2982r2143b3042],
16	719Arg	NN	O	719arg	nn	17	SENT_36	[p2l963t3080r1224b3171],
17	allele	NN	O	allele	nsubj	18	SENT_36	[p2l1245t3082r1413b3148],
18	received	VBD	O	receive	ccomp	29	SENT_36	[p2l1435t3082r1709b3148],
19	greater	JJR	O	greater	amod	20	SENT_36	[p2l1729t3099r1963b3171],
20	beneﬁt	NN	O	beneﬁt	dobj	18	SENT_36	[p2l1981t3082r2137b3148, p2l962t3189r1072b3254],
21	from	IN	O	from	_	0	SENT_36	[p2l1128t3189r1294b3254],
22	pravastatin	NN	O	pravastatin	prep_from	18	SENT_36	[p2l1351t3192r1741b3278],
23	,	,	O	,	_	0	SENT_36	[p2l1351t3192r1741b3278],
24	compared	VBN	O	compare	_	0	SENT_36	[p2l1803t3189r2141b3278],
25	with	IN	O	with	prepc_compared_with	18	SENT_36	[p2l958t3295r1114b3361],
26	placebo	NN	O	placebo	pobj	18	SENT_36	[p2l1141t3295r1415b3384],
27	,	,	O	,	_	0	SENT_36	[p2l1141t3295r1415b3384],
28	than	IN	O	than	advmod	29	SENT_36	[p2l1446t3295r1599b3361],
29	did	VBD	O	do	_	0	SENT_36	[p2l1628t3295r1737b3361],
30	noncarriers	NNS	O	noncarrier	dep	32	SENT_36	[p2l1765t3299r2139b3361],
31	"	``	O	"	punct	32	SENT_36	[p2l83t3378r154b3418],
32	R	NN	O	r	dep	29	SENT_36	[p2l83t3378r154b3418],
33	=	JJ	O	=	amod	32	SENT_36	[p2l181t3390r217b3409],
34	"	``	O	"	punct	32	SENT_36	[p2l245t3377r408b3418],
35	“	FW	O	“	dep	32	SENT_36	[p2l245t3377r408b3418],
36	"	``	O	"	punct	35	SENT_36	[p2l245t3377r408b3418],
37	"	``	O	"	punct	38	SENT_36	[p2l245t3377r408b3418],
38	“	NN	O	“	dep	35	SENT_36	[p2l245t3377r408b3418],
39	'	''	O	'	_	0	SENT_36	[p2l245t3377r408b3418],
40	'	''	O	'	_	0	SENT_36	[p2l433t3377r548b3418],
41	a	DT	O	a	det	43	SENT_36	[p2l433t3377r548b3418],
42	“	NN	O	“	nn	43	SENT_36	[p2l433t3377r548b3418],
43	°	NN	O	°	nsubj	29	SENT_36	[p2l433t3377r548b3418],
44	in	IN	O	in	_	0	SENT_36	[p2l961t3405r1027b3467],
45	the	DT	O	the	det	46	SENT_36	[p2l1075t3402r1182b3468],
46	CARE	NNP	O	CARE	prep_in	43	SENT_36	[p2l1232t3400r1476b3468],
47	and	CC	O	and	_	0	SENT_36	[p2l1527t3402r1651b3468],
48	woscops	NNS	O	woscop	conj_and	43	SENT_36	[p2l1694t3402r2137b3468],
49	CHD	NN	O	chd	nn	53	SENT_36	[p2l81t2728r192b2770],
50	=	JJ	O	=	amod	53	SENT_36	[p2l219t2742r255b2760],
51	coronary	JJ	O	coronary	amod	53	SENT_36	[p2l282t2739r503b2779],
52	heart	NN	O	heart	nn	53	SENT_36	[p2l525t2729r657b2770],
53	disease	NN	O	disease	dep	48	SENT_36	[p2l81t2812r276b2854],

1	CI	NN	O	ci	_	0	SENT_37	[p2l81t2933r131b2974],
2	=	JJ	O	=	amod	4	SENT_37	[p2l160t2947r196b2965],
3	confidence	NN	O	confidence	nn	4	SENT_37	[p2l223t2933r502b2974],
4	interval	NN	O	interval	dep	1	SENT_37	[p2l525t2933r713b2974],

1	CRP	NN	O	crp	_	0	SENT_38	[p2l81t3052r191b3094],
2	=	JJ	O	=	amod	4	SENT_38	[p2l217t3066r253b3085],
3	C-reactive	JJ	O	c-reactive	amod	4	SENT_38	[p2l280t3052r538b3094],
4	protein	NN	O	protein	dep	1	SENT_38	[p2l562t3052r738b3104],

1	HDL-C	NN	O	hdl-c	_	0	SENT_39	[p2l83t3173r234b3214],
2	=	JJ	O	=	amod	5	SENT_39	[p2l262t3186r298b3205],
3	high-density	JJ	O	high-density	amod	5	SENT_39	[p2l326t3173r634b3224],
4	Iipoprotein	NN	MISC	iipoprotein	nn	5	SENT_39	[p2l82t3257r351b3308],
5	cholesterol	NN	O	cholesterol	dep	1	SENT_39	[p2l374t3258r657b3299],

1	LDL-C	NN	O	ldl-c	nn	5	SENT_40	[p3l83t21r225b63],
2	=	JJ	O	=	amod	5	SENT_40	[p3l253t35r289b53],
3	low-density	JJ	O	low-density	amod	5	SENT_40	[p3l317t21r603b72],
4	trials	NNS	O	trial	nn	5	SENT_40	[p3l961t33r1123b98],
5	p	NN	O	p	nsubj	30	SENT_40	[p3l1160t30r1269b113],
6	+	CC	O	+	cc	8	SENT_40	[p3l1160t30r1269b113],
7	Recent	JJ	O	recent	amod	8	SENT_40	[p3l1308t34r1546b98],
8	reviews	NNS	O	review	nsubj	15	SENT_40	[p3l1576t36r1822b99],
9	of	IN	O	of	_	0	SENT_40	[p3l1857t33r1935b98],
10	statin	NN	O	statin	nn	13	SENT_40	[p3l1957t36r2141b98],
11	lipoprotein	NN	O	lipoprotein	nn	13	SENT_40	[p3l82t105r351b156],
12	cholesterol	NN	O	cholesterol	nn	13	SENT_40	[p3l374t106r657b147],
13	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	8	SENT_40	[p3l960t139r1656b228],
14	have	VBP	O	have	aux	15	SENT_40	[p3l1719t139r1879b205],
15	highlighted	VBN	O	highlight	rcmod	5	SENT_40	[p3l1942t139r2137b228, p3l960t246r1198b335],
16	the	DT	O	the	det	17	SENT_40	[p3l1231t246r1337b312],
17	importance	NN	O	importance	dobj	15	SENT_40	[p3l1371t249r1755b335],
18	of	IN	O	of	_	0	SENT_40	[p3l1790t246r1868b312],
19	investigating	VBG	O	investigate	prepc_of	17	SENT_40	[p3l1889t249r2137b312, p3l9t356r224b442],
20	genetic	JJ	O	genetic	amod	21	SENT_40	[p3l276t356r519b442],
21	variants	NNS	O	variant	dobj	19	SENT_40	[p3l570t356r832b419],
22	associated	VBN	O	associate	partmod	21	SENT_40	[p3l890t353r1226b419],
23	with	IN	O	with	_	0	SENT_40	[p3l1277t353r1433b419],
24	statin	NN	O	statin	nn	25	SENT_40	[p3l1489t356r1673b419],
25	response	NN	O	response	prep_with	22	SENT_40	[p3l1728t379r2019b442],
26	in	IN	O	in	_	0	SENT_40	[p3l2075t356r2141b418],
27	multiple	JJ	O	multiple	amod	29	SENT_40	[p3l11t459r292b548],
28	prospective	JJ	O	prospective	amod	29	SENT_40	[p3l317t462r697b548],
29	studies	NNS	O	study	prep_in	25	SENT_40	[p3l726t459r953b525],
30	(	VBP	O	(	_	0	SENT_40	[p3l984t457r1264b539],
31	11-13	CD	NUMBER	11-13	num	32	SENT_40	[p3l984t457r1264b539],
32	)	CD	NUMBER	)	dobj	30	SENT_40	[p3l984t457r1264b539],
33	.	.	O	.	_	0	SENT_40	[p3l984t457r1264b539],

1	Given	VBN	O	give	prep	20	SENT_41	[p3l1297t459r1505b525],
2	the	DT	O	the	det	3	SENT_41	[p3l1530t459r1637b525],
3	importance	NN	O	importance	dep	1	SENT_41	[p3l1663t462r2047b548],
4	of	IN	O	of	_	0	SENT_41	[p3l2075t459r2153b525],
5	multiple	JJ	O	multiple	amod	6	SENT_41	[p3l11t565r292b654],
6	studies	NNS	O	study	prep_of	3	SENT_41	[p3l339t565r566b631],
7	and	CC	O	and	_	0	SENT_41	[p3l614t565r738b631],
8	the	DT	O	the	det	9	SENT_41	[p3l781t565r888b631],
9	use	NN	O	use	conj_and	3	SENT_41	[p3l932t591r1040b631],
10	of	IN	O	of	_	0	SENT_41	[p3l1086t565r1164b631],
11	intensive	JJ	O	intensive	amod	13	SENT_41	[p3l1196t568r1494b631],
12	lipid	NN	O	lipid	nn	13	SENT_41	[p3l1538t565r1692b654],
13	lowering	NN	O	lowering	prep_of	9	SENT_41	[p3l1735t565r2032b654],
14	in	IN	O	in	_	0	SENT_41	[p3l2075t568r2141b630],
15	contemporary	JJ	O	contemporary	amod	17	SENT_41	[p3l11t689r485b761],
16	clinical	JJ	O	clinical	amod	17	SENT_41	[p3l521t672r757b738],
17	practice	NN	O	practice	prep_in	13	SENT_41	[p3l793t675r1074b761],
18	,	,	O	,	_	0	SENT_41	[p3l793t675r1074b761],
19	We	PRP	O	we	nsubj	20	SENT_41	[p3l1112t698r1208b738],
20	thought	VBD	O	think	_	0	SENT_41	[p3l1247t672r1520b761],
21	that	IN	O	that	complm	25	SENT_41	[p3l1557t672r1693b738],
22	it	PRP	O	it	nsubj	25	SENT_41	[p3l1730t675r1779b738],
23	would	MD	O	would	aux	25	SENT_41	[p3l1812t672r2025b738],
24	be	VB	O	be	cop	25	SENT_41	[p3l2061t672r2140b738],
25	important	JJ	O	important	ccomp	20	SENT_41	[p3l10t781r353b867],
26	to	TO	O	to	aux	27	SENT_41	[p3l384t795r451b844],
27	determine	VB	O	determine	xcomp	25	SENT_41	[p3l487t778r829b844],
28	Whether	IN	O	whether	complm	36	SENT_41	[p3l860t778r1142b844],
29	the	DT	O	the	det	30	SENT_41	[p3l1174t778r1281b844],
30	presence	NN	O	presence	nsubj	36	SENT_41	[p3l1314t804r1604b867],
31	of	IN	O	of	_	0	SENT_41	[p3l1640t778r1718b844],
32	the	DT	O	the	det	34	SENT_41	[p3l1739t778r1846b844],
33	719Arg	NNP	O	719Arg	nn	34	SENT_41	[p3l1882t776r2143b867],
34	allele	NN	O	allele	prep_of	30	SENT_41	[p3l12t884r180b950],
35	also	RB	O	also	advmod	36	SENT_41	[p3l210t884r335b950],
36	affects	VBZ	O	affect	dep	25	SENT_41	[p3l367t884r569b950],
37	the	DT	O	the	det	38	SENT_41	[p3l599t884r706b950],
38	magnitude	NN	O	magnitude	dobj	36	SENT_41	[p3l736t884r1098b973],
39	of	IN	O	of	_	0	SENT_41	[p3l1128t884r1206b950],
40	clinical	JJ	O	clinical	amod	41	SENT_41	[p3l1224t884r1460b950],
41	beneﬁt	NN	O	beneﬁt	prep_of	38	SENT_41	[p3l1485t884r1721b950],
42	from	IN	O	from	_	0	SENT_41	[p3l1748t884r1912b950],
43	other	JJ	O	other	amod	49	SENT_41	[p3l1942t884r2138b965],
44	,	,	O	,	_	0	SENT_41	[p3l1942t884r2138b965],
45	more	RBR	O	more	advmod	46	SENT_41	[p3l11t1016r186b1056],
46	intensive	JJ	O	intensive	dep	43	SENT_41	[p3l245t993r566b1071],
47	,	,	O	,	_	0	SENT_41	[p3l245t993r566b1071],
48	statin	JJ	O	statin	amod	49	SENT_41	[p3l628t993r813b1056],
49	regimens	NNS	O	regimen	prep_from	36	SENT_41	[p3l871t993r1199b1079],
50	.	.	O	.	_	0	SENT_41	[p3l871t993r1199b1079],

1	We	PRP	O	we	nsubj	3	SENT_42	[p3l1257t991r1386b1057],
2	therefore	RB	O	therefore	advmod	3	SENT_42	[p3l1444t990r1752b1056],
3	examined	VBD	O	examine	_	0	SENT_42	[p3l1812t990r2140b1056],
4	whether	IN	O	whether	complm	39	SENT_42	[p3l7t1096r290b1162],
5	the	DT	O	the	det	7	SENT_42	[p3l343t1096r450b1162],
6	clinical	JJ	O	clinical	amod	7	SENT_42	[p3l506t1096r742b1162],
7	beneﬁt	NN	O	beneﬁt	nsubj	39	SENT_42	[p3l794t1096r1031b1162],
8	from	IN	O	from	_	0	SENT_42	[p3l1084t1096r1249b1162],
9	intensive	JJ	O	intensive	amod	11	SENT_42	[p3l1304t1099r1602b1162],
10	lipid	NN	O	lipid	nn	11	SENT_42	[p3l1657t1096r2143b1185],
11	—	NN	O	—	prep_from	7	SENT_42	[p3l1657t1096r2143b1185],
12	lowering	VBG	O	lower	partmod	11	SENT_42	[p3l1657t1096r2143b1185],
13	therapy	NN	O	therapy	dobj	12	SENT_42	[p3l10t1202r267b1291],
14	with	IN	O	with	_	0	SENT_42	[p3l300t1202r456b1268],
15	high-dose	JJ	O	high-dose	amod	17	SENT_42	[p3l496t1202r836b1291],
16	atorvastatin	NN	O	atorvastatin	nn	17	SENT_42	[p3l879t1205r1269b1268],
17	(	NN	O	(	prep_with	12	SENT_42	[p3l1312t1200r1419b1282],
18	80	CD	NUMBER	80	num	19	SENT_42	[p3l1312t1200r1419b1282],
19	mg	NN	O	mg	dep	17	SENT_42	[p3l1462t1202r1601b1291],
20	/	:	O	/	punct	21	SENT_42	[p3l1462t1202r1601b1291],
21	day	NN	DURATION	day	dep	17	SENT_42	[p3l1602t1200r1763b1291],
22	)	CD	NUMBER	)	num	21	SENT_42	[p3l1602t1200r1763b1291],
23	,	,	O	,	_	0	SENT_42	[p3l1602t1200r1763b1291],
24	compared	VBN	O	compare	_	0	SENT_42	[p3l1807t1202r2141b1291],
25	with	IN	O	with	prepc_compared_with	39	SENT_42	[p3l7t1308r163b1374],
26	standard	JJ	O	standard	amod	29	SENT_42	[p3l193t1308r668b1374],
27	—	NN	O	—	nn	29	SENT_42	[p3l193t1308r668b1374],
28	dose	NN	O	dose	nn	29	SENT_42	[p3l193t1308r668b1374],
29	pravastatin	NN	O	pravastatin	pobj	39	SENT_42	[p3l696t1311r1064b1397],
30	(	CD	NUMBER	(	number	31	SENT_42	[p3l1096t1306r1203b1388],
31	40	CD	NUMBER	40	num	32	SENT_42	[p3l1096t1306r1203b1388],
32	mg	NN	O	mg	dep	29	SENT_42	[p3l1233t1308r1373b1397],
33	/	:	O	/	punct	34	SENT_42	[p3l1233t1308r1373b1397],
34	day	NN	DURATION	day	dep	29	SENT_42	[p3l1374t1306r1534b1397],
35	)	CD	NUMBER	)	num	34	SENT_42	[p3l1374t1306r1534b1397],
36	,	,	O	,	_	0	SENT_42	[p3l1374t1306r1534b1397],
37	would	MD	O	would	aux	39	SENT_42	[p3l1562t1308r1776b1374],
38	be	VB	O	be	cop	39	SENT_42	[p3l1801t1308r1880b1374],
39	greater	JJR	O	greater	ccomp	3	SENT_42	[p3l1908t1325r2143b1397],
40	among	IN	O	among	_	0	SENT_42	[p3l12t1440r246b1503],
41	carriers	NNS	O	carrier	prep_among	39	SENT_42	[p3l280t1417r520b1480],
42	of	IN	O	of	_	0	SENT_42	[p3l557t1414r635b1480],
43	the	DT	O	the	det	46	SENT_42	[p3l658t1414r765b1480],
44	KIF6	NN	O	kif6	nn	46	SENT_42	[p3l799t1417r984b1480],
45	719Arg	NN	O	719arg	nn	46	SENT_42	[p3l1020t1412r1281b1503],
46	allele	NN	O	allele	prep_of	41	SENT_42	[p3l1315t1414r1483b1480],
47	than	IN	O	than	dep	39	SENT_42	[p3l1518t1414r1671b1480],
48	among	IN	O	among	_	0	SENT_42	[p3l1707t1440r1942b1503],
49	noncarriers	NNS	O	noncarrier	prep_among	39	SENT_42	[p3l1976t1440r2138b1480, p3l11t1522r252b1584],
50	in	IN	O	in	_	0	SENT_42	[p3l285t1522r352b1584],
51	the	DT	O	the	det	53	SENT_42	[p3l383t1519r489b1584],
52	PROVE	NNP	O	PROVE	nn	53	SENT_42	[p3l523t1519r824b1585],
53	IT	NNP	O	IT	prep_in	49	SENT_42	[p3l856t1517r1188b1584],
54	.	.	O	.	_	0	SENT_42	[p3l856t1517r1188b1584],

1	—	NN	O	—	_	0	SENT_43	[p3l856t1517r1188b1584],
2	.	.	O	.	_	0	SENT_43	[p3l856t1517r1188b1584],

1	TIMI	NNP	ORGANIZATION	TIMI	_	0	SENT_44	[p3l856t1517r1188b1584],
2	22	CD	NUMBER	22	num	1	SENT_44	[p3l1220t1522r1303b1585],
3	(	CD	NUMBER	(	num	4	SENT_44	[p3l1340t1517r1740b1599],
4	Pravastatin	NN	O	pravastatin	dep	1	SENT_44	[p3l1340t1517r1740b1599],
5	or	CC	O	or	_	0	SENT_44	[p3l1772t1544r1843b1584],
6	Atorva	NN	O	atorva	nn	9	SENT_44	[p3l1870t1517r2137b1585],
7	—	NN	O	—	nn	9	SENT_44	[p3l1870t1517r2137b1585],
8	statin	NN	O	statin	nn	9	SENT_44	[p3l12t1628r196b1691],
9	Evaluation	NN	O	evaluation	conj_or	4	SENT_44	[p3l247t1625r614b1691],
10	and	CC	O	and	_	0	SENT_44	[p3l665t1625r789b1691],
11	Infection	NN	O	infection	nn	12	SENT_44	[p3l837t1625r1146b1691],
12	Therapy	NN	O	therapy	conj_or	4	SENT_44	[p3l1193t1623r1499b1714],
13	:	:	O	:	_	0	SENT_44	[p3l1193t1623r1499b1714],
14	Thrombolysis	NNP	O	Thrombolysis	dep	4	SENT_44	[p3l1550t1623r2023b1714],
15	in	IN	O	in	_	0	SENT_44	[p3l2075t1628r2141b1690],
16	Myocardial	JJ	O	myocardial	amod	17	SENT_44	[p3l9t1731r399b1820],
17	Infarction	NN	O	infarction	prep_in	14	SENT_44	[p3l441t1731r778b1797],
18	22	CD	NUMBER	22	num	20	SENT_44	[p3l821t1729r930b1811],
19	)	NN	O	)	nn	20	SENT_44	[p3l821t1729r930b1811],
20	trial	NN	O	trial	dep	1	SENT_44	[p3l977t1731r1112b1797],
21	(	CD	NUMBER	(	number	22	SENT_44	[p3l1157t1729r1310b1811],
22	14	CD	NUMBER	14	num	23	SENT_44	[p3l1157t1729r1310b1811],
23	)	NN	O	)	dep	20	SENT_44	[p3l1157t1729r1310b1811],
24	.	.	O	.	_	0	SENT_44	[p3l1157t1729r1310b1811],

1	In	IN	O	in	_	0	SENT_45	[p3l1357t1732r1433b1796],
2	this	DT	O	this	det	3	SENT_45	[p3l1477t1731r1599b1797],
3	trial	NN	O	trial	prep_in	16	SENT_45	[p3l1644t1731r1795b1812],
4	,	,	O	,	_	0	SENT_45	[p3l1644t1731r1795b1812],
5	intensive	JJ	O	intensive	amod	6	SENT_45	[p3l1841t1734r2140b1797],
6	therapy	NN	O	therapy	nsubj	16	SENT_45	[p3l10t1837r267b1926],
7	with	IN	O	with	_	0	SENT_45	[p3l298t1837r454b1903],
8	high-dose	JJ	O	high-dose	amod	12	SENT_45	[p3l491t1837r832b1926],
9	atorvastatin	NN	O	atorvastatin	nn	12	SENT_45	[p3l872t1840r1263b1903],
10	(	NN	O	(	nn	12	SENT_45	[p3l1304t1835r1411b1917],
11	80	CD	NUMBER	80	num	12	SENT_45	[p3l1304t1835r1411b1917],
12	mg	NN	O	mg	prep_with	6	SENT_45	[p3l1451t1837r1591b1926],
13	/	:	O	/	punct	14	SENT_45	[p3l1451t1837r1591b1926],
14	day	NN	DURATION	day	dep	6	SENT_45	[p3l1592t1835r1731b1926],
15	)	CD	NUMBER	)	num	14	SENT_45	[p3l1592t1835r1731b1926],
16	resulted	VBD	O	result	_	0	SENT_45	[p3l1772t1837r2038b1903],
17	in	IN	O	in	_	0	SENT_45	[p3l2075t1840r2141b1902],
18	greater	JJR	O	greater	amod	19	SENT_45	[p3l9t1961r244b2033],
19	protection	NN	O	protection	prep_in	16	SENT_45	[p3l273t1947r622b2033],
20	against	IN	O	against	_	0	SENT_45	[p3l654t1947r891b2033],
21	death	NN	O	death	nn	24	SENT_45	[p3l922t1944r1109b2010],
22	or	CC	O	or	_	0	SENT_45	[p3l1141t1969r1211b2010],
23	cardiovascular	JJ	O	cardiovascular	nn	24	SENT_45	[p3l1243t1944r1717b2010],
24	events	NNS	O	event	prep_against	19	SENT_45	[p3l1748t1961r1954b2010],
25	than	IN	O	than	dep	26	SENT_45	[p3l1987t1944r2141b2010],
26	did	VBD	O	do	advcl	16	SENT_45	[p3l11t2050r121b2116],
27	moderate	JJ	O	moderate	amod	28	SENT_45	[p3l177t2050r495b2116],
28	therapy	NN	O	therapy	dobj	26	SENT_45	[p3l552t2050r809b2139],
29	with	IN	O	with	_	0	SENT_45	[p3l858t2050r1015b2116],
30	standard	JJ	O	standard	amod	33	SENT_45	[p3l1072t2050r1548b2116],
31	—	NN	O	—	nn	33	SENT_45	[p3l1072t2050r1548b2116],
32	dose	NN	O	dose	nn	33	SENT_45	[p3l1072t2050r1548b2116],
33	pravastatin	NN	O	pravastatin	prep_with	26	SENT_45	[p3l1605t2053r1973b2139],
34	(	CD	NUMBER	(	num	36	SENT_45	[p3l2032t2048r2140b2130],
35	40	CD	NUMBER	40	num	36	SENT_45	[p3l2032t2048r2140b2130],
36	mg/day	NN	O	mg/day	nsubj	26	SENT_45	[p3l11t2156r285b2245],
37	,	,	O	,	_	0	SENT_45	[p3l11t2156r285b2245],
38	the	DT	O	the	det	40	SENT_45	[p3l319t2156r426b2222],
39	same	JJ	O	same	amod	40	SENT_45	[p3l460t2182r628b2222],
40	dose	NN	O	dose	appos	36	SENT_45	[p3l661t2156r811b2222],
41	used	VBN	O	use	partmod	40	SENT_45	[p3l842t2156r996b2222],
42	in	IN	O	in	_	0	SENT_45	[p3l1027t2159r1093b2221],
43	the	DT	O	the	det	47	SENT_45	[p3l1124t2156r1231b2222],
44	CARE	NNP	O	CARE	nn	47	SENT_45	[p3l1265t2154r1509b2222],
45	and	CC	O	and	_	0	SENT_45	[p3l1543t2156r1667b2222],
46	WOSCOPS	NNP	O	WOSCOPS	conj_and	44	SENT_45	[p3l1694t2156r2138b2223],
47	trials	NNS	O	trial	prep_in	41	SENT_45	[p3l10t2261r197b2343],
48	)	RB	O	)	advmod	41	SENT_45	[p3l10t2261r197b2343],
49	in	IN	O	in	_	0	SENT_45	[p3l230t2266r296b2328],
50	patients	NNS	O	patient	prep_in	41	SENT_45	[p3l325t2266r589b2352],
51	with	IN	O	with	_	0	SENT_45	[p3l617t2263r773b2329],
52	a	DT	O	a	det	56	SENT_45	[p3l804t2289r838b2329],
53	recent	JJ	O	recent	amod	56	SENT_45	[p3l866t2280r1074b2329],
54	acute	JJ	O	acute	amod	56	SENT_45	[p3l1103t2280r1276b2329],
55	coronary	JJ	O	coronary	amod	56	SENT_45	[p3l1308t2289r1605b2352],
56	syndrome	NN	O	syndrome	prep_with	50	SENT_45	[p3l1632t2263r1979b2352],
57	.	.	O	.	_	0	SENT_45	[p3l1632t2263r1979b2352],

1	Methods	NNS	O	method	_	0	SENT_46	[p3l13t2512r378b2574],

1	Study	NNP	O	Study	_	0	SENT_47	[p3l13t2663r228b2753],
2	population	NN	O	population	dep	1	SENT_47	[p3l264t2663r693b2753],
3	.	.	O	.	_	0	SENT_47	[p3l264t2663r693b2753],

1	The	DT	O	the	det	3	SENT_48	[p3l742t2662r889b2730],
2	study	NN	O	study	nn	3	SENT_48	[p3l932t2664r1121b2753],
3	population	NN	O	population	nsubjpass	9	SENT_48	[p3l1157t2664r1540b2753],
4	for	IN	O	for	_	0	SENT_48	[p3l1580t2664r1681b2730],
5	this	DT	O	this	det	7	SENT_48	[p3l1720t2664r1847b2730],
6	genetic	JJ	O	genetic	amod	7	SENT_48	[p3l1888t2667r2142b2753],
7	study	NN	O	study	prep_for	3	SENT_48	[p3l12t2771r201b2860],
8	was	VBD	O	be	auxpass	9	SENT_48	[p3l241t2797r370b2837],
9	derived	VBN	O	derive	_	0	SENT_48	[p3l420t2771r677b2837],
10	from	IN	O	from	_	0	SENT_48	[p3l723t2771r893b2837],
11	the	DT	O	the	det	13	SENT_48	[p3l940t2771r1051b2837],
12	PROVE	NNP	O	PROVE	nn	13	SENT_48	[p3l1099t2771r1407b2838],
13	IT	NNP	O	IT	prep_from	9	SENT_48	[p3l1455t2769r1797b2836],
14	.	.	O	.	_	0	SENT_48	[p3l1455t2769r1797b2836],

1	—	NN	O	—	_	0	SENT_49	[p3l1455t2769r1797b2836],
2	.	.	O	.	_	0	SENT_49	[p3l1455t2769r1797b2836],

1	TIMI	NNP	ORGANIZATION	TIMI	nn	3	SENT_50	[p3l1455t2769r1797b2836],
2	22	CD	NUMBER	22	num	3	SENT_50	[p3l1844t2774r1929b2838],
3	trial	NN	O	trial	_	0	SENT_50	[p3l1978t2771r2138b2852],
4	,	,	O	,	_	0	SENT_50	[p3l1978t2771r2138b2852],
5	which	WDT	O	which	nsubjpass	8	SENT_50	[p3l7t2877r224b2943],
6	has	VBZ	O	have	aux	8	SENT_50	[p3l259t2877r371b2943],
7	been	VBN	O	be	auxpass	8	SENT_50	[p3l406t2877r572b2943],
8	described	VBN	O	describe	rcmod	3	SENT_50	[p3l608t2877r940b2943],
9	previously	RB	DATE	previously	advmod	8	SENT_50	[p3l973t2877r1333b2966],
10	(	CD	NUMBER	(	number	11	SENT_50	[p3l1367t2875r1526b2957],
11	14	CD	NUMBER	14	num	12	SENT_50	[p3l1367t2875r1526b2957],
12	)	NN	O	)	dobj	8	SENT_50	[p3l1367t2875r1526b2957],
13	.	.	O	.	_	0	SENT_50	[p3l1367t2875r1526b2957],

1	Brieﬂy	NNP	O	Brieﬂy	nsubjpass	25	SENT_51	[p3l1566t2877r1819b2966],
2	,	,	O	,	_	0	SENT_51	[p3l1566t2877r1819b2966],
3	the	DT	O	the	det	4	SENT_51	[p3l1857t2877r1967b2943],
4	trial	NN	O	trial	nsubjpass	25	SENT_51	[p3l2002t2877r2144b2943],
5	comprised	VBN	O	comprise	partmod	4	SENT_51	[p3l11t2983r390b3072],
6	4,162	CD	NUMBER	4,162	num	7	SENT_51	[p3l425t2986r628b3064],
7	patients	NNS	O	patient	dobj	5	SENT_51	[p3l665t2986r954b3072],
8	who	WP	O	who	nsubjpass	11	SENT_51	[p3l989t2983r1144b3049],
9	had	VBD	O	have	aux	11	SENT_51	[p3l1182t2983r1315b3049],
10	been	VBN	O	be	auxpass	11	SENT_51	[p3l1349t2983r1521b3049],
11	hospitalized	VBN	O	hospitalize	rcmod	7	SENT_51	[p3l1557t2983r2003b3072],
12	for	IN	O	for	_	0	SENT_51	[p3l2039t2983r2142b3049],
13	an	DT	O	a	det	16	SENT_51	[p3l12t3116r94b3156],
14	acute	JJ	O	acute	amod	16	SENT_51	[p3l144t3107r331b3156],
15	coronary	JJ	O	coronary	amod	16	SENT_51	[p3l382t3116r704b3179],
16	syndrome	NN	O	syndrome	prep_for	11	SENT_51	[p3l750t3090r1105b3179],
17	within	IN	O	within	_	0	SENT_51	[p3l1150t3090r1391b3156],
18	10	CD	DURATION	10	num	19	SENT_51	[p3l1445t3093r1526b3156],
19	days	NNS	NUMBER	day	prep_within	11	SENT_51	[p3l1577t3090r1731b3179],
20	preceding	VBG	O	precede	partmod	19	SENT_51	[p3l1780t3090r2143b3179],
21	enrollment	NN	O	enrollment	dobj	20	SENT_51	[p3l11t3195r415b3260],
22	and	CC	O	and	_	0	SENT_51	[p3l447t3195r578b3260],
23	who	WP	O	who	dobj	5	SENT_51	[p3l606t3195r762b3261],
24	were	VBD	O	be	auxpass	25	SENT_51	[p3l792t3220r964b3260],
25	enrolled	VBN	O	enrol	_	0	SENT_51	[p3l999t3195r1297b3260],
26	While	IN	O	while	mark	27	SENT_51	[p3l1325t3195r1525b3261],
27	in	IN	O	in	dep	25	SENT_51	[p3l1558t3198r1627b3260],
28	stable	JJ	O	stable	amod	29	SENT_51	[p3l1661t3195r1868b3260],
29	condition	NN	O	condition	pobj	27	SENT_51	[p3l1902t3195r2138b3260, p3l10t3304r156b3367],

1	and	CC	O	and	_	0	SENT_52	[p3l213t3301r343b3367],
2	after	IN	O	after	dep	1	SENT_52	[p3l399t3301r565b3367],
3	any	DT	O	any	det	5	SENT_52	[p3l620t3327r746b3390],
4	planned	JJ	O	planned	amod	5	SENT_52	[p3l797t3301r1091b3390],
5	revascularization	NN	O	revascularization	pobj	2	SENT_52	[p3l1145t3301r1783b3367],
6	.	.	O	.	_	0	SENT_52	[p3l1145t3301r1783b3367],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_53	[p3l1843t3302r2139b3367],
2	were	VBD	O	be	auxpass	3	SENT_53	[p3l7t3431r179b3472],
3	enrolled	VBN	O	enrol	_	0	SENT_53	[p3l238t3406r536b3471],
4	at	IN	O	at	_	0	SENT_53	[p3l594t3423r659b3471],
5	349	CD	NUMBER	349	num	6	SENT_53	[p3l715t3409r846b3472],
6	centers	NNS	O	center	prep_at	3	SENT_53	[p3l907t3423r1161b3471],
7	in	IN	O	in	_	0	SENT_53	[p3l1220t3409r1289b3471],
8	8	CD	NUMBER	8	num	9	SENT_53	[p3l1350t3409r1385b3472],
9	countries	NNS	O	country	prep_in	6	SENT_53	[p3l1446t3409r1779b3471],
10	between	IN	O	between	prep	3	SENT_53	[p3l1836t3406r2141b3472],

1	November	NNP	DATE	November	nsubj	7	SENT_54	[p3l10t3511r397b3577],
2	2000	CD	DATE	2000	num	1	SENT_54	[p3l427t3514r608b3577],
3	and	CC	O	and	_	0	SENT_54	[p3l644t3511r775b3576],
4	December	NNP	DATE	December	conj_and	1	SENT_54	[p3l808t3511r1188b3576],
5	2001	CD	DATE	2001	num	4	SENT_54	[p3l1218t3514r1395b3577],
6	and	CC	O	and	cc	7	SENT_54	[p3l1435t3511r1566b3576],
7	randomized	VBN	O	randomize	_	0	SENT_54	[p3l1599t3511r2037b3576],
8	to	TO	O	to	_	0	SENT_54	[p3l2070t3528r2139b3576],
9	high-dose	JJ	O	high-dose	amod	14	SENT_54	[p4l10t28r379b117],
10	atorvastatin	NN	O	atorvastatin	nn	14	SENT_54	[p4l444t31r873b94],
11	(	NN	O	(	nn	14	SENT_54	[p4l939t26r1053b108],
12	80	CD	NUMBER	80	num	14	SENT_54	[p4l939t26r1053b108],
13	mg/day	JJ	O	mg/day	amod	14	SENT_54	[p4l1118t26r1419b117],
14	)	NN	O	)	prep_to	7	SENT_54	[p4l1118t26r1419b117],
15	or	CC	O	or	_	0	SENT_54	[p4l1486t54r1560b94],
16	standard	JJ	O	standard	amod	19	SENT_54	[p4l1622t28r2140b94],
17	—	NN	O	—	nn	19	SENT_54	[p4l1622t28r2140b94],
18	dose	NN	O	dose	nn	19	SENT_54	[p4l1622t28r2140b94],
19	pravastatin	NN	O	pravastatin	prep_to	7	SENT_54	[p4l9t137r413b223],
20	(	CD	NUMBER	(	number	21	SENT_54	[p4l462t132r577b214],
21	40	CD	NUMBER	40	num	23	SENT_54	[p4l462t132r577b214],
22	mg/day	NN	O	mg/day	nn	23	SENT_54	[p4l625t132r926b223],
23	)	NN	O	)	dep	19	SENT_54	[p4l625t132r926b223],
24	and	CC	O	and	_	0	SENT_54	[p4l978t134r1109b200],
25	to	TO	O	to	_	0	SENT_54	[p4l1155t151r1224b200],
26	gatiﬂoxacin	NN	O	gatiﬂoxacin	conj_and	14	SENT_54	[p4l1272t134r1697b223],
27	or	CC	O	or	_	0	SENT_54	[p4l1745t160r1818b200],
28	placebo	NN	O	placebo	conj_or	26	SENT_54	[p4l1863t134r2139b223],
29	using	VBG	O	use	xcomp	7	SENT_54	[p4l9t243r207b329],
30	a	DT	O	a	det	32	SENT_54	[p4l244t266r278b306],
31	double	JJ	O	double	amod	32	SENT_54	[p4l315t240r813b321],
32	—	NN	O	—	dep	33	SENT_54	[p4l315t240r813b321],
33	blind	JJ	O	blind	dep	29	SENT_54	[p4l315t240r813b321],
34	,	,	O	,	_	0	SENT_54	[p4l315t240r813b321],
35	2	CD	NUMBER	2	num	36	SENT_54	[p4l851t243r892b307],
36	X	NN	O	x	dep	39	SENT_54	[p4l940t250r993b302],
37	2	CD	NUMBER	2	num	39	SENT_54	[p4l1037t243r1078b307],
38	factorial	JJ	O	factorial	amod	39	SENT_54	[p4l1117t240r1418b306],
39	design	NN	O	design	dep	33	SENT_54	[p4l1455t240r1710b329],
40	.	.	O	.	_	0	SENT_54	[p4l1455t240r1710b329],

1	The	DT	O	the	det	3	SENT_55	[p4l1748t238r1899b306],
2	2,061	CD	NUMBER	2,061	num	3	SENT_55	[p4l1935t243r2136b321],
3	patients	NNS	O	patient	nsubj	15	SENT_55	[p4l9t349r311b435],
4	who	WP	O	who	nsubj	5	SENT_55	[p4l381t346r540b412],
5	provided	VBD	O	provide	rcmod	3	SENT_55	[p4l611t346r948b435],
6	institutional	JJ	O	institutional	amod	7	SENT_55	[p4l1018t346r1492b412],
7	review	NN	O	review	dobj	5	SENT_55	[p4l1562t349r1810b412],
8	boardapproved	VBN	O	boardapprove	partmod	7	SENT_55	[p4l1875t346r2142b412, p4l12t453r347b542],
9	informed	JJ	O	informed	amod	10	SENT_55	[p4l407t453r745b519],
10	consent	NN	O	consent	dobj	8	SENT_55	[p4l806t470r1087b519],
11	for	IN	O	for	_	0	SENT_55	[p4l1145t453r1250b519],
12	genetic	JJ	O	genetic	amod	13	SENT_55	[p4l1307t456r1571b542],
13	analysis	NN	O	analysis	prep_for	8	SENT_55	[p4l1632t453r1910b542],
14	were	VBD	O	be	cop	15	SENT_55	[p4l1968t479r2140b519],
15	eligible	JJ	O	eligible	_	0	SENT_55	[p4l11t559r275b648],
16	for	IN	O	for	_	0	SENT_55	[p4l320t559r424b625],
17	inclusion	NN	O	inclusion	prep_for	15	SENT_55	[p4l467t559r800b625],
18	in	IN	O	in	_	0	SENT_55	[p4l844t562r914b624],
19	this	DT	O	this	det	21	SENT_55	[p4l958t559r1090b625],
20	genetic	JJ	O	genetic	amod	21	SENT_55	[p4l1134t562r1398b648],
21	study	NN	O	study	prep_in	17	SENT_55	[p4l1443t559r1639b648],
22	(	CD	NUMBER	(	tmod	15	SENT_55	[p4l1683t557r1796b639],
23	all	DT	O	all	nsubjpass	28	SENT_55	[p4l1683t557r1796b639],
24	of	IN	O	of	_	0	SENT_55	[p4l1840t559r1921b625],
25	these	DT	O	these	det	26	SENT_55	[p4l1953t559r2140b625],
26	patients	NNS	O	patient	prep_of	23	SENT_55	[p4l9t668r298b754],
27	were	VBD	O	be	auxpass	28	SENT_55	[p4l334t691r506b731],
28	enrolled	VBN	O	enrol	rcmod	22	SENT_55	[p4l545t665r843b731],
29	in	IN	O	in	_	0	SENT_55	[p4l880t668r950b730],
30	North	NNP	LOCATION	North	nn	32	SENT_55	[p4l986t665r1212b731],
31	America	NNP	LOCATION	America	nn	32	SENT_55	[p4l1247t663r1612b745],
32	)	NN	O	)	prep_in	28	SENT_55	[p4l1247t663r1612b745],
33	.	.	O	.	_	0	SENT_55	[p4l1247t663r1612b745],

1	We	PRP	O	we	nsubj	2	SENT_56	[p4l1650t666r1782b732],
2	excluded	VBD	O	exclude	_	0	SENT_56	[p4l1821t665r2141b731],
3	32	CD	NUMBER	32	dobj	2	SENT_56	[p4l11t775r96b839],
4	of	IN	O	of	_	0	SENT_56	[p4l145t772r226b838],
5	these	DT	O	these	det	6	SENT_56	[p4l260t772r447b838],
6	patients	NNS	O	patient	prep_of	3	SENT_56	[p4l493t775r782b861],
7	because	IN	O	because	_	0	SENT_56	[p4l828t772r1108b838],
8	of	IN	O	of	_	0	SENT_56	[p4l1156t772r1238b838],
9	inadequate	JJ	O	inadequate	amod	10	SENT_56	[p4l1272t772r1671b861],
10	quantity	NN	O	quantity	prep_because_of	2	SENT_56	[p4l1719t775r2025b861],
11	or	CC	O	or	_	0	SENT_56	[p4l2068t798r2142b838],
12	quality	NN	O	quality	conj_or	10	SENT_56	[p4l11t878r263b967],
13	of	IN	O	of	_	0	SENT_56	[p4l292t878r373b944],
14	deoxyribonucleic	JJ	O	deoxyribonucleic	amod	15	SENT_56	[p4l393t878r1015b967],
15	acid	NN	O	acid	prep_of	10	SENT_56	[p4l1047t878r1192b944],
16	and	CC	O	and	_	0	SENT_56	[p4l1224t878r1355b944],
17	39	CD	NUMBER	39	conj_and	10	SENT_56	[p4l1387t881r1471b944],
18	owing	VBG	O	owe	partmod	17	SENT_56	[p4l1505t881r1729b967],
19	to	TO	O	to	_	0	SENT_56	[p4l1758t895r1828b944],
20	missing	VBG	O	miss	amod	21	SENT_56	[p4l1862t881r2142b967],
21	values	NNS	O	value	prep_to	18	SENT_56	[p4l7t983r228b1049],
22	for	IN	O	for	_	0	SENT_56	[p4l263t983r367b1048],
23	one	CD	NUMBER	one	prep_for	21	SENT_56	[p4l399t1009r527b1048],
24	or	CC	O	or	_	0	SENT_56	[p4l561t1008r635b1048],
25	more	JJR	O	more	prep_for	21	SENT_56	[p4l667t1008r852b1048],
26	of	IN	O	of	_	0	SENT_56	[p4l887t983r968b1048],
27	the	DT	O	the	det	30	SENT_56	[p4l989t983r1102b1048],
28	traditional	JJ	O	traditional	amod	30	SENT_56	[p4l1136t983r1523b1048],
29	risk	NN	O	risk	nn	30	SENT_56	[p4l1554t983r1690b1048],
30	factors	NNS	O	factor	prep_of	23	SENT_56	[p4l1719t983r1961b1048],
31	that	WDT	O	that	nsubjpass	33	SENT_56	[p4l1996t983r2142b1048],
32	were	VBD	O	be	auxpass	33	SENT_56	[p4l7t1115r179b1155],
33	required	VBN	O	require	rcmod	21	SENT_56	[p4l239t1089r546b1178],
34	for	IN	O	for	_	0	SENT_56	[p4l604t1089r709b1155],
35	multivariate	JJ	O	multivariate	amod	36	SENT_56	[p4l767t1089r1208b1155],
36	analysis	NN	O	analysis	prep_for	33	SENT_56	[p4l1270t1089r1569b1178],
37	.	.	O	.	_	0	SENT_56	[p4l1270t1089r1569b1178],

1	Because	IN	O	because	mark	9	SENT_57	[p4l1633t1090r1925b1155],
2	only	RB	O	only	quantmod	3	SENT_57	[p4l1987t1089r2145b1178],
3	10.3	CD	PERCENT	10.3	num	4	SENT_57	[p4l15t1198r237b1261],
4	%	NN	PERCENT	%	nsubj	9	SENT_57	[p4l15t1198r237b1261],
5	of	IN	O	of	_	0	SENT_57	[p4l292t1195r373b1261],
6	the	DT	O	the	det	7	SENT_57	[p4l415t1195r529b1261],
7	patients	NNS	O	patient	prep_of	4	SENT_57	[p4l582t1198r871b1284],
8	were	VBD	O	be	cop	9	SENT_57	[p4l923t1221r1095b1261],
9	nonwhite	JJ	O	nonwhite	advcl	12	SENT_57	[p4l1151t1195r1518b1276],
10	,	,	O	,	_	0	SENT_57	[p4l1151t1195r1518b1276],
11	which	WDT	O	which	nsubj	12	SENT_57	[p4l1572t1195r1796b1261],
12	did	VBD	O	do	_	0	SENT_57	[p4l1851t1195r1967b1261],
13	not	RB	O	not	neg	12	SENT_57	[p4l2022t1212r2142b1261],
14	JACC	NN	O	jacc	nn	15	SENT_57	[p4l1513t1300r1628b1351],
15	Vol	NN	O	vol	dobj	12	SENT_57	[p4l1648t1300r1731b1351],
16	.	.	O	.	_	0	SENT_57	[p4l1648t1300r1731b1351],

1	51	CD	NUMBER	51	_	0	SENT_58	[p4l1755t1300r1829b1359],
2	,	,	O	,	_	0	SENT_58	[p4l1755t1300r1829b1359],
3	No.	NN	O	no.	amod	1	SENT_58	[p4l1854t1300r1926b1351],
4	4	CD	NUMBER	4	number	3	SENT_58	[p4l1950t1300r1992b1359],
5	,	,	O	,	_	0	SENT_58	[p4l1950t1300r1992b1359],
6	2008	CD	DATE	2008	appos	1	SENT_58	[p4l2017t1300r2140b1351],
7	January	NNP	DATE	January	tmod	6	SENT_58	[p4l1514t1388r1690b1451],
8	29	CD	DATE	29	num	7	SENT_58	[p4l1710t1388r1783b1447],
9	,	,	O	,	_	0	SENT_58	[p4l1710t1388r1783b1447],
10	2008:449	CD	NUMBER	2008:449	num	7	SENT_58	[p4l1808t1388r2140b1438],
11	—	CD	NUMBER	—	num	12	SENT_58	[p4l1808t1388r2140b1438],
12	55	CD	NUMBER	55	dep	1	SENT_58	[p4l1808t1388r2140b1438],

1	provide	VB	O	provide	ccomp	13	SENT_59	[p4l9t1608r283b1697],
2	sufficient	JJ	O	sufficient	amod	3	SENT_59	[p4l322t1608r652b1674],
3	power	NN	O	power	dobj	1	SENT_59	[p4l686t1633r912b1697],
4	for	IN	O	for	_	0	SENT_59	[p4l946t1608r1050b1674],
5	a	DT	O	a	det	7	SENT_59	[p4l1087t1634r1121b1674],
6	separate	JJ	O	separate	amod	7	SENT_59	[p4l1158t1625r1452b1697],
7	analysis	NN	O	analysis	prep_for	1	SENT_59	[p4l1491t1608r1768b1697],
8	of	IN	O	of	_	0	SENT_59	[p4l1808t1608r1889b1674],
9	ethnic	JJ	O	ethnic	amod	10	SENT_59	[p4l1914t1608r2142b1674],
10	groups	NNS	O	group	prep_of	7	SENT_59	[p4l9t1740r277b1803],
11	,	,	O	,	_	0	SENT_59	[p4l9t1740r277b1803],
12	we	PRP	O	we	nsubj	13	SENT_59	[p4l337t1740r437b1780],
13	included	VBD	O	include	_	0	SENT_59	[p4l498t1714r814b1780],
14	only	RB	O	only	advmod	17	SENT_59	[p4l874t1714r1032b1803],
15	the	DT	O	the	det	17	SENT_59	[p4l1089t1714r1203b1780],
16	white	JJ	O	white	amod	17	SENT_59	[p4l1260t1714r1465b1780],
17	patients	NNS	O	patient	dobj	13	SENT_59	[p4l1526t1717r1815b1803],
18	in	IN	O	in	_	0	SENT_59	[p4l1877t1717r1946b1779],
19	this	DT	O	this	det	21	SENT_59	[p4l2007t1714r2139b1780],
20	genetic	JJ	O	genetic	amod	21	SENT_59	[p4l9t1823r273b1909],
21	analysis	NN	O	analysis	prep_in	17	SENT_59	[p4l323t1820r622b1909],
22	.	.	O	.	_	0	SENT_59	[p4l323t1820r622b1909],

1	After	IN	O	after	_	0	SENT_60	[p4l672t1818r870b1886],
2	these	DT	O	these	det	3	SENT_60	[p4l917t1820r1104b1886],
3	exclusions	NNS	O	exclusion	prep_after	7	SENT_60	[p4l1154t1820r1546b1901],
4	,	,	O	,	_	0	SENT_60	[p4l1154t1820r1546b1901],
5	1,778	CD	NUMBER	1,778	num	6	SENT_60	[p4l1602t1821r1799b1901],
6	patients	NNS	O	patient	nsubj	7	SENT_60	[p4l1850t1823r2139b1909],
7	remained	VBD	O	remain	_	0	SENT_60	[p4l10t1926r353b1992],
8	in	IN	O	in	_	0	SENT_60	[p4l383t1929r453b1991],
9	the	DT	O	the	det	11	SENT_60	[p4l484t1926r598b1992],
10	genetic	JJ	O	genetic	amod	11	SENT_60	[p4l629t1929r893b2015],
11	cohort	NN	O	cohort	prep_in	7	SENT_60	[p4l924t1926r1162b1992],
12	of	IN	O	of	_	0	SENT_60	[p4l1193t1926r1274b1992],
13	the	DT	O	the	det	17	SENT_60	[p4l1293t1926r1407b1992],
14	PROVE	NNP	O	PROVE	nn	17	SENT_60	[p4l1439t1926r1754b1993],
15	IT-TIMI	NN	O	it-timus	nn	17	SENT_60	[p4l1786t1924r2139b1991],
16	22	CD	NUMBER	22	num	17	SENT_60	[p4l9t2034r96b2097],
17	trial	NN	O	trial	prep_of	11	SENT_60	[p4l134t2031r301b2096],
18	.	.	O	.	_	0	SENT_60	[p4l134t2031r301b2096],

1	End	NN	O	end	_	0	SENT_61	[p4l11t2136r168b2203],
2	point	NN	O	point	nn	5	SENT_61	[p4l200t2141r401b2226],
3	and	CC	O	and	_	0	SENT_61	[p4l434t2136r570b2203],
4	laboratory	NN	O	laboratory	nn	5	SENT_61	[p4l600t2136r985b2226],
5	values	NNS	O	value	dep	1	SENT_61	[p4l1012t2136r1265b2203],
6	.	.	O	.	_	0	SENT_61	[p4l1012t2136r1265b2203],

1	The	DT	O	the	det	3	SENT_62	[p4l1314t2135r1461b2203],
2	end	NN	O	end	nn	3	SENT_62	[p4l1497t2137r1625b2203],
3	point	NN	O	point	nsubj	15	SENT_62	[p4l1658t2140r1846b2226],
4	for	IN	O	for	_	0	SENT_62	[p4l1879t2137r1980b2203],
5	this	DT	O	this	det	7	SENT_62	[p4l2012t2137r2139b2203],
6	genetic	JJ	O	genetic	amod	7	SENT_62	[p4l9t2247r263b2333],
7	study	NN	O	study	prep_for	3	SENT_62	[p4l294t2244r483b2333],
8	was	VBD	O	be	cop	15	SENT_62	[p4l505t2270r634b2310],
9	the	DT	O	the	det	15	SENT_62	[p4l666t2244r776b2310],
10	same	JJ	O	same	amod	15	SENT_62	[p4l809t2270r983b2310],
11	as	IN	O	as	_	0	SENT_62	[p4l1015t2270r1078b2310],
12	the	DT	O	the	det	14	SENT_62	[p4l1110t2244r1220b2310],
13	primary	JJ	O	primary	amod	14	SENT_62	[p4l1250t2247r1530b2333],
14	end	NN	O	end	prep_as	10	SENT_62	[p4l1558t2244r1685b2310],
15	point	NN	O	point	_	0	SENT_62	[p4l1714t2247r1902b2333],
16	of	IN	O	of	_	0	SENT_62	[p4l1932t2244r2012b2310],
17	the	DT	O	the	det	20	SENT_62	[p4l2029t2244r2140b2310],
18	original	JJ	O	original	amod	20	SENT_62	[p4l11t2350r281b2439],
19	PROVE	NNP	O	PROVE	nn	20	SENT_62	[p4l317t2350r625b2417],
20	IT	NNP	O	IT	prep_of	15	SENT_62	[p4l663t2348r1005b2415],
21	.	.	O	.	_	0	SENT_62	[p4l663t2348r1005b2415],

1	—	NN	O	—	_	0	SENT_63	[p4l663t2348r1005b2415],
2	.	.	O	.	_	0	SENT_63	[p4l663t2348r1005b2415],

1	TIMl	NN	O	timl	nsubj	22	SENT_64	[p4l663t2348r1005b2415],
2	22	CD	NUMBER	22	num	1	SENT_64	[p4l1042t2353r1127b2417],
3	study	NN	O	study	tmod	15	SENT_64	[p4l1167t2350r1356b2439],
4	(	CD	NUMBER	(	num	3	SENT_64	[p4l1392t2348r1541b2431],
5	i.e.	FW	O	i.e.	dep	3	SENT_64	[p4l1392t2348r1541b2431],
6	,	,	O	,	_	0	SENT_64	[p4l1392t2348r1541b2431],
7	death	NN	O	death	nsubj	15	SENT_64	[p4l1582t2350r1776b2416],
8	from	IN	O	from	_	0	SENT_64	[p4l1813t2350r1983b2416],
9	any	DT	O	any	det	10	SENT_64	[p4l2022t2376r2145b2439],
10	cause	NN	O	cause	prep_from	7	SENT_64	[p4l11t2482r195b2522],
11	or	CC	O	or	_	0	SENT_64	[p4l226t2482r298b2522],
12	major	JJ	O	major	amod	14	SENT_64	[p4l326t2457r529b2545],
13	cardiovascular	JJ	O	cardiovascular	amod	14	SENT_64	[p4l557t2456r1054b2522],
14	events	NNS	O	event	prep_from	7	SENT_64	[p4l1082t2454r1348b2537],
15	)	VBP	O	)	rcmod	1	SENT_64	[p4l1082t2454r1348b2537],
16	,	,	O	,	_	0	SENT_64	[p4l1082t2454r1348b2537],
17	which	WDT	O	which	nsubj	18	SENT_64	[p4l1376t2456r1594b2522],
18	included	VBD	O	include	rcmod	1	SENT_64	[p4l1622t2456r1926b2522],
19	myocardial	JJ	O	myocardial	amod	20	SENT_64	[p4l1954t2482r2138b2545, p4l11t2563r244b2629],
20	infarction	NN	O	infarction	dobj	18	SENT_64	[p4l292t2563r655b2644],
21	,	,	O	,	_	0	SENT_64	[p4l292t2563r655b2644],
22	documented	VBN	O	document	_	0	SENT_64	[p4l708t2563r1145b2629],
23	unstable	JJ	O	unstable	amod	26	SENT_64	[p4l1193t2563r1485b2629],
24	angina	NN	O	angina	nn	26	SENT_64	[p4l1536t2566r1770b2652],
25	requiring	VBG	O	require	amod	26	SENT_64	[p4l1817t2566r2142b2652],
26	hospitalization	NN	O	hospitalization	dobj	22	SENT_64	[p4l10t2702r553b2791],
27	,	,	O	,	_	0	SENT_64	[p4l10t2702r553b2791],
28	revascularization	NN	O	revascularization	dobj	22	SENT_64	[p4l599t2702r1188b2768],
29	with	IN	O	with	_	0	SENT_64	[p4l1227t2702r1388b2768],
30	either	CC	O	either	preconj	33	SENT_64	[p4l1432t2702r1636b2768],
31	percutaneous	JJ	O	percutaneous	amod	33	SENT_64	[p4l1675t2719r2139b2791],
32	coronary	JJ	O	coronary	amod	33	SENT_64	[p4l11t2867r321b2930],
33	intervention	NN	O	intervention	prep_with	28	SENT_64	[p4l350t2844r782b2907],
34	or	CC	O	or	_	0	SENT_64	[p4l815t2867r887b2907],
35	coronary	JJ	O	coronary	amod	37	SENT_64	[p4l920t2867r1229b2930],
36	artery	NN	O	artery	nn	37	SENT_64	[p4l1260t2858r1463b2930],
37	bypass	NN	O	bypass	conj_or	33	SENT_64	[p4l1490t2841r1717b2930],
38	grafting	VBG	O	graft	partmod	28	SENT_64	[p4l1751t2841r2032b2930],
39	(	CD	NUMBER	(	dobj	38	SENT_64	[p4l2066t2839r2153b2921],
40	if	IN	O	if	mark	44	SENT_64	[p4l2066t2839r2153b2921],
41	these	DT	O	these	det	42	SENT_64	[p4l10t2947r190b3013],
42	procedures	NNS	O	procedure	nsubjpass	44	SENT_64	[p4l242t2947r624b3036],
43	were	VBD	O	be	auxpass	44	SENT_64	[p4l675t2973r841b3013],
44	performed	VBN	O	perform	advcl	38	SENT_64	[p4l894t2947r1264b3036],
45	at	IN	DURATION	at	advmod	48	SENT_64	[p4l1318t2964r1381b3013],
46	least	JJS	DURATION	least	pobj	45	SENT_64	[p4l1431t2947r1589b3013],
47	30	CD	DURATION	30	num	48	SENT_64	[p4l1641t2950r1724b3013],
48	days	NNS	NUMBER	day	tmod	44	SENT_64	[p4l1779t2947r1927b3036],
49	after	IN	O	after	_	0	SENT_64	[p4l1983t2947r2142b3013],
50	randomization	NN	O	randomization	nn	51	SENT_64	[p4l10t3051r578b3134],
51	)	NN	O	)	prep_after	44	SENT_64	[p4l10t3051r578b3134],
52	,	,	O	,	_	0	SENT_64	[p4l10t3051r578b3134],
53	and	CC	O	and	_	0	SENT_64	[p4l636t3053r763b3119],
54	stroke	NN	O	stroke	dobj	22	SENT_64	[p4l817t3053r1047b3119],
55	.	.	O	.	_	0	SENT_64	[p4l817t3053r1047b3119],

1	All	DT	O	all	det	3	SENT_65	[p4l1103t3051r1211b3118],
2	laboratory	NN	O	laboratory	nn	3	SENT_65	[p4l1260t3053r1606b3142],
3	measurements	NNS	O	measurement	nsubjpass	5	SENT_65	[p4l1655t3070r2139b3119],
4	were	VBD	O	be	auxpass	5	SENT_65	[p4l7t3185r168b3225],
5	made	VBN	O	make	_	0	SENT_65	[p4l214t3159r398b3225],
6	in	IN	O	in	_	0	SENT_65	[p4l443t3162r509b3224],
7	a	DT	O	a	det	9	SENT_65	[p4l555t3185r589b3225],
8	core	NN	O	core	nn	9	SENT_65	[p4l634t3185r772b3225],
9	facility	NN	O	facility	prep_in	5	SENT_65	[p4l817t3159r1045b3248],
10	(	CD	NUMBER	(	number	11	SENT_65	[p4l1089t3157r1241b3239],
11	14	CD	NUMBER	14	num	12	SENT_65	[p4l1089t3157r1241b3239],
12	)	NN	O	)	dep	5	SENT_65	[p4l1089t3157r1241b3239],
13	.	.	O	.	_	0	SENT_65	[p4l1089t3157r1241b3239],

1	Low	JJ	O	low	amod	3	SENT_66	[p4l1291t3159r1727b3248],
2	—	NN	O	—	nn	3	SENT_66	[p4l1291t3159r1727b3248],
3	density	NN	O	density	_	0	SENT_66	[p4l1291t3159r1727b3248],
4	lipoprotein	NN	O	lipoprotein	nn	7	SENT_66	[p4l1766t3159r2141b3248],
5	cholesterol	NN	O	cholesterol	nn	7	SENT_66	[p4l11t3265r375b3331],
6	(	NN	O	(	nn	7	SENT_66	[p4l407t3263r737b3345],
7	LDL	NN	O	ldl	dep	3	SENT_66	[p4l407t3263r737b3345],
8	.	.	O	.	_	0	SENT_66	[p4l407t3263r737b3345],

1	—	NN	O	—	_	0	SENT_67	[p4l407t3263r737b3345],
2	.	.	O	.	_	0	SENT_67	[p4l407t3263r737b3345],

1	C	NN	O	c	nn	2	SENT_68	[p4l407t3263r737b3345],
2	)	NN	O	)	nsubjpass	7	SENT_68	[p4l407t3263r737b3345],
3	and	CC	O	and	_	0	SENT_68	[p4l772t3265r896b3331],
4	triglyceride	NN	O	triglyceride	nn	5	SENT_68	[p4l924t3265r1301b3354],
5	levels	NNS	O	level	conj_and	2	SENT_68	[p4l1329t3265r1508b3331],
6	were	VBD	O	be	auxpass	7	SENT_68	[p4l1536t3291r1697b3331],
7	measured	VBN	O	measure	_	0	SENT_68	[p4l1728t3265r2051b3331],
8	at	IN	O	at	_	0	SENT_68	[p4l2081t3282r2143b3331],
9	baseline	NN	O	baseline	prep_at	7	SENT_68	[p4l8t3371r278b3437],
10	and	CC	O	and	_	0	SENT_68	[p4l329t3371r453b3437],
11	at	IN	O	at	_	0	SENT_68	[p4l502t3388r564b3437],
12	the	DT	O	the	conj_and	9	SENT_68	[p4l610t3371r717b3437],
13	following	VBG	O	follow	amod	12	SENT_68	[p4l766t3371r1087b3460],
14	scheduled	VBN	O	schedule	partmod	12	SENT_68	[p4l1135t3371r1469b3437],
15	visits	NNS	O	visit	dobj	14	SENT_68	[p4l1514t3374r1699b3437],
16	:	:	O	:	_	0	SENT_68	[p4l1514t3374r1699b3437],
17	30	CD	DURATION	30	num	18	SENT_68	[p4l1753t3374r1835b3437],
18	days	NNS	NUMBER	day	dobj	14	SENT_68	[p4l1885t3371r2048b3460],
19	,	,	O	,	_	0	SENT_68	[p4l1885t3371r2048b3460],
20	4	CD	DURATION	4	num	21	SENT_68	[p4l2099t3374r2141b3436],
21	months	NNS	NUMBER	month	dobj	14	SENT_68	[p4l11t3477r288b3558],
22	,	,	O	,	_	0	SENT_68	[p4l11t3477r288b3558],
23	8	CD	DURATION	8	num	24	SENT_68	[p4l337t3480r372b3543],
24	months	NNS	NUMBER	month	dobj	14	SENT_68	[p4l419t3477r695b3558],
25	,	,	O	,	_	0	SENT_68	[p4l419t3477r695b3558],
26	16	CD	DURATION	16	num	27	SENT_68	[p4l745t3480r823b3543],
27	months	NNS	NUMBER	month	dobj	14	SENT_68	[p4l869t3477r1145b3558],
28	,	,	O	,	_	0	SENT_68	[p4l869t3477r1145b3558],
29	and	CC	O	and	_	0	SENT_68	[p4l1193t3477r1317b3543],
30	the	DT	O	the	det	31	SENT_68	[p4l1359t3477r1466b3543],
31	end	NN	O	end	dobj	14	SENT_68	[p4l1511t3477r1635b3543],
32	of	IN	O	of	prep	31	SENT_68	[p4l1679t3477r1757b3543],
33	follow	VB	O	follow	dep	32	SENT_68	[p4l1788t3477r2137b3566],
34	—	RB	O	—	advmod	33	SENT_68	[p4l1788t3477r2137b3566],
35	up	RB	O	up	advmod	33	SENT_68	[p4l1788t3477r2137b3566],
36	;	:	O	;	_	0	SENT_68	[p4l1788t3477r2137b3566],
37	follow	VB	O	follow	csubj	46	SENT_68	[p4l10t3583r349b3672],
38	—	CD	NUMBER	—	npadvmod	39	SENT_68	[p4l10t3583r349b3672],
39	up	IN	O	up	advmod	40	SENT_68	[p4l10t3583r349b3672],
40	lasted	VBN	O	last	dep	37	SENT_68	[p4l408t3583r609b3649],
41	18	CD	DURATION	18	number	43	SENT_68	[p4l671t3586r748b3649],
42	to	TO	DURATION	to	dep	43	SENT_68	[p4l810t3600r877b3649],
43	36	CD	DURATION	36	num	44	SENT_68	[p4l939t3586r1020b3649],
44	months	NNS	NUMBER	month	tmod	40	SENT_68	[p4l1082t3583r1344b3649],
45	(	RB	O	(	advmod	46	SENT_68	[p4l1407t3581r1623b3663],
46	mean	VBP	O	mean	parataxis	7	SENT_68	[p4l1407t3581r1623b3663],
47	24	CD	DURATION	24	num	48	SENT_68	[p4l1679t3586r1766b3650],
48	months	NNS	NUMBER	month	tmod	46	SENT_68	[p4l1826t3581r2135b3663],
49	)	RB	O	)	advmod	46	SENT_68	[p4l1826t3581r2135b3663],
50	.	.	O	.	_	0	SENT_68	[p4l1826t3581r2135b3663],

1	C-reactive	JJ	O	c-reactive	amod	2	SENT_69	[p4l12t3689r364b3755],
2	protein	NN	O	protein	nsubjpass	8	SENT_69	[p4l387t3692r632b3778],
3	(	CD	NUMBER	(	num	6	SENT_69	[p4l658t3687r882b3769],
4	CRP	NN	O	crp	nn	6	SENT_69	[p4l658t3687r882b3769],
5	)	NN	O	)	nn	6	SENT_69	[p4l658t3687r882b3769],
6	levels	NNS	O	level	dep	2	SENT_69	[p4l908t3689r1087b3755],
7	were	VBD	O	be	auxpass	8	SENT_69	[p4l1108t3715r1269b3755],
8	measured	VBN	O	measure	_	0	SENT_69	[p4l1294t3689r1617b3755],
9	at	IN	O	at	_	0	SENT_69	[p4l1641t3706r1703b3755],
10	baseline	NN	O	baseline	prep_at	8	SENT_69	[p4l1722t3689r1992b3755],
11	and	CC	O	and	_	0	SENT_69	[p4l2018t3689r2141b3755],
12	at	IN	O	at	_	0	SENT_69	[p5l12t32r73b81],
13	the	DT	O	the	conj_and	10	SENT_69	[p5l103t15r210b81],
14	following	VBG	O	follow	amod	13	SENT_69	[p5l242t15r564b104],
15	scheduled	VBN	O	schedule	partmod	13	SENT_69	[p5l595t15r929b81],
16	visits	NNS	O	visit	dobj	15	SENT_69	[p5l957t18r1142b81],
17	:	:	O	:	_	0	SENT_69	[p5l957t18r1142b81],
18	30	CD	DURATION	30	num	19	SENT_69	[p5l1179t18r1261b81],
19	days	NNS	NUMBER	day	conj_and	10	SENT_69	[p5l1295t15r1458b104],
20	,	,	O	,	_	0	SENT_69	[p5l1295t15r1458b104],
21	4	CD	DURATION	4	num	22	SENT_69	[p5l1492t18r1534b80],
22	months	NNS	NUMBER	month	appos	19	SENT_69	[p5l1566t15r1842b96],
23	,	,	O	,	_	0	SENT_69	[p5l1566t15r1842b96],
24	and	CC	O	and	_	0	SENT_69	[p5l1879t15r2003b81],
25	the	DT	O	the	det	26	SENT_69	[p5l2033t15r2140b81],
26	end	NN	O	end	conj_and	13	SENT_69	[p5l11t121r136b187],
27	of	IN	O	of	prep	26	SENT_69	[p5l180t121r258b187],
28	follow	VB	O	follow	dep	27	SENT_69	[p5l290t121r638b210],
29	—	RB	O	—	advmod	28	SENT_69	[p5l290t121r638b210],
30	up	RB	O	up	advmod	28	SENT_69	[p5l290t121r638b210],
31	.	.	O	.	_	0	SENT_69	[p5l290t121r638b210],

1	KIF6	NN	O	kif6	nn	3	SENT_70	[p5l685t124r871b187],
2	Trp719Arg	NN	O	trp719arg	nn	3	SENT_70	[p5l911t119r1310b210],
3	genotypes	NNS	O	genotype	nsubjpass	5	SENT_70	[p5l1351t138r1688b210],
4	were	VBD	O	be	auxpass	5	SENT_70	[p5l1730t147r1892b187],
5	determined	VBN	O	determine	_	0	SENT_70	[p5l1937t121r2138b187, p5l11t228r228b294],
6	using	VBG	O	use	xcomp	5	SENT_70	[p5l281t231r464b317],
7	an	DT	O	a	det	10	SENT_70	[p5l519t254r597b294],
8	allele	NN	O	allele	nn	10	SENT_70	[p5l653t228r1105b317],
9	—	NN	O	—	nn	10	SENT_70	[p5l653t228r1105b317],
10	speciﬁc	NN	O	speciﬁc	nsubj	16	SENT_70	[p5l653t228r1105b317],
11	real-time	JJ	O	real-time	amod	16	SENT_70	[p5l1159t228r1467b294],
12	polymerase	NN	O	polymerase	nn	16	SENT_70	[p5l1522t228r1902b317],
13	chain	NN	O	chain	nn	16	SENT_70	[p5l1959t228r2141b294],
14	reaction	NN	O	reaction	nn	16	SENT_70	[p5l10t337r294b400],
15	genotyping	NN	O	genotyping	nn	16	SENT_70	[p5l353t337r753b423],
16	assay	NN	O	assay	xcomp	6	SENT_70	[p5l813t360r990b423],
17	at	IN	O	at	_	0	SENT_70	[p5l1048t351r1111b400],
18	a	DT	O	a	det	20	SENT_70	[p5l1172t360r1206b400],
19	core	NN	O	core	nn	20	SENT_70	[p5l1266t360r1410b400],
20	facility	NN	O	facility	prep_at	16	SENT_70	[p5l1471t334r1712b423],
21	(	CD	NUMBER	(	number	22	SENT_70	[p5l1771t332r1931b414],
22	15	CD	NUMBER	15	num	23	SENT_70	[p5l1771t332r1931b414],
23	)	NN	O	)	dep	20	SENT_70	[p5l1771t332r1931b414],
24	.	.	O	.	_	0	SENT_70	[p5l1771t332r1931b414],

1	The	DT	O	the	det	3	SENT_71	[p5l1993t332r2140b400],
2	Trp719Arg	NN	O	trp719arg	nn	3	SENT_71	[p5l8t438r406b529],
3	genotypes	NNS	O	genotype	nsubjpass	10	SENT_71	[p5l440t457r776b529],
4	determined	VBN	O	determine	partmod	3	SENT_71	[p5l815t440r1204b506],
5	with	IN	O	with	_	0	SENT_71	[p5l1236t440r1392b506],
6	this	DT	O	this	det	7	SENT_71	[p5l1428t440r1549b506],
7	assay	NN	O	assay	prep_with	4	SENT_71	[p5l1589t466r1759b529],
8	have	VBP	O	have	aux	10	SENT_71	[p5l1791t440r1944b506],
9	been	VBN	O	be	auxpass	10	SENT_71	[p5l1980t440r2141b506],
10	shown	VBN	O	show	_	0	SENT_71	[p5l12t546r232b612],
11	to	TO	O	to	aux	13	SENT_71	[p5l264t563r330b612],
12	be	VB	O	be	cop	13	SENT_71	[p5l361t546r439b612],
13	>	JJR	O	>	xcomp	10	SENT_71	[p5l477t549r756b612],
14	99.8	CD	PERCENT	99.8	num	15	SENT_71	[p5l477t549r756b612],
15	%	NN	PERCENT	%	tmod	13	SENT_71	[p5l477t549r756b612],
16	concordant	JJ	O	concordant	amod	15	SENT_71	[p5l789t546r1170b612],
17	with	IN	O	with	_	0	SENT_71	[p5l1196t546r1352b612],
18	genotypes	NNS	O	genotype	prep_with	16	SENT_71	[p5l1382t563r1719b635],
19	determined	VBN	O	determine	partmod	18	SENT_71	[p5l1753t546r2141b612],
20	using	VBG	O	use	xcomp	19	SENT_71	[p5l9t656r193b742],
21	a	DT	O	a	det	24	SENT_71	[p5l243t679r277b719],
22	different	JJ	O	different	amod	24	SENT_71	[p5l327t653r610b719],
23	genotyping	NN	O	genotyping	nn	24	SENT_71	[p5l657t656r1040b742],
24	technology	NN	O	technology	dobj	20	SENT_71	[p5l1089t653r1465b742],
25	(	CD	NUMBER	(	num	27	SENT_71	[p5l1514t651r1667b733],
26	16	CD	NUMBER	16	num	27	SENT_71	[p5l1514t651r1667b733],
27	)	NN	O	)	dep	15	SENT_71	[p5l1514t651r1667b733],
28	.	.	O	.	_	0	SENT_71	[p5l1514t651r1667b733],

1	The	DT	O	the	det	3	SENT_72	[p5l1719t651r1862b719],
2	primer	NN	O	primer	nn	3	SENT_72	[p5l1912t656r2142b742],
3	sequences	NNS	O	sequence	nsubj	5	SENT_72	[p5l12t818r342b881],
4	are	VBP	O	be	cop	5	SENT_72	[p5l375t818r472b858],
5	available	JJ	O	available	_	0	SENT_72	[p5l504t792r788b858],
6	upon	IN	O	upon	_	0	SENT_72	[p5l817t818r992b881],
7	request	NN	O	request	prep_upon	5	SENT_72	[p5l1021t809r1281b881],
8	.	.	O	.	_	0	SENT_72	[p5l1021t809r1281b881],

1	Statistical	JJ	O	statistical	amod	2	SENT_73	[p5l13t897r382b964],
2	analyses	NNS	O	analysis	_	0	SENT_73	[p5l438t897r760b987],
3	.	.	O	.	_	0	SENT_73	[p5l438t897r760b987],

1	All	DT	O	all	nsubj	2	SENT_74	[p5l810t896r921b963],
2	reported	VBD	O	report	_	0	SENT_74	[p5l976t898r1275b987],
3	p	NN	O	p	nn	4	SENT_74	[p5l1329t924r1371b987],
4	values	NNS	O	value	nsubj	7	SENT_74	[p5l1426t898r1638b964],
5	are	VBP	O	be	cop	7	SENT_74	[p5l1698t924r1798b964],
6	2	CD	NUMBER	2	number	7	SENT_74	[p5l1854t898r2136b965],
7	—	CD	NUMBER	—	ccomp	2	SENT_74	[p5l1854t898r2136b965],
8	sided	VBD	O	side	rcmod	7	SENT_74	[p5l1854t898r2136b965],
9	.	.	O	.	_	0	SENT_74	[p5l1854t898r2136b965],

1	Differences	NNS	O	difference	nsubjpass	6	SENT_75	[p5l11t1003r408b1068],
2	between	IN	O	between	_	0	SENT_75	[p5l451t1003r744b1069],
3	baseline	NN	O	baseline	nn	4	SENT_75	[p5l786t1003r1067b1068],
4	characteristics	NNS	O	characteristic	prep_between	1	SENT_75	[p5l1112t1003r1606b1068],
5	were	VBD	O	be	auxpass	6	SENT_75	[p5l1647t1028r1814b1069],
6	assessed	VBN	O	assess	_	0	SENT_75	[p5l1859t1003r2142b1068],
7	by	IN	O	by	_	0	SENT_75	[p5l9t1109r95b1198],
8	the	DT	O	the	det	13	SENT_75	[p5l119t1109r229b1175],
9	Wilcoxon	NNP	O	Wilcoxon	nn	13	SENT_75	[p5l254t1109r605b1176],
10	rank	NN	O	rank	nn	13	SENT_75	[p5l633t1109r974b1175],
11	—	NN	O	—	nn	13	SENT_75	[p5l633t1109r974b1175],
12	sum	NN	O	sum	nn	13	SENT_75	[p5l633t1109r974b1175],
13	test	NN	O	test	agent	6	SENT_75	[p5l1002t1126r1127b1175],
14	(	CD	NUMBER	(	num	16	SENT_75	[p5l1157t1107r1571b1189],
15	continuous	JJ	O	continuous	amod	16	SENT_75	[p5l1157t1107r1571b1189],
16	variables	NNS	O	variable	tmod	6	SENT_75	[p5l1598t1107r1929b1189],
17	)	CD	NUMBER	)	nn	25	SENT_75	[p5l1598t1107r1929b1189],
18	or	CC	O	or	_	0	SENT_75	[p5l1962t1135r2034b1175],
19	by	IN	O	by	nn	25	SENT_75	[p5l2059t1109r2145b1198],
20	Fisher	NNP	PERSON	Fisher	nn	23	SENT_75	[p5l11t1214r233b1279],
21	exact	JJ	O	exact	amod	23	SENT_75	[p5l264t1231r441b1279],
22	test	NN	O	test	nn	23	SENT_75	[p5l471t1231r596b1279],
23	(	NN	O	(	pobj	19	SENT_75	[p5l629t1212r924b1294],
24	discrete	JJ	O	discrete	amod	25	SENT_75	[p5l629t1212r924b1294],
25	variables	NNS	O	variable	nsubj	26	SENT_75	[p5l953t1212r1306b1294],
26	)	VBP	O	)	rcmod	16	SENT_75	[p5l953t1212r1306b1294],
27	.	.	O	.	_	0	SENT_75	[p5l953t1212r1306b1294],

1	We	PRP	O	we	nsubj	2	SENT_76	[p5l1338t1215r1469b1280],
2	assessed	VBD	O	assess	_	0	SENT_76	[p5l1503t1214r1785b1279],
3	deviation	NN	O	deviation	dobj	2	SENT_76	[p5l1817t1214r2141b1280],
4	from	IN	O	from	_	0	SENT_76	[p5l10t1320r180b1386],
5	Hardy	NNP	PERSON	Hardy	prep_from	2	SENT_76	[p5l209t1320r830b1409],
6	.	.	O	.	_	0	SENT_76	[p5l209t1320r830b1409],

1	—	NN	O	—	_	0	SENT_77	[p5l209t1320r830b1409],
2	.	.	O	.	_	0	SENT_77	[p5l209t1320r830b1409],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_78	[p5l209t1320r830b1409],
2	equilibrium	NN	O	equilibrium	_	0	SENT_78	[p5l857t1320r1266b1409],
3	using	VBG	O	use	partmod	2	SENT_78	[p5l1293t1323r1483b1409],
4	an	DT	O	a	det	9	SENT_78	[p5l1511t1346r1591b1386],
5	exact	JJ	O	exact	amod	9	SENT_78	[p5l1620t1337r1797b1386],
6	test	NN	O	test	nn	9	SENT_78	[p5l1823t1337r1948b1386],
7	(	NN	O	(	nn	9	SENT_78	[p5l1977t1318r2136b1400],
8	17	CD	NUMBER	17	num	9	SENT_78	[p5l1977t1318r2136b1400],
9	)	NN	O	)	dobj	3	SENT_78	[p5l1977t1318r2136b1400],
10	.	.	O	.	_	0	SENT_78	[p5l1977t1318r2136b1400],

1	A	DT	O	a	det	3	SENT_79	[p5l8t1425r75b1492],
2	chi	NN	O	chus	nn	3	SENT_79	[p5l98t1427r465b1516],
3	—	NN	O	—	nsubjpass	7	SENT_79	[p5l98t1427r465b1516],
4	square	JJ	O	square	amod	5	SENT_79	[p5l98t1427r465b1516],
5	test	NN	O	test	dep	3	SENT_79	[p5l490t1444r614b1493],
6	was	VBD	O	be	auxpass	7	SENT_79	[p5l633t1453r762b1493],
7	used	VBN	O	use	_	0	SENT_79	[p5l787t1427r946b1493],
8	to	TO	O	to	aux	9	SENT_79	[p5l969t1444r1037b1493],
9	test	VB	O	test	xcomp	7	SENT_79	[p5l1062t1444r1187b1493],
10	for	IN	O	for	_	0	SENT_79	[p5l1209t1427r1310b1493],
11	differences	NNS	O	difference	prep_for	9	SENT_79	[p5l1333t1427r1703b1493],
12	in	IN	O	in	_	0	SENT_79	[p5l1729t1430r1797b1492],
13	genotype	NN	O	genotype	nn	14	SENT_79	[p5l1820t1444r2140b1516],
14	frequencies	NNS	O	frequency	prep_in	11	SENT_79	[p5l10t1533r406b1622],
15	across	IN	O	across	_	0	SENT_79	[p5l435t1559r641b1599],
16	studies	NNS	O	study	prep_across	9	SENT_79	[p5l670t1533r928b1599],
17	.	.	O	.	_	0	SENT_79	[p5l670t1533r928b1599],

1	Cox	NN	O	cox	nsubjpass	6	SENT_80	[p5l959t1533r1106b1599],
2	proportional	JJ	O	proportional	amod	4	SENT_80	[p5l1129t1533r1572b1622],
3	hazards	NNS	O	hazard	nn	4	SENT_80	[p5l1597t1533r1862b1599],
4	models	NNS	O	model	dep	1	SENT_80	[p5l1891t1533r2139b1599],
5	were	VBD	O	be	auxpass	6	SENT_80	[p5l7t1665r173b1705],
6	used	VBN	O	use	_	0	SENT_80	[p5l199t1639r358b1705],
7	to	TO	O	to	aux	8	SENT_80	[p5l383t1656r451b1705],
8	assess	VB	O	assess	xcomp	6	SENT_80	[p5l479t1665r675b1705],
9	the	DT	O	the	det	10	SENT_80	[p5l702t1639r813b1705],
10	effect	NN	O	effect	dobj	8	SENT_80	[p5l840t1639r1025b1705],
11	of	IN	O	of	_	0	SENT_80	[p5l1050t1639r1130b1705],
12	intensive	JJ	O	intensive	amod	13	SENT_80	[p5l1144t1642r1456b1705],
13	therapy	NN	O	therapy	prep_of	10	SENT_80	[p5l1482t1639r1765b1728],
14	,	,	O	,	_	0	SENT_80	[p5l1482t1639r1765b1728],
15	compared	VBN	O	compare	_	0	SENT_80	[p5l1795t1639r2142b1728],
16	with	IN	O	with	prepc_compared_with	8	SENT_80	[p5l7t1745r168b1811],
17	moderate	JJ	O	moderate	amod	18	SENT_80	[p5l199t1745r528b1811],
18	therapy	NN	O	therapy	pobj	8	SENT_80	[p5l558t1745r841b1834],
19	,	,	O	,	_	0	SENT_80	[p5l558t1745r841b1834],
20	on	IN	O	on	_	0	SENT_80	[p5l874t1771r962b1811],
21	incident	NN	O	incident	nn	22	SENT_80	[p5l991t1745r1281b1811],
22	events	NNS	O	event	prep_on	6	SENT_80	[p5l1309t1762r1525b1811],
23	in	IN	O	in	_	0	SENT_80	[p5l1556t1748r1624b1810],
24	KIF6	NN	O	kif6	nn	26	SENT_80	[p5l1652t1748r1842b1811],
25	719Arg	NN	O	719arg	nn	26	SENT_80	[p5l1873t1743r2143b1834],
26	carriers	NNS	O	carrier	prep_in	22	SENT_80	[p5l11t1853r264b1915],
27	and	CC	O	and	_	0	SENT_80	[p5l307t1850r435b1915],
28	noncarriers	NNS	O	noncarrier	prep_in	22	SENT_80	[p5l475t1853r886b1915],
29	.	.	O	.	_	0	SENT_80	[p5l475t1853r886b1915],

1	To	TO	O	to	aux	2	SENT_81	[p5l927t1848r1032b1915],
2	estimate	VB	O	estimate	purpcl	24	SENT_81	[p5l1075t1853r1367b1915],
3	hazard	NN	O	hazard	nn	4	SENT_81	[p5l1407t1850r1644b1915],
4	ratios	NNS	O	ratio	nsubj	5	SENT_81	[p5l1683t1853r1875b1915],
5	(	VBP	O	(	ccomp	2	SENT_81	[p5l1919t1848r2137b1930],
6	HRS	NNS	DURATION	hr	nsubj	8	SENT_81	[p5l1919t1848r2137b1930],
7	)	RB	O	)	advmod	8	SENT_81	[p5l1919t1848r2137b1930],
8	adjusted	VBN	O	adjust	xcomp	5	SENT_81	[p5l12t1956r303b2045],
9	for	IN	O	for	_	0	SENT_81	[p5l328t1956r429b2022],
10	the	DT	O	the	det	11	SENT_81	[p5l453t1956r563b2022],
11	effects	NNS	O	effect	prep_for	8	SENT_81	[p5l590t1956r804b2022],
12	of	IN	O	of	_	0	SENT_81	[p5l832t1956r912b2022],
13	other	JJ	O	other	amod	15	SENT_81	[p5l926t1956r1112b2022],
14	risk	NN	O	risk	nn	15	SENT_81	[p5l1136t1956r1267b2022],
15	factors	NNS	O	factor	prep_of	11	SENT_81	[p5l1289t1956r1520b2022],
16	and	CC	O	and	_	0	SENT_81	[p5l1549t1956r1676b2022],
17	study	NN	O	study	nn	19	SENT_81	[p5l1703t1956r1892b2045],
18	design	NN	O	design	nn	19	SENT_81	[p5l1915t1956r2141b2045],
19	variables	NNS	O	variable	prep_of	11	SENT_81	[p5l7t2062r332b2142],
20	,	,	O	,	_	0	SENT_81	[p5l7t2062r332b2142],
21	baseline	NN	O	baseline	nn	22	SENT_81	[p5l389t2062r671b2127],
22	covariates	NNS	O	covariate	nsubjpass	31	SENT_81	[p5l728t2065r1069b2128],
23	were	VBD	O	be	auxpass	24	SENT_81	[p5l1123t2087r1290b2128],
24	included	VBN	O	include	_	0	SENT_81	[p5l1346t2062r1650b2127],
25	in	IN	O	in	_	0	SENT_81	[p5l1705t2065r1772b2127],
26	the	DT	O	the	det	28	SENT_81	[p5l1828t2062r1938b2127],
27	Cox	NN	O	cox	nn	28	SENT_81	[p5l1996t2062r2142b2128],
28	models	NNS	O	model	prep_in	24	SENT_81	[p5l11t2168r260b2234],
29	and	CC	O	and	_	0	SENT_81	[p5l298t2168r426b2234],
30	were	VBD	O	be	auxpass	31	SENT_81	[p5l457t2194r623b2234],
31	coded	VBN	O	code	conj_and	24	SENT_81	[p5l660t2168r868b2234],
32	either	CC	O	either	prep	31	SENT_81	[p5l903t2168r1107b2234],
33	continuously	RB	O	continuously	advmod	34	SENT_81	[p5l1141t2168r1595b2257],
34	(	JJ	O	(	amod	35	SENT_81	[p5l1630t2166r1791b2257],
35	age	NN	O	age	dep	32	SENT_81	[p5l1630t2166r1791b2257],
36	,	,	O	,	_	0	SENT_81	[p5l1630t2166r1791b2257],
37	LDL-C	NN	O	ldl-c	appos	35	SENT_81	[p5l1831t2168r2138b2249],
38	,	,	O	,	_	0	SENT_81	[p5l1831t2168r2138b2249],
39	high-density	JJ	O	high-density	amod	41	SENT_81	[p5l10t2274r464b2363],
40	lipoprotein	NN	O	lipoprotein	nn	41	SENT_81	[p5l483t2274r875b2363],
41	cholesterol	NN	O	cholesterol	appos	35	SENT_81	[p5l901t2274r1282b2340],
42	[	CD	NUMBER	[	num	43	SENT_81	[p5l1311t2272r1694b2355],
43	HDL	NN	O	hdl	dep	41	SENT_81	[p5l1311t2272r1694b2355],
44	.	.	O	.	_	0	SENT_81	[p5l1311t2272r1694b2355],

1	—	NN	O	—	_	0	SENT_82	[p5l1311t2272r1694b2355],
2	.	.	O	.	_	0	SENT_82	[p5l1311t2272r1694b2355],

1	C	NN	O	c	nn	2	SENT_83	[p5l1311t2272r1694b2355],
2	]	NN	O	]	_	0	SENT_83	[p5l1311t2272r1694b2355],
3	,	,	O	,	_	0	SENT_83	[p5l1311t2272r1694b2355],
4	triglyceride	NN	O	triglyceride	appos	2	SENT_83	[p5l1722t2274r2138b2363],
5	,	,	O	,	_	0	SENT_83	[p5l1722t2274r2138b2363],
6	and	CC	O	and	_	0	SENT_83	[p5l12t2380r139b2446],
7	CRP	NN	O	crp	nn	8	SENT_83	[p5l175t2380r352b2446],
8	levels	NNS	O	level	conj_and	4	SENT_83	[p5l386t2378r600b2460],
9	)	CD	NUMBER	)	dep	8	SENT_83	[p5l386t2378r600b2460],
10	or	CC	O	or	_	0	SENT_83	[p5l640t2406r712b2446],
11	dichotomously	RB	O	dichotomously	advmod	8	SENT_83	[p5l746t2380r1271b2469],
12	(	CD	NUMBER	(	num	13	SENT_83	[p5l1305t2378r1590b2469],
13	gender	NN	O	gender	conj_and	4	SENT_83	[p5l1305t2378r1590b2469],
14	,	,	O	,	_	0	SENT_83	[p5l1305t2378r1590b2469],
15	smoking	NN	O	smoking	nn	16	SENT_83	[p5l1629t2380r1932b2469],
16	[	NN	O	[	appos	13	SENT_83	[p5l1971t2378r2138b2460, p5l10t2503r152b2552],
17	current	JJ	DATE	current	amod	4	SENT_83	[p5l1971t2378r2138b2460, p5l10t2503r152b2552],
18	vs.	CC	O	vs.	prep	4	SENT_83	[p5l183t2512r272b2552],
19	never	RB	O	never	advmod	26	SENT_83	[p5l313t2512r502b2552],
20	or	CC	O	or	dep	21	SENT_83	[p5l536t2512r608b2552],
21	past	RB	DATE	past	dep	19	SENT_83	[p5l641t2484r834b2575],
22	]	RB	O	]	advmod	21	SENT_83	[p5l641t2484r834b2575],
23	,	,	O	,	_	0	SENT_83	[p5l641t2484r834b2575],
24	hypertension	NN	O	hypertension	nn	25	SENT_83	[p5l872t2486r1330b2575],
25	[	NN	O	[	appos	21	SENT_83	[p5l1371t2484r1658b2566],
26	deﬁned	VBN	O	deﬁned	dep	18	SENT_83	[p5l1371t2484r1658b2566],
27	as	IN	O	as	_	0	SENT_83	[p5l1695t2512r1758b2552],
28	history	NN	O	history	prep_as	26	SENT_83	[p5l1795t2486r2040b2575],
29	of	IN	O	of	_	0	SENT_83	[p5l2073t2486r2153b2552],
30	hypertension	NN	O	hypertension	prep_of	28	SENT_83	[p5l10t2592r488b2681],
31	,	,	O	,	_	0	SENT_83	[p5l10t2592r488b2681],
32	systolic	JJ	O	systolic	amod	37	SENT_83	[p5l543t2592r796b2681],
33	blood	NN	O	blood	nn	37	SENT_83	[p5l845t2592r1046b2658],
34	pressure	NN	O	pressure	nn	37	SENT_83	[p5l1096t2618r1383b2681],
35	2140	CD	DATE	2140	num	37	SENT_83	[p5l1440t2595r1638b2658],
36	mm	NN	O	mm	nn	37	SENT_83	[p5l1690t2618r1829b2657],
37	Hg	NN	O	hg	conj_or	30	SENT_83	[p5l1881t2593r2016b2681],
38	,	,	O	,	_	0	SENT_83	[p5l1881t2593r2016b2681],
39	or	CC	O	or	_	0	SENT_83	[p5l2070t2618r2143b2658],
40	diastolic	JJ	O	diastolic	amod	45	SENT_83	[p5l11t2698r303b2764],
41	blood	NN	O	blood	nn	45	SENT_83	[p5l332t2698r534b2764],
42	pressure	NN	O	pressure	nn	45	SENT_83	[p5l563t2724r851b2787],
43	290	CD	NUMBER	290	num	45	SENT_83	[p5l888t2701r1041b2764],
44	mm	NN	O	mm	nn	45	SENT_83	[p5l1075t2724r1213b2763],
45	Hg	NN	O	hg	conj_or	30	SENT_83	[p5l1246t2696r1412b2787],
46	]	CD	NUMBER	]	dobj	26	SENT_83	[p5l1246t2696r1412b2787],
47	,	,	O	,	_	0	SENT_83	[p5l1246t2696r1412b2787],
48	diabetes	NN	O	diabetes	conj_and	46	SENT_83	[p5l1448t2698r1751b2779],
49	,	,	O	,	_	0	SENT_83	[p5l1448t2698r1751b2779],
50	and	CC	O	and	_	0	SENT_83	[p5l1787t2698r1915b2764],
51	treatment	NN	O	treatment	conj_and	46	SENT_83	[p5l1945t2715r2138b2764, p5l11t2821r194b2870],
52	with	IN	O	with	_	0	SENT_83	[p5l222t2804r384b2870],
53	gatiﬂoxacin	NN	O	gatiﬂoxacin	nn	54	SENT_83	[p5l416t2802r871b2893],
54	)	NN	O	)	prep_with	46	SENT_83	[p5l416t2802r871b2893],
55	.	.	O	.	_	0	SENT_83	[p5l416t2802r871b2893],

1	After	IN	O	after	_	0	SENT_84	[p5l907t2802r1098b2870],
2	estimating	VBG	O	estimate	prepc_after	36	SENT_84	[p5l1131t2807r1502b2893],
3	the	DT	O	the	det	4	SENT_84	[p5l1533t2804r1644b2870],
4	benefit	NN	O	benefit	dobj	2	SENT_84	[p5l1676t2804r1921b2870],
5	of	IN	O	of	_	0	SENT_84	[p5l1954t2804r2034b2870],
6	80	CD	NUMBER	80	num	8	SENT_84	[p5l2058t2807r2139b2870],
7	mg	NN	O	mg	nn	8	SENT_84	[p5l11t2937r124b3000],
8	atorvastatin	NN	O	atorvastatin	prep_of	4	SENT_84	[p5l165t2914r594b2992],
9	,	,	O	,	_	0	SENT_84	[p5l165t2914r594b2992],
10	compared	VBN	O	compare	_	0	SENT_84	[p5l640t2911r986b3000],
11	with	IN	O	with	prepc_compared_with	2	SENT_84	[p5l1024t2911r1185b2977],
12	40	CD	NUMBER	40	num	14	SENT_84	[p5l1226t2914r1311b2977],
13	mg	NN	O	mg	nn	14	SENT_84	[p5l1354t2937r1467b3000],
14	pravastatin	NN	O	pravastatin	pobj	2	SENT_84	[p5l1505t2914r1911b3000],
15	,	,	O	,	_	0	SENT_84	[p5l1505t2914r1911b3000],
16	separately	RB	O	separately	advmod	2	SENT_84	[p5l1957t2937r2138b3000, p5l10t3017r207b3106],
17	in	IN	O	in	_	0	SENT_84	[p5l232t3020r299b3082],
18	carriers	NNS	O	carrier	prep_in	2	SENT_84	[p5l329t3020r581b3083],
19	and	CC	O	and	_	0	SENT_84	[p5l613t3017r741b3083],
20	noncarriers	NNS	O	noncarrier	conj_and	18	SENT_84	[p5l769t3020r1182b3098],
21	,	,	O	,	_	0	SENT_84	[p5l769t3020r1182b3098],
22	the	DT	O	the	det	24	SENT_84	[p5l1213t3017r1323b3083],
23	p	NN	O	p	nn	24	SENT_84	[p5l1352t3043r1394b3106],
24	value	NN	O	value	nsubjpass	36	SENT_84	[p5l1420t3017r1602b3083],
25	for	IN	O	for	_	0	SENT_84	[p5l1631t3017r1732b3083],
26	interaction	NN	O	interaction	prep_for	24	SENT_84	[p5l1758t3020r2140b3083],
27	between	IN	O	between	_	0	SENT_84	[p5l9t3123r302b3189],
28	KIF6	NN	O	kif6	nn	31	SENT_84	[p5l342t3126r533b3189],
29	719Arg	NN	O	719arg	nn	31	SENT_84	[p5l576t3121r845b3212],
30	carrier	NN	O	carrier	nn	31	SENT_84	[p5l886t3126r1110b3189],
31	status	NN	O	status	prep_between	26	SENT_84	[p5l1151t3140r1348b3189],
32	and	CC	O	and	_	0	SENT_84	[p5l1392t3123r1520b3189],
33	statin	NN	O	statin	nn	34	SENT_84	[p5l1562t3126r1754b3189],
34	treatment	NN	O	treatment	prep_between	26	SENT_84	[p5l1796t3140r2142b3189],
35	was	VBD	O	be	auxpass	36	SENT_84	[p5l7t3254r136b3294],
36	determined	VBN	O	determine	_	0	SENT_84	[p5l180t3228r584b3293],
37	from	IN	O	from	_	0	SENT_84	[p5l624t3228r794b3293],
38	likelihood	NN	O	likelihood	nn	40	SENT_84	[p5l835t3228r1191b3293],
39	ratio	NN	O	ratio	nn	40	SENT_84	[p5l1232t3231r1392b3293],
40	tests	NNS	O	test	prep_from	36	SENT_84	[p5l1435t3245r1588b3293],
41	that	WDT	O	that	nsubj	42	SENT_84	[p5l1630t3228r1771b3293],
42	evaluated	VBD	O	evaluate	rcmod	40	SENT_84	[p5l1812t3228r2141b3294],
43	potential	JJ	O	potential	amod	44	SENT_84	[p5l9t3334r325b3423],
44	heterogeneity	NN	O	heterogeneity	dobj	42	SENT_84	[p5l377t3334r861b3423],
45	of	IN	O	of	_	0	SENT_84	[p5l911t3334r991b3400],
46	the	DT	DURATION	the	det	47	SENT_84	[p5l1032t3334r1142b3400],
47	HRS	NNS	DURATION	hr	prep_of	44	SENT_84	[p5l1197t3335r1380b3400],
48	.	.	O	.	_	0	SENT_84	[p5l1197t3335r1380b3400],

1	The	DT	O	the	det	2	SENT_85	[p5l1435t3332r1582b3400],
2	Kaplan	NNP	PERSON	Kaplan	_	0	SENT_85	[p5l1639t3334r2142b3423],
3	.	.	O	.	_	0	SENT_85	[p5l1639t3334r2142b3423],

1	—	NN	O	—	_	0	SENT_86	[p5l1639t3334r2142b3423],
2	.	.	O	.	_	0	SENT_86	[p5l1639t3334r2142b3423],

1	Meier	JJR	PERSON	meier	amod	2	SENT_87	[p5l1639t3334r2142b3423],
2	method	NN	O	method	nsubjpass	4	SENT_87	[p5l11t3439r284b3504],
3	was	VBD	O	be	auxpass	4	SENT_87	[p5l319t3465r448b3505],
4	used	VBN	O	use	_	0	SENT_87	[p5l488t3439r647b3504],
5	to	TO	O	to	aux	6	SENT_87	[p5l685t3456r753b3504],
6	estimate	VB	O	estimate	xcomp	4	SENT_87	[p5l794t3442r1087b3504],
7	the	DT	O	the	det	9	SENT_87	[p5l1127t3439r1237b3504],
8	cumulative	JJ	O	cumulative	amod	9	SENT_87	[p5l1277t3439r1659b3505],
9	incidence	NN	O	incidence	dobj	6	SENT_87	[p5l1699t3439r2032b3504],
10	of	IN	O	of	_	0	SENT_87	[p5l2073t3439r2153b3504],
11	death	NN	O	death	nn	15	SENT_87	[p6l11t27r206b93],
12	or	CC	O	or	_	0	SENT_87	[p6l244t53r315b93],
13	major	JJ	O	major	nn	15	SENT_87	[p6l351t28r555b116],
14	cardiovascular	JJ	O	cardiovascular	amod	15	SENT_87	[p6l591t27r1089b93],
15	events	NNS	O	event	prep_of	9	SENT_87	[p6l1125t44r1362b108],
16	,	,	O	,	_	0	SENT_87	[p6l1125t44r1362b108],
17	and	CC	O	and	_	0	SENT_87	[p6l1403t27r1530b93],
18	differences	NNS	O	difference	nsubjpass	20	SENT_87	[p6l1568t27r1938b93],
19	were	VBD	O	be	auxpass	20	SENT_87	[p6l1974t53r2140b93],
20	assessed	VBN	O	assess	conj_and	4	SENT_87	[p6l12t133r294b199],
21	with	IN	O	with	_	0	SENT_87	[p6l339t133r500b199],
22	the	DT	O	the	det	26	SENT_87	[p6l549t133r659b199],
23	log	NN	O	log	nn	26	SENT_87	[p6l707t133r1015b222],
24	—	CD	NUMBER	—	num	26	SENT_87	[p6l707t133r1015b222],
25	rank	NN	O	rank	nn	26	SENT_87	[p6l707t133r1015b222],
26	test	NN	O	test	prep_with	20	SENT_87	[p6l1060t150r1184b199],
27	at	IN	O	at	_	0	SENT_87	[p6l1233t150r1296b199],
28	2	CD	DURATION	2	num	29	SENT_87	[p6l1341t136r1382b200],
29	years	NNS	NUMBER	year	prep_at	26	SENT_87	[p6l1430t159r1605b222],
30	of	IN	O	of	_	0	SENT_87	[p6l1656t133r1736b199],
31	follow	VBP	O	follow	prepc_of	29	SENT_87	[p6l1772t133r2136b222],
32	—	RB	O	—	advmod	31	SENT_87	[p6l1772t133r2136b222],
33	up	RB	O	up	advmod	31	SENT_87	[p6l1772t133r2136b222],
34	.	.	O	.	_	0	SENT_87	[p6l1772t133r2136b222],

1	Absolute	JJ	O	absolute	amod	3	SENT_88	[p6l8t236r327b303],
2	risk	NN	O	risk	nn	3	SENT_88	[p6l360t238r491b303],
3	reduction	NN	O	reduction	nsubjpass	5	SENT_88	[p6l519t238r856b303],
4	was	VBD	O	be	auxpass	5	SENT_88	[p6l885t264r1014b304],
5	estimated	VBN	O	estimate	_	0	SENT_88	[p6l1049t238r1389b303],
6	from	IN	O	from	_	0	SENT_88	[p6l1421t238r1591b303],
7	the	DT	O	the	det	8	SENT_88	[p6l1624t238r1734b303],
8	differences	NNS	O	difference	prep_from	5	SENT_88	[p6l1769t238r2139b303],
9	JACC	NNP	O	JACC	nn	10	SENT_88	[p6l7t343r122b394],
10	Vol	NNP	O	Vol	dep	8	SENT_88	[p6l149t343r232b394],
11	.	.	O	.	_	0	SENT_88	[p6l149t343r232b394],

1	51	CD	NUMBER	51	_	0	SENT_89	[p6l262t343r337b402],
2	,	,	O	,	_	0	SENT_89	[p6l262t343r337b402],
3	No.	NN	O	no.	amod	1	SENT_89	[p6l369t343r441b394],
4	4	CD	NUMBER	4	number	3	SENT_89	[p6l471t343r513b402],
5	,	,	O	,	_	0	SENT_89	[p6l471t343r513b402],
6	2008	CD	DATE	2008	appos	1	SENT_89	[p6l544t343r668b394],
7	January	NNP	DATE	January	tmod	6	SENT_89	[p6l7t431r184b494],
8	29	CD	DATE	29	num	7	SENT_89	[p6l210t431r283b490],
9	,	,	O	,	_	0	SENT_89	[p6l210t431r283b490],
10	2008:449	CD	NUMBER	2008:449	num	7	SENT_89	[p6l315t431r649b481],
11	—	CD	NUMBER	—	num	12	SENT_89	[p6l315t431r649b481],
12	55	CD	NUMBER	55	dep	1	SENT_89	[p6l315t431r649b481],

1	in	IN	O	in	_	0	SENT_90	[p6l8t655r76b717],
2	the	DT	O	the	det	4	SENT_90	[p6l100t652r211b718],
3	cumulative	JJ	O	cumulative	amod	4	SENT_90	[p6l236t652r620b718],
4	incidence	NN	O	incidence	pobj	1	SENT_90	[p6l645t652r980b718],
5	of	IN	O	of	_	0	SENT_90	[p6l1005t652r1085b718],
6	events	NNS	O	event	prep_of	4	SENT_90	[p6l1098t669r1315b718],
7	at	IN	O	at	_	0	SENT_90	[p6l1341t669r1405b718],
8	2	CD	DURATION	2	num	9	SENT_90	[p6l1425t655r1466b719],
9	years	NNS	NUMBER	year	prep_at	6	SENT_90	[p6l1488t678r1664b741],
10	of	IN	O	of	_	0	SENT_90	[p6l1690t652r1771b718],
11	follow-up	NN	O	follow-up	prep_of	9	SENT_90	[p6l1781t652r2148b741],
12	.	.	O	.	_	0	SENT_90	[p6l1781t652r2148b741],

1	SAS	NNP	O	SAS	nn	2	SENT_91	[p6l12t756r166b824],
2	version	NN	O	version	nsubjpass	15	SENT_91	[p6l197t761r453b824],
3	9	CD	NUMBER	9	num	4	SENT_91	[p6l486t761r523b824],
4	software	NN	O	software	dep	2	SENT_91	[p6l558t758r853b824],
5	(	CD	NUMBER	(	num	13	SENT_91	[p6l888t756r1073b838],
6	SAS	NNP	ORGANIZATION	SAS	nn	13	SENT_91	[p6l888t756r1073b838],
7	Institute	NNP	ORGANIZATION	Institute	nn	13	SENT_91	[p6l1107t759r1429b839],
8	,	,	O	,	_	0	SENT_91	[p6l1107t759r1429b839],
9	Cary	NNP	PERSON	Cary	appos	13	SENT_91	[p6l1466t758r1654b847],
10	,	,	O	,	_	0	SENT_91	[p6l1466t758r1654b847],
11	North	NNP	LOCATION	North	appos	13	SENT_91	[p6l1688t758r1908b824],
12	Carolina	NNP	LOCATION	Carolina	nn	13	SENT_91	[p6l1941t758r2149b824, p6l7t862r163b944],
13	)	NN	O	)	dep	2	SENT_91	[p6l1941t758r2149b824, p6l7t862r163b944],
14	was	VBD	O	be	auxpass	15	SENT_91	[p6l197t890r327b930],
15	used	VBN	O	use	_	0	SENT_91	[p6l362t864r522b930],
16	for	IN	O	for	_	0	SENT_91	[p6l555t864r656b930],
17	all	DT	O	all	det	19	SENT_91	[p6l690t864r770b930],
18	regression	NN	O	regression	nn	19	SENT_91	[p6l802t867r1160b953],
19	models	NNS	O	model	prep_for	15	SENT_91	[p6l1195t864r1445b930],
20	and	CC	O	and	_	0	SENT_91	[p6l1482t864r1610b930],
21	for	IN	O	for	_	0	SENT_91	[p6l1643t864r1744b930],
22	generating	VBG	O	generate	prep_for	15	SENT_91	[p6l1775t867r2154b953],
23	Kaplan	NNP	PERSON	Kaplan	dobj	22	SENT_91	[p6l11t970r518b1059],
24	.	.	O	.	_	0	SENT_91	[p6l11t970r518b1059],

1	—	NN	O	—	_	0	SENT_92	[p6l11t970r518b1059],
2	.	.	O	.	_	0	SENT_92	[p6l11t970r518b1059],

1	Meier	JJR	PERSON	meier	_	0	SENT_93	[p6l11t970r518b1059],
2	estimates	NNS	O	estimate	dep	1	SENT_93	[p6l550t973r895b1036],
3	.	.	O	.	_	0	SENT_93	[p6l550t973r895b1036],

1	Results	NNS	O	result	_	0	SENT_94	[p6l11t1180r334b1243],

1	Baseline	NN	O	baseline	_	0	SENT_95	[p6l9t1332r325b1399],
2	characteristics	NNS	O	characteristic	dep	1	SENT_95	[p6l352t1332r883b1399],
3	and	CC	O	and	_	0	SENT_95	[p6l912t1332r1048b1399],
4	allele	NN	O	allele	nn	5	SENT_95	[p6l1074t1332r1269b1399],
5	frequencies	NNS	O	frequency	dep	1	SENT_95	[p6l1294t1332r1743b1422],
6	.	.	O	.	_	0	SENT_95	[p6l1294t1332r1743b1422],

1	The	DT	O	the	det	3	SENT_96	[p6l1792t1331r1940b1399],
2	baseline	NN	O	baseline	nn	3	SENT_96	[p6l1965t1333r2150b1399, p6l7t1439r137b1505],
3	characteristics	NNS	O	characteristic	_	0	SENT_96	[p6l168t1439r664b1505],
4	for	IN	O	for	_	0	SENT_96	[p6l695t1439r796b1505],
5	traditional	JJ	O	traditional	amod	7	SENT_96	[p6l824t1439r1195b1505],
6	risk	NN	O	risk	nn	7	SENT_96	[p6l1222t1439r1354b1505],
7	factors	NNS	O	factor	prep_for	3	SENT_96	[p6l1379t1439r1612b1505],
8	of	IN	O	of	_	0	SENT_96	[p6l1644t1439r1724b1505],
9	this	DT	O	this	det	11	SENT_96	[p6l1741t1439r1869b1505],
10	genetic	JJ	O	genetic	amod	11	SENT_96	[p6l1898t1442r2153b1528],
11	cohort	NN	O	cohort	prep_of	3	SENT_96	[p6l9t1546r240b1612],
12	of	IN	O	of	_	0	SENT_96	[p6l266t1546r346b1612],
13	the	DT	O	the	det	15	SENT_96	[p6l361t1546r472b1612],
14	PROVE	NNP	O	PROVE	nn	15	SENT_96	[p6l501t1546r810b1613],
15	lT	NN	O	lt	prep_of	11	SENT_96	[p6l839t1544r1183b1612],
16	.	.	O	.	_	0	SENT_96	[p6l839t1544r1183b1612],

1	—	NN	O	—	_	0	SENT_97	[p6l839t1544r1183b1612],
2	.	.	O	.	_	0	SENT_97	[p6l839t1544r1183b1612],

1	TIMl	NN	O	timl	nn	3	SENT_98	[p6l839t1544r1183b1612],
2	22	CD	NUMBER	22	num	3	SENT_98	[p6l1210t1549r1296b1613],
3	trial	NN	O	trial	nsubjpass	12	SENT_98	[p6l1325t1546r1467b1612],
4	according	VBG	O	accord	_	0	SENT_98	[p6l1495t1546r1840b1635],
5	to	TO	O	to	prepc_according_to	3	SENT_98	[p6l1865t1563r1933b1612],
6	KIF	NNP	ORGANIZATION	KIF	pobj	3	SENT_98	[p6l1961t1549r2118b1612],
7	6	CD	NUMBER	6	num	6	SENT_98	[p6l2115t1553r2153b1613],
8	719Arg	NN	O	719arg	nn	10	SENT_98	[p6l10t1651r281b1741],
9	carrier	NN	O	carrier	nn	10	SENT_98	[p6l314t1655r539b1718],
10	status	NN	O	status	dep	6	SENT_98	[p6l572t1669r769b1718],
11	are	VBP	O	be	auxpass	12	SENT_98	[p6l806t1678r907b1718],
12	presented	VBN	O	present	_	0	SENT_98	[p6l939t1652r1283b1741],
13	in	IN	O	in	_	0	SENT_98	[p6l1315t1655r1383b1717],
14	Table	NNP	O	Table	prep_in	12	SENT_98	[p6l1413t1650r1619b1718],
15	1	CD	NUMBER	1	num	14	SENT_98	[p6l1657t1656r1712b1718],
16	.	.	O	.	_	0	SENT_98	[p6l1657t1656r1712b1718],

1	The	DT	O	the	det	2	SENT_99	[p6l1747t1650r1894b1718],
2	prevalence	NN	O	prevalence	nsubj	9	SENT_99	[p6l1927t1678r2150b1741, p6l7t1758r188b1825],
3	of	IN	O	of	_	0	SENT_99	[p6l229t1758r310b1825],
4	risk	NN	O	risk	nn	5	SENT_99	[p6l337t1758r469b1825],
5	factors	NNS	O	factor	prep_of	2	SENT_99	[p6l504t1758r737b1825],
6	for	IN	O	for	_	0	SENT_99	[p6l779t1758r880b1825],
7	CHD	NN	O	chd	prep_for	5	SENT_99	[p6l920t1758r1129b1825],
8	was	VBD	O	be	cop	9	SENT_99	[p6l1167t1784r1297b1825],
9	similar	JJ	O	similar	dep	31	SENT_99	[p6l1340t1758r1580b1825],
10	in	IN	O	in	_	0	SENT_99	[p6l1618t1761r1686b1824],
11	carriers	NNS	O	carrier	prep_in	9	SENT_99	[p6l1728t1761r1981b1825],
12	and	CC	O	and	_	0	SENT_99	[p6l2025t1758r2153b1825],
13	noncarriers	NNS	O	noncarrier	conj_and	11	SENT_99	[p6l10t1868r403b1931],
14	of	IN	O	of	_	0	SENT_99	[p6l441t1865r521b1931],
15	the	DT	O	the	det	17	SENT_99	[p6l544t1865r655b1931],
16	719Arg	NN	O	719arg	nn	17	SENT_99	[p6l693t1864r964b1954],
17	variant	NN	O	variant	prep_of	11	SENT_99	[p6l994t1868r1259b1946],
18	,	,	O	,	_	0	SENT_99	[p6l994t1868r1259b1946],
19	with	IN	O	with	_	0	SENT_99	[p6l1294t1865r1456b1931],
20	the	DT	O	the	det	21	SENT_99	[p6l1491t1865r1602b1931],
21	exception	NN	O	exception	prep_with	9	SENT_99	[p6l1639t1868r1977b1954],
22	that	WDT	O	that	dobj	27	SENT_99	[p6l2012t1865r2154b1931],
23	current	JJ	DATE	current	amod	24	SENT_99	[p6l9t1989r264b2038],
24	smoking	NN	O	smoking	nsubj	27	SENT_99	[p6l302t1972r607b2061],
25	was	VBD	O	be	cop	27	SENT_99	[p6l640t1998r769b2038],
26	less	RBR	O	less	advmod	27	SENT_99	[p6l808t1972r929b2038],
27	frequent	JJ	O	frequent	rcmod	21	SENT_99	[p6l969t1972r1269b2061],
28	among	IN	O	among	_	0	SENT_99	[p6l1307t1998r1550b2061],
29	719Arg	NNP	O	719Arg	nn	30	SENT_99	[p6l1588t1971r1859b2061],
30	carriers	NNS	O	carrier	prep_among	27	SENT_99	[p6l1896t1975r2151b2038],
31	(	VBP	O	(	_	0	SENT_99	[p6l11t2076r79b2167],
32	p	NN	O	p	nsubj	33	SENT_99	[p6l11t2076r79b2167],
33	=	JJ	O	=	xcomp	31	SENT_99	[p6l127t2104r180b2124],
34	0.042	CD	NUMBER	0.042	num	35	SENT_99	[p6l227t2076r473b2159],
35	)	NN	O	)	nsubj	31	SENT_99	[p6l227t2076r473b2159],
36	.	.	O	.	_	0	SENT_99	[p6l227t2076r473b2159],

1	The	DT	O	the	det	3	SENT_100	[p6l512t2076r660b2144],
2	treatment	NN	O	treatment	nn	3	SENT_100	[p6l699t2095r1047b2144],
3	groups	NNS	O	group	nsubjpass	11	SENT_100	[p6l1082t2104r1320b2167],
4	in	IN	O	in	_	0	SENT_100	[p6l1359t2081r1427b2143],
5	this	DT	O	this	det	7	SENT_100	[p6l1465t2078r1592b2144],
6	genetic	JJ	O	genetic	amod	7	SENT_100	[p6l1631t2081r1885b2167],
7	cohort	NN	O	cohort	prep_in	3	SENT_100	[p6l1923t2078r2154b2144],
8	also	RB	O	also	advmod	11	SENT_100	[p6l10t2184r141b2250],
9	were	VBD	O	be	auxpass	11	SENT_100	[p6l175t2210r342b2250],
10	well	RB	O	well	advmod	11	SENT_100	[p6l376t2184r523b2250],
11	balanced	VBN	O	balance	dep	19	SENT_100	[p6l555t2184r868b2250],
12	with	IN	O	with	_	0	SENT_100	[p6l900t2184r1062b2251],
13	regard	NN	O	regard	prep_with	11	SENT_100	[p6l1098t2184r1323b2273],
14	to	TO	O	to	_	0	SENT_100	[p6l1358t2201r1426b2250],
15	baseline	NN	O	baseline	nn	18	SENT_100	[p6l1462t2184r1745b2250],
16	traditional	JJ	O	traditional	amod	18	SENT_100	[p6l1782t2184r2153b2250],
17	risk	NN	O	risk	nn	18	SENT_100	[p6l8t2290r139b2356],
18	factors	NNS	O	factor	prep_to	11	SENT_100	[p6l169t2290r402b2356],
19	(	VBP	O	(	_	0	SENT_100	[p6l441t2288r508b2379],
20	p	NN	O	p	dep	21	SENT_100	[p6l441t2288r508b2379],
21	>	JJR	O	>	dobj	19	SENT_100	[p6l548t2301r608b2351],
22	0.29	CD	NUMBER	0.29	nsubj	19	SENT_100	[p6l648t2293r821b2371],
23	;	:	O	;	_	0	SENT_100	[p6l648t2293r821b2371],
24	data	NNS	O	datum	dep	22	SENT_100	[p6l858t2290r1007b2356],
25	not	RB	O	not	neg	26	SENT_100	[p6l1041t2307r1158b2356],
26	presented	VBN	O	present	rcmod	24	SENT_100	[p6l1189t2288r1580b2379],
27	)	NN	O	)	dobj	26	SENT_100	[p6l1189t2288r1580b2379],
28	.	.	O	.	_	0	SENT_100	[p6l1189t2288r1580b2379],

1	Carriers	NNS	O	carrier	nsubj	6	SENT_101	[p6l1620t2290r1903b2357],
2	of	IN	O	of	_	0	SENT_101	[p6l1939t2290r2020b2356],
3	the	DT	O	the	det	4	SENT_101	[p6l2041t2290r2152b2356],
4	719Arg	NN	O	719arg	prep_of	1	SENT_101	[p6l10t2396r281b2486],
5	variant	JJ	O	variant	amod	4	SENT_101	[p6l301t2400r548b2463],
6	constituted	VBN	O	constitute	_	0	SENT_101	[p6l573t2397r969b2463],
7	58.9	CD	PERCENT	58.9	num	8	SENT_101	[p6l994t2397r1214b2464],
8	%	NN	PERCENT	%	dobj	6	SENT_101	[p6l994t2397r1214b2464],
9	of	IN	O	of	_	0	SENT_101	[p6l1240t2397r1320b2463],
10	the	DT	O	the	det	12	SENT_101	[p6l1333t2397r1444b2463],
11	PROVE	NNP	O	PROVE	nn	12	SENT_101	[p6l1470t2397r1781b2464],
12	lT	NN	O	lt	prep_of	8	SENT_101	[p6l1806t2395r2150b2463],
13	.	.	O	.	_	0	SENT_101	[p6l1806t2395r2150b2463],

1	—	NN	O	—	_	0	SENT_102	[p6l1806t2395r2150b2463],
2	.	.	O	.	_	0	SENT_102	[p6l1806t2395r2150b2463],

1	TIMI	NNP	ORGANIZATION	TIMI	_	0	SENT_103	[p6l1806t2395r2150b2463],

1	22	CD	NUMBER	22	num	2	SENT_104	[p6l7t2541r93b2605],
2	trial	NN	O	trial	_	0	SENT_104	[p6l149t2538r291b2604],
3	genetic	JJ	O	genetic	amod	4	SENT_104	[p6l343t2541r597b2627],
4	cohort	NN	O	cohort	dep	2	SENT_104	[p6l652t2538r899b2604],
5	.	.	O	.	_	0	SENT_104	[p6l652t2538r899b2604],

1	The	DT	O	the	det	3	SENT_105	[p6l955t2536r1102b2604],
2	genotype	NN	O	genotype	nn	3	SENT_105	[p6l1156t2555r1479b2627],
3	frequencies	NNS	O	frequency	nsubj	6	SENT_105	[p6l1533t2538r1932b2628],
4	were	VBD	O	be	cop	6	SENT_105	[p6l1984t2564r2152b2604],
5	13.5	CD	PERCENT	13.5	num	6	SENT_105	[p6l13t2644r249b2725],
6	%	NN	PERCENT	%	_	0	SENT_105	[p6l13t2644r249b2725],
7	,	,	O	,	_	0	SENT_105	[p6l13t2644r249b2725],
8	45.4	CD	PERCENT	45.4	num	9	SENT_105	[p6l311t2644r552b2725],
9	%	NN	PERCENT	%	conj_and	6	SENT_105	[p6l311t2644r552b2725],
10	,	,	O	,	_	0	SENT_105	[p6l311t2644r552b2725],
11	and	CC	O	and	_	0	SENT_105	[p6l616t2644r744b2710],
12	41.1	CD	PERCENT	41.1	num	13	SENT_105	[p6l802t2647r1024b2710],
13	%	NN	PERCENT	%	conj_and	6	SENT_105	[p6l802t2647r1024b2710],
14	for	IN	O	for	_	0	SENT_105	[p6l1083t2644r1185b2710],
15	Arg/Arg	NN	O	arg/arg	nn	17	SENT_105	[p6l1240t2642r1571b2733],
16	,	,	O	,	_	0	SENT_105	[p6l1240t2642r1571b2733],
17	Arg/Trp	NN	O	arg/trp	prep_for	13	SENT_105	[p6l1631t2642r1961b2733],
18	,	,	O	,	_	0	SENT_105	[p6l1631t2642r1961b2733],
19	and	CC	O	and	_	0	SENT_105	[p6l2025t2644r2153b2710],
20	Trp/Trp	NN	O	trp/trp	conj_and	17	SENT_105	[p6l6t2748r335b2839],
21	,	,	O	,	_	0	SENT_105	[p6l6t2748r335b2839],
22	respectively	RB	O	respectively	advmod	17	SENT_105	[p6l376t2750r805b2839],
23	,	,	O	,	_	0	SENT_105	[p6l376t2750r805b2839],
24	and	CC	O	and	_	0	SENT_105	[p6l848t2750r976b2816],
25	the	DT	O	the	det	26	SENT_105	[p6l1014t2750r1125b2816],
26	distribution	NN	O	distribution	nsubj	32	SENT_105	[p6l1165t2750r1580b2816],
27	of	IN	O	of	_	0	SENT_105	[p6l1620t2750r1700b2816],
28	these	DT	O	these	det	29	SENT_105	[p6l1726t2750r1907b2816],
29	genotypes	NNS	O	genotype	prep_of	26	SENT_105	[p6l1945t2776r2150b2839, p6l8t2873r187b2945],
30	did	VBD	O	do	aux	32	SENT_105	[p6l231t2856r345b2922],
31	not	RB	O	not	neg	32	SENT_105	[p6l387t2873r505b2922],
32	deviate	VB	O	deviate	conj_and	6	SENT_105	[p6l546t2856r793b2922],
33	from	IN	O	from	_	0	SENT_105	[p6l836t2856r1007b2922],
34	Hardy	NNP	PERSON	Hardy	prep_from	32	SENT_105	[p6l1050t2856r1674b2945],
35	.	.	O	.	_	0	SENT_105	[p6l1050t2856r1674b2945],

1	—	NN	O	—	_	0	SENT_106	[p6l1050t2856r1674b2945],
2	.	.	O	.	_	0	SENT_106	[p6l1050t2856r1674b2945],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_107	[p6l1050t2856r1674b2945],
2	expectations	NNS	O	expectation	nsubj	5	SENT_107	[p6l1716t2859r2151b2945],
3	(	IN	O	(	_	0	SENT_107	[p6l11t2961r79b3052],
4	p	NN	O	p	prep_(	2	SENT_107	[p6l11t2961r79b3052],
5	=	JJ	O	=	_	0	SENT_107	[p6l129t2989r183b3009],
6	0.51	CD	NUMBER	0.51	num	7	SENT_107	[p6l233t2961r434b3043],
7	)	NN	O	)	dobj	5	SENT_107	[p6l233t2961r434b3043],
8	.	.	O	.	_	0	SENT_107	[p6l233t2961r434b3043],

1	These	DT	O	these	det	3	SENT_108	[p6l476t2961r693b3029],
2	genotype	NN	O	genotype	nn	3	SENT_108	[p6l734t2980r1056b3052],
3	frequencies	NNS	O	frequency	nsubj	12	SENT_108	[p6l1097t2963r1495b3052],
4	were	VBD	O	be	aux	12	SENT_108	[p6l1533t2989r1701b3029],
5	not	RB	O	not	neg	12	SENT_108	[p6l1744t2980r1861b3029],
6	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_108	[p6l1902t2963r2149b3052, p6l9t3069r222b3158],
7	different	JJ	O	different	amod	12	SENT_108	[p6l246t3069r544b3135],
8	(	NN	O	(	nn	12	SENT_108	[p6l572t3067r639b3158],
9	p	NN	O	p	nn	12	SENT_108	[p6l572t3067r639b3158],
10	=	JJ	O	=	amod	12	SENT_108	[p6l677t3095r730b3115],
11	0.32	CD	NUMBER	0.32	num	12	SENT_108	[p6l766t3067r945b3150],
12	)	NN	O	)	_	0	SENT_108	[p6l766t3067r945b3150],
13	than	IN	O	than	mark	16	SENT_108	[p6l975t3069r1135b3135],
14	the	DT	O	the	det	15	SENT_108	[p6l1162t3069r1272b3135],
15	frequencies	NNS	O	frequency	nsubj	16	SENT_108	[p6l1299t3069r1698b3158],
16	reported	VBD	O	report	advcl	12	SENT_108	[p6l1727t3069r2027b3158],
17	for	IN	O	for	_	0	SENT_108	[p6l2053t3069r2154b3135],
18	the	DT	O	the	det	21	SENT_108	[p6l8t3175r119b3241],
19	CARE	NNP	O	CARE	nn	21	SENT_108	[p6l160t3174r410b3242],
20	trial	NN	O	trial	nn	21	SENT_108	[p6l449t3175r591b3241],
21	cohort	NN	O	cohort	prep_for	16	SENT_108	[p6l629t3175r860b3241],
22	and	CC	O	and	_	0	SENT_108	[p6l897t3175r1025b3241],
23	the	DT	O	the	det	25	SENT_108	[p6l1062t3175r1173b3241],
24	control	NN	O	control	nn	25	SENT_108	[p6l1213t3175r1465b3241],
25	group	NN	O	group	dep	37	SENT_108	[p6l1501t3201r1707b3264],
26	in	IN	O	in	_	0	SENT_108	[p6l1746t3178r1814b3240],
27	a	DT	O	a	det	32	SENT_108	[p6l1853t3201r1888b3241],
28	nested	JJ	O	nested	amod	32	SENT_108	[p6l1926t3175r2153b3241],
29	case	NN	O	case	nn	32	SENT_108	[p6l9t3281r443b3347],
30	—	CD	NUMBER	—	num	32	SENT_108	[p6l9t3281r443b3347],
31	control	NN	O	control	nn	32	SENT_108	[p6l9t3281r443b3347],
32	study	NN	O	study	prep_in	25	SENT_108	[p6l476t3281r666b3370],
33	of	IN	O	of	_	0	SENT_108	[p6l696t3281r777b3347],
34	the	DT	O	the	det	36	SENT_108	[p6l798t3281r909b3347],
35	WOSCOPS	JJ	O	woscops	amod	36	SENT_108	[p6l939t3281r1395b3348],
36	trial	NN	O	trial	prep_of	32	SENT_108	[p6l1431t3281r1573b3347],
37	+	CC	O	+	conj_and	16	SENT_108	[p6l1609t3279r1724b3362],

1	lakoubova	NN	O	lakoubova	_	0	SENT_109	[p6l1361t3383r1647b3434],
2	et	FW	O	et	nn	3	SENT_109	[p6l1676t3385r1733b3434],
3	al.	FW	O	al.	dep	1	SENT_109	[p6l1754t3383r1821b3434],
4	451	CD	NUMBER	451	dep	1	SENT_109	[p6l2028t3383r2138b3434],

1	KIF5	NN	O	kif5	nn	2	SENT_110	[p6l478t3469r611b3522],
2	Trp719Arg	NN	O	trp719arg	_	0	SENT_110	[p6l630t3469r939b3532],
3	in	IN	O	in	_	0	SENT_110	[p6l964t3470r1011b3521],
4	the	DT	O	the	det	6	SENT_110	[p6l1036t3470r1128b3522],
5	PROVE	NNP	O	PROVE	nn	6	SENT_110	[p6l1155t3469r1345b3522],
6	IT-TIMI	NN	O	it-timus	prep_in	2	SENT_110	[p6l1371t3470r1568b3521],
7	22	CD	NUMBER	22	num	8	SENT_110	[p6l1596t3469r1670b3521],
8	Trial	NN	O	trial	dep	2	SENT_110	[p6l1693t3470r1820b3522],

1	Outcome	NN	O	outcome	_	0	SENT_111	[p7l13t88r361b154],
2	of	IN	O	of	_	0	SENT_111	[p7l395t87r478b154],
3	therapy	NN	O	therapy	nn	6	SENT_111	[p7l497t87r780b177],
4	and	CC	O	and	_	0	SENT_111	[p7l809t87r945b154],
5	KIF6	NN	O	kif6	nn	6	SENT_111	[p7l973t91r1172b154],
6	Trp719Arg	NN	O	trp719arg	prep_of	1	SENT_111	[p7l1202t85r1643b177],
7	.	.	O	.	_	0	SENT_111	[p7l1202t85r1643b177],

1	Carriers	NNS	O	carrier	nsubj	7	SENT_112	[p7l1697t88r1978b154],
2	and	CC	O	and	_	0	SENT_112	[p7l2014t88r2141b154],
3	noncarriers	NNS	O	noncarrier	conj_and	1	SENT_112	[p7l12t200r403b263],
4	of	IN	O	of	_	0	SENT_112	[p7l439t197r519b263],
5	KIF6	NN	O	kif6	nn	6	SENT_112	[p7l539t200r729b263],
6	719Arg	NN	O	719arg	prep_of	1	SENT_112	[p7l765t195r1034b286],
7	received	VBD	O	receive	_	0	SENT_112	[p7l1066t197r1352b263],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_112	[p7l1387t197r1815b286],
9	different	JJ	O	different	amod	10	SENT_112	[p7l1846t197r2142b263],
10	beneﬁt	NN	O	beneﬁt	dobj	7	SENT_112	[p7l9t304r254b370],
11	from	IN	O	from	_	0	SENT_112	[p7l282t304r452b370],
12	high-dose	JJ	O	high-dose	amod	14	SENT_112	[p7l484t304r838b393],
13	atorvastatin	NN	O	atorvastatin	nn	14	SENT_112	[p7l871t307r1281b371],
14	therapy	NN	O	therapy	prep_from	7	SENT_112	[p7l1311t304r1578b394],
15	compared	VBN	O	compare	_	0	SENT_112	[p7l1606t304r1954b394],
16	with	IN	O	with	prepc_compared_with	14	SENT_112	[p7l1979t304r2141b371],
17	standard	JJ	O	standard	amod	21	SENT_112	[p7l12t413r508b479],
18	—	NN	O	—	nn	21	SENT_112	[p7l12t413r508b479],
19	dose	NN	O	dose	nn	21	SENT_112	[p7l12t413r508b479],
20	pravastatin	NN	O	pravastatin	nn	21	SENT_112	[p7l534t416r919b502],
21	therapy	NN	O	therapy	pobj	14	SENT_112	[p7l944t413r1225b502],
22	.	.	O	.	_	0	SENT_112	[p7l944t413r1225b502],

1	Speciﬁcally	RB	O	speciﬁcally	advmod	22	SENT_113	[p7l1259t413r1671b502],
2	,	,	O	,	_	0	SENT_113	[p7l1259t413r1671b502],
3	in	IN	O	in	_	0	SENT_113	[p7l1699t416r1767b478],
4	carriers	NNS	O	carrier	prep_in	22	SENT_113	[p7l1793t416r2045b479],
5	of	IN	O	of	_	0	SENT_113	[p7l2073t413r2153b479],
6	the	DT	O	the	det	8	SENT_113	[p7l10t521r120b587],
7	719Arg	NNP	O	719Arg	nn	8	SENT_113	[p7l148t519r417b610],
8	allele	NN	O	allele	prep_of	4	SENT_113	[p7l442t521r639b602],
9	,	,	O	,	_	0	SENT_113	[p7l442t521r639b602],
10	high-dose	JJ	O	high-dose	amod	12	SENT_113	[p7l666t521r1021b610],
11	atorvastatin	NN	O	atorvastatin	nn	12	SENT_113	[p7l1048t524r1458b587],
12	therapy	NN	O	therapy	nsubj	22	SENT_113	[p7l1482t521r1766b610],
13	,	,	O	,	_	0	SENT_113	[p7l1482t521r1766b610],
14	compared	VBN	O	compare	_	0	SENT_113	[p7l1795t521r2141b610],
15	with	IN	O	with	prepc_compared_with	12	SENT_113	[p7l7t629r168b696],
16	standard	JJ	O	standard	amod	20	SENT_113	[p7l201t629r697b696],
17	—	NN	O	—	nn	20	SENT_113	[p7l201t629r697b696],
18	dose	NN	O	dose	nn	20	SENT_113	[p7l201t629r697b696],
19	pravastatin	NN	O	pravastatin	nn	20	SENT_113	[p7l729t632r1114b719],
20	therapy	NN	O	therapy	pobj	12	SENT_113	[p7l1146t630r1429b719],
21	,	,	O	,	_	0	SENT_113	[p7l1146t630r1429b719],
22	reduced	VBD	O	reduce	_	0	SENT_113	[p7l1464t629r1741b696],
23	the	DT	O	the	det	24	SENT_113	[p7l1772t630r1882b696],
24	risk	NN	O	risk	iobj	22	SENT_113	[p7l1914t630r2044b696],
25	of	IN	O	of	_	0	SENT_113	[p7l2073t629r2153b696],
26	death	NN	O	death	prep_of	24	SENT_113	[p7l11t737r206b803],
27	or	CC	O	or	_	0	SENT_113	[p7l239t763r311b803],
28	major	JJ	O	major	amod	30	SENT_113	[p7l342t739r546b826],
29	cardiovascular	JJ	O	cardiovascular	amod	30	SENT_113	[p7l577t737r1074b804],
30	events	NNS	O	event	iobj	22	SENT_113	[p7l1106t754r1321b804],
31	by	IN	O	by	_	0	SENT_113	[p7l1354t737r1440b826],
32	41	CD	PERCENT	41	num	33	SENT_113	[p7l1468t740r1620b803],
33	%	NN	PERCENT	%	prep_by	30	SENT_113	[p7l1468t740r1620b803],
34	(	CD	NUMBER	(	dobj	22	SENT_113	[p7l1656t735r1975b826],
35	adjusted	VBN	O	adjust	partmod	34	SENT_113	[p7l1656t735r1975b826],
36	HR	NN	DURATION	hr	dobj	35	SENT_113	[p7l2007t738r2144b803],
37	0.59	CD	NUMBER	0.59	num	36	SENT_113	[p7l11t846r183b927],
38	,	,	O	,	_	0	SENT_113	[p7l11t846r183b927],
39	95	CD	PERCENT	95	number	40	SENT_113	[p7l214t846r364b912],
40	%	NN	PERCENT	%	amod	42	SENT_113	[p7l214t846r364b912],
41	conﬁdence	NN	O	conﬁdence	nn	42	SENT_113	[p7l392t846r769b912],
42	interval	NN	O	interval	appos	36	SENT_113	[p7l796t846r1061b912],
43	[	CD	NUMBER	[	num	44	SENT_113	[p7l1092t844r1239b926],
44	CI	NN	O	ci	dep	55	SENT_113	[p7l1092t844r1239b926],
45	]	CD	NUMBER	]	num	46	SENT_113	[p7l1092t844r1239b926],
46	0.45	CD	NUMBER	0.45	dep	44	SENT_113	[p7l1272t846r1421b912],
47	to	TO	O	to	_	0	SENT_113	[p7l1451t863r1519b912],
48	0.77	CD	NUMBER	0.77	prep_to	46	SENT_113	[p7l1547t847r1719b927],
49	;	:	O	;	_	0	SENT_113	[p7l1547t847r1719b927],
50	p	NN	O	p	dep	46	SENT_113	[p7l1747t872r1789b935],
51	<	JJR	O	<	dep	50	SENT_113	[p7l1822t856r1882b907],
52	0.001	CD	NUMBER	0.001	num	53	SENT_113	[p7l1915t844r2137b926],
53	)	NN	O	)	dep	55	SENT_113	[p7l1915t844r2137b926],
54	(	CD	NUMBER	(	num	55	SENT_113	[p7l13t951r241b1034],
55	Table	NNP	O	Table	dep	36	SENT_113	[p7l13t951r241b1034],
56	2	CD	NUMBER	2	num	55	SENT_113	[p7l274t951r364b1034],
57	)	CD	NUMBER	)	dep	55	SENT_113	[p7l274t951r364b1034],
58	.	.	O	.	_	0	SENT_113	[p7l274t951r364b1034],

1	The	DT	DURATION	the	det	2	SENT_114	[p7l399t952r546b1020],
2	HRS	NNS	DURATION	hr	nsubj	4	SENT_114	[p7l582t954r745b1020],
3	were	VBD	O	be	cop	4	SENT_114	[p7l777t979r943b1020],
4	similar	JJ	O	similar	_	0	SENT_114	[p7l979t953r1218b1020],
5	in	IN	O	in	_	0	SENT_114	[p7l1249t956r1317b1019],
6	Arg/Arg	NN	O	arg/arg	nn	7	SENT_114	[p7l1349t952r1659b1042],
7	homozygotes	NNS	O	homozygote	prep_in	4	SENT_114	[p7l1691t953r2139b1042],
8	and	CC	O	and	_	0	SENT_114	[p7l12t1061r136b1127],
9	in	IN	O	in	_	0	SENT_114	[p7l182t1064r248b1126],
10	Arg/Trp	NN	O	arg/trp	nn	11	SENT_114	[p7l293t1059r589b1150],
11	heterozygotes	NNS	O	heterozygote	prep_in	4	SENT_114	[p7l637t1061r1120b1150],
12	,	,	O	,	_	0	SENT_114	[p7l637t1061r1120b1150],
13	which	WDT	O	which	nsubj	15	SENT_114	[p7l1167t1061r1377b1127],
14	is	VBZ	O	be	cop	15	SENT_114	[p7l1424t1064r1473b1127],
15	consistent	JJ	O	consistent	rcmod	11	SENT_114	[p7l1523t1064r1861b1127],
16	with	IN	O	with	_	0	SENT_114	[p7l1903t1061r2059b1127],
17	a	DT	O	a	det	20	SENT_114	[p7l2108t1087r2142b1127],
18	dominant	JJ	O	dominant	amod	20	SENT_114	[p7l11t1169r343b1236],
19	genetic	JJ	O	genetic	amod	20	SENT_114	[p7l375t1172r617b1259],
20	model	NN	O	model	prep_with	15	SENT_114	[p7l652t1169r880b1236],
21	.	.	O	.	_	0	SENT_114	[p7l652t1169r880b1236],

1	In	IN	O	in	_	0	SENT_115	[p7l918t1170r994b1235],
2	contrast	NN	O	contrast	prep_in	14	SENT_115	[p7l1029t1186r1315b1250],
3	,	,	O	,	_	0	SENT_115	[p7l1029t1186r1315b1250],
4	high-dose	JJ	O	high-dose	amod	5	SENT_115	[p7l1352t1169r1692b1259],
5	atorvastatin	NN	O	atorvastatin	appos	2	SENT_115	[p7l1729t1172r2138b1250],
6	,	,	O	,	_	0	SENT_115	[p7l1729t1172r2138b1250],
7	compared	VBN	O	compare	_	0	SENT_115	[p7l11t1278r358b1367],
8	with	IN	O	with	prepc_compared_with	14	SENT_115	[p7l383t1278r545b1344],
9	standard	JJ	O	standard	amod	12	SENT_115	[p7l576t1278r1072b1344],
10	—	NN	O	—	nn	12	SENT_115	[p7l576t1278r1072b1344],
11	dose	NN	O	dose	nn	12	SENT_115	[p7l576t1278r1072b1344],
12	pravastatin	NN	O	pravastatin	pobj	14	SENT_115	[p7l1101t1281r1506b1367],
13	,	,	O	,	_	0	SENT_115	[p7l1101t1281r1506b1367],
14	was	VBD	O	be	_	0	SENT_115	[p7l1535t1304r1664b1344],
15	of	IN	O	of	_	0	SENT_115	[p7l1696t1278r1776b1344],
16	no	DT	O	no	det	18	SENT_115	[p7l1794t1304r1880b1344],
17	significant	JJ	O	significant	amod	18	SENT_115	[p7l1913t1278r2138b1367, p7l10t1390r183b1453],
18	beneﬁt	NN	O	beneﬁt	prep_of	14	SENT_115	[p7l204t1387r449b1453],
19	in	IN	O	in	_	0	SENT_115	[p7l472t1390r540b1452],
20	noncarriers	NNS	O	noncarrier	prep_in	14	SENT_115	[p7l566t1390r958b1453],
21	(	RB	O	(	advmod	22	SENT_115	[p7l987t1385r1306b1476],
22	adjusted	VBN	O	adjust	amod	20	SENT_115	[p7l987t1385r1306b1476],
23	HR	NN	DURATION	hr	nsubj	14	SENT_115	[p7l1331t1388r1467b1452],
24	0.94	CD	NUMBER	0.94	num	23	SENT_115	[p7l1490t1390r1662b1468],
25	,	,	O	,	_	0	SENT_115	[p7l1490t1390r1662b1468],
26	95	CD	PERCENT	95	number	27	SENT_115	[p7l1692t1387r1842b1453],
27	%	NN	PERCENT	%	amod	28	SENT_115	[p7l1692t1387r1842b1453],
28	CI	NN	O	ci	appos	23	SENT_115	[p7l1869t1387r1961b1453],
29	0.70	CD	NUMBER	0.70	num	31	SENT_115	[p7l1989t1388r2139b1453],
30	to	TO	O	to	dep	31	SENT_115	[p7l10t1511r78b1560],
31	1.27	CD	NUMBER	1.27	dep	28	SENT_115	[p7l129t1496r297b1575],
32	;	:	O	;	_	0	SENT_115	[p7l129t1496r297b1575],
33	p	NN	O	p	dep	28	SENT_115	[p7l344t1521r386b1584],
34	=	JJ	O	=	dep	33	SENT_115	[p7l441t1520r495b1540],
35	0.70	CD	NUMBER	0.70	iobj	34	SENT_115	[p7l550t1492r727b1575],
36	)	CD	NUMBER	)	number	37	SENT_115	[p7l550t1492r727b1575],
37	(	CD	NUMBER	(	num	38	SENT_115	[p7l779t1492r1007b1575],
38	Table	NNP	O	Table	dobj	34	SENT_115	[p7l779t1492r1007b1575],
39	2	CD	NUMBER	2	num	38	SENT_115	[p7l1052t1492r1142b1575],
40	)	CD	NUMBER	)	dep	33	SENT_115	[p7l1052t1492r1142b1575],
41	.	.	O	.	_	0	SENT_115	[p7l1052t1492r1142b1575],

1	This	DT	O	this	det	2	SENT_116	[p7l1189t1493r1352b1560],
2	difference	NN	O	difference	nsubj	12	SENT_116	[p7l1401t1494r1740b1560],
3	in	IN	O	in	_	0	SENT_116	[p7l1786t1497r1854b1560],
4	beneﬁt	NN	O	beneﬁt	prep_in	2	SENT_116	[p7l1897t1494r2143b1560],
5	between	IN	O	between	_	0	SENT_116	[p7l9t1602r302b1668],
6	carriers	NNS	O	carrier	prep_between	4	SENT_116	[p7l332t1605r584b1668],
7	and	CC	O	and	_	0	SENT_116	[p7l616t1602r744b1668],
8	noncarriers	NNS	O	noncarrier	prep_between	4	SENT_116	[p7l773t1605r1164b1668],
9	was	VBD	O	be	cop	12	SENT_116	[p7l1191t1628r1320b1668],
10	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_116	[p7l1352t1602r1717b1691],
11	(	NN	O	(	nn	12	SENT_116	[p7l1747t1600r1814b1691],
12	p	NN	O	p	_	0	SENT_116	[p7l1747t1600r1814b1691],
13	=	JJ	O	=	amod	12	SENT_116	[p7l1853t1628r1906b1648],
14	0.018	CD	NUMBER	0.018	tmod	13	SENT_116	[p7l1944t1605r2137b1668],
15	for	IN	O	for	_	0	SENT_116	[p7l10t1711r111b1777],
16	interaction	NN	O	interaction	prep_for	12	SENT_116	[p7l159t1714r541b1777],
17	between	IN	O	between	_	0	SENT_116	[p7l589t1711r883b1777],
18	KIF6	NN	O	kif6	nn	21	SENT_116	[p7l931t1714r1122b1777],
19	719Arg	NN	O	719arg	nn	21	SENT_116	[p7l1173t1709r1442b1800],
20	carrier	NN	O	carrier	nn	21	SENT_116	[p7l1491t1714r1715b1777],
21	status	NN	O	status	prep_between	16	SENT_116	[p7l1765t1728r1961b1777],
22	and	CC	O	and	_	0	SENT_116	[p7l2014t1711r2141b1777],
23	treatment	NN	O	treatment	prep_for	12	SENT_116	[p7l10t1816r381b1898],
24	)	CD	NUMBER	)	number	25	SENT_116	[p7l10t1816r381b1898],
25	(	CD	NUMBER	(	num	26	SENT_116	[p7l421t1816r648b1898],
26	Table	NNP	O	Table	dep	23	SENT_116	[p7l421t1816r648b1898],
27	2	CD	NUMBER	2	number	28	SENT_116	[p7l680t1816r771b1898],
28	)	CD	NUMBER	)	num	26	SENT_116	[p7l680t1816r771b1898],
29	.	.	O	.	_	0	SENT_116	[p7l680t1816r771b1898],

1	In	IN	O	in	_	0	SENT_117	[p7l99t1927r176b1991],
2	terms	NNS	O	term	prep_in	33	SENT_117	[p7l216t1943r411b1992],
3	of	IN	O	of	_	0	SENT_117	[p7l454t1926r534b1992],
4	absolute	JJ	O	absolute	amod	6	SENT_117	[p7l564t1926r851b1992],
5	event	NN	O	event	nn	6	SENT_117	[p7l893t1943r1080b1992],
6	rates	NNS	O	rate	prep_of	2	SENT_117	[p7l1118t1943r1301b2007],
7	,	,	O	,	_	0	SENT_117	[p7l1118t1943r1301b2007],
8	among	IN	O	among	_	0	SENT_117	[p7l1346t1952r1587b2015],
9	carriers	NNS	O	carrier	prep_among	2	SENT_117	[p7l1626t1929r1879b1992],
10	of	IN	O	of	_	0	SENT_117	[p7l1922t1926r2002b1992],
11	the	DT	O	the	det	14	SENT_117	[p7l2030t1926r2140b1992],
12	KIF6	NN	O	kif6	nn	14	SENT_117	[p7l9t2038r199b2101],
13	719Arg	NN	O	719arg	nn	14	SENT_117	[p7l246t2033r515b2124],
14	variant	NN	O	variant	prep_of	9	SENT_117	[p7l554t2037r800b2101],
15	the	DT	O	the	det	17	SENT_117	[p7l842t2034r952b2101],
16	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	17	SENT_117	[p7l1001t2034r1504b2124],
17	estimates	NNS	O	estimate	dep	9	SENT_117	[p7l1548t2037r1871b2101],
18	of	IN	O	of	_	0	SENT_117	[p7l1918t2034r1997b2101],
19	the	DT	O	the	det	21	SENT_117	[p7l2030t2034r2139b2101],
20	cumulative	JJ	O	cumulative	amod	21	SENT_117	[p7l11t2142r393b2208],
21	incidence	NN	O	incidence	prep_of	17	SENT_117	[p7l417t2142r750b2208],
22	of	IN	O	of	_	0	SENT_117	[p7l775t2142r855b2208],
23	death	NN	O	death	prep_of	21	SENT_117	[p7l866t2142r1061b2208],
24	or	CC	O	or	_	0	SENT_117	[p7l1084t2168r1156b2208],
25	major	JJ	O	major	amod	27	SENT_117	[p7l1178t2144r1382b2231],
26	cardiovascular	JJ	O	cardiovascular	amod	27	SENT_117	[p7l1404t2142r1901b2209],
27	events	NNS	O	event	prep_among	2	SENT_117	[p7l1923t2159r2139b2209],
28	at	IN	O	at	_	0	SENT_117	[p7l12t2268r75b2317],
29	2	CD	DURATION	2	num	30	SENT_117	[p7l98t2254r139b2318],
30	years	NNS	NUMBER	year	prep_at	27	SENT_117	[p7l165t2276r339b2340],
31	was	VBD	O	be	cop	33	SENT_117	[p7l364t2277r493b2317],
32	26.0	CD	PERCENT	26.0	num	33	SENT_117	[p7l520t2254r741b2318],
33	%	NN	PERCENT	%	_	0	SENT_117	[p7l520t2254r741b2318],
34	in	IN	O	in	_	0	SENT_117	[p7l767t2254r835b2316],
35	the	DT	O	the	det	40	SENT_117	[p7l861t2251r972b2317],
36	standard	JJ	O	standard	amod	40	SENT_117	[p7l1001t2251r1497b2317],
37	—	NN	O	—	nn	40	SENT_117	[p7l1001t2251r1497b2317],
38	dose	NN	O	dose	nn	40	SENT_117	[p7l1001t2251r1497b2317],
39	pravastatin	NN	O	pravastatin	nn	40	SENT_117	[p7l1524t2254r1909b2340],
40	group	NN	O	group	prep_in	33	SENT_117	[p7l1934t2276r2139b2340],
41	and	CC	O	and	_	0	SENT_117	[p7l12t2358r139b2425],
42	16.1	CD	PERCENT	16.1	num	43	SENT_117	[p7l186t2362r401b2425],
43	%	NN	PERCENT	%	prep_in	33	SENT_117	[p7l186t2362r401b2425],
44	in	IN	O	in	_	0	SENT_117	[p7l444t2361r512b2424],
45	the	DT	O	the	det	51	SENT_117	[p7l554t2358r664b2424],
46	high-dose	JJ	O	high-dose	amod	51	SENT_117	[p7l708t2358r1063b2447],
47	atorvastatin	NN	O	atorvastatin	nn	51	SENT_117	[p7l1108t2361r1518b2425],
48	group	NN	O	group	nn	51	SENT_117	[p7l1560t2384r1764b2448],
49	(	CD	NUMBER	(	num	51	SENT_117	[p7l1812t2356r2145b2447],
50	log-rank	NN	O	log-rank	nn	51	SENT_117	[p7l1812t2356r2145b2447],
51	p	NN	O	p	prep_in	33	SENT_117	[p7l9t2492r51b2555],
52	<	JJR	O	<	amod	51	SENT_117	[p7l92t2476r152b2527],
53	0.001	CD	NUMBER	0.001	num	56	SENT_117	[p7l192t2464r415b2546],
54	)	NN	O	)	nn	56	SENT_117	[p7l192t2464r415b2546],
55	(	CD	NUMBER	(	num	56	SENT_117	[p7l455t2464r616b2555],
56	Fig	NN	O	fig	nsubj	33	SENT_117	[p7l455t2464r616b2555],
57	.	.	O	.	_	0	SENT_117	[p7l455t2464r616b2555],

1	1A	NN	O	1a	nn	2	SENT_118	[p7l660t2464r811b2547],
2	)	NN	O	)	_	0	SENT_118	[p7l660t2464r811b2547],
3	,	,	O	,	_	0	SENT_118	[p7l660t2464r811b2547],
4	an	DT	O	a	det	7	SENT_118	[p7l850t2492r930b2532],
5	absolute	JJ	O	absolute	amod	7	SENT_118	[p7l966t2466r1253b2532],
6	risk	NN	O	risk	nn	7	SENT_118	[p7l1288t2466r1418b2532],
7	reduction	NN	O	reduction	appos	2	SENT_118	[p7l1448t2466r1785b2532],
8	of	IN	O	of	_	0	SENT_118	[p7l1820t2466r1899b2532],
9	10.0	CD	PERCENT	10.0	num	10	SENT_118	[p7l1926t2469r2141b2532],
10	%	NN	PERCENT	%	prep_of	7	SENT_118	[p7l1926t2469r2141b2532],
11	(	CD	PERCENT	(	num	14	SENT_118	[p7l13t2572r192b2655],
12	95	CD	PERCENT	95	number	13	SENT_118	[p7l13t2572r192b2655],
13	%	NN	PERCENT	%	amod	14	SENT_118	[p7l13t2572r192b2655],
14	CI	NN	PERCENT	ci	dep	10	SENT_118	[p7l243t2574r335b2641],
15	4.9	CD	PERCENT	4.9	number	19	SENT_118	[p7l386t2578r561b2641],
16	%	NN	PERCENT	%	dep	19	SENT_118	[p7l386t2578r561b2641],
17	to	TO	O	to	dep	19	SENT_118	[p7l610t2592r678b2641],
18	15.0	CD	PERCENT	15.0	number	19	SENT_118	[p7l733t2572r974b2655],
19	%	NN	PERCENT	%	dep	10	SENT_118	[p7l733t2572r974b2655],
20	)	CD	NUMBER	)	dep	19	SENT_118	[p7l733t2572r974b2655],
21	favoring	VBG	O	favor	partmod	10	SENT_118	[p7l1026t2574r1317b2664],
22	the	DT	O	the	det	26	SENT_118	[p7l1365t2574r1475b2641],
23	intensive	JJ	O	intensive	amod	26	SENT_118	[p7l1525t2575r2144b2664],
24	—	NN	O	—	nn	26	SENT_118	[p7l1525t2575r2144b2664],
25	therapy	NN	O	therapy	nn	26	SENT_118	[p7l1525t2575r2144b2664],
26	regimen	NN	O	regimen	dobj	21	SENT_118	[p7l10t2686r317b2772],
27	.	.	O	.	_	0	SENT_118	[p7l10t2686r317b2772],

1	However	RB	O	however	_	0	SENT_119	[p7l359t2684r700b2764],
2	,	,	O	,	_	0	SENT_119	[p7l359t2684r700b2764],
3	among	IN	O	among	dep	1	SENT_119	[p7l741t2709r982b2772],
4	noncarriers	NNS	O	noncarrier	pobj	3	SENT_119	[p7l1018t2686r1430b2764],
5	,	,	O	,	_	0	SENT_119	[p7l1018t2686r1430b2764],
6	the	DT	O	the	det	8	SENT_119	[p7l1469t2683r1580b2749],
7	cumulative	JJ	O	cumulative	amod	8	SENT_119	[p7l1618t2683r2000b2750],
8	inTable	NN	O	intable	appos	4	SENT_119	[p7l2037t2686r2138b2749, p7l196t2838r275b2862],

1	1	CD	NUMBER	1	num	3	SENT_120	[p7l288t2838r307b2861],
2	Baseline	NN	O	baseline	nn	3	SENT_120	[p7l359t2838r484b2862],
3	Characteristics	NNS	O	characteristic	_	0	SENT_120	[p7l497t2838r724b2862],
4	of	IN	O	of	_	0	SENT_120	[p7l737t2838r765b2862],
5	the	DT	O	the	det	6	SENT_120	[p7l775t2838r823b2862],
6	Patients	NNS	O	patient	prep_of	3	SENT_120	[p7l836t2838r959b2862],
7	According	VBG	O	accord	_	0	SENT_120	[p7l971t2838r1121b2868],
8	to	TO	O	to	prepc_according_to	3	SENT_120	[p7l1132t2839r1162b2862],
9	KIF6	NN	O	kif6	nn	11	SENT_120	[p7l1176t2838r1245b2862],
10	Trp719Arg	NN	O	trp719arg	nn	11	SENT_120	[p7l1255t2838r1413b2868],
11	Genotypes	NNS	O	genotype	pobj	3	SENT_120	[p7l1425t2838r1581b2867],
12	and	CC	O	and	_	0	SENT_120	[p7l1593t2838r1645b2862],
13	719Arg	NN	O	719arg	nn	15	SENT_120	[p7l1660t2838r1769b2868],
14	Carrier	NN	O	carrier	nn	15	SENT_120	[p7l1781t2838r1881b2862],
15	Status	NN	O	status	pobj	3	SENT_120	[p7l1892t2838r1989b2862],

1	ArgArg	NNP	O	ArgArg	nn	4	SENT_121	[p7l893t3051r1071b3101],
2	Genotype	NNP	O	Genotype	nn	4	SENT_121	[p7l1091t3051r1332b3101],
3	Arg/Trp	NNP	O	Arg/Trp	nn	4	SENT_121	[p7l1525t3051r1730b3101],
4	Genotype	NNP	O	Genotype	_	0	SENT_121	[p7l1751t3051r1992b3101],
5	characteristic	JJ	O	characteristic	amod	7	SENT_121	[p7l201t3120r564b3161],
6	(	NN	O	(	nn	7	SENT_121	[p7l982t3121r1031b3170],
7	n	NN	O	n	dep	4	SENT_121	[p7l982t3121r1031b3170],
8	=	JJ	O	=	quantmod	10	SENT_121	[p7l1059t3134r1094b3152],
9	240	CD	NUMBER	240	number	10	SENT_121	[p7l1121t3120r1241b3170],
10	)	CD	NUMBER	)	num	15	SENT_121	[p7l1121t3120r1241b3170],
11	(	NN	O	(	nn	15	SENT_121	[p7l1628t3121r1677b3170],
12	n	NN	O	n	nn	15	SENT_121	[p7l1628t3121r1677b3170],
13	=	JJ	O	=	amod	15	SENT_121	[p7l1705t3134r1740b3152],
14	808	CD	NUMBER	808	num	15	SENT_121	[p7l1767t3120r1888b3170],
15	)	NN	O	)	dep	7	SENT_121	[p7l1767t3120r1888b3170],

1	Age	NNP	O	Age	nsubj	3	SENT_122	[p7l60t3251r166b3301],
2	,	,	O	,	_	0	SENT_122	[p7l60t3251r166b3301],
3	yrs	VBZ	DURATION	yr	_	0	SENT_122	[p7l186t3260r256b3301],
4	58.1	CD	NUMBER	58.1	dobj	3	SENT_122	[p7l958t3251r1072b3291],
5	:	:	O	:	_	0	SENT_122	[p7l1095t3254r1130b3289],
6	10.9	CD	NUMBER	10.9	number	7	SENT_122	[p7l1157t3251r1268b3291],
7	57.3	CD	NUMBER	57.3	dep	4	SENT_122	[p7l1604t3251r1716b3291],
8	:	:	O	:	_	0	SENT_122	[p7l1741t3254r1777b3289],
9	11.0	CD	NUMBER	11.0	num	10	SENT_122	[p7l1803t3251r1914b3291],
10	Male	NN	O	male	dep	7	SENT_122	[p7l63t3332r193b3380],
11	,	,	O	,	_	0	SENT_122	[p7l63t3332r193b3380],
12	n	NN	O	n	appos	10	SENT_122	[p7l216t3342r241b3371],
13	(	CD	PERCENT	(	num	14	SENT_122	[p7l263t3332r339b3381],
14	%	NN	PERCENT	%	dep	36	SENT_122	[p7l263t3332r339b3381],
15	)	CD	NUMBER	)	number	16	SENT_122	[p7l263t3332r339b3381],
16	188	CD	NUMBER	188	dep	14	SENT_122	[p7l983t3332r1080b3372],
17	(	NN	O	(	dep	16	SENT_122	[p7l1097t3332r1245b3381],
18	78.3	CD	NUMBER	78.3	num	17	SENT_122	[p7l1097t3332r1245b3381],
19	)	NN	O	)	dep	36	SENT_122	[p7l1097t3332r1245b3381],
20	636	CD	NUMBER	636	num	19	SENT_122	[p7l1627t3332r1726b3372],
21	(	CD	NUMBER	(	number	22	SENT_122	[p7l1743t3332r1891b3381],
22	79.0	CD	NUMBER	79.0	num	36	SENT_122	[p7l1743t3332r1891b3381],
23	)	NN	O	)	nn	36	SENT_122	[p7l1743t3332r1891b3381],
24	BMI	NN	O	bmus	nn	36	SENT_122	[p7l63t3414r167b3461],
25	,	,	O	,	_	0	SENT_122	[p7l63t3414r167b3461],
26	kg/m2	NN	O	kg/m2	dep	36	SENT_122	[p7l191t3401r350b3463],
27	30.4	CD	NUMBER	30.4	dep	26	SENT_122	[p7l957t3413r1071b3454],
28	:	:	O	:	_	0	SENT_122	[p7l1096t3416r1130b3451],
29	6.2	CD	NUMBER	6.2	num	30	SENT_122	[p7l1156t3413r1233b3453],
30	30.1	CD	NUMBER	30.1	dep	26	SENT_122	[p7l1604t3413r1718b3454],
31	:	:	O	:	_	0	SENT_122	[p7l1742t3416r1777b3451],
32	5.7	CD	NUMBER	5.7	num	34	SENT_122	[p7l1802t3414r1879b3454],
33	Smoking	NN	O	smoking	nn	34	SENT_122	[p7l60t3494r280b3544],
34	status	NN	O	status	dep	30	SENT_122	[p7l297t3497r460b3542],
35	,	,	O	,	_	0	SENT_122	[p7l297t3497r460b3542],
36	n	NN	O	n	dep	39	SENT_122	[p7l483t3504r507b3534],
37	(	CD	PERCENT	(	num	38	SENT_122	[p7l529t3494r606b3543],
38	%	NN	PERCENT	%	dep	36	SENT_122	[p7l529t3494r606b3543],
39	)	CD	NUMBER	)	dep	4	SENT_122	[p7l529t3494r606b3543],

1	Current	JJ	DATE	current	amod	2	SENT_123	[p7l119t3575r299b3615],
2	87	CD	NUMBER	87	dep	16	SENT_123	[p7l1015t3575r1078b3615],
3	(	CD	NUMBER	(	number	4	SENT_123	[p7l1097t3575r1245b3624],
4	36.3	CD	NUMBER	36.3	num	5	SENT_123	[p7l1097t3575r1245b3624],
5	)	NN	O	)	dep	2	SENT_123	[p7l1097t3575r1245b3624],
6	291	CD	NUMBER	291	num	7	SENT_123	[p7l1627t3574r1727b3615],
7	(	NN	O	(	dep	5	SENT_123	[p7l1743t3575r1891b3624],
8	36.0	CD	NUMBER	36.0	number	9	SENT_123	[p7l1743t3575r1891b3624],
9	)	CD	NUMBER	)	num	10	SENT_123	[p7l1743t3575r1891b3624],
10	Past	JJ	DATE	past	dep	7	SENT_123	[p7l121t3657r227b3697],
11	251	CD	NUMBER	251	number	12	SENT_123	[p7l981t3656r1080b3697],
12	(	CD	NUMBER	(	num	10	SENT_123	[p7l1097t3656r1245b3705],
13	34.4	CD	NUMBER	34.4	num	14	SENT_123	[p7l1097t3656r1245b3705],
14	)	NN	O	)	dep	16	SENT_123	[p7l1097t3656r1245b3705],
15	307	CD	NUMBER	307	num	16	SENT_123	[p7l1627t3656r1724b3697],
16	(	NN	O	(	dep	23	SENT_123	[p7l1743t3656r1891b3705],
17	38.0	CD	NUMBER	38.0	num	18	SENT_123	[p7l1743t3656r1891b3705],
18	)	CD	NUMBER	)	npadvmod	19	SENT_123	[p7l1743t3656r1891b3705],
19	Never	RB	O	never	advmod	21	SENT_123	[p7l121t3737r260b3777],
20	173	CD	NUMBER	173	num	21	SENT_123	[p7l983t3737r1079b3777],
21	(	CD	NUMBER	(	dep	16	SENT_123	[p7l1097t3737r1245b3786],
22	23.7	CD	NUMBER	23.7	amod	21	SENT_123	[p7l1097t3737r1245b3786],
23	)	NN	O	)	dep	25	SENT_123	[p7l1097t3737r1245b3786],
24	210	CD	NUMBER	210	num	23	SENT_123	[p7l1627t3737r1725b3777],
25	(	NN	O	(	dep	27	SENT_123	[p7l1743t3737r1891b3786],
26	26.0	CD	NUMBER	26.0	num	25	SENT_123	[p7l1743t3737r1891b3786],
27	)	NN	O	)	_	0	SENT_123	[p7l1743t3737r1891b3786],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_124	[p8l63t23r291b70],
2	,	,	O	,	_	0	SENT_124	[p8l63t23r291b70],
3	n	NN	O	n	dep	12	SENT_124	[p8l314t32r338b62],
4	(	CD	PERCENT	(	num	5	SENT_124	[p8l360t23r436b72],
5	%	NN	PERCENT	%	dep	3	SENT_124	[p8l360t23r436b72],
6	)	CD	NUMBER	)	number	7	SENT_124	[p8l360t23r436b72],
7	41	CD	NUMBER	41	num	8	SENT_124	[p8l1015t22r1080b62],
8	(	NN	O	(	dep	5	SENT_124	[p8l1097t22r1245b72],
9	17.1	CD	NUMBER	17.1	num	10	SENT_124	[p8l1097t22r1245b72],
10	)	NN	O	)	dep	12	SENT_124	[p8l1097t22r1245b72],
11	150	CD	NUMBER	150	num	12	SENT_124	[p8l1628t22r1725b63],
12	(	NN	O	(	dep	19	SENT_124	[p8l1743t22r1891b72],
13	18.6	CD	NUMBER	18.6	number	14	SENT_124	[p8l1743t22r1891b72],
14	)	CD	NUMBER	)	num	15	SENT_124	[p8l1743t22r1891b72],
15	Hypertension	NN	O	hypertension	dep	12	SENT_124	[p8l63t105r396b154],
16	,	,	O	,	_	0	SENT_124	[p8l63t105r396b154],
17	n	NN	O	n	appos	15	SENT_124	[p8l420t114r444b144],
18	(	CD	PERCENT	(	num	19	SENT_124	[p8l466t105r572b153],
19	%	NN	PERCENT	%	dep	21	SENT_124	[p8l466t105r572b153],
20	)	CD	NUMBER	)	num	21	SENT_124	[p8l466t105r572b153],
21	*	NN	O	*	dep	27	SENT_124	[p8l466t105r572b153],
22	138	CD	NUMBER	138	number	23	SENT_124	[p8l983t104r1080b145],
23	(	CD	NUMBER	(	dep	21	SENT_124	[p8l1097t105r1245b153],
24	57.5	CD	NUMBER	57.5	num	25	SENT_124	[p8l1097t105r1245b153],
25	)	NN	O	)	dep	23	SENT_124	[p8l1097t105r1245b153],
26	452	CD	NUMBER	452	num	27	SENT_124	[p8l1627t104r1724b145],
27	(	NN	O	(	dep	39	SENT_124	[p8l1743t104r1891b153],
28	55.9	CD	NUMBER	55.9	number	29	SENT_124	[p8l1743t104r1891b153],
29	)	CD	NUMBER	)	num	32	SENT_124	[p8l1743t104r1891b153],
30	Prior	JJ	O	prior	amod	32	SENT_124	[p8l63t185r177b225],
31	statin	NN	O	statin	nn	32	SENT_124	[p8l195t185r330b225],
32	therapy	NN	O	therapy	dep	27	SENT_124	[p8l351t185r549b235],
33	,	,	O	,	_	0	SENT_124	[p8l351t185r549b235],
34	n	NN	O	n	appos	32	SENT_124	[p8l572t195r597b225],
35	(	CD	PERCENT	(	num	36	SENT_124	[p8l619t185r695b234],
36	%	NN	PERCENT	%	dep	34	SENT_124	[p8l619t185r695b234],
37	)	CD	NUMBER	)	number	38	SENT_124	[p8l619t185r695b234],
38	60	CD	NUMBER	60	num	36	SENT_124	[p8l1015t185r1079b225],
39	(	NN	O	(	dep	41	SENT_124	[p8l1097t185r1245b234],
40	25.0	CD	NUMBER	25.0	num	39	SENT_124	[p8l1097t185r1245b234],
41	)	NN	O	)	dep	43	SENT_124	[p8l1097t185r1245b234],
42	209	CD	NUMBER	209	num	41	SENT_124	[p8l1627t185r1725b225],
43	(	NN	O	(	dep	45	SENT_124	[p8l1743t185r1891b234],
44	25.9	CD	NUMBER	25.9	num	43	SENT_124	[p8l1743t185r1891b234],
45	)	CD	NUMBER	)	dep	47	SENT_124	[p8l1743t185r1891b234],
46	Total	JJ	O	total	amod	47	SENT_124	[p8l59t266r179b306],
47	cholesterol	NN	O	cholesterol	dep	1	SENT_124	[p8l201t266r482b313],
48	,	,	O	,	_	0	SENT_124	[p8l201t266r482b313],
49	mg/dl	NN	O	mg/dl	dep	1	SENT_124	[p8l506t266r651b315],

1	Median	JJ	MISC	median	_	0	SENT_125	[p8l121t348r298b388],
2	187	CD	NUMBER	187	number	3	SENT_125	[p8l1065t347r1161b388],
3	181	CD	NUMBER	181	dep	1	SENT_125	[p8l1711t347r1809b388],
4	IQR	NN	O	iqr	dep	3	SENT_125	[p8l121t429r205b477],
5	163-208 162-207	CD	NUMBER	163-208 162-207	num	4	SENT_125	[p8l1646t429r1873b469],[p8l1000t429r1228b469],

1	Low-density	JJ	O	low-density	amod	3	SENT_126	[p8l63t510r350b559],
2	lipoprotein	NN	O	lipoprotein	nn	3	SENT_126	[p8l371t510r629b559],
3	cholesterol	NN	O	cholesterol	_	0	SENT_126	[p8l204t589r485b636],
4	,	,	O	,	_	0	SENT_126	[p8l204t589r485b636],
5	mg/dl	NN	O	mg/dl	appos	3	SENT_126	[p8l508t589r655b638],

1	Median	JJ	MISC	median	_	0	SENT_127	[p8l121t671r298b711],
2	108	CD	NUMBER	108	number	3	SENT_127	[p8l1065t670r1162b711],
3	106	CD	NUMBER	106	num	4	SENT_127	[p8l1711t670r1809b711],
4	IQR	NN	O	iqr	dep	1	SENT_127	[p8l121t752r205b800],
5	89-129	CD	NUMBER	89-129	num	6	SENT_127	[p8l1032t752r1227b792],
6	89-130	CD	NUMBER	89-130	dep	4	SENT_127	[p8l1678t752r1874b792],

1	High-density	JJ	O	high-density	amod	3	SENT_128	[p8l63t833r363b882],
2	lipoprotein	NN	O	lipoprotein	nn	3	SENT_128	[p8l383t833r642b882],
3	cholesterol	NN	O	cholesterol	_	0	SENT_128	[p8l204t912r485b959],
4	,	,	O	,	_	0	SENT_128	[p8l204t912r485b959],
5	mg/dl	NN	O	mg/dl	appos	3	SENT_128	[p8l508t912r655b961],

1	Median	JJ	MISC	median	amod	2	SENT_129	[p8l121t994r298b1034],
2	39	CD	NUMBER	39	_	0	SENT_129	[p8l1097t993r1162b1034],
3	38	CD	NUMBER	38	num	4	SENT_129	[p8l1743t993r1809b1034],
4	IQR	NN	O	iqr	dep	2	SENT_129	[p8l121t1075r205b1123],
5	33-46	CD	NUMBER	33-46	num	6	SENT_129	[p8l1032t1075r1193b1115],
6	33-45	CD	NUMBER	33-45	dep	2	SENT_129	[p8l1678t1075r1840b1115],

1	Triglycerides	NNS	MISC	triglyceride	_	0	SENT_130	[p8l59t1156r380b1205],
2	,	,	O	,	_	0	SENT_130	[p8l59t1156r380b1205],
3	mg/dl	NN	O	mg/dl	appos	1	SENT_130	[p8l403t1156r549b1205],

1	Median	JJ	MISC	median	_	0	SENT_131	[p8l121t1238r298b1278],
2	160	CD	NUMBER	160	number	3	SENT_131	[p8l1065t1237r1162b1278],
3	163	CD	NUMBER	163	dep	1	SENT_131	[p8l1711t1237r1808b1278],
4	IQR	NN	O	iqr	dep	3	SENT_131	[p8l121t1319r205b1367],
5	121-228 127-218	CD	NUMBER	121-228 127-218	num	4	SENT_131	[p8l1646t1319r1874b1359],[p8l1000t1319r1228b1359],

1	Arg	NN	O	arg	_	0	SENT_132	[p8l806t1387r890b1434],
2	Variant	JJ	O	variant	amod	3	SENT_132	[p8l908t1386r1081b1425],
3	Carriers	NNS	O	carrier	dep	1	SENT_132	[p8l1101t1386r1304b1433],
4	,	,	O	,	_	0	SENT_132	[p8l1101t1386r1304b1433],
5	Arg	NN	O	arg	nn	7	SENT_132	[p8l37t1452r121b1500],
6	Variant	JJ	O	variant	amod	7	SENT_132	[p8l139t1452r311b1491],
7	Noncarriers	NNS	O	noncarrier	appos	3	SENT_132	[p8l334t1452r623b1499],
8	,	,	O	,	_	0	SENT_132	[p8l334t1452r623b1499],
9	Arg/Arg	NN	O	arg/arg	appos	3	SENT_132	[p8l819t1452r1020b1500],
10	+	CC	O	+	_	0	SENT_132	[p8l1043t1457r1077b1490],
11	Arg/Trp	NN	O	arg/trp	appos	3	SENT_132	[p8l1101t1452r1293b1500],

1	Trp/Trp	NNP	O	Trp/Trp	nn	3	SENT_133	[p8l115t1518r300b1565],
2	Genotype	NNP	O	Genotype	nn	3	SENT_133	[p8l321t1518r547b1565],
3	Genotypes	NNP	O	Genotypes	_	0	SENT_133	[p8l930t1518r1183b1565],

1	(	NN	O	(	nn	2	SENT_134	[p8l208t1585r254b1631],
2	n	NN	O	n	dep	32	SENT_134	[p8l208t1585r254b1631],
3	=	JJ	O	=	dep	2	SENT_134	[p8l280t1597r314b1614],
4	730	CD	NUMBER	730	number	5	SENT_134	[p8l341t1584r452b1631],
5	)	CD	NUMBER	)	num	15	SENT_134	[p8l341t1584r452b1631],
6	(	NN	O	(	nn	15	SENT_134	[p8l909t1585r955b1632],
7	n	NN	O	n	nn	15	SENT_134	[p8l909t1585r955b1632],
8	=	JJ	O	=	amod	15	SENT_134	[p8l981t1597r1015b1614],
9	1,048	CD	NUMBER	1,048	number	10	SENT_134	[p8l1040t1584r1202b1632],
10	)	CD	NUMBER	)	num	15	SENT_134	[p8l1040t1584r1202b1632],
11	p	NN	O	p	nn	15	SENT_134	[p8l1491t1594r1516b1632],
12	Value1	NN	O	value1	nn	15	SENT_134	[p8l1535t1585r1699b1631],
13	'	''	O	'	_	0	SENT_134	[p8l1535t1585r1699b1631],
14	p	NN	O	p	nn	15	SENT_134	[p8l1885t1594r1911b1632],
15	Value	NN	O	value	dep	3	SENT_134	[p8l1930t1585r2094b1631],
16	:	:	O	:	_	0	SENT_134	[p8l1930t1585r2094b1631],
17	|	CD	NUMBER	|	num	19	SENT_134	[p8l1930t1585r2094b1631],
18	:	:	O	:	_	0	SENT_134	[p8l1930t1585r2094b1631],
19	57.7	CD	NUMBER	57.7	dep	3	SENT_134	[p8l185t1677r291b1715],
20	:	:	O	:	_	0	SENT_134	[p8l315t1680r348b1713],
21	11.0	CD	NUMBER	11.0	number	22	SENT_134	[p8l373t1677r477b1715],
22	57.5	CD	NUMBER	57.5	dep	19	SENT_134	[p8l911t1677r1017b1715],
23	:	:	O	:	_	0	SENT_134	[p8l1040t1680r1073b1713],
24	11.0	CD	NUMBER	11.0	num	25	SENT_134	[p8l1098t1677r1203b1715],
25	0.53	CD	NUMBER	0.53	dep	3	SENT_134	[p8l1542t1677r1647b1715],
26	0.54	CD	NUMBER	0.54	num	28	SENT_134	[p8l1921t1677r2027b1715],
27	564	CD	NUMBER	564	num	28	SENT_134	[p8l207t1755r300b1792],
28	(	NN	O	(	dep	25	SENT_134	[p8l317t1755r456b1801],
29	77.3	CD	NUMBER	77.3	num	30	SENT_134	[p8l317t1755r456b1801],
30	)	NN	O	)	dep	32	SENT_134	[p8l317t1755r456b1801],
31	826	CD	NUMBER	826	num	32	SENT_134	[p8l932t1755r1025b1792],
32	(	NN	O	(	dep	46	SENT_134	[p8l1042t1755r1181b1801],
33	78.8	CD	NUMBER	78.8	number	34	SENT_134	[p8l1042t1755r1181b1801],
34	)	CD	NUMBER	)	num	35	SENT_134	[p8l1042t1755r1181b1801],
35	0.72	CD	NUMBER	0.72	dep	32	SENT_134	[p8l1542t1755r1647b1792],
36	0.45	CD	NUMBER	0.45	num	37	SENT_134	[p8l1921t1755r2027b1792],
37	30.1	CD	NUMBER	30.1	dep	35	SENT_134	[p8l185t1833r292b1871],
38	:	:	O	:	_	0	SENT_134	[p8l315t1836r348b1869],
39	5.8	CD	NUMBER	5.8	number	40	SENT_134	[p8l371t1833r446b1871],
40	30.1	CD	NUMBER	30.1	dep	35	SENT_134	[p8l911t1833r1018b1871],
41	:	:	O	:	_	0	SENT_134	[p8l1040t1836r1073b1869],
42	5.9	CD	NUMBER	5.9	dep	40	SENT_134	[p8l1096t1833r1171b1871],
43	0.92	CD	NUMBER	0.92	number	44	SENT_134	[p8l1542t1833r1647b1871],
44	0.92	CD	NUMBER	0.92	amod	42	SENT_134	[p8l1921t1833r2026b1871],
45	0.09	CD	NUMBER	0.09	num	46	SENT_134	[p8l1542t1911r1647b1949],
46	0.042	CD	NUMBER	0.042	_	0	SENT_134	[p8l1921t1911r2057b1948],

1	*	NN	O	*	nn	2	SENT_135	[p8l43t3583r189b3604],
2	Hypertension	NN	O	hypertension	nsubjpass	4	SENT_135	[p8l43t3583r189b3604],
3	was	VBD	O	be	auxpass	4	SENT_135	[p8l195t3587r235b3600],
4	defined	VBN	O	define	_	0	SENT_135	[p8l241t3583r316b3600],
5	as	IN	O	as	_	0	SENT_135	[p8l322t3587r345b3600],
6	the	DT	O	the	det	7	SENT_135	[p8l350t3583r383b3600],
7	history	NN	O	history	prep_as	4	SENT_135	[p8l390t3583r457b3604],
8	of	IN	O	of	_	0	SENT_135	[p8l462t3583r482b3600],
9	hypertension	NN	O	hypertension	prep_of	7	SENT_135	[p8l488t3583r624b3604],
10	,	,	O	,	_	0	SENT_135	[p8l488t3583r624b3604],
11	systolic	JJ	O	systolic	amod	16	SENT_135	[p8l630t3583r705b3604],
12	blood	NN	O	blood	nn	16	SENT_135	[p8l712t3583r766b3600],
13	pressure	NN	O	pressure	nn	16	SENT_135	[p8l774t3587r860b3604],
14	2140	CD	DATE	2140	num	16	SENT_135	[p8l867t3583r927b3600],
15	mm	NN	O	mm	nn	16	SENT_135	[p8l934t3587r973b3600],
16	Hg	NN	O	hg	conj_or	9	SENT_135	[p8l981t3583r1011b3604],
17	,	,	O	,	_	0	SENT_135	[p8l981t3583r1011b3604],
18	or	CC	O	or	_	0	SENT_135	[p8l1018t3587r1038b3600],
19	diastolic	JJ	O	diastolic	amod	24	SENT_135	[p8l1044t3583r1128b3600],
20	blood	NN	O	blood	nn	24	SENT_135	[p8l1135t3583r1189b3600],
21	pressure	NN	O	pressure	nn	24	SENT_135	[p8l1197t3587r1283b3604],
22	:90	CD	NUMBER	:90	num	24	SENT_135	[p8l1290t3583r1336b3600],
23	mm	NN	O	mm	nn	24	SENT_135	[p8l1343t3587r1382b3600],
24	Hg	NN	O	hg	prep_of	7	SENT_135	[p8l1389t3583r1420b3604],
25	.	.	O	.	_	0	SENT_135	[p8l1389t3583r1420b3604],

1	1-Associations	NNS	O	1-association	nsubjpass	10	SENT_136	[p8l1428t3583r1569b3604],
2	between	IN	O	between	_	0	SENT_136	[p8l1576t3583r1661b3600],
3	baseline	NN	O	baseline	nn	4	SENT_136	[p8l1668t3583r1753b3600],
4	characteristics	NNS	O	characteristic	prep_between	1	SENT_136	[p8l1759t3583r1908b3600],
5	and	CC	O	and	_	0	SENT_136	[p8l1913t3583r1950b3600],
6	KIF6	NN	O	kif6	nn	8	SENT_136	[p8l1957t3583r2003b3600],
7	Trp719Arg	NN	O	trp719arg	nn	8	SENT_136	[p8l2008t3583r2118b3604],
8	genotypes	NNS	O	genotype	conj_and	4	SENT_136	[p8l43t3615r147b3635],
9	were	VBD	O	be	auxpass	10	SENT_136	[p8l152t3618r201b3631],
10	tested	VBN	O	test	_	0	SENT_136	[p8l207t3614r270b3631],
11	with	IN	O	with	_	0	SENT_136	[p8l276t3614r318b3631],
12	the	DT	O	the	det	14	SENT_136	[p8l324t3614r357b3631],
13	Kruskal-Wallis	NN	MISC	kruskal-walli	nn	14	SENT_136	[p8l364t3614r508b3631],
14	test	NN	O	test	prep_with	10	SENT_136	[p8l514t3615r552b3631],
15	for	IN	O	for	_	0	SENT_136	[p8l557t3614r585b3631],
16	continuous	JJ	O	continuous	amod	17	SENT_136	[p8l591t3614r703b3631],
17	variables	NNS	O	variable	prep_for	14	SENT_136	[p8l708t3614r800b3631],
18	and	CC	O	and	_	0	SENT_136	[p8l806t3614r843b3631],
19	the	DT	O	the	det	21	SENT_136	[p8l849t3614r882b3631],
20	chi-square	JJ	O	chi-square	amod	21	SENT_136	[p8l888t3614r993b3635],
21	test	NN	O	test	prep_with	10	SENT_136	[p8l998t3615r1037b3631],
22	for	IN	O	for	_	0	SENT_136	[p8l1042t3614r1070b3631],
23	discrete	JJ	O	discrete	amod	24	SENT_136	[p8l1075t3614r1156b3631],
24	variables	NNS	O	variable	prep_for	21	SENT_136	[p8l1161t3614r1258b3631],
25	.	.	O	.	_	0	SENT_136	[p8l1161t3614r1258b3631],

1	¢	NN	O	¢	nn	2	SENT_137	[p8l1266t3614r1407b3635],
2	Associations	NNS	O	association	nsubjpass	12	SENT_137	[p8l1266t3614r1407b3635],
3	between	IN	O	between	_	0	SENT_137	[p8l1414t3614r1499b3631],
4	baseline	NN	O	baseline	nn	5	SENT_137	[p8l1507t3614r1591b3631],
5	characteristics	NNS	O	characteristic	prep_between	2	SENT_137	[p8l1597t3614r1746b3631],
6	and	CC	O	and	_	0	SENT_137	[p8l1752t3614r1789b3631],
7	KIF6	NN	O	kif6	nn	10	SENT_137	[p8l1796t3614r1842b3631],
8	719Arg	NN	O	719arg	nn	10	SENT_137	[p8l1848t3614r1924b3635],
9	carrier	NN	O	carrier	nn	10	SENT_137	[p8l1929t3614r1995b3631],
10	status	NN	O	status	prep_between	2	SENT_137	[p8l2000t3615r2063b3631],
11	were	VBD	O	be	auxpass	12	SENT_137	[p8l2068t3618r2117b3631],
12	tested	VBN	O	test	_	0	SENT_137	[p8l42t3645r105b3662],
13	with	IN	O	with	_	0	SENT_137	[p8l114t3645r155b3662],
14	the	DT	O	the	det	18	SENT_137	[p8l164t3645r196b3662],
15	Wilcoxon	NNP	PERSON	Wilcoxon	nn	18	SENT_137	[p8l204t3645r295b3662],
16	rank	NN	O	rank	nn	18	SENT_137	[p8l305t3645r350b3662],
17	sum	NN	O	sum	nn	18	SENT_137	[p8l357t3649r401b3662],
18	test	NN	O	test	prep_with	12	SENT_137	[p8l409t3646r447b3662],
19	for	IN	O	for	_	0	SENT_137	[p8l455t3645r483b3662],
20	continuous	JJ	O	continuous	amod	21	SENT_137	[p8l490t3645r602b3662],
21	variables	NNS	O	variable	prep_for	18	SENT_137	[p8l610t3645r702b3662],
22	and	CC	O	and	_	0	SENT_137	[p8l710t3645r746b3662],
23	Fisher	NNP	PERSON	Fisher	nn	25	SENT_137	[p8l756t3645r817b3662],
24	exact	JJ	O	exact	amod	25	SENT_137	[p8l825t3646r879b3662],
25	test	NN	O	test	conj_and	18	SENT_137	[p8l886t3646r924b3662],
26	for	IN	O	for	_	0	SENT_137	[p8l932t3645r960b3662],
27	discrete	JJ	O	discrete	amod	28	SENT_137	[p8l968t3645r1048b3662],
28	variables	NNS	O	variable	prep_for	25	SENT_137	[p8l1056t3645r1153b3662],
29	.	.	O	.	_	0	SENT_137	[p8l1056t3645r1153b3662],

1	BMI	NN	O	bmus	_	0	SENT_138	[p8l68t3677r105b3694],
2	=	JJ	O	=	amod	5	SENT_138	[p8l116t3683r130b3689],
3	body	NN	O	body	nn	5	SENT_138	[p8l141t3677r189b3698],
4	mass	NN	O	mass	nn	5	SENT_138	[p8l197t3681r251b3694],
5	index	NN	O	index	dep	1	SENT_138	[p8l260t3677r318b3697],
6	;	:	O	;	_	0	SENT_138	[p8l260t3677r318b3697],
7	IQR	NN	O	iqr	dep	1	SENT_138	[p8l328t3677r363b3697],
8	=	JJ	O	=	amod	10	SENT_138	[p8l373t3683r388b3689],
9	interquartile	JJ	O	interquartile	amod	10	SENT_138	[p8l399t3677r523b3698],
10	range	NN	O	range	dep	7	SENT_138	[p8l532t3679r594b3698],
11	.	.	O	.	_	0	SENT_138	[p8l532t3679r594b3698],

1	452	CD	NUMBER	452	num	2	SENT_139	[p9l42t44r95b69],
2	lakoubova	NN	O	lakoubova	_	0	SENT_139	[p9l194t44r328b69],
3	et	FW	O	et	nn	4	SENT_139	[p9l338t45r365b69],
4	al.	FW	O	al.	dep	2	SENT_139	[p9l372t44r404b69],
5	.	.	O	.	_	0	SENT_139	[p9l372t44r404b69],

1	JACC	NNP	O	JACC	nn	2	SENT_140	[p9l1823t45r1877b69],
2	Vol	NNP	O	Vol	_	0	SENT_140	[p9l1886t45r1925b69],
3	.	.	O	.	_	0	SENT_140	[p9l1886t45r1925b69],

1	51	CD	NUMBER	51	_	0	SENT_141	[p9l1936t45r1971b73],
2	,	,	O	,	_	0	SENT_141	[p9l1936t45r1971b73],
3	No.	NN	O	no.	amod	1	SENT_141	[p9l1983t45r2017b69],
4	4	CD	NUMBER	4	number	3	SENT_141	[p9l2028t45r2048b73],
5	,	,	O	,	_	0	SENT_141	[p9l2028t45r2048b73],
6	2008	CD	DATE	2008	num	8	SENT_141	[p9l2059t45r2117b69],
7	KIF6	NN	O	kif6	nn	8	SENT_141	[p9l194t85r256b110],
8	Trp719Arg	NN	O	trp719arg	appos	1	SENT_141	[p9l262t85r407b115],
9	in	IN	O	in	_	0	SENT_141	[p9l416t85r438b110],
10	the	DT	O	the	det	12	SENT_141	[p9l447t85r490b110],
11	PROVE	NNP	O	PROVE	nn	12	SENT_141	[p9l500t85r589b110],
12	IT-TIMI	NN	O	it-timus	prep_in	8	SENT_141	[p9l599t85r691b110],
13	22	CD	NUMBER	22	num	12	SENT_141	[p9l701t85r736b110],
14	Trial	NNP	O	Trial	nn	15	SENT_141	[p9l744t85r804b110],
15	January	NNP	DATE	January	dep	1	SENT_141	[p9l1823t86r1906b116],
16	29	CD	DATE	29	num	15	SENT_141	[p9l1915t86r1950b114],
17	,	,	O	,	_	0	SENT_141	[p9l1915t86r1950b114],
18	2008:449	CD	NUMBER	2008:449	num	15	SENT_141	[p9l1961t86r2117b110],
19	—	CD	NUMBER	—	number	20	SENT_141	[p9l1961t86r2117b110],
20	55	CD	NUMBER	55	dep	15	SENT_141	[p9l1961t86r2117b110],

1	Table	NNP	O	Table	nn	3	SENT_142	[p9l68t228r147b251],
2	2	CD	NUMBER	2	num	3	SENT_142	[p9l160t228r178b251],
3	Effect	NN	O	effect	dep	11	SENT_142	[p9l231t209r316b233],
4	of	IN	O	of	_	0	SENT_142	[p9l329t209r357b233],
5	80	CD	NUMBER	80	prep_of	3	SENT_142	[p9l368t209r406b233],
6	mg	NN	O	mg	nn	8	SENT_142	[p9l420t212r465b239],
7	Atorvastatin	NNP	O	Atorvastatin	nn	8	SENT_142	[p9l476t209r658b233],
8	Versus	NNP	O	Versus	dep	11	SENT_142	[p9l671t209r770b233],
9	40	CD	NUMBER	40	num	11	SENT_142	[p9l783t209r821b233],
10	mg	NN	O	mg	nn	11	SENT_142	[p9l835t212r880b239],
11	Pravastatin	NN	O	pravastatin	dep	18	SENT_142	[p9l892t209r1060b233],
12	on	IN	O	on	_	0	SENT_142	[p9l1073t215r1107b233],
13	Death	NN	O	death	nn	17	SENT_142	[p9l1121t209r1207b233],
14	or	CC	O	or	_	0	SENT_142	[p9l230t253r258b271],
15	Major	JJ	O	major	nn	17	SENT_142	[p9l271t247r355b276],
16	cardiovascular	JJ	O	cardiovascular	amod	17	SENT_142	[p9l367t247r587b271],
17	Events	NNS	O	event	prep_on	11	SENT_142	[p9l599t247r697b271],
18	According	VBG	O	accord	_	0	SENT_142	[p9l709t247r860b276],
19	to	TO	O	to	pcomp	18	SENT_142	[p9l870t248r900b271],
20	KIF6	NN	O	kif6	nn	22	SENT_142	[p9l914t247r984b271],
21	Trp719Arg	NN	O	trp719arg	nn	22	SENT_142	[p9l993t247r1152b276],
22	Genotype	NN	O	genotype	pobj	19	SENT_142	[p9l1163t247r1303b276],

1	Unadjusted	JJ	O	unadjusted	_	0	SENT_143	[p9l1244t326r1379b350],
2	Adjusted	VBN	O	adjust	dep	1	SENT_143	[p9l1801t326r1921b350],
3	*	NN	O	*	dobj	2	SENT_143	[p9l1801t326r1921b350],

1	Subgroup	NN	ORGANIZATION	subgroup	nn	2	SENT_144	[p9l122t394r235b418],
2	Treatment	NN	ORGANIZATION	treatment	dep	20	SENT_144	[p9l390t394r514b413],
3	On-Trial	JJ	ORGANIZATION	on-trial	amod	4	SENT_144	[p9l617t394r706b413],
4	CHD	NN	ORGANIZATION	chd	dep	2	SENT_144	[p9l717t394r777b417],
5	,	,	O	,	_	0	SENT_144	[p9l717t394r777b417],
6	n	NN	O	n	nn	7	SENT_144	[p9l789t399r801b413],
7	Total	NNP	O	Total	appos	4	SENT_144	[p9l896t394r964b417],
8	,	,	O	,	_	0	SENT_144	[p9l896t394r964b417],
9	n	NN	O	n	nn	10	SENT_144	[p9l975t399r988b413],
10	HR	NN	DURATION	hr	appos	4	SENT_144	[p9l1093t394r1127b413],
11	95	CD	PERCENT	95	num	12	SENT_144	[p9l1250t394r1300b413],
12	%	NN	PERCENT	%	dep	20	SENT_144	[p9l1250t394r1300b413],
13	CI	NN	O	ci	nn	20	SENT_144	[p9l1310t394r1334b413],
14	p	NN	O	p	nn	20	SENT_144	[p9l1449t399r1462b418],
15	Value	NN	O	value	nn	20	SENT_144	[p9l1472t394r1538b413],
16	HR	NN	DURATION	hr	nn	20	SENT_144	[p9l1644t394r1678b413],
17	95	CD	PERCENT	95	num	20	SENT_144	[p9l1800t394r1851b413],
18	%	NN	PERCENT	%	nn	20	SENT_144	[p9l1800t394r1851b413],
19	CI	NN	O	ci	nn	20	SENT_144	[p9l1861t394r1884b413],
20	p	NN	O	p	dep	25	SENT_144	[p9l2000t399r2013b418],
21	Value	NN	O	value	nn	22	SENT_144	[p9l2023t394r2089b413],
22	Arg/Arg	NN	O	arg/arg	dep	20	SENT_144	[p9l67t439r159b463],
23	+	CC	O	+	_	0	SENT_144	[p9l170t441r186b458],
24	Arg/Trp	NN	O	arg/trp	dep	20	SENT_144	[p9l197t439r285b463],
25	Atorvastatin	NN	O	atorvastatin	dep	28	SENT_144	[p9l380t439r519b459],
26	88	CD	NUMBER	88	num	25	SENT_144	[p9l702t439r732b459],
27	525	CD	NUMBER	525	num	28	SENT_144	[p9l919t439r966b459],
28	0.59	CD	NUMBER	0.59	dep	37	SENT_144	[p9l1083t439r1136b459],
29	0.45-0	CD	NUMBER	0.45-0	number	30	SENT_144	[p9l1232t439r1353b459],
30	.78	CD	NUMBER	.78	num	31	SENT_144	[p9l1232t439r1353b459],
31	<	JJR	O	<	dep	28	SENT_144	[p9l1449t439r1540b459],
32	0.001	CD	NUMBER	0.001	number	33	SENT_144	[p9l1449t439r1540b459],
33	0.59	CD	NUMBER	0.59	num	35	SENT_144	[p9l1634t439r1687b459],
34	0.45-0	CD	NUMBER	0.45-0	number	35	SENT_144	[p9l1782t439r1903b459],
35	.77	CD	NUMBER	.77	npadvmod	36	SENT_144	[p9l1782t439r1903b459],
36	<	JJR	O	<	amod	31	SENT_144	[p9l2000t439r2090b459],
37	0.001	CD	NUMBER	0.001	_	0	SENT_144	[p9l2000t439r2090b459],

1	Pravastatin	NN	O	pravastatin	_	0	SENT_145	[p9l381t477r510b496],
2	139	CD	NUMBER	139	number	3	SENT_145	[p9l687t477r732b496],
3	523	CD	NUMBER	523	dep	1	SENT_145	[p9l919t477r965b496],
4	1.00	CD	NUMBER	1.00	num	5	SENT_145	[p9l1084t477r1136b496],
5	ref	NN	O	ref	dep	3	SENT_145	[p9l1278t477r1308b496],
6	1.00	CD	NUMBER	1.00	num	7	SENT_145	[p9l1635t477r1687b496],
7	ref	NN	O	ref	dep	1	SENT_145	[p9l1829t477r1859b496],

1	Trp/Trp	NNP	O	Trp/Trp	nn	2	SENT_146	[p9l67t514r153b537],
2	Atorvastatin	NNP	O	Atorvastatin	dep	7	SENT_146	[p9l380t514r519b533],
3	86	CD	NUMBER	86	num	4	SENT_146	[p9l702t514r732b533],
4	367	CD	NUMBER	367	dep	2	SENT_146	[p9l919t514r965b533],
5	0.98	CD	NUMBER	0.98	dep	7	SENT_146	[p9l1083t514r1136b533],
6	0.72-1	CD	NUMBER	0.72-1	num	7	SENT_146	[p9l1232t514r1353b533],
7	.31	CD	NUMBER	.31	dep	12	SENT_146	[p9l1232t514r1353b533],
8	0.87	CD	NUMBER	0.87	number	9	SENT_146	[p9l1470t514r1523b533],
9	0.94	CD	NUMBER	0.94	dep	7	SENT_146	[p9l1634t514r1687b533],
10	0.70-1	CD	NUMBER	0.70-1	dep	9	SENT_146	[p9l1782t514r1903b533],
11	.27	CD	NUMBER	.27	num	12	SENT_146	[p9l1782t514r1903b533],
12	0.70	CD	NUMBER	0.70	_	0	SENT_146	[p9l2021t514r2074b533],

1	Pravastatin	NNP	O	Pravastatin	_	0	SENT_147	[p9l381t552r510b571],
2	88	CD	NUMBER	88	num	1	SENT_147	[p9l702t552r732b571],
3	363	CD	NUMBER	363	num	5	SENT_147	[p9l919t552r965b571],
4	1.00	CD	NUMBER	1.00	num	5	SENT_147	[p9l1084t552r1136b571],
5	ref	NN	O	ref	dep	1	SENT_147	[p9l1278t552r1308b571],
6	1.00	CD	NUMBER	1.00	num	9	SENT_147	[p9l1635t552r1687b571],
7	ref	NN	O	ref	nn	9	SENT_147	[p9l1829t552r1859b571],
8	interaction	NN	O	interaction	nn	9	SENT_147	[p9l1177t590r1299b609],
9	p	NN	O	p	dep	1	SENT_147	[p9l1310t595r1322b613],
10	=	JJ	O	=	quantmod	12	SENT_147	[p9l1334t597r1350b603],
11	0.0141	CD	NUMBER	0.0141	number	12	SENT_147	[p9l1362t590r1446b613],
12	‘	CD	NUMBER	‘	num	17	SENT_147	[p9l1362t590r1446b613],
13	interaction	NN	O	interaction	nn	17	SENT_147	[p9l1728t590r1850b609],
14	p	NN	O	p	nn	17	SENT_147	[p9l1861t595r1873b613],
15	=	JJ	O	=	amod	17	SENT_147	[p9l1884t597r1901b603],
16	0.0181	CD	NUMBER	0.0181	num	17	SENT_147	[p9l1913t590r1997b613],
17	‘	NN	O	‘	dep	9	SENT_147	[p9l1913t590r1997b613],

1	Arg/Trp	NNP	O	Arg/Trp	nn	2	SENT_148	[p9l67t628r155b652],
2	Atorvastatin	NNP	O	Atorvastatin	_	0	SENT_148	[p9l380t628r519b647],
3	66	CD	NUMBER	66	dep	2	SENT_148	[p9l702t628r732b647],
4	391	CD	NUMBER	391	number	5	SENT_148	[p9l919t628r966b647],
5	0.58	CD	NUMBER	0.58	dep	8	SENT_148	[p9l1083t628r1136b647],
6	0.43-0	CD	NUMBER	0.43-0	number	7	SENT_148	[p9l1232t628r1352b647],
7	.79	CD	NUMBER	.79	npadvmod	8	SENT_148	[p9l1232t628r1352b647],
8	<	JJR	O	<	amod	3	SENT_148	[p9l1449t628r1540b647],
9	0.001	CD	NUMBER	0.001	number	10	SENT_148	[p9l1449t628r1540b647],
10	0.57	CD	NUMBER	0.57	num	12	SENT_148	[p9l1634t628r1687b647],
11	0.42-0	CD	NUMBER	0.42-0	number	12	SENT_148	[p9l1782t628r1903b647],
12	.78	CD	NUMBER	.78	npadvmod	13	SENT_148	[p9l1782t628r1903b647],
13	<	JJR	O	<	dep	8	SENT_148	[p9l2000t628r2090b647],
14	0.001	CD	NUMBER	0.001	dep	2	SENT_148	[p9l2000t628r2090b647],

1	Pravastatin	NN	O	pravastatin	_	0	SENT_149	[p9l381t665r510b684],
2	113	CD	NUMBER	113	number	3	SENT_149	[p9l687t665r732b684],
3	417	CD	NUMBER	417	dep	1	SENT_149	[p9l919t665r965b684],
4	1.00	CD	NUMBER	1.00	num	5	SENT_149	[p9l1084t665r1136b684],
5	ref	NN	O	ref	dep	3	SENT_149	[p9l1278t665r1308b684],
6	1.00	CD	NUMBER	1.00	num	7	SENT_149	[p9l1635t665r1687b684],
7	ref	NN	O	ref	dep	1	SENT_149	[p9l1829t665r1859b684],

1	Arg/Arg	NNP	O	Arg/Arg	nn	2	SENT_150	[p9l67t703r159b727],
2	Atorvastatin	NNP	O	Atorvastatin	dep	8	SENT_150	[p9l380t703r519b723],
3	22	CD	NUMBER	22	dep	2	SENT_150	[p9l702t703r732b722],
4	134	CD	NUMBER	134	number	5	SENT_150	[p9l920t703r966b722],
5	0.65	CD	NUMBER	0.65	dep	3	SENT_150	[p9l1083t703r1136b723],
6	0.37-1	CD	NUMBER	0.37-1	dep	8	SENT_150	[p9l1232t703r1353b723],
7	.14	CD	NUMBER	.14	num	8	SENT_150	[p9l1232t703r1353b723],
8	0.13	CD	NUMBER	0.13	dep	12	SENT_150	[p9l1470t703r1523b723],
9	0.69	CD	NUMBER	0.69	num	10	SENT_150	[p9l1634t703r1687b723],
10	0.38-1	CD	NUMBER	0.38-1	dep	8	SENT_150	[p9l1783t703r1903b723],
11	.24	CD	NUMBER	.24	num	12	SENT_150	[p9l1783t703r1903b723],
12	0.21	CD	NUMBER	0.21	_	0	SENT_150	[p9l2021t703r2074b722],

1	Pravastatin	NNP	O	Pravastatin	_	0	SENT_151	[p9l381t741r510b760],
2	26	CD	NUMBER	26	num	1	SENT_151	[p9l702t741r732b760],
3	106	CD	NUMBER	106	number	4	SENT_151	[p9l920t741r966b760],
4	1.00	CD	NUMBER	1.00	num	5	SENT_151	[p9l1084t741r1136b760],
5	ref	NN	O	ref	dep	1	SENT_151	[p9l1278t741r1308b760],
6	1.00	CD	NUMBER	1.00	num	7	SENT_151	[p9l1635t741r1687b760],
7	ref	NN	O	ref	dep	5	SENT_151	[p9l1829t741r1859b760],

1	*	NN	O	*	nsubj	2	SENT_152	[p9l44t813r144b834],
2	Adjusted	VBN	O	adjust	_	0	SENT_152	[p9l44t813r144b834],
3	for	IN	O	for	_	0	SENT_152	[p9l153t813r181b830],
4	gender	NN	O	gender	nn	16	SENT_152	[p9l189t813r264b834],
5	,	,	O	,	_	0	SENT_152	[p9l189t813r264b834],
6	age	NN	O	age	dep	16	SENT_152	[p9l273t815r315b834],
7	,	,	O	,	_	0	SENT_152	[p9l273t815r315b834],
8	smoking	NN	O	smoking	dep	16	SENT_152	[p9l324t813r417b834],
9	,	,	O	,	_	0	SENT_152	[p9l324t813r417b834],
10	hypertension	NN	O	hypertension	dep	16	SENT_152	[p9l427t813r563b834],
11	,	,	O	,	_	0	SENT_152	[p9l427t813r563b834],
12	diabetes	NN	O	diabetes	dep	16	SENT_152	[p9l572t813r665b833],
13	,	,	O	,	_	0	SENT_152	[p9l572t813r665b833],
14	low-density	JJ	O	low-density	amod	16	SENT_152	[p9l675t813r788b834],
15	lipoprotein	NN	O	lipoprotein	nn	16	SENT_152	[p9l796t813r904b834],
16	cholesterol	NN	O	cholesterol	prep_for	2	SENT_152	[p9l913t813r1030b833],
17	,	,	O	,	_	0	SENT_152	[p9l913t813r1030b833],
18	high-density	JJ	O	high-density	amod	20	SENT_152	[p9l1040t813r1162b834],
19	lipoprotein	NN	O	lipoprotein	nn	20	SENT_152	[p9l1171t813r1278b834],
20	cholesterol	NN	O	cholesterol	prep_for	2	SENT_152	[p9l1288t813r1405b833],
21	,	,	O	,	_	0	SENT_152	[p9l1288t813r1405b833],
22	and	CC	O	and	_	0	SENT_152	[p9l1414t813r1451b830],
23	treatment	NN	O	treatment	prep_for	2	SENT_152	[p9l1460t814r1562b830],
24	with	IN	O	with	_	0	SENT_152	[p9l1570t813r1612b830],
25	gatifloxacin	NN	O	gatifloxacin	prep_with	2	SENT_152	[p9l1621t813r1743b834],
26	.	.	O	.	_	0	SENT_152	[p9l1621t813r1743b834],

1	fLikeIihood	NN	O	flikeiihood	nn	3	SENT_153	[p9l1753t813r1871b834],
2	ratio	NN	O	ratio	nn	3	SENT_153	[p9l1881t813r1926b830],
3	test	NN	O	test	_	0	SENT_153	[p9l1934t814r1972b830],
4	of	IN	O	of	_	0	SENT_153	[p9l1981t813r2000b830],
5	interaction	NN	O	interaction	prep_of	3	SENT_153	[p9l2009t813r2117b830],
6	between	IN	O	between	_	0	SENT_153	[p9l10t859r185b893],
7	KIF6	NN	O	kif6	nn	9	SENT_153	[p9l204t858r299b893],
8	carrier	NN	O	carrier	nn	9	SENT_153	[p9l315t859r449b893],
9	status	NN	O	status	prep_between	3	SENT_153	[p9l464t861r592b893],
10	and	CC	O	and	_	0	SENT_153	[p9l609t859r684b893],
11	treatment	NN	O	treatment	conj_and	9	SENT_153	[p9l702t861r922b893],
12	.	.	O	.	_	0	SENT_153	[p9l702t861r922b893],

1	CHD	NN	O	chd	nn	5	SENT_154	[p9l58t922r147b957],
2	=	JJ	O	=	amod	5	SENT_154	[p9l169t934r198b946],
3	coronary	JJ	O	coronary	amod	5	SENT_154	[p9l220t931r400b965],
4	heart	NN	O	heart	nn	5	SENT_154	[p9l418t923r525b957],
5	disease	NN	O	disease	_	0	SENT_154	[p9l542t923r711b963],
6	;	:	O	;	_	0	SENT_154	[p9l542t923r711b963],
7	CI	NN	O	ci	dep	5	SENT_154	[p9l730t922r767b957],
8	=	JJ	O	=	amod	10	SENT_154	[p9l790t934r819b946],
9	confidence	NN	O	confidence	nn	10	SENT_154	[p9l841t922r1068b957],
10	interval	NN	O	interval	dep	7	SENT_154	[p9l1086t923r1250b963],
11	;	:	O	;	_	0	SENT_154	[p9l1086t923r1250b963],
12	HR	NN	DURATION	hr	dep	5	SENT_154	[p9l1270t923r1328b956],
13	=	JJ	O	=	amod	15	SENT_154	[p9l1350t934r1380b946],
14	hazard	NN	O	hazard	nn	15	SENT_154	[p9l1403t923r1540b957],
15	ratio	NN	O	ratio	dep	12	SENT_154	[p9l1560t923r1663b963],
16	;	:	O	;	_	0	SENT_154	[p9l1560t923r1663b963],
17	ref	NN	O	ref	dep	5	SENT_154	[p9l1683t922r1737b957],
18	=	JJ	O	=	amod	20	SENT_154	[p9l1758t934r1788b946],
19	reference	NN	O	reference	nn	20	SENT_154	[p9l1810t922r2007b957],
20	group	NN	O	group	dep	17	SENT_154	[p9l2023t927r2153b965],
21	.	.	O	.	_	0	SENT_154	[p9l2023t927r2153b965],

1	cidence	NN	O	cidence	nsubj	8	SENT_155	[p9l10t1107r262b1170],
2	of	IN	O	of	_	0	SENT_155	[p9l295t1107r372b1170],
3	death	NN	O	death	nn	7	SENT_155	[p9l394t1107r581b1170],
4	or	CC	O	or	_	0	SENT_155	[p9l614t1131r683b1170],
5	major	JJ	O	major	conj_or	3	SENT_155	[p9l715t1108r911b1192],
6	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_155	[p9l943t1107r1421b1170],
7	events	NNS	O	event	prep_of	1	SENT_155	[p9l1453t1123r1660b1170],
8	was	VBD	O	be	_	0	SENT_155	[p9l1691t1132r1815b1170],
9	essentially	RB	O	essentially	advmod	8	SENT_155	[p9l1851t1132r2058b1170, p9l9t1208r178b1293],
10	the	DT	O	the	det	11	SENT_155	[p9l217t1208r323b1271],
11	same	JJ	O	same	dep	41	SENT_155	[p9l369t1233r536b1271],
12	in	IN	O	in	_	0	SENT_155	[p9l580t1211r645b1271],
13	the	DT	O	the	det	16	SENT_155	[p9l689t1208r795b1271],
14	2	CD	NUMBER	2	num	16	SENT_155	[p9l837t1211r877b1272],
15	treatment	NN	O	treatment	nn	16	SENT_155	[p9l922t1224r1255b1271],
16	groups	NNS	O	group	prep_in	11	SENT_155	[p9l1296t1232r1542b1293],
17	:	:	O	:	_	0	SENT_155	[p9l1296t1232r1542b1293],
18	24.7	CD	PERCENT	24.7	num	19	SENT_155	[p9l1588t1210r1801b1272],
19	%	NN	PERCENT	%	dep	11	SENT_155	[p9l1588t1210r1801b1272],
20	in	IN	O	in	_	0	SENT_155	[p9l1845t1211r1910b1271],
21	the	DT	O	the	det	26	SENT_155	[p9l1954t1208r2059b1271],
22	standard	JJ	O	standard	amod	26	SENT_155	[p9l11t1309r489b1372],
23	—	NN	O	—	nn	26	SENT_155	[p9l11t1309r489b1372],
24	dose	NN	O	dose	nn	26	SENT_155	[p9l11t1309r489b1372],
25	pravastatin	NN	O	pravastatin	nn	26	SENT_155	[p9l511t1312r882b1394],
26	group	NN	O	group	prep_in	19	SENT_155	[p9l903t1333r1100b1394],
27	and	CC	O	and	_	0	SENT_155	[p9l1125t1309r1247b1372],
28	23.9	CD	PERCENT	23.9	num	29	SENT_155	[p9l1267t1312r1480b1373],
29	%	NN	PERCENT	%	conj_and	11	SENT_155	[p9l1267t1312r1480b1373],
30	in	IN	O	in	_	0	SENT_155	[p9l1502t1312r1567b1372],
31	the	DT	O	the	det	35	SENT_155	[p9l1589t1309r1695b1372],
32	high	JJ	O	high	amod	35	SENT_155	[p9l1718t1309r2059b1394],
33	—	NN	O	—	nn	35	SENT_155	[p9l1718t1309r2059b1394],
34	dose	NN	O	dose	nn	35	SENT_155	[p9l1718t1309r2059b1394],
35	atorvastatin	NN	O	atorvastatin	prep_in	29	SENT_155	[p9l11t1413r405b1474],
36	group	NN	O	group	dep	41	SENT_155	[p9l430t1435r627b1496],
37	(	CD	NUMBER	(	num	36	SENT_155	[p9l657t1408r977b1495],
38	log	NN	O	log	nn	41	SENT_155	[p9l657t1408r977b1495],
39	—	CD	NUMBER	—	num	41	SENT_155	[p9l657t1408r977b1495],
40	rank	NN	O	rank	nn	41	SENT_155	[p9l657t1408r977b1495],
41	p	NN	O	p	dep	8	SENT_155	[p9l998t1435r1038b1496],
42	=	JJ	O	=	quantmod	44	SENT_155	[p9l1074t1434r1125b1454],
43	1.0	CD	NUMBER	1.0	number	44	SENT_155	[p9l1164t1408r1288b1487],
44	)	CD	NUMBER	)	dep	41	SENT_155	[p9l1164t1408r1288b1487],
45	(	CD	NUMBER	(	num	46	SENT_155	[p9l1320t1408r1475b1495],
46	Fig	NN	O	fig	dep	44	SENT_155	[p9l1320t1408r1475b1495],
47	.	.	O	.	_	0	SENT_155	[p9l1320t1408r1475b1495],

1	1B	NN	O	1b	nn	2	SENT_156	[p9l1509t1408r1648b1487],
2	)	NN	O	)	_	0	SENT_156	[p9l1509t1408r1648b1487],
3	,	,	O	,	_	0	SENT_156	[p9l1509t1408r1648b1487],
4	an	DT	O	a	det	7	SENT_156	[p9l1678t1435r1756b1473],
5	absolute	JJ	O	absolute	amod	7	SENT_156	[p9l1783t1410r2059b1474],
6	risk	NN	O	risk	nn	7	SENT_156	[p9l9t1511r135b1575],
7	reduction	NN	O	reduction	appos	2	SENT_156	[p9l163t1511r487b1575],
8	of	IN	O	of	_	0	SENT_156	[p9l519t1511r596b1575],
9	0.8	CD	PERCENT	0.8	number	10	SENT_156	[p9l616t1515r784b1575],
10	%	NN	PERCENT	%	amod	14	SENT_156	[p9l616t1515r784b1575],
11	(	CD	PERCENT	(	number	12	SENT_156	[p9l819t1509r990b1588],
12	95	CD	PERCENT	95	dep	13	SENT_156	[p9l819t1509r990b1588],
13	%	NN	PERCENT	%	dep	14	SENT_156	[p9l819t1509r990b1588],
14	CI	NN	O	ci	prep_of	7	SENT_156	[p9l1024t1511r1113b1575],
15	—	CD	PERCENT	—	number	20	SENT_156	[p9l1155t1511r1386b1575],
16	5.6	CD	PERCENT	5.6	number	20	SENT_156	[p9l1155t1511r1386b1575],
17	%	NN	PERCENT	%	dep	20	SENT_156	[p9l1155t1511r1386b1575],
18	to	TO	O	to	dep	20	SENT_156	[p9l1418t1527r1483b1575],
19	7.3	CD	PERCENT	7.3	number	20	SENT_156	[p9l1518t1509r1730b1588],
20	%	NN	PERCENT	%	dep	2	SENT_156	[p9l1518t1509r1730b1588],
21	)	CD	NUMBER	)	dep	20	SENT_156	[p9l1518t1509r1730b1588],
22	.	.	O	.	_	0	SENT_156	[p9l1518t1509r1730b1588],

1	Moreover	RB	O	moreover	advmod	23	SENT_157	[p9l93t1614r448b1691],
2	,	,	O	,	_	0	SENT_157	[p9l93t1614r448b1691],
3	in	IN	O	in	_	0	SENT_157	[p9l502t1616r567b1676],
4	carriers	NNS	O	carrier	prep_in	23	SENT_157	[p9l620t1616r863b1677],
5	of	IN	O	of	_	0	SENT_157	[p9l917t1613r993b1677],
6	719Arg	NNP	O	719Arg	prep_of	4	SENT_157	[p9l1035t1612r1311b1699],
7	,	,	O	,	_	0	SENT_157	[p9l1035t1612r1311b1699],
8	the	DT	O	the	det	12	SENT_157	[p9l1365t1614r1471b1677],
9	substantial	JJ	O	substantial	amod	12	SENT_157	[p9l1525t1613r1886b1677],
10	and	CC	O	and	_	0	SENT_157	[p9l1938t1613r2061b1677],
11	signiﬁcant	JJ	O	signiﬁcant	conj_and	9	SENT_157	[p9l11t1715r362b1801],
12	beneﬁt	NN	O	beneﬁt	nsubj	33	SENT_157	[p9l399t1715r635b1779],
13	from	IN	O	from	_	0	SENT_157	[p9l673t1715r837b1779],
14	intensive	JJ	O	intensive	amod	15	SENT_157	[p9l877t1718r1178b1779],
15	therapy	NN	O	therapy	prep_from	12	SENT_157	[p9l1218t1716r1491b1801],
16	,	,	O	,	_	0	SENT_157	[p9l1218t1716r1491b1801],
17	compared	VBN	O	compare	_	0	SENT_157	[p9l1535t1715r1869b1801],
18	with	IN	O	with	prepc_compared_with	12	SENT_157	[p9l1905t1715r2060b1779],
19	moderate	JJ	O	moderate	amod	20	SENT_157	[p9l10t1817r328b1880],
20	therapy	NN	O	therapy	pobj	12	SENT_157	[p9l375t1817r647b1902],
21	,	,	O	,	_	0	SENT_157	[p9l375t1817r647b1902],
22	was	VBD	O	be	cop	23	SENT_157	[p9l694t1841r818b1880],
23	evident	JJ	O	evident	_	0	SENT_157	[p9l867t1817r1115b1880],
24	as	IN	O	as	_	0	SENT_157	[p9l1161t1841r1222b1880],
25	early	JJ	O	early	prep_as	23	SENT_157	[p9l1272t1817r1432b1902],
26	as	IN	O	as	_	0	SENT_157	[p9l1477t1841r1537b1880],
27	30	CD	DURATION	30	num	28	SENT_157	[p9l1587t1820r1667b1880],
28	days	NNS	NUMBER	day	prep_as	25	SENT_157	[p9l1716t1817r1859b1902],
29	after	IN	O	after	_	0	SENT_157	[p9l1909t1817r2062b1880],
30	randomization	NN	O	randomization	prep_after	23	SENT_157	[p9l9t1918r508b1981],
31	and	CC	O	and	_	0	SENT_157	[p9l563t1918r686b1981],
32	remained	VBD	O	remain	cop	33	SENT_157	[p9l738t1918r1056b1981],
33	signiﬁcant	JJ	O	signiﬁcant	conj_and	23	SENT_157	[p9l1111t1918r1462b2003],
34	throughout	IN	O	throughout	_	0	SENT_157	[p9l1514t1918r1902b2003],
35	the	DT	O	the	det	36	SENT_157	[p9l1953t1918r2059b1981],
36	trial	NN	O	trial	prep_throughout	33	SENT_157	[p9l9t2019r161b2082],
37	:	:	O	:	_	0	SENT_157	[p9l9t2019r161b2082],
38	the	DT	DATE	the	det	40	SENT_157	[p9l194t2019r300b2082],
39	unadjusted	JJ	DATE	unadjusted	amod	40	SENT_157	[p9l329t2019r700b2104],
40	HR	NN	DATE	hr	nsubj	49	SENT_157	[p9l729t2020r860b2081],
41	at	IN	O	at	_	0	SENT_157	[p9l888t2035r949b2082],
42	30	CD	DURATION	30	num	43	SENT_157	[p9l977t2022r1057b2082],
43	days	NNS	NUMBER	day	prep_at	40	SENT_157	[p9l1088t2019r1231b2104],
44	was	VBD	O	be	cop	49	SENT_157	[p9l1258t2043r1382b2082],
45	0.18	CD	PERCENT	0.18	num	49	SENT_157	[p9l1413t2022r1557b2082],
46	(	CD	PERCENT	(	number	47	SENT_157	[p9l1591t2017r1763b2095],
47	95	CD	PERCENT	95	dep	48	SENT_157	[p9l1591t2017r1763b2095],
48	%	NN	PERCENT	%	dep	49	SENT_157	[p9l1591t2017r1763b2095],
49	CI	NN	O	ci	parataxis	23	SENT_157	[p9l1794t2019r1882b2082],
50	0.04	CD	NUMBER	0.04	number	53	SENT_157	[p9l1914t2022r2060b2082],
51	to	TO	O	to	dep	53	SENT_157	[p9l9t2135r75b2182],
52	0.81	CD	NUMBER	0.81	number	53	SENT_157	[p9l116t2117r287b2196],
53	)	CD	NUMBER	)	dep	49	SENT_157	[p9l116t2117r287b2196],
54	(	CD	NUMBER	(	num	55	SENT_157	[p9l333t2117r489b2204],
55	Fig	NN	O	fig	dep	53	SENT_157	[p9l333t2117r489b2204],
56	.	.	O	.	_	0	SENT_157	[p9l333t2117r489b2204],

1	2	CD	NUMBER	2	num	2	SENT_158	[p9l531t2117r618b2196],
2	)	CD	NUMBER	)	_	0	SENT_158	[p9l531t2117r618b2196],
3	.	.	O	.	_	0	SENT_158	[p9l531t2117r618b2196],

1	In	IN	O	in	_	0	SENT_159	[p9l661t2120r736b2181],
2	contrast	NN	O	contrast	prep_in	14	SENT_159	[p9l777t2135r1048b2182],
3	to	TO	O	to	_	0	SENT_159	[p9l1086t2135r1152b2182],
4	the	DT	O	the	det	6	SENT_159	[p9l1193t2119r1299b2182],
5	early	JJ	O	early	amod	6	SENT_159	[p9l1341t2119r1501b2204],
6	beneﬁt	NN	O	beneﬁt	prep_to	2	SENT_159	[p9l1536t2119r1771b2182],
7	seen	VBN	O	see	partmod	6	SENT_159	[p9l1811t2144r1955b2182],
8	in	IN	O	in	_	0	SENT_159	[p9l1995t2122r2060b2181],
9	carriers	NNS	O	carrier	prep_in	7	SENT_159	[p9l10t2223r274b2297],
10	,	,	O	,	_	0	SENT_159	[p9l10t2223r274b2297],
11	in	IN	O	in	_	0	SENT_159	[p9l316t2223r381b2282],
12	noncarriers	NNS	O	noncarrier	prep_in	7	SENT_159	[p9l421t2223r797b2283],
13	there	EX	O	there	expl	14	SENT_159	[p9l837t2220r1009b2283],
14	was	VBD	O	be	_	0	SENT_159	[p9l1045t2245r1169b2283],
15	no	DT	O	no	det	17	SENT_159	[p9l1210t2245r1293b2283],
16	signiﬁcant	JJ	O	signiﬁcant	amod	17	SENT_159	[p9l1334t2220r1686b2305],
17	beneﬁt	NN	O	beneﬁt	nsubj	14	SENT_159	[p9l1721t2220r1957b2283],
18	of	IN	O	of	_	0	SENT_159	[p9l1995t2220r2072b2283],
19	intensive	JJ	O	intensive	amod	20	SENT_159	[p9l9t2325r310b2385],
20	therapy	NN	O	therapy	prep_of	17	SENT_159	[p9l342t2322r614b2407],
21	,	,	O	,	_	0	SENT_159	[p9l342t2322r614b2407],
22	compared	VBN	O	compare	_	0	SENT_159	[p9l649t2322r983b2407],
23	with	IN	O	with	prepc_compared_with	14	SENT_159	[p9l1010t2322r1165b2385],
24	moderate	JJ	O	moderate	amod	25	SENT_159	[p9l1197t2322r1514b2385],
25	therapy	NN	O	therapy	pobj	14	SENT_159	[p9l1546t2322r1818b2407],
26	,	,	O	,	_	0	SENT_159	[p9l1546t2322r1818b2407],
27	at	IN	O	at	_	0	SENT_159	[p9l1854t2338r1914b2385],
28	any	DT	O	any	det	32	SENT_159	[p9l1945t2347r2064b2407],
29	time	NN	O	time	nn	32	SENT_159	[p9l9t2459r161b2519],
30	point	NN	O	point	nn	32	SENT_159	[p9l192t2459r374b2541],
31	(	CD	NUMBER	(	num	32	SENT_159	[p9l407t2454r562b2541],
32	Fig	NN	O	fig	prep_at	14	SENT_159	[p9l407t2454r562b2541],
33	.	.	O	.	_	0	SENT_159	[p9l407t2454r562b2541],

1	2	CD	NUMBER	2	num	2	SENT_160	[p9l596t2454r683b2533],
2	)	CD	NUMBER	)	_	0	SENT_160	[p9l596t2454r683b2533],
3	.	.	O	.	_	0	SENT_160	[p9l596t2454r683b2533],

1	Because	IN	O	because	_	0	SENT_161	[p9l95t2558r366b2621],
2	LDL	NN	O	ldl	pobj	1	SENT_161	[p9l392t2557r667b2621],
3	.	.	O	.	_	0	SENT_161	[p9l392t2557r667b2621],

1	—	NN	O	—	_	0	SENT_162	[p9l392t2557r667b2621],
2	.	.	O	.	_	0	SENT_162	[p9l392t2557r667b2621],

1	C	NN	O	c	nn	2	SENT_163	[p9l392t2557r667b2621],
2	cholesterol	NN	O	cholesterol	nsubjpass	18	SENT_163	[p9l695t2557r1079b2634],
3	,	,	O	,	_	0	SENT_163	[p9l695t2557r1079b2634],
4	CRP	NN	ORGANIZATION	crp	conj_and	2	SENT_163	[p9l1109t2557r1298b2634],
5	,	,	O	,	_	0	SENT_163	[p9l1109t2557r1298b2634],
6	and	CC	O	and	_	0	SENT_163	[p9l1326t2557r1449b2621],
7	triglyceride	NN	O	triglyceride	nn	8	SENT_163	[p9l1473t2557r1854b2642],
8	levels	NNS	O	level	conj_and	2	SENT_163	[p9l1878t2557r2059b2621],
9	are	VBP	O	be	cop	11	SENT_163	[p9l11t2683r108b2722],
10	risk	NN	O	risk	nn	11	SENT_163	[p9l135t2658r261b2722],
11	factors	NNS	O	factor	ccomp	28	SENT_163	[p9l284t2658r506b2722],
12	for	IN	O	for	_	0	SENT_163	[p9l535t2658r632b2722],
13	cardiovascular	JJ	O	cardiovascular	amod	14	SENT_163	[p9l658t2658r1137b2722],
14	events	NNS	O	event	prep_for	11	SENT_163	[p9l1163t2675r1370b2722],
15	and	CC	O	and	_	0	SENT_163	[p9l1400t2658r1523b2722],
16	can	MD	O	can	aux	18	SENT_163	[p9l1550t2684r1663b2722],
17	be	VB	O	be	auxpass	18	SENT_163	[p9l1688t2658r1766b2722],
18	reduced	VBN	O	reduce	ccomp	28	SENT_163	[p9l1793t2658r2061b2722],
19	by	IN	O	by	_	0	SENT_163	[p9l7t2761r90b2846],
20	intensive	JJ	O	intensive	amod	22	SENT_163	[p9l112t2763r412b2824],
21	statin	NN	O	statin	nn	22	SENT_163	[p9l439t2763r624b2824],
22	therapy	NN	O	therapy	agent	18	SENT_163	[p9l649t2760r906b2846],
23	(	CD	NUMBER	(	number	24	SENT_163	[p9l931t2758r1193b2838],
24	18,19	CD	NUMBER	18,19	num	25	SENT_163	[p9l931t2758r1193b2838],
25	)	NN	O	)	dobj	11	SENT_163	[p9l931t2758r1193b2838],
26	,	,	O	,	_	0	SENT_163	[p9l931t2758r1193b2838],
27	we	PRP	O	we	nsubj	28	SENT_163	[p9l1217t2785r1311b2824],
28	explored	VBD	O	explore	_	0	SENT_163	[p9l1338t2760r1627b2846],
29	whether	IN	O	whether	complm	52	SENT_163	[p9l1648t2760r1930b2824],
30	the	DT	O	the	det	31	SENT_163	[p9l1954t2761r2059b2824],
31	changes	NNS	O	change	nsubj	52	SENT_163	[p9l10t2861r276b2947],
32	in	IN	O	in	_	0	SENT_163	[p9l320t2864r385b2924],
33	the	DT	O	the	det	34	SENT_163	[p9l427t2861r533b2925],
34	levels	NNS	O	level	prep_in	31	SENT_163	[p9l575t2861r755b2925],
35	of	IN	O	of	_	0	SENT_163	[p9l799t2861r876b2925],
36	these	DT	O	these	det	38	SENT_163	[p9l906t2862r1079b2925],
37	risk	NN	O	risk	nn	38	SENT_163	[p9l1122t2862r1248b2925],
38	factors	NNS	O	factor	prep_of	34	SENT_163	[p9l1285t2861r1508b2925],
39	in	IN	O	in	_	0	SENT_163	[p9l1552t2864r1617b2924],
40	response	NN	O	response	prep_in	38	SENT_163	[p9l1659t2886r1951b2947],
41	to	TO	O	to	_	0	SENT_163	[p9l1993t2878r2059b2925],
42	treatment	NN	O	treatment	prep_to	40	SENT_163	[p9l9t2979r343b3026],
43	with	IN	O	with	prep	40	SENT_163	[p9l378t2963r533b3026],
44	either	CC	O	either	dep	43	SENT_163	[p9l574t2963r769b3026],
45	high	JJ	O	high	amod	48	SENT_163	[p9l808t2963r1149b3048],
46	—	NN	O	—	nn	48	SENT_163	[p9l808t2963r1149b3048],
47	dose	NN	O	dose	nn	48	SENT_163	[p9l808t2963r1149b3048],
48	atorvastatin	NN	O	atorvastatin	conj	43	SENT_163	[p9l1191t2966r1585b3026],
49	or	CC	O	or	_	0	SENT_163	[p9l1626t2987r1695b3026],
50	standarddose	NN	O	standarddose	nn	51	SENT_163	[p9l1735t2963r2057b3026, p9l10t3064r159b3127],
51	pravastatin	NN	O	pravastatin	conj_or	48	SENT_163	[p9l185t3067r556b3149],
52	differed	VBD	O	differ	ccomp	28	SENT_163	[p9l582t3064r838b3127],
53	between	IN	O	between	_	0	SENT_163	[p9l861t3064r1144b3127],
54	carriers	NNS	O	carrier	prep_between	52	SENT_163	[p9l1170t3067r1413b3127],
55	and	CC	O	and	_	0	SENT_163	[p9l1442t3064r1564b3127],
56	noncarriers	NNS	O	noncarrier	prep_between	52	SENT_163	[p9l1590t3067r1967b3127],
57	of	IN	O	of	_	0	SENT_163	[p9l1995t3064r2072b3127],
58	the	DT	O	the	det	59	SENT_163	[p9l9t3165r115b3228],
59	KIF	NN	ORGANIZATION	kif	prep_of	54	SENT_163	[p9l139t3168r290b3227],
60	6	CD	NUMBER	6	num	62	SENT_163	[p9l287t3171r322b3228],
61	719Arg	NN	O	719arg	nn	62	SENT_163	[p9l349t3163r608b3250],
62	allele	NN	O	allele	dep	59	SENT_163	[p9l632t3165r820b3228],
63	.	.	O	.	_	0	SENT_163	[p9l632t3165r820b3228],

1	We	PRP	O	we	nsubj	2	SENT_164	[p9l845t3166r970b3228],
2	found	VBD	O	find	_	0	SENT_164	[p9l996t3165r1195b3228],
3	no	DT	O	no	det	4	SENT_164	[p9l1220t3189r1303b3228],
4	evidence	NN	O	evidence	dobj	2	SENT_164	[p9l1329t3165r1619b3228],
5	in	IN	O	in	_	0	SENT_164	[p9l1644t3168r1709b3227],
6	either	CC	O	either	prep_in	2	SENT_164	[p9l1735t3165r1930b3228],
7	the	DT	O	the	det	12	SENT_164	[p9l1953t3165r2059b3228],
8	high	JJ	O	high	amod	12	SENT_164	[p9l9t3265r350b3350],
9	—	NN	O	—	nn	12	SENT_164	[p9l9t3265r350b3350],
10	dose	NN	O	dose	nn	12	SENT_164	[p9l9t3265r350b3350],
11	atorvastatin	NN	O	atorvastatin	nn	12	SENT_164	[p9l384t3268r778b3328],
12	group	NN	O	group	conj	2	SENT_164	[p9l808t3289r1005b3350],
13	or	CC	O	or	_	0	SENT_164	[p9l1039t3289r1108b3328],
14	in	IN	O	in	_	0	SENT_164	[p9l1137t3268r1202b3327],
15	the	DT	O	the	det	20	SENT_164	[p9l1233t3265r1339b3328],
16	standard	JJ	O	standard	amod	20	SENT_164	[p9l1372t3265r1850b3328],
17	—	NN	O	—	nn	20	SENT_164	[p9l1372t3265r1850b3328],
18	dose	NN	O	dose	nn	20	SENT_164	[p9l1372t3265r1850b3328],
19	pravastatin	NN	O	pravastatin	nn	20	SENT_164	[p9l1881t3289r2057b3350, p9l11t3369r232b3429],
20	group	NN	O	group	prep_in	2	SENT_164	[p9l256t3390r453b3451],
21	that	WDT	O	that	dobj	25	SENT_164	[p9l478t3366r614b3429],
22	these	DT	O	these	det	24	SENT_164	[p9l636t3366r809b3429],
23	risk	NN	O	risk	nn	24	SENT_164	[p9l834t3366r960b3429],
24	factors	NNS	O	factor	nsubj	25	SENT_164	[p9l980t3366r1203b3429],
25	differed	VBD	O	differ	rcmod	20	SENT_164	[p9l1230t3366r1486b3429],
26	between	IN	O	between	_	0	SENT_164	[p9l1507t3366r1790b3429],
27	carriers	NNS	O	carrier	prep_between	25	SENT_164	[p9l1815t3369r2059b3429],
28	and	CC	O	and	_	0	SENT_164	[p9l11t3468r133b3531],
29	noncarriers	NNS	O	noncarrier	conj_and	27	SENT_164	[p9l165t3471r542b3531],
30	at	IN	O	at	_	0	SENT_164	[p9l577t3484r637b3531],
31	any	DT	O	any	det	32	SENT_164	[p9l668t3493r787b3553],
32	time	NN	O	time	prep_at	25	SENT_164	[p9l815t3471r966b3531],
33	during	IN	O	during	_	0	SENT_164	[p9l999t3468r1224b3553],
34	therapy	NN	O	therapy	prep_during	25	SENT_164	[p9l1253t3468r1524b3553],
35	.	.	O	.	_	0	SENT_164	[p9l1253t3468r1524b3553],

1	Speciﬁcally	RB	O	speciﬁcally	dep	6	SENT_165	[p9l1563t3468r1961b3553],
2	,	,	O	,	_	0	SENT_165	[p9l1563t3468r1961b3553],
3	in	IN	O	in	dep	6	SENT_165	[p9l1995t3471r2060b3530],
4	both	DT	O	both	det	6	SENT_165	[p9l7t3569r165b3632],
5	treatment	NN	O	treatment	nn	6	SENT_165	[p9l194t3585r527b3632],
6	groups	NNS	O	group	_	0	SENT_165	[p9l553t3593r801b3654],
7	,	,	O	,	_	0	SENT_165	[p9l553t3593r801b3654],
8	no	DT	O	no	det	10	SENT_165	[p9l834t3594r916b3632],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_165	[p9l948t3569r1299b3654],
10	differences	NNS	O	difference	appos	6	SENT_165	[p9l1327t3569r1684b3632],
11	in	IN	O	in	_	0	SENT_165	[p9l1714t3572r1779b3631],
12	median	NN	O	median	nn	13	SENT_165	[p9l1809t3569r2060b3632],
13	LDL	NN	O	ldl	prep_in	6	SENT_165	[p9l10t3670r306b3747],
14	.	.	O	.	_	0	SENT_165	[p9l10t3670r306b3747],

1	—	NN	O	—	_	0	SENT_166	[p9l10t3670r306b3747],
2	.	.	O	.	_	0	SENT_166	[p9l10t3670r306b3747],

1	C	NN	O	c	nn	3	SENT_167	[p9l10t3670r306b3747],
2	,	,	O	,	_	0	SENT_167	[p9l10t3670r306b3747],
3	CRP	NN	O	crp	nsubjpass	9	SENT_167	[p9l352t3670r541b3747],
4	,	,	O	,	_	0	SENT_167	[p9l352t3670r541b3747],
5	or	CC	O	or	_	0	SENT_167	[p9l586t3694r655b3733],
6	triglyceride	NN	O	triglyceride	nn	7	SENT_167	[p9l695t3670r1076b3755],
7	levels	NNS	O	level	conj_or	3	SENT_167	[p9l1117t3670r1297b3733],
8	were	VBD	O	be	auxpass	9	SENT_167	[p9l1337t3694r1497b3733],
9	found	VBN	O	find	_	0	SENT_167	[p9l1539t3670r1739b3733],
10	between	IN	O	between	_	0	SENT_167	[p9l1777t3670r2060b3733],
11	carriers	NNS	O	carrier	prep_between	9	SENT_167	[p10l10t18r254b78],
12	and	CC	O	and	_	0	SENT_167	[p10l285t15r407b78],
13	noncarriers	NNS	O	noncarrier	conj_and	11	SENT_167	[p10l436t18r812b78],
14	at	IN	O	at	_	0	SENT_167	[p10l844t31r905b78],
15	baseline	NN	O	baseline	prep_at	9	SENT_167	[p10l929t15r1200b78],
16	or	CC	O	or	_	0	SENT_167	[p10l1230t39r1299b78],
17	at	IN	O	at	_	0	SENT_167	[p10l1327t31r1388b78],
18	any	DT	O	any	det	20	SENT_167	[p10l1416t40r1534b100],
19	scheduled	VBN	O	schedule	amod	20	SENT_167	[p10l1560t15r1895b78],
20	visit	NN	O	visit	prep_at	9	SENT_167	[p10l1920t18r2062b78],
21	during	IN	O	during	_	0	SENT_167	[p10l10t116r235b201],
22	the	DT	O	the	det	25	SENT_167	[p10l265t116r371b179],
23	study	NN	O	study	nn	25	SENT_167	[p10l404t116r586b201],
24	(	NN	O	(	nn	25	SENT_167	[p10l618t114r682b201],
25	p	NN	O	p	prep_during	20	SENT_167	[p10l618t114r682b201],
26	2	CD	NUMBER	2	number	27	SENT_167	[p10l720t127r777b172],
27	0.3	CD	NUMBER	0.3	amod	25	SENT_167	[p10l815t119r938b193],
28	;	:	O	;	_	0	SENT_167	[p10l815t119r938b193],
29	data	NNS	O	datum	dep	20	SENT_167	[p10l973t116r1115b179],
30	not	RB	O	not	neg	31	SENT_167	[p10l1147t132r1260b179],
31	presented	VBN	O	present	rcmod	29	SENT_167	[p10l1289t114r1663b201],
32	)	NN	O	)	dobj	31	SENT_167	[p10l1289t114r1663b201],
33	.	.	O	.	_	0	SENT_167	[p10l1289t114r1663b201],

1	KIF6	NN	O	kif6	nn	2	SENT_168	[p10l7t220r198b280],
2	719Arg	NN	O	719arg	_	0	SENT_168	[p10l254t215r518b302],
3	and	CC	O	and	_	0	SENT_168	[p10l571t216r701b280],
4	risk	NN	O	risk	conj_and	2	SENT_168	[p10l754t216r891b280],
5	of	IN	O	of	_	0	SENT_168	[p10l942t216r1023b280],
6	events	NNS	O	event	prep_of	2	SENT_168	[p10l1067t232r1312b280],
7	.	.	O	.	_	0	SENT_168	[p10l1067t232r1312b280],

1	Because	IN	O	because	mark	13	SENT_169	[p10l1362t218r1633b280],
2	a	DT	O	a	det	5	SENT_169	[p10l1690t242r1723b280],
3	previous	JJ	O	previous	amod	5	SENT_169	[p10l1776t220r2058b302],
4	genetic	JJ	O	genetic	amod	5	SENT_169	[p10l8t321r252b403],
5	study	NN	O	study	nsubj	13	SENT_169	[p10l298t318r480b403],
6	of	IN	O	of	_	0	SENT_169	[p10l523t318r600b381],
7	the	DT	O	the	det	11	SENT_169	[p10l633t318r739b381],
8	CARE	NNP	O	CARE	nn	11	SENT_169	[p10l788t316r1028b381],
9	and	CC	O	and	_	0	SENT_169	[p10l1076t318r1198b381],
10	WOSCOPS	NNP	O	WOSCOPS	nn	11	SENT_169	[p10l1240t318r1677b382],
11	trials	NNS	O	trial	prep_of	5	SENT_169	[p10l1725t318r1888b381],
12	had	VBD	O	have	aux	13	SENT_169	[p10l1936t318r2061b381],
13	shown	VBN	O	show	advcl	54	SENT_169	[p10l11t419r229b482],
14	that	IN	O	that	complm	21	SENT_169	[p10l272t419r408b482],
15	carriers	NNS	O	carrier	nsubj	21	SENT_169	[p10l450t422r693b482],
16	of	IN	O	of	_	0	SENT_169	[p10l739t419r816b482],
17	the	DT	O	the	det	20	SENT_169	[p10l847t419r953b482],
18	KIF6	NN	O	kif6	nn	20	SENT_169	[p10l996t422r1179b482],
19	719Arg	NN	O	719arg	nn	20	SENT_169	[p10l1224t417r1483b504],
20	variant	NN	O	variant	prep_of	15	SENT_169	[p10l1521t422r1757b482],
21	were	VBD	O	be	ccomp	13	SENT_169	[p10l1795t443r1956b482],
22	at	IN	O	at	_	0	SENT_169	[p10l2001t435r2062b482],
23	increased	VBN	O	increase	amod	24	SENT_169	[p10l9t520r324b583],
24	risk	NN	O	risk	prep_at	21	SENT_169	[p10l383t520r508b583],
25	of	IN	O	of	_	0	SENT_169	[p10l564t520r642b583],
26	CHD	NN	O	chd	prep_of	24	SENT_169	[p10l691t520r890b583],
27	compared	VBN	O	compare	_	0	SENT_169	[p10l952t520r1286b605],
28	with	IN	O	with	prepc_compared_with	21	SENT_169	[p10l1342t520r1497b583],
29	noncarriers	NNS	O	noncarrier	pobj	21	SENT_169	[p10l1557t523r1934b583],
30	in	IN	O	in	_	0	SENT_169	[p10l1995t523r2060b582],
31	placebo	NN	O	placebo	nn	32	SENT_169	[p10l8t621r539b706],
32	—	NN	O	—	prep_in	29	SENT_169	[p10l8t621r539b706],
33	treated	VBN	O	treat	partmod	32	SENT_169	[p10l8t621r539b706],
34	patients	NNS	O	patient	dobj	33	SENT_169	[p10l566t624r833b706],
35	and	CC	O	and	_	0	SENT_169	[p10l866t621r988b684],
36	that	IN	O	that	complm	40	SENT_169	[p10l1017t621r1153b684],
37	standard-dose	JJ	O	standard-dose	amod	39	SENT_169	[p10l1182t621r1660b684],
38	pravastatin	NN	O	pravastatin	nn	39	SENT_169	[p10l1689t624r2060b706],
39	treatment	NN	O	treatment	nsubj	40	SENT_169	[p10l9t738r343b785],
40	ameliorated	VBD	O	ameliorate	ccomp	13	SENT_169	[p10l368t722r767b785],
41	the	DT	O	the	det	43	SENT_169	[p10l792t722r898b785],
42	increased	VBN	O	increase	amod	43	SENT_169	[p10l924t722r1239b785],
43	risk	NN	O	risk	dobj	40	SENT_169	[p10l1264t722r1389b785],
44	associated	VBN	O	associate	partmod	43	SENT_169	[p10l1412t722r1751b785],
45	with	IN	O	with	_	0	SENT_169	[p10l1773t722r1928b786],
46	the	DT	O	the	det	49	SENT_169	[p10l1954t722r2059b785],
47	719Arg	NN	O	719arg	nn	49	SENT_169	[p10l11t822r270b909],
48	variant	JJ	O	variant	amod	49	SENT_169	[p10l307t827r543b887],
49	(	NN	O	(	prep_with	44	SENT_169	[p10l587t822r763b901],
50	8,9	CD	NUMBER	8,9	num	51	SENT_169	[p10l587t822r763b901],
51	)	NN	O	)	dep	49	SENT_169	[p10l587t822r763b901],
52	,	,	O	,	_	0	SENT_169	[p10l587t822r763b901],
53	we	PRP	O	we	nsubj	54	SENT_169	[p10l805t849r899b887],
54	investigated	VBD	O	investigate	_	0	SENT_169	[p10l941t824r1348b909],
55	the	DT	O	the	det	56	SENT_169	[p10l1389t824r1495b887],
56	association	NN	O	association	dobj	54	SENT_169	[p10l1539t827r1907b887],
57	between	IN	O	between	_	0	SENT_169	[p10l1947t824r2057b887, p10l9t941r210b988],
58	719Arg	NNP	O	719Arg	nn	59	SENT_169	[p10l244t923r504b1010],
59	allele	NN	O	allele	prep_between	56	SENT_169	[p10l536t925r705b988],
60	and	CC	O	and	_	0	SENT_169	[p10l740t925r863b988],
61	risk	NN	O	risk	conj_and	59	SENT_169	[p10l894t925r1020b988],
62	in	IN	O	in	_	0	SENT_169	[p10l1048t928r1113b987],
63	the	DT	O	the	det	67	SENT_169	[p10l1145t925r1251b988],
64	PROVE	NNP	O	PROVE	nn	67	SENT_169	[p10l1285t925r1581b989],
65	IT-TIMI	NN	O	it-timus	nn	67	SENT_169	[p10l1614t923r1944b987],
66	22	CD	NUMBER	22	num	67	SENT_169	[p10l1976t928r2058b989],
67	trial	NN	O	trial	prep_in	59	SENT_169	[p10l9t1026r161b1089],
68	.	.	O	.	_	0	SENT_169	[p10l9t1026r161b1089],

1	As	IN	O	as	mark	2	SENT_170	[p10l192t1024r283b1089],
2	observed	VBN	O	observe	advcl	11	SENT_170	[p10l314t1026r610b1089],
3	in	IN	O	in	_	0	SENT_170	[p10l638t1029r703b1089],
4	the	DT	O	the	det	8	SENT_170	[p10l731t1026r837b1089],
5	CARE	NNP	O	CARE	nn	8	SENT_170	[p10l868t1024r1108b1089],
6	and	CC	O	and	_	0	SENT_170	[p10l1138t1026r1261b1089],
7	WOSCOPS	NNP	O	WOSCOPS	nn	8	SENT_170	[p10l1285t1026r1722b1090],
8	trials	NNS	O	trial	prep_in	2	SENT_170	[p10l1753t1026r1937b1103],
9	,	,	O	,	_	0	SENT_170	[p10l1753t1026r1937b1103],
10	we	PRP	O	we	nsubj	11	SENT_170	[p10l1965t1051r2059b1089],
11	found	VBD	O	find	_	0	SENT_170	[p10l9t1128r209b1191],
12	that	IN	O	that	complm	26	SENT_170	[p10l233t1128r369b1191],
13	in	IN	O	in	_	0	SENT_170	[p10l392t1131r457b1190],
14	the	DT	O	the	det	17	SENT_170	[p10l481t1128r587b1191],
15	standard-dose	JJ	O	standard-dose	amod	17	SENT_170	[p10l615t1128r1092b1191],
16	pravastatin	NN	O	pravastatin	nn	17	SENT_170	[p10l1117t1128r1769b1213],
17	—	NN	O	—	prep_in	26	SENT_170	[p10l1117t1128r1769b1213],
18	treated	VBN	O	treat	partmod	17	SENT_170	[p10l1117t1128r1769b1213],
19	patients	NNS	O	patient	nn	20	SENT_170	[p10l1792t1131r2058b1213],
20	carriers	NNS	O	carrier	dobj	18	SENT_170	[p10l10t1232r265b1292],
21	of	IN	O	of	_	0	SENT_170	[p10l303t1229r381b1292],
22	the	DT	O	the	det	23	SENT_170	[p10l404t1229r513b1292],
23	KIF6	NN	O	kif6	prep_of	20	SENT_170	[p10l547t1232r736b1292],
24	719Arg	NN	O	719arg	nn	25	SENT_170	[p10l772t1227r1040b1314],
25	allele	NN	O	allele	nsubj	26	SENT_170	[p10l1074t1229r1253b1292],
26	were	VBD	O	be	ccomp	11	SENT_170	[p10l1284t1253r1450b1292],
27	not	RB	O	not	neg	26	SENT_170	[p10l1486t1245r1602b1292],
28	at	IN	O	at	_	0	SENT_170	[p10l1637t1245r1699b1292],
29	increased	VBN	O	increase	amod	30	SENT_170	[p10l1732t1229r2061b1292],
30	risk	NN	O	risk	prep_at	26	SENT_170	[p10l10t1333r146b1399],
31	of	IN	O	of	_	0	SENT_170	[p10l190t1333r272b1399],
32	death	NN	O	death	prep_of	30	SENT_170	[p10l307t1333r508b1399],
33	or	CC	O	or	_	0	SENT_170	[p10l556t1359r630b1399],
34	major	JJ	O	major	amod	36	SENT_170	[p10l676t1334r887b1422],
35	coronary	JJ	O	coronary	amod	36	SENT_170	[p10l933t1359r1254b1422],
36	events	NNS	O	event	conj_or	30	SENT_170	[p10l1298t1350r1523b1399],
37	compared	VBN	O	compare	_	0	SENT_170	[p10l1573t1333r1931b1422],
38	with	IN	O	with	prepc_compared_with	36	SENT_170	[p10l1974t1333r2141b1399],
39	noncarriers	NNS	O	noncarrier	pobj	36	SENT_170	[p10l12t1443r421b1506],
40	(	RB	O	(	advmod	41	SENT_170	[p10l454t1438r787b1529],
41	adjusted	VBN	O	adjust	partmod	39	SENT_170	[p10l454t1438r787b1529],
42	HR	NN	DURATION	hr	dep	41	SENT_170	[p10l816t1441r954b1506],
43	1.12	CD	NUMBER	1.12	num	42	SENT_170	[p10l984t1443r1159b1521],
44	,	,	O	,	_	0	SENT_170	[p10l984t1443r1159b1521],
45	95	CD	PERCENT	95	number	46	SENT_170	[p10l1193t1440r1346b1507],
46	%	NN	PERCENT	%	amod	47	SENT_170	[p10l1193t1440r1346b1507],
47	CI	NN	O	ci	appos	42	SENT_170	[p10l1377t1440r1471b1507],
48	0.85	CD	NUMBER	0.85	number	50	SENT_170	[p10l1502t1440r1656b1507],
49	to	TO	O	to	dep	50	SENT_170	[p10l1688t1457r1758b1506],
50	1.45	CD	NUMBER	1.45	num	47	SENT_170	[p10l1792t1440r1967b1521],
51	;	:	O	;	_	0	SENT_170	[p10l1792t1440r1967b1521],
52	p	NN	O	p	dep	36	SENT_170	[p10l1998t1466r2040b1529],
53	=	JJ	O	=	amod	55	SENT_170	[p10l2078t1466r2132b1486],
54	0.45	CD	NUMBER	0.45	tmod	53	SENT_170	[p10l11t1545r219b1628],
55	)	NN	O	)	dep	52	SENT_170	[p10l11t1545r219b1628],
56	.	.	O	.	_	0	SENT_170	[p10l11t1545r219b1628],

1	In	IN	O	in	_	0	SENT_171	[p10l259t1548r338b1613],
2	the	DT	O	the	det	7	SENT_171	[p10l374t1547r487b1613],
3	high	JJ	O	high	amod	7	SENT_171	[p10l524t1547r893b1636],
4	—	NN	O	—	nn	7	SENT_171	[p10l524t1547r893b1636],
5	dose	NN	O	dose	nn	7	SENT_171	[p10l524t1547r893b1636],
6	atorvastatin	NN	O	atorvastatin	nn	7	SENT_171	[p10l931t1550r1360b1613],
7	group	NN	O	group	prep_in	10	SENT_171	[p10l1395t1573r1629b1636],
8	,	,	O	,	_	0	SENT_171	[p10l1395t1573r1629b1636],
9	carriers	NNS	O	carrier	appos	7	SENT_171	[p10l1669t1550r1934b1613],
10	were	VBD	O	be	_	0	SENT_171	[p10l1968t1573r2140b1614],
11	actually	RB	O	actually	advmod	10	SENT_171	[p10l12t1654r293b1743],
12	at	IN	O	at	_	0	SENT_171	[p10l317t1671r382b1721],
13	decreased	VBN	O	decrease	amod	14	SENT_171	[p10l408t1654r761b1721],
14	risk	NN	O	risk	prep_at	10	SENT_171	[p10l786t1654r922b1721],
15	(	RB	O	(	advmod	16	SENT_171	[p10l948t1652r1281b1743],
16	adjusted	VBN	O	adjust	amod	14	SENT_171	[p10l948t1652r1281b1743],
17	HR	NN	DURATION	hr	nsubj	10	SENT_171	[p10l1307t1655r1445b1720],
18	0.65	CD	NUMBER	0.65	num	17	SENT_171	[p10l1469t1654r1648b1735],
19	,	,	O	,	_	0	SENT_171	[p10l1469t1654r1648b1735],
20	95	CD	PERCENT	95	number	21	SENT_171	[p10l1679t1654r1832b1721],
21	%	NN	PERCENT	%	amod	22	SENT_171	[p10l1679t1654r1832b1721],
22	CI	NN	O	ci	appos	17	SENT_171	[p10l1861t1654r1955b1721],
23	0.48	CD	NUMBER	0.48	num	25	SENT_171	[p10l1983t1658r2137b1721],
24	to	TO	O	to	dep	25	SENT_171	[p10l10t1777r80b1827],
25	0.88	CD	NUMBER	0.88	dep	22	SENT_171	[p10l119t1764r297b1841],
26	;	:	O	;	_	0	SENT_171	[p10l119t1764r297b1841],
27	p	NN	O	p	dep	22	SENT_171	[p10l335t1787r377b1850],
28	=	JJ	O	=	amod	30	SENT_171	[p10l424t1786r477b1807],
29	0.005	CD	NUMBER	0.005	tmod	28	SENT_171	[p10l523t1759r777b1841],
30	)	NN	O	)	dep	27	SENT_171	[p10l523t1759r777b1841],
31	.	.	O	.	_	0	SENT_171	[p10l523t1759r777b1841],

1	Discussion	NN	O	discussion	_	0	SENT_172	[p10l13t2010r469b2073],

1	In	IN	O	in	_	0	SENT_173	[p10l10t2182r87b2247],
2	this	DT	O	this	det	4	SENT_173	[p10l120t2181r246b2247],
3	genetic	JJ	O	genetic	amod	4	SENT_173	[p10l280t2184r533b2270],
4	study	NN	O	study	pobj	1	SENT_173	[p10l566t2181r755b2270],
5	of	IN	O	of	_	0	SENT_173	[p10l784t2181r864b2247],
6	the	DT	O	the	det	8	SENT_173	[p10l885t2181r995b2247],
7	PROVE	NNP	O	PROVE	nn	8	SENT_173	[p10l1029t2181r1336b2248],
8	IT	NNP	O	IT	prep_of	4	SENT_173	[p10l1370t2179r1712b2247],
9	.	.	O	.	_	0	SENT_173	[p10l1370t2179r1712b2247],

1	—	NN	O	—	_	0	SENT_174	[p10l1370t2179r1712b2247],
2	.	.	O	.	_	0	SENT_174	[p10l1370t2179r1712b2247],

1	TIMl	NN	O	timl	nn	3	SENT_175	[p10l1370t2179r1712b2247],
2	22	CD	NUMBER	22	num	3	SENT_175	[p10l1744t2184r1830b2248],
3	study	NN	O	study	ccomp	19	SENT_175	[p10l1866t2181r2070b2270],
4	,	,	O	,	_	0	SENT_175	[p10l1866t2181r2070b2270],
5	a	DT	O	a	det	7	SENT_175	[p10l2107t2207r2142b2247],
6	clinical	JJ	O	clinical	amod	7	SENT_175	[p10l11t2288r260b2354],
7	trial	NN	O	trial	appos	3	SENT_175	[p10l315t2288r455b2354],
8	that	WDT	O	that	nsubj	9	SENT_175	[p10l510t2288r651b2354],
9	enrolled	VBD	O	enrol	rcmod	7	SENT_175	[p10l707t2288r993b2354],
10	patients	NNS	O	patient	dobj	9	SENT_175	[p10l1048t2291r1324b2378],
11	with	IN	O	with	_	0	SENT_175	[p10l1379t2288r1540b2355],
12	a	DT	O	a	det	16	SENT_175	[p10l1598t2315r1632b2354],
13	recent	JJ	O	recent	amod	16	SENT_175	[p10l1687t2305r1904b2354],
14	acute	JJ	O	acute	amod	16	SENT_175	[p10l1960t2305r2139b2354],
15	coronary	JJ	O	coronary	amod	16	SENT_175	[p10l11t2422r321b2486],
16	syndrome	NN	O	syndrome	prep_with	9	SENT_175	[p10l353t2396r716b2486],
17	,	,	O	,	_	0	SENT_175	[p10l353t2396r716b2486],
18	we	PRP	O	we	nsubj	19	SENT_175	[p10l750t2423r849b2463],
19	found	VBD	O	find	_	0	SENT_175	[p10l884t2396r1092b2463],
20	that	IN	O	that	_	0	SENT_175	[p10l1126t2397r1267b2463],
21	intensive	JJ	O	intensive	amod	23	SENT_175	[p10l1301t2399r1612b2463],
22	statin	NN	O	statin	nn	23	SENT_175	[p10l1650t2399r1842b2463],
23	therapy	NN	O	therapy	prep_that	19	SENT_175	[p10l1877t2397r2145b2486],

1	(	NN	O	(	nn	4	SENT_176	[p10l13t2536r124b2618],
2	80	CD	NUMBER	80	num	4	SENT_176	[p10l13t2536r124b2618],
3	mg	NN	O	mg	nn	4	SENT_176	[p10l162t2564r274b2627],
4	atorvastatin	NN	O	atorvastatin	nsubj	34	SENT_176	[p10l310t2540r720b2604],
5	per	IN	O	per	_	0	SENT_176	[p10l755t2563r868b2627],
6	day	NN	DURATION	day	prep_per	4	SENT_176	[p10l904t2537r1042b2627],
7	,	,	O	,	_	0	SENT_176	[p10l904t2537r1042b2627],
8	the	DT	O	the	det	11	SENT_176	[p10l1080t2538r1190b2604],
9	highest	JJS	O	highest	amod	11	SENT_176	[p10l1227t2537r1486b2627],
10	approved	VBN	O	approve	amod	11	SENT_176	[p10l1522t2537r1844b2627],
11	dose	NN	O	dose	appos	6	SENT_176	[p10l1881t2537r2035b2604],
12	of	IN	O	of	_	0	SENT_176	[p10l2073t2537r2153b2604],
13	this	DT	O	this	det	16	SENT_176	[p10l10t2680r137b2746],
14	potent	JJ	O	potent	amod	16	SENT_176	[p10l175t2697r406b2769],
15	statin	NN	O	statin	nn	16	SENT_176	[p10l444t2678r685b2761],
16	)	NN	O	)	prep_of	11	SENT_176	[p10l444t2678r685b2761],
17	,	,	O	,	_	0	SENT_176	[p10l444t2678r685b2761],
18	compared	VBN	O	compare	partmod	4	SENT_176	[p10l727t2680r1074b2769],
19	with	IN	O	with	_	0	SENT_176	[p10l1107t2680r1268b2746],
20	standard	JJ	O	standard	amod	22	SENT_176	[p10l1307t2680r1609b2746],
21	statin	NN	O	statin	nn	22	SENT_176	[p10l1647t2683r1840b2746],
22	therapy	NN	O	therapy	prep_with	18	SENT_176	[p10l1877t2680r2145b2769],
23	(	CD	NUMBER	(	number	24	SENT_176	[p10l13t2784r124b2866],
24	40	CD	NUMBER	40	num	26	SENT_176	[p10l13t2784r124b2866],
25	mg	NN	O	mg	nn	26	SENT_176	[p10l162t2812r275b2875],
26	pravastatin	NN	O	pravastatin	dobj	18	SENT_176	[p10l308t2789r693b2875],
27	per	IN	O	per	_	0	SENT_176	[p10l729t2812r842b2875],
28	day	NN	DURATION	day	prep_per	26	SENT_176	[p10l877t2784r1045b2875],
29	)	CD	NUMBER	)	num	28	SENT_176	[p10l877t2784r1045b2875],
30	,	,	O	,	_	0	SENT_176	[p10l877t2784r1045b2875],
31	was	VBD	O	be	cop	34	SENT_176	[p10l1081t2812r1210b2852],
32	signiﬁcantly	RB	O	signiﬁcantly	advmod	34	SENT_176	[p10l1249t2786r1678b2875],
33	more	RBR	O	more	advmod	34	SENT_176	[p10l1711t2812r1891b2852],
34	eﬂica	JJ	O	eﬂica	_	0	SENT_176	[p10l1929t2786r2138b2852],
35	—	NN	O	—	nn	36	SENT_176	[p10l1929t2786r2138b2852],
36	cious	NNS	O	cious	tmod	34	SENT_176	[p10l11t2896r186b2959],
37	in	IN	O	in	_	0	SENT_176	[p10l222t2896r290b2958],
38	reducing	VBG	O	reduce	prepc_in	36	SENT_176	[p10l323t2893r632b2982],
39	death	NN	O	death	dobj	38	SENT_176	[p10l665t2893r859b2959],
40	and	CC	O	and	_	0	SENT_176	[p10l894t2893r1022b2959],
41	major	JJ	O	major	amod	43	SENT_176	[p10l1055t2894r1259b2982],
42	cardiovascular	JJ	O	cardiovascular	amod	43	SENT_176	[p10l1292t2893r1789b2959],
43	events	NNS	O	event	conj_and	39	SENT_176	[p10l1822t2910r2037b2959],
44	in	IN	O	in	_	0	SENT_176	[p10l2073t2896r2140b2958],
45	the	DT	O	the	det	47	SENT_176	[p10l10t3000r120b3066],
46	59	CD	PERCENT	59	num	47	SENT_176	[p10l169t3000r321b3066],
47	%	NN	PERCENT	%	prep_in	38	SENT_176	[p10l169t3000r321b3066],
48	of	IN	O	of	_	0	SENT_176	[p10l369t3000r449b3066],
49	the	DT	O	the	det	50	SENT_176	[p10l484t3000r594b3066],
50	patients	NNS	O	patient	prep_of	47	SENT_176	[p10l641t3003r918b3089],
51	who	WP	O	who	nsubj	53	SENT_176	[p10l963t3000r1115b3067],
52	were	VBD	O	be	cop	53	SENT_176	[p10l1160t3026r1327b3066],
53	carriers	NNS	O	carrier	rcmod	50	SENT_176	[p10l1376t3003r1628b3066],
54	of	IN	O	of	_	0	SENT_176	[p10l1678t3000r1758b3066],
55	the	DT	O	the	det	58	SENT_176	[p10l1793t3000r1904b3066],
56	KIF6	NN	O	kif6	nn	58	SENT_176	[p10l1950t3003r2140b3067],
57	719Arg	NN	O	719arg	nn	58	SENT_176	[p10l12t3106r281b3196],
58	variant	NN	O	variant	prep_of	53	SENT_176	[p10l300t3110r546b3174],
59	than	IN	O	than	advmod	53	SENT_176	[p10l567t3107r726b3173],
60	in	IN	O	in	_	0	SENT_176	[p10l749t3110r817b3173],
61	the	DT	O	the	det	64	SENT_176	[p10l840t3107r950b3173],
62	remaining	VBG	O	remain	amod	64	SENT_176	[p10l974t3110r1335b3196],
63	41	CD	PERCENT	41	num	64	SENT_176	[p10l1357t3111r1509b3173],
64	%	NN	PERCENT	%	prep_in	59	SENT_176	[p10l1357t3111r1509b3173],
65	of	IN	O	of	_	0	SENT_176	[p10l1533t3107r1613b3173],
66	the	DT	O	the	det	67	SENT_176	[p10l1625t3107r1734b3173],
67	population	NN	O	population	prep_of	64	SENT_176	[p10l1758t3107r2140b3197],
68	who	WP	O	who	nsubj	74	SENT_176	[p10l7t3214r159b3280],
69	were	VBD	O	be	cop	74	SENT_176	[p10l195t3240r361b3280],
70	noncarriers	JJ	O	noncarriers	amod	74	SENT_176	[p10l401t3217r792b3280],
71	(	NN	O	(	nn	74	SENT_176	[p10l835t3212r1115b3294],
72	relative	JJ	O	relative	amod	74	SENT_176	[p10l835t3212r1115b3294],
73	risk	NN	O	risk	nn	74	SENT_176	[p10l1153t3214r1284b3280],
74	reduction	NN	O	reduction	rcmod	67	SENT_176	[p10l1318t3214r1655b3280],
75	41	CD	PERCENT	41	num	76	SENT_176	[p10l1692t3218r1845b3280],
76	%	NN	PERCENT	%	dep	74	SENT_176	[p10l1692t3218r1845b3280],
77	vs.	CC	O	vs.	prep	76	SENT_176	[p10l1880t3240r1968b3280],
78	6	CD	PERCENT	6	num	79	SENT_176	[p10l2012t3218r2138b3294],
79	%	NN	PERCENT	%	dep	77	SENT_176	[p10l2012t3218r2138b3294],
80	,	,	O	,	_	0	SENT_176	[p10l2012t3218r2138b3294],
81	respectively	RB	O	respectively	advmod	36	SENT_176	[p10l10t3320r464b3412],
82	)	CD	NUMBER	)	dep	36	SENT_176	[p10l10t3320r464b3412],
83	.	.	O	.	_	0	SENT_176	[p10l10t3320r464b3412],

1	In	IN	O	in	_	0	SENT_177	[p10l502t3323r580b3388],
2	the	DT	O	the	det	3	SENT_177	[p10l614t3323r723b3389],
3	face	NN	O	face	prep_in	19	SENT_177	[p10l758t3322r894b3389],
4	of	IN	O	of	_	0	SENT_177	[p10l929t3322r1009b3389],
5	equal	JJ	O	equal	amod	7	SENT_177	[p10l1032t3322r1218b3412],
6	lipid	NN	O	lipid	nn	7	SENT_177	[p10l1249t3322r1410b3412],
7	lowering	NN	O	lowering	prep_of	3	SENT_177	[p10l1442t3323r1751b3412],
8	in	IN	O	in	_	0	SENT_177	[p10l1784t3325r1851b3388],
9	carriers	NNS	O	carrier	prep_in	7	SENT_177	[p10l1886t3325r2139b3389],
10	and	CC	O	and	_	0	SENT_177	[p10l12t3430r139b3495],
11	in	IN	O	in	_	0	SENT_177	[p10l174t3433r242b3494],
12	noncarriers	NNS	O	noncarrier	prep_in	7	SENT_177	[p10l278t3433r691b3510],
13	,	,	O	,	_	0	SENT_177	[p10l278t3433r691b3510],
14	absolute	JJ	O	absolute	amod	16	SENT_177	[p10l731t3430r1018b3495],
15	risk	NN	O	risk	nn	16	SENT_177	[p10l1054t3430r1185b3495],
16	reductions	NNS	O	reduction	nsubj	19	SENT_177	[p10l1216t3430r1582b3495],
17	were	VBD	O	be	cop	19	SENT_177	[p10l1616t3455r1782b3495],
18	10.0	CD	PERCENT	10.0	num	19	SENT_177	[p10l1822t3433r2038b3495],
19	%	NN	PERCENT	%	_	0	SENT_177	[p10l1822t3433r2038b3495],
20	in	IN	O	in	_	0	SENT_177	[p10l2073t3433r2140b3494],
21	carriers	NNS	O	carrier	prep_in	19	SENT_177	[p11l11t23r264b86],
22	and	CC	O	and	_	0	SENT_177	[p11l301t20r428b86],
23	0.8	CD	PERCENT	0.8	num	24	SENT_177	[p11l461t23r635b86],
24	%	NN	PERCENT	%	conj_and	19	SENT_177	[p11l461t23r635b86],
25	in	IN	O	in	_	0	SENT_177	[p11l669t23r737b85],
26	noncarriers	NNS	O	noncarrier	prep_in	24	SENT_177	[p11l772t23r1163b86],
27	after	IN	O	after	_	0	SENT_177	[p11l1199t20r1358b86],
28	2	CD	DURATION	2	num	29	SENT_177	[p11l1388t23r1430b87],
29	years	NNS	NUMBER	year	prep_after	19	SENT_177	[p11l1462t45r1636b109],
30	of	IN	O	of	_	0	SENT_177	[p11l1672t20r1752b86],
31	treatment	NN	O	treatment	prep_of	29	SENT_177	[p11l1773t37r2136b86],
32	.	.	O	.	_	0	SENT_177	[p11l1773t37r2136b86],

1	Thus	RB	O	thus	advmod	36	SENT_178	[p11l8t124r221b207],
2	,	,	O	,	_	0	SENT_178	[p11l8t124r221b207],
3	only	RB	O	only	quantmod	4	SENT_178	[p11l251t126r409b215],
4	10	CD	NUMBER	10	num	5	SENT_178	[p11l436t129r518b192],
5	carriers	NNS	O	carrier	nsubj	36	SENT_178	[p11l547t129r812b192],
6	of	IN	O	of	_	0	SENT_178	[p11l841t126r922b192],
7	the	DT	O	the	det	8	SENT_178	[p11l937t126r1050b192],
8	KIF	NN	ORGANIZATION	kif	prep_of	5	SENT_178	[p11l1077t129r1237b191],
9	6	CD	NUMBER	6	num	10	SENT_178	[p11l1236t133r1272b192],
10	719Arg	NN	O	719arg	npadvmod	11	SENT_178	[p11l1301t124r1579b215],
11	variant	JJ	O	variant	amod	8	SENT_178	[p11l1600t129r1857b192],
12	needed	VBN	O	need	partmod	8	SENT_178	[p11l1883t126r2141b192],
13	to	TO	O	to	aux	15	SENT_178	[p11l10t251r80b300],
14	be	VB	O	be	auxpass	15	SENT_178	[p11l121t234r203b300],
15	treated	VBN	O	treat	xcomp	12	SENT_178	[p11l245t234r500b300],
16	with	IN	O	with	_	0	SENT_178	[p11l537t234r704b300],
17	intensive	JJ	O	intensive	amod	19	SENT_178	[p11l745t237r1071b300],
18	statin	NN	O	statin	nn	19	SENT_178	[p11l1115t237r1316b300],
19	therapy	NN	O	therapy	prep_with	15	SENT_178	[p11l1357t234r1635b323],
20	to	TO	O	to	aux	21	SENT_178	[p11l1673t251r1742b300],
21	prevent	VB	O	prevent	xcomp	15	SENT_178	[p11l1784t251r2060b323],
22	1	CD	NUMBER	1	num	23	SENT_178	[p11l2104t238r2135b299],
23	event	NN	O	event	dobj	21	SENT_178	[p11l11t358r225b421],
24	;	:	O	;	_	0	SENT_178	[p11l11t358r225b421],
25	in	IN	O	in	_	0	SENT_178	[p11l295t344r364b406],
26	contrast	NN	O	contrast	prep_in	8	SENT_178	[p11l431t358r745b421],
27	,	,	O	,	_	0	SENT_178	[p11l431t358r745b421],
28	the	DT	O	the	det	29	SENT_178	[p11l814t341r928b407],
29	number	NN	O	number	appos	8	SENT_178	[p11l996t341r1279b407],
30	needed	VBN	O	need	partmod	29	SENT_178	[p11l1344t341r1603b407],
31	to	TO	O	to	aux	32	SENT_178	[p11l1668t358r1738b407],
32	treat	VB	O	treat	xcomp	30	SENT_178	[p11l1805t358r1974b407],
33	for	IN	O	for	_	0	SENT_178	[p11l2038t341r2142b407],
34	noncarriers	NNS	O	noncarrier	prep_for	32	SENT_178	[p11l12t450r421b513],
35	was	VBD	O	be	cop	36	SENT_178	[p11l455t473r588b513],
36	125	CD	NUMBER	125	_	0	SENT_178	[p11l630t447r779b514],
37	.	.	O	.	_	0	SENT_178	[p11l630t447r779b514],

1	Our	PRP$	O	we	poss	2	SENT_179	[p11l101t554r246b621],
2	ﬁndings	NNS	O	ﬁndings	nsubj	10	SENT_179	[p11l301t554r583b644],
3	in	IN	O	in	_	0	SENT_179	[p11l642t557r709b620],
4	the	DT	O	the	det	8	SENT_179	[p11l766t555r876b621],
5	PROVE	NNP	O	PROVE	nn	8	SENT_179	[p11l934t554r1242b621],
6	IT-TIMI	NN	O	it-timus	nn	8	SENT_179	[p11l1299t553r1641b620],
7	22	CD	NUMBER	22	num	8	SENT_179	[p11l1697t558r1783b622],
8	trial	NN	O	trial	prep_in	2	SENT_179	[p11l1841t554r1982b621],
9	are	VBP	O	be	cop	10	SENT_179	[p11l2039t580r2139b621],
10	consistent	JJ	O	consistent	_	0	SENT_179	[p11l11t663r366b726],
11	with	IN	O	with	prep	10	SENT_179	[p11l402t660r564b726],
12	and	CC	O	and	_	0	SENT_179	[p11l607t660r735b726],
13	extend	VB	O	extend	conj_and	10	SENT_179	[p11l777t660r1010b726],
14	observations	NNS	O	observation	dobj	13	SENT_179	[p11l1052t661r1487b726],
15	made	VBN	O	make	partmod	14	SENT_179	[p11l1531t660r1720b726],
16	in	IN	O	in	_	0	SENT_179	[p11l1763t663r1830b725],
17	2	CD	NUMBER	2	num	22	SENT_179	[p11l1870t664r1912b727],
18	other	JJ	O	other	amod	22	SENT_179	[p11l1956t660r2142b726],
19	distinct	JJ	O	distinct	amod	22	SENT_179	[p11l11t768r275b834],
20	clinical	JJ	O	clinical	amod	22	SENT_179	[p11l309t768r557b834],
21	trial	NN	O	trial	nn	22	SENT_179	[p11l591t768r732b834],
22	populations	NNS	O	population	prep_in	15	SENT_179	[p11l765t768r1197b857],
23	:	:	O	:	_	0	SENT_179	[p11l765t768r1197b857],
24	CARE	NNP	O	CARE	dep	22	SENT_179	[p11l1239t766r1488b834],
25	and	CC	O	and	_	0	SENT_179	[p11l1526t768r1653b834],
26	WOSCOPS	NNP	O	WOSCOPS	dep	22	SENT_179	[p11l1684t768r2137b835],
27	(	CD	NUMBER	(	number	28	SENT_179	[p11l13t872r128b954],
28	8	CD	NUMBER	8	num	29	SENT_179	[p11l13t872r128b954],
29	)	NN	O	)	dep	24	SENT_179	[p11l13t872r128b954],
30	.	.	O	.	_	0	SENT_179	[p11l13t872r128b954],

1	The	DT	O	the	det	5	SENT_180	[p11l157t872r304b940],
2	KIF	NN	ORGANIZATION	kif	nn	5	SENT_180	[p11l331t877r487b939],
3	6	CD	NUMBER	6	num	5	SENT_180	[p11l485t881r521b940],
4	719Arg	NN	O	719arg	nn	5	SENT_180	[p11l551t872r820b963],
5	variant	NN	O	variant	nsubjpass	9	SENT_180	[p11l843t877r1088b940],
6	has	VBZ	O	have	aux	9	SENT_180	[p11l1114t874r1226b940],
7	now	RB	DATE	now	advmod	9	SENT_180	[p11l1257t900r1408b940],
8	been	VBN	O	be	auxpass	9	SENT_180	[p11l1430t874r1597b940],
9	investigated	VBN	O	investigate	_	0	SENT_180	[p11l1624t874r2046b963],
10	in	IN	O	in	_	0	SENT_180	[p11l2073t877r2140b939],
11	genetic	JJ	O	genetic	amod	12	SENT_180	[p11l9t984r263b1070],
12	studies	NNS	O	study	prep_in	9	SENT_180	[p11l294t981r531b1047],
13	of	IN	O	of	_	0	SENT_180	[p11l564t981r644b1047],
14	3	CD	NUMBER	3	num	15	SENT_180	[p11l663t984r698b1047],
15	trials	NNS	O	trial	prep_of	12	SENT_180	[p11l733t981r902b1047],
16	that	WDT	O	that	nsubj	17	SENT_180	[p11l934t981r1075b1047],
17	included	VBD	O	include	rcmod	15	SENT_180	[p11l1103t981r1407b1047],
18	over	IN	O	over	_	0	SENT_180	[p11l1437t1007r1585b1047],
19	6,200	CD	NUMBER	6,200	num	20	SENT_180	[p11l1615t984r1809b1062],
20	patients	NNS	O	patient	prep_over	17	SENT_180	[p11l1839t984r2136b1070],
21	:	:	O	:	_	0	SENT_180	[p11l1839t984r2136b1070],
22	2	CD	NUMBER	2	num	23	SENT_180	[p11l9t1091r50b1155],
23	studies	NNS	O	study	nsubj	28	SENT_180	[p11l88t1088r326b1154],
24	of	IN	O	of	_	0	SENT_180	[p11l363t1088r443b1154],
25	40	CD	NUMBER	40	num	27	SENT_180	[p11l465t1091r550b1155],
26	mg	NN	O	mg	nn	27	SENT_180	[p11l586t1114r699b1177],
27	pravastatin	NN	O	pravastatin	prep_of	23	SENT_180	[p11l731t1091r1116b1177],
28	(	VBD	O	(	parataxis	9	SENT_180	[p11l1154t1086r1216b1169],
29	a	DT	O	a	det	32	SENT_180	[p11l1154t1086r1216b1169],
30	lipophilic	JJ	O	lipophilic	amod	32	SENT_180	[p11l1248t1088r1584b1177],
31	statin	NN	O	statin	nn	32	SENT_180	[p11l1619t1086r1837b1169],
32	)	NN	O	)	nsubj	48	SENT_180	[p11l1619t1086r1837b1169],
33	per	IN	O	per	_	0	SENT_180	[p11l1875t1114r1988b1177],
34	day	NN	DURATION	day	prep_per	32	SENT_180	[p11l2022t1088r2145b1177],
35	versus	CC	O	versus	prep	34	SENT_180	[p11l7t1221r220b1262],
36	placebo	NN	O	placebo	dep	35	SENT_180	[p11l256t1195r522b1285],
37	(	CD	NUMBER	(	number	38	SENT_180	[p11l563t1193r656b1276],
38	8	CD	NUMBER	8	num	39	SENT_180	[p11l563t1193r656b1276],
39	)	NN	O	)	dep	36	SENT_180	[p11l563t1193r656b1276],
40	and	CC	O	and	_	0	SENT_180	[p11l697t1195r824b1261],
41	the	DT	O	the	det	43	SENT_180	[p11l859t1195r969b1261],
42	present	JJ	DATE	present	amod	43	SENT_180	[p11l1004t1212r1263b1285],
43	study	NN	O	study	dep	35	SENT_180	[p11l1298t1195r1487b1284],
44	of	IN	O	of	_	0	SENT_180	[p11l1519t1195r1599b1261],
45	80	CD	NUMBER	80	num	47	SENT_180	[p11l1626t1199r1707b1262],
46	mg	NN	O	mg	nn	47	SENT_180	[p11l1744t1222r1857b1284],
47	atorvastatin	NN	O	atorvastatin	prep_of	43	SENT_180	[p11l1892t1212r2138b1262, p11l12t1306r204b1369],
48	(	VBD	O	(	ccomp	28	SENT_180	[p11l232t1301r294b1384],
49	a	DT	O	a	det	52	SENT_180	[p11l232t1301r294b1384],
50	hydrophilic	JJ	O	hydrophilic	amod	52	SENT_180	[p11l317t1303r723b1393],
51	statin	NN	O	statin	nn	52	SENT_180	[p11l748t1301r966b1384],
52	)	NN	O	)	dobj	48	SENT_180	[p11l748t1301r966b1384],
53	per	IN	O	per	_	0	SENT_180	[p11l993t1329r1107b1393],
54	day	NN	DURATION	day	prep_per	52	SENT_180	[p11l1131t1303r1253b1392],
55	versus	CC	O	versus	_	0	SENT_180	[p11l1271t1329r1484b1370],
56	40	CD	NUMBER	40	num	58	SENT_180	[p11l1510t1307r1594b1370],
57	mg	NN	O	mg	nn	58	SENT_180	[p11l1621t1330r1733b1392],
58	pravastatin	NN	O	pravastatin	dobj	48	SENT_180	[p11l1755t1306r2140b1393],
59	per	IN	O	per	_	0	SENT_180	[p11l9t1436r122b1500],
60	day	NN	DURATION	day	prep_per	58	SENT_180	[p11l153t1410r290b1500],
61	.	.	O	.	_	0	SENT_180	[p11l153t1410r290b1500],

1	In	IN	O	in	_	0	SENT_181	[p11l325t1411r402b1476],
2	all	DT	O	all	quantmod	3	SENT_181	[p11l435t1410r515b1477],
3	3	CD	NUMBER	3	prep_in	27	SENT_181	[p11l545t1414r581b1477],
4	of	IN	O	of	_	0	SENT_181	[p11l618t1410r697b1477],
5	these	DT	O	these	det	7	SENT_181	[p11l716t1410r896b1477],
6	genetic	JJ	O	genetic	amod	7	SENT_181	[p11l926t1413r1179b1500],
7	studies	NNS	O	study	prep_of	3	SENT_181	[p11l1211t1410r1471b1491],
8	,	,	O	,	_	0	SENT_181	[p11l1211t1410r1471b1491],
9	the	DT	O	the	det	10	SENT_181	[p11l1504t1410r1615b1477],
10	eﬂicacy	NN	O	eﬂicacy	nsubj	27	SENT_181	[p11l1647t1410r1903b1500],
11	of	IN	O	of	_	0	SENT_181	[p11l1931t1410r2011b1477],
12	the	DT	O	the	det	16	SENT_181	[p11l2030t1410r2139b1477],
13	more	JJR	O	more	amod	16	SENT_181	[p11l11t1544r190b1585],
14	intensive	JJ	O	intensive	amod	16	SENT_181	[p11l222t1522r534b1585],
15	lipid	NN	O	lipid	nn	16	SENT_181	[p11l565t1519r1074b1608],
16	—	NN	O	—	prep_of	10	SENT_181	[p11l565t1519r1074b1608],
17	lowering	VBG	O	lower	partmod	16	SENT_181	[p11l565t1519r1074b1608],
18	therapy	NN	O	therapy	dobj	17	SENT_181	[p11l1102t1519r1370b1608],
19	in	IN	O	in	_	0	SENT_181	[p11l1398t1522r1465b1584],
20	reducing	VBG	O	reduce	prepc_in	17	SENT_181	[p11l1496t1519r1805b1608],
21	coronary	JJ	O	coronary	amod	22	SENT_181	[p11l1835t1544r2145b1608],
22	events	NNS	O	event	nsubj	24	SENT_181	[p11l11t1643r227b1692],
23	was	VBD	O	be	cop	24	SENT_181	[p11l273t1652r403b1692],
24	greater	JJR	O	greater	ccomp	20	SENT_181	[p11l452t1643r697b1715],
25	in	IN	O	in	_	0	SENT_181	[p11l744t1629r811b1691],
26	carriers	NNS	O	carrier	prep_in	24	SENT_181	[p11l861t1629r1113b1692],
27	(	VBP	O	(	_	0	SENT_181	[p11l1166t1624r1345b1706],
28	37	CD	PERCENT	37	number	32	SENT_181	[p11l1166t1624r1345b1706],
29	%	NN	PERCENT	%	dep	32	SENT_181	[p11l1166t1624r1345b1706],
30	to	TO	O	to	dep	32	SENT_181	[p11l1393t1643r1461b1692],
31	50	CD	PERCENT	50	number	32	SENT_181	[p11l1511t1626r1663b1692],
32	%	NN	PERCENT	%	num	35	SENT_181	[p11l1511t1626r1663b1692],
33	relative	JJ	O	relative	amod	35	SENT_181	[p11l1711t1626r1965b1692],
34	risk	NN	O	risk	nn	35	SENT_181	[p11l2014t1626r2145b1692],
35	reductions	NNS	O	reduction	dobj	27	SENT_181	[p11l10t1731r404b1812],
36	)	RB	O	)	advmod	27	SENT_181	[p11l10t1731r404b1812],
37	than	IN	O	than	dep	27	SENT_181	[p11l436t1733r595b1798],
38	in	IN	O	in	_	0	SENT_181	[p11l623t1736r691b1797],
39	noncarriers	JJ	O	noncarriers	amod	40	SENT_181	[p11l721t1736r1112b1798],
40	(	NN	O	(	prep_in	27	SENT_181	[p11l1146t1731r1280b1812],
41	6	CD	PERCENT	6	number	45	SENT_181	[p11l1146t1731r1280b1812],
42	%	NN	PERCENT	%	dep	45	SENT_181	[p11l1146t1731r1280b1812],
43	to	TO	O	to	dep	45	SENT_181	[p11l1309t1750r1377b1798],
44	20	CD	PERCENT	20	number	45	SENT_181	[p11l1405t1736r1559b1799],
45	%	NN	PERCENT	%	num	47	SENT_181	[p11l1405t1736r1559b1799],
46	risk	NN	O	risk	nn	47	SENT_181	[p11l1588t1733r1719b1798],
47	reductions	NNS	O	reduction	nsubj	48	SENT_181	[p11l1743t1731r2137b1813],
48	)	VBP	O	)	rcmod	40	SENT_181	[p11l1743t1731r2137b1813],
49	(	CD	NUMBER	(	num	50	SENT_181	[p11l13t1839r175b1930],
50	Fig	NN	O	fig	dobj	48	SENT_181	[p11l13t1839r175b1930],
51	.	.	O	.	_	0	SENT_181	[p11l13t1839r175b1930],

1	3	CD	NUMBER	3	_	0	SENT_182	[p11l213t1839r300b1921],
2	)	NN	O	)	dep	1	SENT_182	[p11l213t1839r300b1921],
3	.	.	O	.	_	0	SENT_182	[p11l213t1839r300b1921],

1	JACC	NNP	O	JACC	nn	2	SENT_183	[p11l7t2091r122b2142],
2	Vol	NNP	O	Vol	_	0	SENT_183	[p11l148t2091r231b2142],
3	.	.	O	.	_	0	SENT_183	[p11l148t2091r231b2142],

1	51	CD	NUMBER	51	_	0	SENT_184	[p11l262t2091r336b2150],
2	,	,	O	,	_	0	SENT_184	[p11l262t2091r336b2150],
3	No.	NN	O	no.	amod	1	SENT_184	[p11l368t2091r440b2142],
4	4	CD	NUMBER	4	number	3	SENT_184	[p11l470t2091r512b2150],
5	,	,	O	,	_	0	SENT_184	[p11l470t2091r512b2150],
6	2008	CD	DATE	2008	appos	1	SENT_184	[p11l543t2091r667b2142],
7	January	NNP	DATE	January	tmod	6	SENT_184	[p11l7t2179r184b2242],
8	29	CD	DATE	29	num	7	SENT_184	[p11l210t2179r283b2238],
9	,	,	O	,	_	0	SENT_184	[p11l210t2179r283b2238],
10	2008:449	CD	NUMBER	2008:449	num	7	SENT_184	[p11l314t2179r648b2229],
11	—	CD	NUMBER	—	num	12	SENT_184	[p11l314t2179r648b2229],
12	55	CD	NUMBER	55	dep	1	SENT_184	[p11l314t2179r648b2229],

1	A	DT	O	a	det	2	SENT_185	[p12l57t200r138b291],
2	Carriers	NNS	O	carrier	_	0	SENT_185	[p12l60t303r273b352],
3	of	IN	O	of	_	0	SENT_185	[p12l295t300r347b349],
4	KIFS	NN	O	kif	nn	8	SENT_185	[p12l363t300r492b349],
5	7	CD	NUMBER	7	num	8	SENT_185	[p12l508t297r701b355],
6	‘	NN	O	‘	nn	8	SENT_185	[p12l508t297r701b355],
7	i9Arg	NN	O	i9arg	nn	8	SENT_185	[p12l508t297r701b355],
8	variant	NN	O	variant	prep_of	2	SENT_185	[p12l720t297r904b345],

1	_	RB	O	_	dep	2	SENT_186	[p12l337t445r395b461],
2	40	CD	NUMBER	40	_	0	SENT_186	[p12l437t393r501b436],
3	.	.	O	.	_	0	SENT_186	[p12l524t441r526b448],

1	-	:	O	-	_	0	SENT_187	[p12l591t429r608b435],
2	=	JJ	O	=	dep	6	SENT_187	[p12l633t429r649b435],
3	=	SYM	O	=	dep	2	SENT_187	[p12l672t426r691b433],
4	-	:	O	-	_	0	SENT_187	[p12l713t426r726b432],
5	High-dose	JJ	O	high-dose	amod	6	SENT_187	[p12l742t397r1019b458],
6	atorvastatin	NN	O	atorvastatin	_	0	SENT_187	[p12l1038t393r1350b445],
7	_	CD	NUMBER	_	dep	6	SENT_187	[p12l1405t461r1411b463],
8	"	``	O	"	punct	7	SENT_187	[p12l196t480r244b532],
9	5	CD	NUMBER	5	num	10	SENT_187	[p12l196t480r244b532],
10	§	NN	O	§	dep	7	SENT_187	[p12l337t467r398b538],
11	.	.	O	.	_	0	SENT_187	[p12l591t467r1132b516],

1	—	NN	O	—	_	0	SENT_188	[p12l591t467r1132b516],
2	.	.	O	.	_	0	SENT_188	[p12l591t467r1132b516],

1	.	.	O	.	_	0	SENT_189	[p12l591t467r1132b516],

1	—	NN	O	—	_	0	SENT_190	[p12l591t467r1132b516],
2	.	.	O	.	_	0	SENT_190	[p12l591t467r1132b516],

1	Standard-close	JJ	O	standard-close	amod	2	SENT_191	[p12l591t467r1132b516],
2	prav	NN	O	prav	_	0	SENT_191	[p12l1154t464r1447b522],
3	.	.	O	.	_	0	SENT_191	[p12l1154t464r1447b522],

1	ast	NN	O	ast	_	0	SENT_192	[p12l1154t464r1447b522],
2	.	.	O	.	_	0	SENT_192	[p12l1154t464r1447b522],

1	atin	NN	O	atin	nn	2	SENT_193	[p12l1154t464r1447b522],
2	S	NN	O	s	_	0	SENT_193	[p12l208t551r501b635],
3	-	:	O	-	_	0	SENT_193	[p12l208t551r501b635],
4	§	CD	NUMBER	§	num	7	SENT_193	[p12l208t551r501b635],
5	3o	NN	O	3o	nn	7	SENT_193	[p12l208t551r501b635],
6	E	NN	O	e	nn	7	SENT_193	[p12l208t618r244b683],
7	Q.m	NN	O	q.m	dep	2	SENT_193	[p12l279t625r386b677],
8	A	DT	O	a	det	9	SENT_193	[p12l535t651r536b657],
9	13	CD	NUMBER	13	dep	7	SENT_193	[p12l199t686r247b715],
10	,	,	O	,	_	0	SENT_193	[p12l199t686r247b715],
11	-	:	O	-	_	0	SENT_193	[p12l199t686r247b715],
12	«	NN	O	«	nn	13	SENT_193	[p12l279t676r318b706],
13	W	NN	O	w	dep	2	SENT_193	[p12l279t676r318b706],
14	»	CD	NUMBER	»	number	15	SENT_193	[p12l279t676r318b706],
15	.7	CD	NUMBER	.7	dep	13	SENT_193	[p12l353t673r386b703],
16	?	.	O	?	_	0	SENT_193	[p12l353t673r386b703],

1	:	:	O	:	_	0	SENT_194	[p12l212t763r244b793],
2	5	CD	NUMBER	5	num	3	SENT_194	[p12l282t776r318b793],
3	1	CD	NUMBER	1	nsubj	6	SENT_194	[p12l350t760r386b784],
4	'	''	O	'	_	0	SENT_194	[p12l350t760r386b784],
5	‘	CD	NUMBER	‘	dep	6	SENT_194	[p12l350t760r386b784],
6	>	JJR	O	>	_	0	SENT_194	[p12l443t757r505b799],
7	+	CC	O	+	cc	8	SENT_194	[p12l443t757r505b799],
8	J	NN	O	j	dobj	6	SENT_194	[p12l1942t753r2058b805],
9	,	,	O	,	_	0	SENT_194	[p12l1942t753r2058b805],
10	.	.	O	.	_	0	SENT_194	[p12l1942t753r2058b805],

1	—	NN	O	—	_	0	SENT_195	[p12l1942t753r2058b805],
2	.	.	O	.	_	0	SENT_195	[p12l1942t753r2058b805],

1	a	DT	O	a	_	0	SENT_196	[p12l1942t753r2058b805],
2	''	''	O	''	_	0	SENT_196	[p12l1942t753r2058b805],
3	.	.	O	.	_	0	SENT_196	[p12l1942t753r2058b805],

1	—	NN	O	—	_	0	SENT_197	[p12l1942t753r2058b805],
2	.	.	O	.	_	0	SENT_197	[p12l1942t753r2058b805],
3	'	''	O	'	_	0	SENT_197	[p12l1942t753r2058b805],

1	-	:	O	-	_	0	SENT_198	[p12l199t799r247b808],
2	cs	NN	O	c	nn	3	SENT_198	[p12l282t798r318b831],
3	E	NN	O	e	dep	4	SENT_198	[p12l340t785r389b828],
4	____	CD	NUMBER	____	_	0	SENT_198	[p12l1726t799r1939b844],
5	,	,	O	,	_	0	SENT_198	[p12l1726t799r1939b844],
6	__	CD	NUMBER	__	appos	4	SENT_198	[p12l1726t799r1939b844],
7	r	SYM	O	r	dep	6	SENT_198	[p12l1726t799r1939b844],
8	-	:	O	-	_	0	SENT_198	[p12l1726t799r1939b844],
9	''	''	O	''	_	0	SENT_198	[p12l1726t799r1939b844],

1	%	NN	O	%	dep	6	SENT_199	[p12l202t927r248b1004],
2	8	CD	NUMBER	8	dep	1	SENT_199	[p12l270t934r318b1008],
3	E	NN	O	e	dep	6	SENT_199	[p12l353t927r389b1024],
4	1	CD	NUMBER	1	num	3	SENT_199	[p12l449t937r505b982],
5	°	CD	NUMBER	°	num	6	SENT_199	[p12l449t937r505b982],
6	V	NN	O	v	dep	10	SENT_199	[p12l538t998r540b1002],
7	«	CD	NUMBER	«	num	8	SENT_199	[p12l750t977r752b985],
8	V	NN	O	v	dep	6	SENT_199	[p12l781t1011r783b1013],
9	--	:	O	--	_	0	SENT_199	[p12l848t943r984b985],
10	"	``	O	"	_	0	SENT_199	[p12l848t943r984b985],
11	"	``	O	"	punct	10	SENT_199	[p12l848t943r984b985],
12	He	PRP	O	he	npadvmod	13	SENT_199	[p12l1408t959r1797b1011],
13	=	JJ	O	=	dep	10	SENT_199	[p12l1408t959r1797b1011],
14	:	:	O	:	_	0	SENT_199	[p12l1408t959r1797b1011],
15	.	.	O	.	_	0	SENT_199	[p12l1408t959r1797b1011],

1	:	:	O	:	_	0	SENT_200	[p12l1408t959r1797b1011],
2	n.	NN	O	n.	nn	3	SENT_200	[p12l1408t959r1797b1011],
3	t5e	NN	O	t5e	dep	24	SENT_200	[p12l1408t959r1797b1011],
4	(	CD	PERCENT	(	num	7	SENT_200	[p12l1408t959r1797b1011],
5	95	CD	PERCENT	95	number	6	SENT_200	[p12l1408t959r1797b1011],
6	%	NN	PERCENT	%	amod	7	SENT_200	[p12l1408t959r1797b1011],
7	cI	NN	O	ci	rcmod	3	SENT_200	[p12l1408t959r1797b1011],
8	:	:	O	:	_	0	SENT_200	[p12l1408t959r1797b1011],
9	cu.-15	NN	O	cu.-15	dep	7	SENT_200	[p12l1817t956r2058b1008],
10	.0.73	CD	NUMBER	.0.73	num	9	SENT_200	[p12l1817t956r2058b1008],
11	}	CD	NUMBER	}	num	12	SENT_200	[p12l1817t956r2058b1008],
12	E5	NN	O	e5	dep	9	SENT_200	[p12l212t1008r247b1061],
13	‘	CD	NUMBER	‘	number	14	SENT_200	[p12l343t1027r389b1072],
14	-5	CD	NUMBER	-5	num	15	SENT_200	[p12l343t1027r389b1072],
15	F.	NNP	O	F.	dep	12	SENT_200	[p12l713t1019r784b1069],
16	-	:	O	-	_	0	SENT_200	[p12l713t1019r784b1069],
17	'	''	O	'	_	0	SENT_200	[p12l713t1019r784b1069],
18	*	CD	NUMBER	*	dep	7	SENT_200	[p12l713t1019r784b1069],
19	3	CD	NUMBER	3	num	20	SENT_200	[p12l215t1059r251b1088],
20	‘	NN	O	‘	dep	3	SENT_200	[p12l353t1069r389b1124],
21	-5	CD	NUMBER	-5	num	24	SENT_200	[p12l353t1069r389b1124],
22	U	NNP	O	U	nn	24	SENT_200	[p12l202t1094r251b1133],
23	U	NNP	O	U	nn	24	SENT_200	[p12l343t1127r392b1169],
24	o	NN	O	o	_	0	SENT_200	[p12l479t1114r508b1159],

1	o	NN	O	o	_	0	SENT_201	[p12l520t1152r550b1223],
2	at	IN	O	at	prep	1	SENT_201	[p12l672t1148r740b1223],
3	e	SYM	O	e	dep	2	SENT_201	[p12l826t1178r855b1220],
4	e	SYM	O	e	dep	1	SENT_201	[p12l980t1149r1006b1220],
5	12 151329124	CD	NUMBER	12 151329124	dep	1	SENT_201	[p12l1276t1141r1788b1217],[p12l1118t1175r1174b1217],
6	2	CD	NUMBER	2	dep	5	SENT_201	[p12l1884t1165r1942b1207],
7	?	.	O	?	_	0	SENT_201	[p12l1884t1165r1942b1207],

1	tan	NN	O	tan	_	0	SENT_202	[p12l2024t1135r2096b1207],

1	Months	NNS	DURATION	month	_	0	SENT_203	[p12l1083t1275r1280b1323],
2	of	IN	O	of	_	0	SENT_203	[p12l1299t1274r1353b1323],
3	Fellow-urp	NN	O	fellow-urp	prep_of	1	SENT_203	[p12l1370t1274r1630b1330],

1	Me	PRP	O	I	nsubj	2	SENT_204	[p12l128t1438r215b1487],
2	»	RB	O	»	_	0	SENT_204	[p12l128t1438r215b1487],
3	.	.	O	.	_	0	SENT_204	[p12l128t1438r215b1487],

1	of	IN	O	of	_	0	SENT_205	[p12l237t1438r289b1487],
2	Carriers	NNS	O	carrier	pobj	1	SENT_205	[p12l305t1435r521b1484],
3	at	IN	O	at	_	0	SENT_205	[p12l540t1438r591b1481],
4	Risk	NN	O	risk	prep_at	2	SENT_205	[p12l610t1432r726b1481],

1	Pravastatiin	NN	O	pravastatiin	_	0	SENT_206	[p12l128t1577r427b1626],
2	52.0	CD	NUMBER	52.0	number	3	SENT_206	[p12l494t1577r594b1622],
3	439	CD	NUMBER	439	dep	1	SENT_206	[p12l797t1573r900b1619],
4	399	CD	NUMBER	399	num	5	SENT_206	[p12l1106t1570r1206b1618],
5	:3	NN	O	:3	dep	3	SENT_206	[p12l1405t1567r1495b1615],
6	?	.	O	?	_	0	SENT_206	[p12l1405t1567r1495b1615],

1	1	CD	NUMBER	1	number	2	SENT_207	[p12l1405t1567r1495b1615],
2	230	CD	NUMBER	230	num	3	SENT_207	[p12l1716t1564r1817b1612],
3	p	NN	O	p	_	0	SENT_207	[p12l2028t1561r2096b1644],
4	>	JJR	O	>	dep	3	SENT_207	[p12l2028t1561r2096b1644],
5	+	CC	O	+	_	0	SENT_207	[p12l2028t1561r2096b1644],
6	At-nwaetaﬁn	JJ	O	at-nwaetaﬁn	amod	8	SENT_207	[p12l125t1648r447b1699],
7	524 459 430 413	CD	NUMBER	524 459 430 413	number	8	SENT_207	[p12l1405t1638r1505b1686],[p12l494t1647r595b1696],
8	269	CD	NUMBER	269	conj_+	3	SENT_207	[p12l1717t1635r1817b1683],
9	66	CD	NUMBER	66	dep	3	SENT_207	[p12l2028t1631r2096b1680],

1	Nonearriiers	NNP	O	Nonearriiers	_	0	SENT_208	[p12l57t1924r370b1973],
2	ef	NN	O	ef	nn	5	SENT_208	[p12l389t1924r440b1973],
3	K-IFS	NN	O	k-if	nn	5	SENT_208	[p12l456t1924r588b1973],
4	719Arg	NN	O	719arg	nn	5	SENT_208	[p12l604t1924r797b1985],
5	variant	NN	O	variant	dep	1	SENT_208	[p12l816t1924r1000b1973],

1	40	CD	NUMBER	40	num	2	SENT_209	[p12l433t2008r495b2050],
2	oth	NN	O	oth	_	0	SENT_209	[p12l585t2043r604b2053],
3	>	JJR	O	>	dep	2	SENT_209	[p12l585t2043r604b2053],
4	+	CC	O	+	_	0	SENT_209	[p12l585t2043r604b2053],
5	M	NN	O	m	dep	2	SENT_209	[p12l627t2043r643b2053],
6	>	JJR	O	>	dep	5	SENT_209	[p12l627t2043r643b2053],
7	+	CC	O	+	_	0	SENT_209	[p12l627t2043r643b2053],
8	P	NN	O	p	dep	9	SENT_209	[p12l668t2043r685b2050],
9	>	JJR	O	>	conj_+	5	SENT_209	[p12l668t2043r685b2050],
10	+	CC	O	+	_	0	SENT_209	[p12l668t2043r685b2050],
11	»	NN	O	»	nn	15	SENT_209	[p12l707t2043r723b2050],
12	=	JJ	O	=	amod	15	SENT_209	[p12l707t2043r723b2050],
13	High-dteee	JJ	O	high-dteee	amod	15	SENT_209	[p12l739t2017r1013b2076],
14	atenraetatin	NN	O	atenraetatin	nn	15	SENT_209	[p12l1032t2017r1347b2063],
15	t	NN	O	t	conj_+	3	SENT_209	[p12l585t2114r710b2120],
16	:	:	O	:	_	0	SENT_209	[p12l585t2114r710b2120],
17	Standard-dose	NN	O	standard-dose	nn	18	SENT_209	[p12l726t2085r1128b2134],
18	pravaetatiin	NN	O	pravaetatiin	dep	15	SENT_209	[p12l1147t2085r1440b2146],

1	DJ	NNP	O	DJ	nn	2	SENT_210	[p12l434t2188r463b2233],
2	ID	NNP	O	ID	_	0	SENT_210	[p12l466t2188r495b2233],

1	Cumulative	JJ	O	cumulative	amod	2	SENT_211	[p12l189t2445r238b2748],
2	Incidence	NN	O	incidence	_	0	SENT_211	[p12l192t2165r238b2420],
3	of	IN	O	of	prep	2	SENT_211	[p12l189t2092r238b2146],

1	Death	NN	O	death	_	0	SENT_212	[p12l260t2464r309b2622],
2	or	CC	O	or	_	0	SENT_212	[p12l273t2387r308b2442],
3	Major	JJ	O	major	amod	4	SENT_212	[p12l260t2220r321b2368],
4	3	CD	NUMBER	3	conj_or	1	SENT_212	[p12l437t2554r495b2597],

1	Cardimrascula	NNP	LOCATION	Cardimrascula	_	0	SENT_213	[p12l331t2374r379b2783],
2	.	.	O	.	_	0	SENT_213	[p12l331t2374r379b2783],

1	r	NN	O	r	nn	2	SENT_214	[p12l331t2374r379b2783],
2	Events	NNS	O	event	_	0	SENT_214	[p12l331t2172r379b2355],
3	o	NN	O	o	nn	4	SENT_214	[p12l331t2059r392b2153],
4	%	NN	O	%	dep	2	SENT_214	[p12l331t2059r392b2153],
5	)	CD	NUMBER	)	num	7	SENT_214	[p12l331t2059r392b2153],
6	e	LS	O	e	dep	7	SENT_214	[p12l469t2731r498b2773],
7	E	NN	O	e	dep	2	SENT_214	[p12l434t2371r495b2413],

1	Months	NNS	DURATION	month	_	0	SENT_215	[p12l1070t2898r1267b2947],
2	-	:	O	-	_	0	SENT_215	[p12l1286t2898r1341b2947],
3	of	IN	O	of	dep	1	SENT_215	[p12l1286t2898r1341b2947],
4	Felilinw-up	NN	O	felilinw-up	pobj	3	SENT_215	[p12l1357t2898r1617b2957],

1	No.	NN	O	no.	_	0	SENT_216	[p12l112t3053r199b3101],
2	of	IN	O	of	_	0	SENT_216	[p12l224t3053r276b3101],
3	Nuncarriers	NNS	O	nuncarrier	prep_of	1	SENT_216	[p12l292t3053r604b3101],
4	at	IN	O	at	_	0	SENT_216	[p12l623t3056r675b3101],
5	Risk	NN	O	risk	prep_at	1	SENT_216	[p12l694t3053r810b3098],

1	Pravastatin	NNP	O	Pravastatin	_	0	SENT_217	[p12l112t3194r411b3240],
2	362 303 230 261	CD	NUMBER	362 303 230 261	num	1	SENT_217	[p12l1389t3191r1479b3240],[p12l478t3194r576b3240],
3	'	''	O	'	_	0	SENT_217	[p12l1704t3191r1723b3239],
4	1	CD	NUMBER	1	dep	1	SENT_217	[p12l1704t3191r1723b3239],
5	85	CD	NUMBER	85	number	6	SENT_217	[p12l1736t3191r1801b3240],
6	511	CD	NUMBER	511	num	7	SENT_217	[p12l2015t3191r2070b3239],
7	Atnnraetatin	NN	O	atnnraetatin	dep	1	SENT_217	[p12l109t3265r431b3310],
8	366 309 273 263	CD	NUMBER	366 309 273 263	dep	1	SENT_217	[p12l1389t3262r1489b3310],[p12l478t3265r579b3310],
9	"	``	O	"	punct	8	SENT_217	[p12l1704t3262r1801b3310],
10	169	CD	NUMBER	169	num	11	SENT_217	[p12l1704t3262r1801b3310],
11	41	CD	NUMBER	41	dep	8	SENT_217	[p12l2012t3262r2070b3310],

1	Primary	JJ	O	primary	amod	3	SENT_218	[p12l437t3443r675b3505],
2	End	NN	O	end	nn	3	SENT_218	[p12l703t3443r814b3494],
3	Point	NN	O	point	_	0	SENT_218	[p12l846t3443r1007b3494],
4	According	VBG	O	accord	_	0	SENT_218	[p12l1033t3443r1355b3506],
5	to	TO	O	to	prepc_according_to	3	SENT_218	[p12l432t3525r497b3574],
6	Treatment	NN	O	treatment	pobj	3	SENT_218	[p12l522t3523r851b3574],
7	and	CC	O	and	_	0	SENT_218	[p12l878t3523r988b3574],
8	KlF6	NN	O	klf6	nn	11	SENT_218	[p12l1020t3523r1168b3574],
9	719Arg	NN	O	719arg	nn	11	SENT_218	[p12l1192t3523r1427b3586],
10	Carrier	NN	O	carrier	nn	11	SENT_218	[p12l1452t3523r1666b3574],
11	Status	NN	O	status	pobj	3	SENT_218	[p12l1690t3523r1898b3574],

1	Kap	NN	O	kap	_	0	SENT_219	[p12l65t3684r391b3735],
2	|	CD	NUMBER	|	num	1	SENT_219	[p12l65t3684r391b3735],
3	an	DT	O	a	dep	1	SENT_219	[p12l65t3684r391b3735],
4	.	.	O	.	_	0	SENT_219	[p12l65t3684r391b3735],

1	—	NN	O	—	_	0	SENT_220	[p12l65t3684r391b3735],
2	.	.	O	.	_	0	SENT_220	[p12l65t3684r391b3735],

1	Meier	JJR	PERSON	meier	amod	2	SENT_221	[p12l65t3684r391b3735],
2	estimates	NNS	O	estimate	_	0	SENT_221	[p12l412t3684r661b3726],
3	of	IN	O	of	_	0	SENT_221	[p12l685t3684r733b3725],
4	the	DT	O	the	det	6	SENT_221	[p12l751t3685r830b3726],
5	cumulative	JJ	O	cumulative	amod	6	SENT_221	[p12l853t3684r1122b3726],
6	incidence	NN	O	incidence	prep_of	2	SENT_221	[p12l1147t3684r1381b3726],
7	of	IN	O	of	_	0	SENT_221	[p12l1405t3684r1454b3726],
8	death	NN	O	death	prep_of	6	SENT_221	[p12l1473t3684r1612b3726],
9	or	CC	O	or	_	0	SENT_221	[p12l1637t3694r1685b3726],
10	major	JJ	O	major	amod	12	SENT_221	[p12l1707t3684r1846b3736],
11	cardiovascular	JJ	O	cardiovascular	amod	12	SENT_221	[p12l1867t3685r2032b3726, p12l60t3765r271b3806],
12	events	NNS	O	event	prep_of	2	SENT_221	[p12l291t3768r455b3806],
13	in	IN	O	in	_	0	SENT_221	[p12l481t3765r519b3806],
14	the	DT	O	the	det	16	SENT_221	[p12l542t3765r620b3806],
15	high-dose	JJ	O	high-dose	amod	16	SENT_221	[p12l646t3765r883b3816],
16	atorvastatin	NN	O	atorvastatin	prep_in	12	SENT_221	[p12l907t3765r1201b3806],
17	and	CC	O	and	_	0	SENT_221	[p12l1228t3765r1315b3806],
18	standard-dose	JJ	O	standard-dose	amod	21	SENT_221	[p12l1340t3765r1697b3806],
19	pravastatin	NN	O	pravastatin	nn	21	SENT_221	[p12l1722t3765r1997b3815],
20	treatment	NN	O	treatment	nn	21	SENT_221	[p13l60t20r307b59],
21	groups	NNS	O	group	conj_and	16	SENT_221	[p13l327t23r511b69],
22	:	:	O	:	_	0	SENT_221	[p13l327t23r511b69],
23	(	CD	NUMBER	(	dep	2	SENT_221	[p13l537t17r612b68],
24	A	DT	O	a	det	25	SENT_221	[p13l537t17r612b68],
25	)	NN	O	)	dep	23	SENT_221	[p13l537t17r612b68],
26	among	IN	O	among	_	0	SENT_221	[p13l639t23r807b69],
27	carriers	NNS	O	carrier	prep_among	25	SENT_221	[p13l827t17r1014b58],
28	of	IN	O	of	_	0	SENT_221	[p13l1038t17r1086b58],
29	the	DT	O	the	det	32	SENT_221	[p13l1103t17r1182b59],
30	KIF6	NN	O	kif6	nn	32	SENT_221	[p13l1209t17r1321b59],
31	719Arg	NN	O	719arg	nn	32	SENT_221	[p13l1341t17r1522b69],
32	variant	NN	O	variant	prep_of	27	SENT_221	[p13l1542t17r1725b65],
33	;	:	O	;	_	0	SENT_221	[p13l1542t17r1725b65],
34	(	NN	O	(	nn	36	SENT_221	[p13l1751t17r1827b68],
35	B	NN	O	b	nn	36	SENT_221	[p13l1751t17r1827b68],
36	)	NN	O	)	dep	2	SENT_221	[p13l1751t17r1827b68],
37	among	IN	O	among	_	0	SENT_221	[p13l1854t23r2021b69],
38	noncarriers	NNS	O	noncarrier	prep_among	36	SENT_221	[p13l64t98r342b139],
39	of	IN	O	of	_	0	SENT_221	[p13l366t97r414b139],
40	the	DT	O	the	det	43	SENT_221	[p13l432t98r511b139],
41	KIF6	NN	O	kif6	nn	43	SENT_221	[p13l537t97r649b139],
42	719Arg	NN	O	719arg	nn	43	SENT_221	[p13l669t97r851b149],
43	variant	NN	O	variant	prep_of	38	SENT_221	[p13l870t98r1053b139],
44	.	.	O	.	_	0	SENT_221	[p13l870t98r1053b139],

1	The	DT	O	the	det	3	SENT_222	[p13l1077t98r1166b139],
2	|	CD	NUMBER	|	num	3	SENT_222	[p13l1192t98r1385b149],
3	og	NN	O	og	nsubjpass	9	SENT_222	[p13l1192t98r1385b149],
4	—	CD	NUMBER	—	num	7	SENT_222	[p13l1192t98r1385b149],
5	rank	NN	O	rank	nn	7	SENT_222	[p13l1192t98r1385b149],
6	p	NN	O	p	nn	7	SENT_222	[p13l1409t107r1435b148],
7	values	NNS	O	value	dep	3	SENT_222	[p13l1455t98r1617b139],
8	are	VBP	O	be	auxpass	9	SENT_222	[p13l1641t107r1718b139],
9	based	VBN	O	base	_	0	SENT_222	[p13l1742t98r1891b139],
10	on	IN	O	on	_	0	SENT_222	[p13l1916t107r1973b139],
11	2	CD	DURATION	2	num	12	SENT_222	[p13l1999t97r2028b138],
12	years	NNS	NUMBER	year	prep_on	9	SENT_222	[p13l60t188r194b229],
13	of	IN	O	of	_	0	SENT_222	[p13l217t178r266b219],
14	follow-up	NN	O	follow-up	prep_of	12	SENT_222	[p13l283t178r518b228],
15	.	.	O	.	_	0	SENT_222	[p13l283t178r518b228],

1	The	DT	O	the	det	4	SENT_223	[p13l542t178r631b219],
2	unadjusted	JJ	O	unadjusted	amod	4	SENT_223	[p13l656t178r930b229],
3	hazard	NN	O	hazard	nn	4	SENT_223	[p13l957t178r1118b219],
4	ratios	NNS	O	ratio	nsubj	5	SENT_223	[p13l1145t178r1283b219],
5	(	VBP	O	(	_	0	SENT_223	[p13l1307t178r1410b229],
6	HR	NN	DURATION	hr	nn	7	SENT_223	[p13l1307t178r1410b229],
7	)	NN	O	)	nsubj	13	SENT_223	[p13l1307t178r1410b229],
8	and	CC	O	and	_	0	SENT_223	[p13l1436t178r1523b219],
9	95	CD	PERCENT	95	number	10	SENT_223	[p13l1548t178r1655b219],
10	%	NN	PERCENT	%	amod	12	SENT_223	[p13l1548t178r1655b219],
11	confidence	NN	O	confidence	nn	12	SENT_223	[p13l1677t178r1946b219],
12	intervals	NNS	O	interval	nsubj	13	SENT_223	[p13l1972t178r2094b219, p13l60t258r158b300],
13	(	VBP	O	(	ccomp	5	SENT_223	[p13l183t258r264b309],
14	CI	NN	O	ci	nn	15	SENT_223	[p13l183t258r264b309],
15	)	NN	O	)	nsubjpass	17	SENT_223	[p13l183t258r264b309],
16	are	VBP	O	be	auxpass	17	SENT_223	[p13l289t268r364b300],
17	based	VBN	O	base	ccomp	13	SENT_223	[p13l389t258r538b300],
18	on	IN	O	on	_	0	SENT_223	[p13l563t268r620b299],
19	30	CD	DURATION	30	num	20	SENT_223	[p13l646t258r711b300],
20	months	NNS	NUMBER	month	prep_on	17	SENT_223	[p13l736t258r920b300],
21	of	IN	O	of	_	0	SENT_223	[p13l944t258r992b299],
22	follow-up	NN	O	follow-up	prep_of	20	SENT_223	[p13l1010t258r1244b309],
23	.	.	O	.	_	0	SENT_223	[p13l1010t258r1244b309],

1	Among	IN	O	among	_	0	SENT_224	[p13l96t542r370b633],
2	carriers	NNS	O	carrier	prep_among	19	SENT_224	[p13l396t547r650b610],
3	of	IN	O	of	_	0	SENT_224	[p13l680t544r760b610],
4	KIF	NN	ORGANIZATION	kif	nn	6	SENT_224	[p13l774t547r931b609],
5	6	CD	NUMBER	6	num	6	SENT_224	[p13l929t551r966b610],
6	719Arg	NN	O	719arg	prep_of	2	SENT_224	[p13l994t542r1265b633],
7	the	DT	O	the	det	8	SENT_224	[p13l1290t544r1401b610],
8	superiority	NN	O	superiority	dep	6	SENT_224	[p13l1431t547r1811b633],
9	of	IN	O	of	_	0	SENT_224	[p13l1836t544r1916b610],
10	intensive	JJ	O	intensive	prep_of	8	SENT_224	[p13l1931t547r2146b610, p13l10t653r157b731],
11	,	,	O	,	_	0	SENT_224	[p13l1931t547r2146b610, p13l10t653r157b731],
12	compared	VBN	O	compare	_	0	SENT_224	[p13l188t650r537b739],
13	with	IN	O	with	prepc_compared_with	19	SENT_224	[p13l560t650r722b716],
14	standard	NN	O	standard	pobj	19	SENT_224	[p13l750t650r1073b731],
15	,	,	O	,	_	0	SENT_224	[p13l750t650r1073b731],
16	statin	NN	O	statin	nn	17	SENT_224	[p13l1104t653r1298b716],
17	therapy	NN	O	therapy	nsubj	19	SENT_224	[p13l1324t650r1593b739],
18	was	VBD	O	be	cop	19	SENT_224	[p13l1613t676r1743b716],
19	substantial	JJ	O	substantial	_	0	SENT_224	[p13l1773t650r2151b716],
20	and	CC	O	and	_	0	SENT_224	[p13l10t756r138b822],
21	signiﬁcant	JJ	O	signiﬁcant	conj_and	19	SENT_224	[p13l185t756r552b845],
22	as	RB	O	as	advmod	23	SENT_224	[p13l597t782r660b822],
23	early	RB	O	early	advmod	39	SENT_224	[p13l709t756r877b845],
24	as	IN	O	as	dep	39	SENT_224	[p13l920t782r984b822],
25	30	CD	DURATION	30	num	26	SENT_224	[p13l1032t759r1116b822],
26	days	NNS	NUMBER	day	npadvmod	39	SENT_224	[p13l1164t756r1314b845],
27	after	IN	O	after	_	0	SENT_224	[p13l1363t756r1522b822],
28	the	DT	O	the	det	29	SENT_224	[p13l1566t756r1677b822],
29	start	NN	O	start	prep_after	39	SENT_224	[p13l1725t773r1879b822],
30	of	IN	O	of	_	0	SENT_224	[p13l1924t756r2004b822],
31	the	DT	O	the	det	32	SENT_224	[p13l2038t756r2148b822],
32	treatment	NN	O	treatment	prep_of	29	SENT_224	[p13l8t879r374b943],
33	;	:	O	;	_	0	SENT_224	[p13l8t879r374b943],
34	however	RB	O	however	advmod	32	SENT_224	[p13l410t862r725b943],
35	,	,	O	,	_	0	SENT_224	[p13l410t862r725b943],
36	in	IN	O	in	_	0	SENT_224	[p13l760t865r828b927],
37	noncarriers	NNS	O	noncarrier	prep_in	32	SENT_224	[p13l862t865r1255b928],
38	there	EX	O	there	expl	39	SENT_224	[p13l1289t862r1468b928],
39	was	VBD	O	be	ccomp	19	SENT_224	[p13l1498t888r1628b928],
40	no	DT	O	no	det	42	SENT_224	[p13l1663t888r1749b928],
41	signiﬁcant	JJ	O	signiﬁcant	amod	42	SENT_224	[p13l1784t862r2151b951],
42	beneﬁt	NN	O	beneﬁt	nsubj	39	SENT_224	[p13l6t969r253b1035],
43	from	IN	O	from	_	0	SENT_224	[p13l275t969r446b1035],
44	intensive	JJ	O	intensive	amod	45	SENT_224	[p13l471t972r785b1035],
45	therapy	NN	O	therapy	prep_from	42	SENT_224	[p13l810t969r1079b1058],
46	at	IN	O	at	_	0	SENT_224	[p13l1101t986r1165b1035],
47	any	DT	O	any	det	48	SENT_224	[p13l1189t995r1313b1058],
48	point	NN	O	point	prep_at	39	SENT_224	[p13l1333t972r1522b1058],
49	during	IN	O	during	_	0	SENT_224	[p13l1546t969r1780b1058],
50	the	DT	O	the	det	51	SENT_224	[p13l1803t969r1914b1035],
51	study	NN	O	study	prep_during	48	SENT_224	[p13l1941t969r2145b1058],
52	.	.	O	.	_	0	SENT_224	[p13l1941t969r2145b1058],

1	This	DT	O	this	det	3	SENT_225	[p13l6t1109r170b1177],
2	early	JJ	O	early	amod	3	SENT_225	[p13l199t1111r367b1200],
3	superiority	NN	O	superiority	nsubj	11	SENT_225	[p13l391t1114r771b1200],
4	of	IN	O	of	_	0	SENT_225	[p13l795t1111r874b1177],
5	intensive	JJ	O	intensive	amod	6	SENT_225	[p13l889t1114r1202b1177],
6	therapy	NN	O	therapy	prep_of	3	SENT_225	[p13l1229t1111r1498b1200],
7	in	IN	O	in	_	0	SENT_225	[p13l1520t1114r1588b1176],
8	carriers	NNS	O	carrier	prep_in	6	SENT_225	[p13l1616t1114r1869b1177],
9	may	MD	O	may	aux	11	SENT_225	[p13l1899t1137r2047b1200],
10	be	VB	O	be	cop	11	SENT_225	[p13l2068t1111r2149b1177],
11	due	JJ	O	due	_	0	SENT_225	[p13l9t1217r134b1283],
12	to	TO	O	to	_	0	SENT_225	[p13l178t1234r246b1283],
13	an	DT	O	a	det	16	SENT_225	[p13l292t1243r373b1283],
14	early	JJ	O	early	amod	16	SENT_225	[p13l417t1217r585b1306],
15	plaque	NN	O	plaque	nn	16	SENT_225	[p13l623t1217r1262b1306],
16	—	NN	O	—	prep_to	11	SENT_225	[p13l623t1217r1262b1306],
17	stabilizing	VBG	O	stabilize	partmod	16	SENT_225	[p13l623t1217r1262b1306],
18	effect	NN	O	effect	dobj	17	SENT_225	[p13l1305t1217r1491b1283],
19	of	IN	O	of	_	0	SENT_225	[p13l1533t1217r1613b1283],
20	the	DT	O	the	det	22	SENT_225	[p13l1644t1217r1754b1283],
21	intensivetreatment	JJ	O	intensivetreatment	amod	22	SENT_225	[p13l1799t1220r2146b1283, p13l8t1341r357b1390],
22	regimen	NN	O	regimen	prep_of	18	SENT_225	[p13l393t1327r703b1413],
23	,	,	O	,	_	0	SENT_225	[p13l393t1327r703b1413],
24	a	DT	O	a	det	26	SENT_225	[p13l745t1350r780b1390],
25	pleiotropic	JJ	O	pleiotropic	amod	26	SENT_225	[p13l816t1324r1199b1413],
26	effect	NN	O	effect	appos	22	SENT_225	[p13l1238t1324r1424b1390],
27	that	WDT	O	that	nsubjpass	30	SENT_225	[p13l1461t1324r1602b1390],
28	has	VBZ	O	have	aux	30	SENT_225	[p13l1639t1324r1752b1390],
29	been	VBN	O	be	auxpass	30	SENT_225	[p13l1790t1324r1957b1390],
30	proposed	VBN	O	propose	rcmod	26	SENT_225	[p13l1994t1350r2147b1413, p13l7t1430r212b1519],
31	to	TO	O	to	aux	32	SENT_225	[p13l248t1447r316b1496],
32	explain	VB	O	explain	xcomp	30	SENT_225	[p13l355t1430r606b1519],
33	the	DT	O	the	det	35	SENT_225	[p13l642t1430r752b1496],
34	early	JJ	O	early	amod	35	SENT_225	[p13l791t1430r959b1519],
35	beneﬁt	NN	O	beneﬁt	dobj	32	SENT_225	[p13l989t1430r1235b1496],
36	from	IN	O	from	_	0	SENT_225	[p13l1270t1430r1440b1496],
37	statin	NN	O	statin	nn	38	SENT_225	[p13l1479t1433r1672b1496],
38	therapy	NN	O	therapy	prep_from	32	SENT_225	[p13l1708t1430r1977b1519],
39	that	WDT	O	that	nsubj	40	SENT_225	[p13l2009t1430r2151b1496],
40	appears	VBZ	O	appear	rcmod	38	SENT_225	[p13l10t1562r272b1625],
41	not	RB	O	not	neg	44	SENT_225	[p13l311t1553r429b1602],
42	to	TO	O	to	aux	44	SENT_225	[p13l464t1553r532b1602],
43	be	VB	O	be	cop	44	SENT_225	[p13l568t1536r649b1602],
44	due	JJ	O	due	xcomp	40	SENT_225	[p13l688t1536r812b1602],
45	to	TO	O	to	_	0	SENT_225	[p13l849t1553r918b1602],
46	LDL	NN	O	ldl	nn	47	SENT_225	[p13l957t1537r1143b1601],
47	lowering	NN	O	lowering	prep_to	44	SENT_225	[p13l1179t1536r1491b1625],
48	(	CD	NUMBER	(	number	49	SENT_225	[p13l1528t1534r1800b1617],
49	20,21	CD	NUMBER	20,21	num	50	SENT_225	[p13l1528t1534r1800b1617],
50	)	NN	O	)	dep	47	SENT_225	[p13l1528t1534r1800b1617],
51	.	.	O	.	_	0	SENT_225	[p13l1528t1534r1800b1617],

1	A	DT	O	a	det	3	SENT_226	[p13l1839t1534r1906b1601],
2	pleio	NN	O	pleio	nn	3	SENT_226	[p13l1940t1536r2146b1625],
3	—	NN	O	—	nsubj	8	SENT_226	[p13l1940t1536r2146b1625],
4	tropic	JJ	O	tropic	amod	5	SENT_226	[p13l8t1645r216b1731],
5	mechanism	NN	O	mechanism	dep	3	SENT_226	[p13l244t1642r647b1708],
6	would	MD	O	would	aux	8	SENT_226	[p13l672t1642r893b1708],
7	be	VB	O	be	cop	8	SENT_226	[p13l918t1642r999b1708],
8	consistent	JJ	O	consistent	_	0	SENT_226	[p13l1029t1645r1385b1708],
9	with	IN	O	with	_	0	SENT_226	[p13l1407t1642r1569b1708],
10	our	PRP$	O	we	poss	11	SENT_226	[p13l1598t1668r1716b1708],
11	observation	NN	O	observation	prep_with	8	SENT_226	[p13l1742t1642r2149b1708],
12	that	IN	O	that	complm	13	SENT_226	[p13l8t1747r150b1812],
13	on	IN	O	on	dep	8	SENT_226	[p13l202t1764r677b1812],
14	—	NN	O	—	nn	17	SENT_226	[p13l202t1764r677b1812],
15	treatment	NN	O	treatment	nn	17	SENT_226	[p13l202t1764r677b1812],
16	median	NN	O	median	nn	17	SENT_226	[p13l729t1747r991b1812],
17	LDL	NN	O	ldl	pobj	13	SENT_226	[p13l1046t1747r1333b1813],
18	.	.	O	.	_	0	SENT_226	[p13l1046t1747r1333b1813],

1	—	NN	O	—	_	0	SENT_227	[p13l1046t1747r1333b1813],
2	.	.	O	.	_	0	SENT_227	[p13l1046t1747r1333b1813],

1	C	NN	O	c	nn	2	SENT_228	[p13l1046t1747r1333b1813],
2	levels	NNS	O	level	nsubj	5	SENT_228	[p13l1386t1747r1575b1813],
3	did	VBD	O	do	aux	5	SENT_228	[p13l1631t1747r1744b1812],
4	not	RB	O	not	neg	5	SENT_228	[p13l1797t1764r1915b1812],
5	differ	VB	O	differ	_	0	SENT_228	[p13l1967t1747r2151b1812],
6	between	IN	O	between	_	0	SENT_228	[p13l6t1853r302b1919],
7	carriers	NNS	O	carrier	prep_between	5	SENT_228	[p13l349t1856r603b1919],
8	and	CC	O	and	_	0	SENT_228	[p13l653t1853r781b1919],
9	noncarriers	NNS	O	noncarrier	prep_between	5	SENT_228	[p13l828t1856r1241b1919],
10	.	.	O	.	_	0	SENT_228	[p13l828t1856r1241b1919],

1	Additionally	RB	O	additionally	advmod	17	SENT_229	[p13l1290t1851r1759b1942],
2	,	,	O	,	_	0	SENT_229	[p13l1290t1851r1759b1942],
3	this	DT	O	this	det	5	SENT_229	[p13l1809t1853r1936b1919],
4	early	JJ	O	early	amod	5	SENT_229	[p13l1985t1853r2153b1942],
5	beneﬁt	NN	O	beneﬁt	nsubj	17	SENT_229	[p13l6t1959r253b2025],
6	from	IN	O	from	_	0	SENT_229	[p13l297t1959r468b2025],
7	intensive	JJ	O	intensive	amod	9	SENT_229	[p13l515t1962r828b2025],
8	statin	NN	O	statin	nn	9	SENT_229	[p13l877t1962r1070b2025],
9	therapy	NN	O	therapy	prep_from	5	SENT_229	[p13l1116t1959r1385b2048],
10	in	IN	O	in	_	0	SENT_229	[p13l1427t1962r1495b2024],
11	carriers	NNS	O	carrier	prep_in	9	SENT_229	[p13l1543t1962r1796b2025],
12	of	IN	O	of	_	0	SENT_229	[p13l1845t1959r1925b2025],
13	KIF6	NN	O	kif6	nn	15	SENT_229	[p13l1958t1962r2149b2025],
14	719Arg	NN	O	719arg	nn	15	SENT_229	[p13l10t2063r295b2154],
15	variant	NN	O	variant	prep_of	11	SENT_229	[p13l357t2068r621b2131],
16	is	VBZ	O	be	cop	17	SENT_229	[p13l687t2068r740b2131],
17	likely	JJ	O	likely	_	0	SENT_229	[p13l808t2065r1015b2154],
18	to	TO	O	to	aux	20	SENT_229	[p13l1078t2082r1149b2131],
19	be	VB	O	be	cop	20	SENT_229	[p13l1216t2065r1300b2131],
20	distinct	JJ	O	distinct	xcomp	17	SENT_229	[p13l1369t2065r1654b2131],
21	from	IN	O	from	_	0	SENT_229	[p13l1719t2065r1898b2131],
22	antiinﬂammatory	JJ	O	antiinﬂammatory	amod	23	SENT_229	[p13l1968t2068r2145b2131, p13l8t2171r492b2259],
23	mechanisms	NNS	O	mechanism	prep_from	20	SENT_229	[p13l520t2171r954b2237],
24	related	VBN	O	relate	partmod	23	SENT_229	[p13l987t2171r1227b2237],
25	to	TO	O	to	_	0	SENT_229	[p13l1257t2188r1325b2237],
26	the	DT	O	the	det	27	SENT_229	[p13l1358t2171r1468b2237],
27	reduction	NN	O	reduction	prep_to	24	SENT_229	[p13l1500t2171r1838b2237],
28	of	IN	O	of	_	0	SENT_229	[p13l1870t2171r1950b2237],
29	CRP	NN	ORGANIZATION	crp	nn	30	SENT_229	[p13l1971t2171r2149b2237],
30	lakoubova	NN	O	lakoubova	prep_of	27	SENT_229	[p13l1361t2272r1647b2324],
31	et	FW	O	et	nn	32	SENT_229	[p13l1676t2275r1733b2324],
32	al.	FW	O	al.	tmod	24	SENT_229	[p13l1754t2272r1821b2324],
33	453	CD	NUMBER	453	dep	32	SENT_229	[p13l2028t2272r2140b2324],

1	KIF6	NN	O	kif6	nn	2	SENT_230	[p13l478t2359r611b2412],
2	Trp719Arg	NN	O	trp719arg	nsubj	9	SENT_230	[p13l630t2359r939b2422],
3	in	IN	O	in	_	0	SENT_230	[p13l964t2360r1011b2411],
4	the	DT	O	the	det	6	SENT_230	[p13l1036t2360r1128b2412],
5	PROVE	NNP	O	PROVE	nn	6	SENT_230	[p13l1155t2359r1345b2412],
6	IT-TIMI	NN	O	it-timus	prep_in	2	SENT_230	[p13l1371t2360r1568b2411],
7	22	CD	NUMBER	22	num	9	SENT_230	[p13l1596t2359r1670b2411],
8	Trial	NN	O	trial	nn	9	SENT_230	[p13l1693t2360r1820b2412],
9	levels	NNS	O	level	_	0	SENT_230	[p13l9t2582r218b2662],
10	,	,	O	,	_	0	SENT_230	[p13l9t2582r218b2662],
11	because	IN	O	because	mark	17	SENT_230	[p13l268t2582r538b2647],
12	carriers	NNS	O	carrier	nsubj	17	SENT_230	[p13l589t2585r841b2647],
13	and	CC	O	and	_	0	SENT_230	[p13l894t2582r1022b2647],
14	noncarriers	NNS	O	noncarrier	conj_and	12	SENT_230	[p13l1071t2585r1462b2647],
15	did	VBD	O	do	aux	17	SENT_230	[p13l1515t2582r1627b2647],
16	not	RB	O	not	neg	17	SENT_230	[p13l1677t2599r1794b2647],
17	differ	VB	O	differ	dep	9	SENT_230	[p13l1843t2582r2025b2647],
18	in	IN	O	in	_	0	SENT_230	[p13l2073t2585r2141b2647],
19	median	JJ	O	median	amod	21	SENT_230	[p13l11t2688r272b2754],
20	CRP	NN	O	crp	nn	21	SENT_230	[p13l307t2688r484b2754],
21	levels	NNS	O	level	prep_in	17	SENT_230	[p13l516t2688r703b2754],
22	at	IN	O	at	_	0	SENT_230	[p13l739t2705r802b2754],
23	baseline	NN	O	baseline	prep_at	17	SENT_230	[p13l831t2688r1113b2754],
24	or	CC	O	or	dep	25	SENT_230	[p13l1148t2714r1220b2754],
25	during	IN	O	during	dep	9	SENT_230	[p13l1252t2688r1485b2777],
26	the	DT	O	the	det	27	SENT_230	[p13l1516t2688r1626b2754],
27	trial	NN	O	trial	pobj	25	SENT_230	[p13l1660t2688r1818b2754],
28	.	.	O	.	_	0	SENT_230	[p13l1660t2688r1818b2754],

1	The	DT	O	the	det	4	SENT_231	[p13l96t2792r244b2860],
2	KIF6	NN	O	kif6	nn	4	SENT_231	[p13l290t2797r480b2860],
3	719Arg	NN	O	719arg	nn	4	SENT_231	[p13l528t2792r798b2883],
4	variant	NN	O	variant	nsubjpass	6	SENT_231	[p13l840t2797r1085b2860],
5	was	VBD	O	be	auxpass	6	SENT_231	[p13l1127t2820r1256b2860],
6	associated	VBN	O	associate	_	0	SENT_231	[p13l1306t2794r1658b2860],
7	with	IN	O	with	_	0	SENT_231	[p13l1700t2794r1862b2860],
8	an	DT	O	a	det	10	SENT_231	[p13l1910t2820r1990b2860],
9	increased	VBN	O	increase	amod	10	SENT_231	[p13l2037t2797r2137b2859, p13l11t2900r266b2966],
10	risk	NN	O	risk	prep_with	6	SENT_231	[p13l299t2900r430b2966],
11	of	IN	O	of	_	0	SENT_231	[p13l461t2900r541b2966],
12	coronary	JJ	O	coronary	amod	13	SENT_231	[p13l564t2926r873b2989],
13	events	NNS	O	event	prep_of	10	SENT_231	[p13l904t2917r1120b2966],
14	in	IN	O	in	_	0	SENT_231	[p13l1155t2903r1223b2965],
15	the	DT	O	the	det	17	SENT_231	[p13l1257t2900r1367b2966],
16	ARIC	NNP	ORGANIZATION	ARIC	nn	17	SENT_231	[p13l1400t2898r1624b2966],
17	study	NN	O	study	prep_in	13	SENT_231	[p13l1661t2900r1866b2989],
18	,	,	O	,	_	0	SENT_231	[p13l1661t2900r1866b2989],
19	a	DT	O	a	det	22	SENT_231	[p13l1905t2926r1939b2966],
20	large	JJ	O	large	amod	22	SENT_231	[p13l1971t2900r2140b2989],
21	population	NN	O	population	nn	22	SENT_231	[p13l9t3006r627b3095],
22	—	NN	O	—	nsubj	67	SENT_231	[p13l9t3006r627b3095],
23	based	VBN	O	base	partmod	22	SENT_231	[p13l9t3006r627b3095],
24	cohort	NN	O	cohort	dobj	23	SENT_231	[p13l659t3006r888b3072],
25	of	IN	O	of	_	0	SENT_231	[p13l919t3006r999b3072],
26	over	IN	O	over	advmod	31	SENT_231	[p13l1019t3032r1168b3072],
27	15,000	CD	NUMBER	15,000	num	28	SENT_231	[p13l1202t3006r1438b3087],
28	subjects	NNS	O	subject	pobj	26	SENT_231	[p13l1472t3006r1743b3095],
29	(	JJ	O	(	amod	31	SENT_231	[p13l1780t3004r1896b3087],
30	9	CD	NUMBER	9	num	31	SENT_231	[p13l1780t3004r1896b3087],
31	)	NN	O	)	prep_of	24	SENT_231	[p13l1780t3004r1896b3087],
32	,	,	O	,	_	0	SENT_231	[p13l1780t3004r1896b3087],
33	in	IN	O	in	_	0	SENT_231	[p13l1931t3009r1998b3071],
34	the	DT	O	the	det	35	SENT_231	[p13l2030t3006r2140b3072],
35	WHS	NN	O	wh	prep_in	31	SENT_231	[p13l7t3112r244b3193],
36	,	,	O	,	_	0	SENT_231	[p13l7t3112r244b3193],
37	a	DT	O	a	det	40	SENT_231	[p13l304t3138r339b3178],
38	large	JJ	O	large	amod	40	SENT_231	[p13l392t3112r561b3201],
39	population	NN	O	population	nn	40	SENT_231	[p13l616t3112r1234b3201],
40	—	NN	O	—	appos	35	SENT_231	[p13l616t3112r1234b3201],
41	based	VBN	O	base	partmod	40	SENT_231	[p13l616t3112r1234b3201],
42	cohort	NN	O	cohort	nsubj	47	SENT_231	[p13l1290t3112r1518b3178],
43	of	IN	O	of	_	0	SENT_231	[p13l1573t3112r1653b3178],
44	over	IN	O	over	amod	46	SENT_231	[p13l1697t3138r1845b3178],
45	25,000	CD	NUMBER	25,000	num	46	SENT_231	[p13l1897t3112r2139b3193],
46	women	NNS	O	woman	prep_of	42	SENT_231	[p13l7t3244r269b3284],
47	(	VBP	O	(	ccomp	41	SENT_231	[p13l301t3216r462b3299],
48	10	CD	NUMBER	10	number	49	SENT_231	[p13l301t3216r462b3299],
49	)	CD	NUMBER	)	dobj	47	SENT_231	[p13l301t3216r462b3299],
50	,	,	O	,	_	0	SENT_231	[p13l301t3216r462b3299],
51	and	CC	O	and	_	0	SENT_231	[p13l496t3218r623b3284],
52	in	IN	O	in	_	0	SENT_231	[p13l652t3221r720b3283],
53	the	DT	O	the	det	55	SENT_231	[p13l748t3218r858b3284],
54	placebo	NN	O	placebo	nn	55	SENT_231	[p13l888t3218r1154b3307],
55	groups	NNS	O	group	prep_in	56	SENT_231	[p13l1183t3244r1419b3307],
56	of	IN	O	of	dobj	47	SENT_231	[p13l1451t3218r1530b3284],
57	the	DT	O	the	det	61	SENT_231	[p13l1547t3218r1657b3284],
58	WOSCOPS	NNP	O	WOSCOPS	nn	61	SENT_231	[p13l1684t3218r2138b3285],
59	and	CC	O	and	_	0	SENT_231	[p13l12t3324r139b3390],
60	CARE	NNP	O	CARE	nn	61	SENT_231	[p13l181t3322r430b3390],
61	trials	NNS	O	trial	pobj	56	SENT_231	[p13l471t3324r641b3390],
62	+	CC	O	+	_	0	SENT_231	[p13l686t3322r801b3404],
63	However	RB	O	however	advmod	47	SENT_231	[p13l846t3325r1187b3405],
64	,	,	O	,	_	0	SENT_231	[p13l846t3325r1187b3405],
65	statin	NN	O	statin	nn	66	SENT_231	[p13l1231t3327r1424b3390],
66	therapy	NN	O	therapy	ccomp	41	SENT_231	[p13l1464t3324r1731b3413],
67	appears	VBZ	O	appear	dep	6	SENT_231	[p13l1769t3350r2030b3413],
68	to	TO	O	to	aux	69	SENT_231	[p13l2071t3341r2139b3390],
69	ameliorate	VB	O	ameliorate	xcomp	67	SENT_231	[p13l12t3430r379b3496],
70	this	DT	O	this	det	71	SENT_231	[p13l405t3430r531b3496],
71	risk	NN	O	risk	dobj	69	SENT_231	[p13l558t3430r703b3496],
72	:	:	O	:	_	0	SENT_231	[p13l558t3430r703b3496],
73	carriers	NNS	O	carrier	nsubj	86	SENT_231	[p13l733t3433r985b3496],
74	of	IN	O	of	_	0	SENT_231	[p13l1013t3430r1093b3496],
75	the	DT	O	the	det	77	SENT_231	[p13l1106t3430r1216b3496],
76	719Arg	NN	O	719arg	nn	77	SENT_231	[p13l1244t3428r1513b3519],
77	variant	NN	O	variant	prep_of	73	SENT_231	[p13l1533t3433r1779b3496],
78	who	WP	O	who	nsubjpass	80	SENT_231	[p13l1799t3430r1950b3496],
79	were	VBD	O	be	auxpass	80	SENT_231	[p13l1973t3456r2140b3496],
80	treated	VBN	O	treat	rcmod	77	SENT_231	[p13l10t3536r255b3602],
81	with	IN	O	with	_	0	SENT_231	[p13l276t3536r437b3602],
82	standard	JJ	O	standard	amod	85	SENT_231	[p13l463t3536r960b3602],
83	—	NN	O	—	nn	85	SENT_231	[p13l463t3536r960b3602],
84	dose	NN	O	dose	nn	85	SENT_231	[p13l463t3536r960b3602],
85	pravastatin	NN	O	pravastatin	prep_with	80	SENT_231	[p13l985t3539r1370b3625],
86	were	VBD	O	be	parataxis	6	SENT_231	[p13l1392t3562r1559b3602],
87	not	RB	O	not	neg	86	SENT_231	[p13l1586t3553r1703b3602],
88	at	IN	O	at	_	0	SENT_231	[p13l1728t3553r1791b3602],
89	increased	VBN	O	increase	amod	90	SENT_231	[p13l1815t3536r2141b3602],
90	risk	NN	O	risk	prep_at	86	SENT_231	[p13l10t3642r148b3708],
91	compared	VBN	O	compare	_	0	SENT_231	[p13l212t3642r576b3731],
92	with	IN	O	with	prepc_compared_with	90	SENT_231	[p13l639t3642r808b3708],
93	noncarriers	NNS	O	noncarrier	pobj	90	SENT_231	[p13l876t3645r1292b3708],
94	in	IN	O	in	_	0	SENT_231	[p13l1360t3645r1431b3707],
95	the	DT	O	the	det	96	SENT_231	[p13l1497t3642r1612b3708],
96	CARE	NNP	O	CARE	prep_in	93	SENT_231	[p13l1682t3640r1939b3708],
97	and	CC	O	and	cc	96	SENT_231	[p13l2008t3642r2140b3708],

1	WOSCOPS	NN	O	woscop	nn	2	SENT_232	[p14l7t17r460b84],
2	trials	NNS	O	trial	nsubj	3	SENT_232	[p14l523t17r693b83],
3	=	JJ	O	=	_	0	SENT_232	[p14l757t15r872b97],
4	+	CC	O	+	rcmod	3	SENT_232	[p14l757t15r872b97],
5	And	CC	O	and	_	0	SENT_232	[p14l934t15r1093b83],
6	similarly	RB	O	similarly	advmod	3	SENT_232	[p14l1153t17r1471b106],
7	,	,	O	,	_	0	SENT_232	[p14l1153t17r1471b106],
8	in	IN	O	in	amod	11	SENT_232	[p14l1533t20r1601b82],
9	the	DT	O	the	det	11	SENT_232	[p14l1661t17r1770b83],
10	PROVE	NNP	O	PROVE	nn	11	SENT_232	[p14l1832t17r2139b84],
11	IT	NNP	O	IT	conj_and	3	SENT_232	[p14l10t121r352b188],
12	.	.	O	.	_	0	SENT_232	[p14l10t121r352b188],

1	—	NN	O	—	_	0	SENT_233	[p14l10t121r352b188],
2	.	.	O	.	_	0	SENT_233	[p14l10t121r352b188],

1	Tll\/ll	NN	O	tll\/ll	nn	3	SENT_234	[p14l10t121r352b188],
2	22	CD	NUMBER	22	num	3	SENT_234	[p14l378t126r463b190],
3	trial	NN	O	trial	nsubj	16	SENT_234	[p14l490t123r650b204],
4	,	,	O	,	_	0	SENT_234	[p14l490t123r650b204],
5	carriers	NNS	O	carrier	appos	3	SENT_234	[p14l680t126r932b189],
6	of	IN	O	of	_	0	SENT_234	[p14l960t123r1040b189],
7	719Arg	NN	O	719arg	prep_of	5	SENT_234	[p14l1056t121r1325b212],
8	who	WP	O	who	nsubjpass	10	SENT_234	[p14l1345t123r1497b189],
9	were	VBD	O	be	auxpass	10	SENT_234	[p14l1521t149r1687b189],
10	treated	VBN	O	treat	rcmod	5	SENT_234	[p14l1713t123r1958b189],
11	with	IN	O	with	_	0	SENT_234	[p14l1979t123r2140b189],
12	standard	JJ	O	standard	amod	15	SENT_234	[p14l12t229r508b295],
13	—	NN	O	—	nn	15	SENT_234	[p14l12t229r508b295],
14	dose	NN	O	dose	nn	15	SENT_234	[p14l12t229r508b295],
15	pravastatin	NN	O	pravastatin	prep_with	10	SENT_234	[p14l546t232r932b318],
16	were	VBD	O	be	_	0	SENT_234	[p14l966t255r1132b295],
17	not	RB	O	not	neg	16	SENT_234	[p14l1173t246r1289b295],
18	at	IN	O	at	_	0	SENT_234	[p14l1327t246r1391b295],
19	increased	VBN	O	increase	amod	20	SENT_234	[p14l1427t229r1754b295],
20	risk	NN	O	risk	prep_at	16	SENT_234	[p14l1791t229r1922b295],
21	compared	VBN	O	compare	_	0	SENT_234	[p14l1957t255r2138b295, p14l9t335r206b424],
22	with	IN	O	with	prepc_compared_with	20	SENT_234	[p14l226t335r387b401],
23	noncarriers	NNS	O	noncarrier	pobj	20	SENT_234	[p14l413t338r804b401],
24	who	WP	O	who	nsubjpass	26	SENT_234	[p14l826t335r978b401],
25	were	VBD	O	be	auxpass	26	SENT_234	[p14l1001t361r1167b401],
26	treated	VBN	O	treat	rcmod	23	SENT_234	[p14l1192t335r1436b401],
27	with	IN	O	with	_	0	SENT_234	[p14l1456t335r1618b401],
28	standard	JJ	O	standard	amod	31	SENT_234	[p14l1643t335r2140b401],
29	—	NN	O	—	nn	31	SENT_234	[p14l1643t335r2140b401],
30	dose	NN	O	dose	nn	31	SENT_234	[p14l1643t335r2140b401],
31	pravastatin	NN	O	pravastatin	prep_with	26	SENT_234	[p14l9t444r413b530],
32	.	.	O	.	_	0	SENT_234	[p14l9t444r413b530],

1	A	DT	O	a	det	2	SENT_235	[p14l447t439r514b506],
2	hypothesis	NN	O	hypothesis	nsubj	8	SENT_235	[p14l545t441r917b530],
3	that	IN	O	that	nsubj	5	SENT_235	[p14l952t441r1093b507],
4	could	MD	O	could	aux	5	SENT_235	[p14l1124t441r1315b507],
5	explain	VB	O	explain	rcmod	2	SENT_235	[p14l1348t441r1598b530],
6	these	DT	O	these	det	7	SENT_235	[p14l1630t441r1810b507],
7	observations	NNS	O	observation	dobj	5	SENT_235	[p14l1844t441r2138b507, p14l10t551r181b614],
8	is	VBZ	O	be	_	0	SENT_235	[p14l232t551r282b614],
9	that	IN	O	that	complm	22	SENT_235	[p14l333t548r492b629],
10	,	,	O	,	_	0	SENT_235	[p14l333t548r492b629],
11	for	IN	O	for	dep	22	SENT_235	[p14l544t548r645b614],
12	patients	NNS	O	patient	pobj	11	SENT_235	[p14l692t551r968b637],
13	on	IN	O	on	_	0	SENT_235	[p14l1020t574r1108b614],
14	statin	NN	O	statin	nn	15	SENT_235	[p14l1159t551r1351b614],
15	therapy	NN	O	therapy	prep_on	12	SENT_235	[p14l1400t548r1684b637],
16	,	,	O	,	_	0	SENT_235	[p14l1400t548r1684b637],
17	the	DT	O	the	det	18	SENT_235	[p14l1736t548r1846b614],
18	risk	NN	O	risk	nsubj	22	SENT_235	[p14l1896t548r2026b614],
19	of	IN	O	of	_	0	SENT_235	[p14l2073t548r2152b614],
20	coronary	JJ	O	coronary	amod	21	SENT_235	[p14l11t680r321b743],
21	events	NNS	O	event	prep_of	18	SENT_235	[p14l369t671r584b720],
22	depends	VBZ	O	depend	ccomp	8	SENT_235	[p14l639t654r926b743],
23	on	IN	O	on	_	0	SENT_235	[p14l980t680r1067b720],
24	the	DT	O	the	det	25	SENT_235	[p14l1118t654r1228b720],
25	balance	NN	O	balance	prep_on	22	SENT_235	[p14l1279t654r1542b720],
26	between	IN	O	between	_	0	SENT_235	[p14l1592t654r1886b720],
27	the	DT	O	the	det	29	SENT_235	[p14l1937t654r2047b720],
28	2	CD	NUMBER	2	num	29	SENT_235	[p14l2098t657r2139b721],
29	effects	NNS	O	effect	prep_between	25	SENT_235	[p14l11t760r225b826],
30	associated	VBN	O	associate	partmod	29	SENT_235	[p14l258t760r610b826],
31	with	IN	O	with	_	0	SENT_235	[p14l635t760r797b826],
32	the	DT	O	the	det	34	SENT_235	[p14l827t760r937b826],
33	719Arg	NN	O	719arg	nn	34	SENT_235	[p14l969t758r1239b849],
34	variant	NN	O	variant	prep_with	30	SENT_235	[p14l1263t763r1526b826],
35	:	:	O	:	_	0	SENT_235	[p14l1263t763r1526b826],
36	increased	VBN	O	increase	amod	37	SENT_235	[p14l1560t760r1887b826],
37	risk	NN	O	risk	dep	34	SENT_235	[p14l1916t760r2046b826],
38	of	IN	O	of	_	0	SENT_235	[p14l2073t760r2153b826],
39	coronary	JJ	O	coronary	amod	40	SENT_235	[p14l11t892r321b955],
40	events	NNS	O	event	prep_of	37	SENT_235	[p14l353t883r569b932],
41	and	CC	O	and	_	0	SENT_235	[p14l608t866r735b932],
42	enhanced	VBD	O	enhance	conj_and	22	SENT_235	[p14l771t866r1107b932],
43	beneﬁt	NN	O	beneﬁt	dobj	42	SENT_235	[p14l1140t866r1385b932],
44	from	IN	O	from	_	0	SENT_235	[p14l1419t866r1589b932],
45	statin	NN	O	statin	nn	46	SENT_235	[p14l1626t869r1819b932],
46	therapy	NN	O	therapy	prep_from	42	SENT_235	[p14l1854t866r2136b955],
47	.	.	O	.	_	0	SENT_235	[p14l1854t866r2136b955],

1	Thus	RB	O	thus	advmod	11	SENT_236	[p14l8t970r214b1053],
2	,	,	O	,	_	0	SENT_236	[p14l8t970r214b1053],
3	among	IN	O	among	_	0	SENT_236	[p14l241t998r483b1061],
4	patients	NNS	O	patient	prep_among	11	SENT_236	[p14l503t975r779b1061],
5	on	IN	O	on	_	0	SENT_236	[p14l805t998r893b1038],
6	placebo	NN	O	placebo	prep_on	4	SENT_236	[p14l915t972r1202b1061],
7	,	,	O	,	_	0	SENT_236	[p14l915t972r1202b1061],
8	carriers	NNS	O	carrier	nsubj	11	SENT_236	[p14l1229t975r1481b1038],
9	of	IN	O	of	_	0	SENT_236	[p14l1508t972r1587b1038],
10	719Arg	NN	O	719arg	prep_of	8	SENT_236	[p14l1600t970r1869b1061],
11	were	VBD	O	be	_	0	SENT_236	[p14l1887t998r2054b1038],
12	at	IN	O	at	_	0	SENT_236	[p14l2079t989r2142b1038],
13	50	CD	PERCENT	50	number	14	SENT_236	[p14l11t1078r162b1144],
14	%	NN	PERCENT	%	amod	16	SENT_236	[p14l11t1078r162b1144],
15	greater	JJR	O	greater	amod	16	SENT_236	[p14l219t1095r464b1167],
16	risk	NN	O	risk	prep_at	11	SENT_236	[p14l519t1078r650b1144],
17	compared	VBN	O	compare	_	0	SENT_236	[p14l704t1078r1051b1167],
18	with	IN	O	with	prepc_compared_with	16	SENT_236	[p14l1103t1078r1265b1144],
19	noncarriers	NNS	O	noncarrier	pobj	16	SENT_236	[p14l1323t1081r1734b1144],
20	.	.	O	.	_	0	SENT_236	[p14l1323t1081r1734b1144],

1	However	RB	O	however	advmod	14	SENT_237	[p14l1797t1079r2137b1159],
2	,	,	O	,	_	0	SENT_237	[p14l1797t1079r2137b1159],
3	among	IN	O	among	_	0	SENT_237	[p14l12t1211r253b1274],
4	patients	NNS	O	patient	prep_among	14	SENT_237	[p14l289t1188r566b1274],
5	on	IN	O	on	_	0	SENT_237	[p14l608t1211r695b1251],
6	standard	JJ	O	standard	amod	9	SENT_237	[p14l736t1185r1232b1251],
7	—	NN	O	—	nn	9	SENT_237	[p14l736t1185r1232b1251],
8	dose	NN	O	dose	nn	9	SENT_237	[p14l736t1185r1232b1251],
9	pravastatin	NN	O	pravastatin	prep_on	4	SENT_237	[p14l1271t1188r1676b1274],
10	,	,	O	,	_	0	SENT_237	[p14l1271t1188r1676b1274],
11	carriers	NNS	O	carrier	nsubj	14	SENT_237	[p14l1719t1188r1972b1251],
12	and	CC	O	and	_	0	SENT_237	[p14l2014t1185r2141b1251],
13	noncarriers	NNS	O	noncarrier	nsubj	14	SENT_237	[p14l11t1294r403b1356],
14	were	VBD	O	be	_	0	SENT_237	[p14l462t1316r628b1357],
15	at	IN	O	at	dep	14	SENT_237	[p14l692t1308r755b1356],
16	similar	JJ	O	similar	amod	17	SENT_237	[p14l815t1291r1054b1356],
17	levels	NNS	O	level	pobj	15	SENT_237	[p14l1112t1291r1299b1357],
18	of	IN	O	of	_	0	SENT_237	[p14l1362t1291r1443b1356],
19	risk	NN	O	risk	prep_of	17	SENT_237	[p14l1491t1291r1637b1371],
20	,	,	O	,	_	0	SENT_237	[p14l1491t1291r1637b1371],
21	because	IN	O	because	mark	31	SENT_237	[p14l1699t1291r1968b1356],
22	the	DT	O	the	det	24	SENT_237	[p14l2030t1291r2140b1356],
23	increased	VBN	O	increase	amod	24	SENT_237	[p14l10t1397r337b1463],
24	risk	NN	O	risk	nsubj	31	SENT_237	[p14l379t1397r510b1463],
25	associated	VBN	O	associate	partmod	24	SENT_237	[p14l550t1397r902b1463],
26	with	IN	O	with	_	0	SENT_237	[p14l941t1397r1102b1463],
27	the	DT	O	the	det	29	SENT_237	[p14l1145t1397r1255b1463],
28	719Arg	NNP	O	719Arg	nn	29	SENT_237	[p14l1301t1395r1570b1486],
29	allele	NN	O	allele	prep_with	25	SENT_237	[p14l1613t1397r1789b1463],
30	was	VBD	O	be	cop	31	SENT_237	[p14l1829t1423r1958b1463],
31	balanced	JJ	O	balanced	dep	19	SENT_237	[p14l2000t1397r2138b1463, p14l12t1503r232b1584],
32	,	,	O	,	_	0	SENT_237	[p14l2000t1397r2138b1463, p14l12t1503r232b1584],
33	or	CC	O	or	_	0	SENT_237	[p14l263t1529r335b1569],
34	offset	VBN	O	offset	dep	14	SENT_237	[p14l361t1503r565b1584],
35	,	,	O	,	_	0	SENT_237	[p14l361t1503r565b1584],
36	by	IN	O	by	_	0	SENT_237	[p14l593t1503r679b1592],
37	the	DT	O	the	det	39	SENT_237	[p14l701t1503r812b1569],
38	increased	VBN	O	increase	amod	39	SENT_237	[p14l839t1503r1166b1569],
39	beneﬁt	NN	O	beneﬁt	prep_by	14	SENT_237	[p14l1190t1503r1435b1569],
40	from	IN	O	from	_	0	SENT_237	[p14l1460t1503r1630b1569],
41	statin	NN	O	statin	nn	42	SENT_237	[p14l1658t1506r1851b1569],
42	therapy	NN	O	therapy	prep_from	39	SENT_237	[p14l1877t1503r2145b1592],
43	associated	VBN	O	associate	partmod	42	SENT_237	[p14l12t1609r364b1675],
44	with	IN	O	with	_	0	SENT_237	[p14l396t1609r557b1675],
45	the	DT	O	the	det	47	SENT_237	[p14l593t1609r704b1675],
46	719Arg	NNP	O	719Arg	nn	47	SENT_237	[p14l743t1607r1012b1698],
47	allele	NN	O	allele	prep_with	43	SENT_237	[p14l1048t1609r1243b1675],
48	.	.	O	.	_	0	SENT_237	[p14l1048t1609r1243b1675],

1	Finally	RB	O	finally	advmod	25	SENT_238	[p14l1285t1609r1546b1698],
2	,	,	O	,	_	0	SENT_238	[p14l1285t1609r1546b1698],
3	among	IN	O	among	_	0	SENT_238	[p14l1587t1635r1829b1698],
4	patients	NNS	O	patient	prep_among	25	SENT_238	[p14l1862t1612r2139b1698],
5	on	IN	O	on	_	0	SENT_238	[p14l11t1742r99b1782],
6	the	DT	O	the	det	13	SENT_238	[p14l122t1716r232b1782],
7	more	RBR	O	more	advmod	8	SENT_238	[p14l258t1742r437b1782],
8	potent	JJ	O	potent	amod	13	SENT_238	[p14l460t1733r692b1805],
9	high	JJ	O	high	amod	13	SENT_238	[p14l714t1716r1068b1805],
10	—	NN	O	—	nn	13	SENT_238	[p14l714t1716r1068b1805],
11	dose	NN	O	dose	nn	13	SENT_238	[p14l714t1716r1068b1805],
12	atorvastatin	NN	O	atorvastatin	nn	13	SENT_238	[p14l1095t1719r1504b1782],
13	regimen	NN	O	regimen	prep_on	4	SENT_238	[p14l1528t1719r1836b1805],
14	,	,	O	,	_	0	SENT_238	[p14l1528t1719r1836b1805],
15	carriers	NNS	O	carrier	nsubj	25	SENT_238	[p14l1864t1719r2138b1797],
16	,	,	O	,	_	0	SENT_238	[p14l1864t1719r2138b1797],
17	with	IN	O	with	_	0	SENT_238	[p14l7t1822r168b1888],
18	their	PRP$	O	they	poss	20	SENT_238	[p14l228t1822r394b1888],
19	enhanced	VBN	O	enhance	amod	20	SENT_238	[p14l453t1822r788b1888],
20	beneﬁt	NN	O	beneﬁt	prep_with	15	SENT_238	[p14l845t1822r1090b1888],
21	from	IN	O	from	_	0	SENT_238	[p14l1148t1822r1318b1888],
22	statin	NN	O	statin	nn	23	SENT_238	[p14l1379t1825r1572b1888],
23	therapy	NN	O	therapy	prep_from	20	SENT_238	[p14l1631t1822r1914b1911],
24	,	,	O	,	_	0	SENT_238	[p14l1631t1822r1914b1911],
25	were	VBD	O	be	_	0	SENT_238	[p14l1973t1848r2140b1888],
26	actually	RB	O	actually	advmod	25	SENT_238	[p14l12t1928r281b2017],
27	at	IN	O	at	_	0	SENT_238	[p14l309t1945r372b1994],
28	decreased	VBN	O	decrease	amod	29	SENT_238	[p14l400t1928r739b1994],
29	risk	NN	O	risk	prep_at	25	SENT_238	[p14l768t1928r899b1994],
30	of	IN	O	of	_	0	SENT_238	[p14l925t1928r1005b1994],
31	coronary	JJ	O	coronary	amod	32	SENT_238	[p14l1023t1954r1333b2017],
32	events	NNS	O	event	prep_of	29	SENT_238	[p14l1359t1945r1575b1994],
33	compared	VBN	O	compare	_	0	SENT_238	[p14l1607t1928r1954b2017],
34	with	IN	O	with	prepc_compared_with	32	SENT_238	[p14l1979t1928r2141b1994],
35	noncarriers	NNS	O	noncarrier	pobj	32	SENT_238	[p14l11t2039r423b2079],
36	.	.	O	.	_	0	SENT_238	[p14l11t2039r423b2079],

1	In	IN	O	in	_	0	SENT_239	[p14l99t2121r176b2185],
2	the	DT	O	the	det	5	SENT_239	[p14l225t2120r335b2186],
3	KIF6	NN	O	kif6	nn	5	SENT_239	[p14l383t2123r573b2186],
4	719Arg	NN	O	719arg	nn	5	SENT_239	[p14l623t2118r893b2209],
5	variant	NN	O	variant	prep_in	11	SENT_239	[p14l936t2123r1200b2201],
6	,	,	O	,	_	0	SENT_239	[p14l936t2123r1200b2201],
7	a	DT	O	a	det	10	SENT_239	[p14l1253t2146r1287b2186],
8	basic	JJ	O	basic	amod	10	SENT_239	[p14l1333t2120r1507b2186],
9	arginine	NN	O	arginine	nn	10	SENT_239	[p14l1556t2123r1842b2209],
10	residue	NN	O	residue	nsubj	11	SENT_239	[p14l1891t2120r2140b2186],
11	replaces	VBZ	O	replace	_	0	SENT_239	[p14l10t2227r286b2316],
12	a	DT	O	a	det	15	SENT_239	[p14l319t2253r353b2293],
13	nonpolar	JJ	O	nonpolar	amod	15	SENT_239	[p14l382t2227r699b2316],
14	tryptophan	NN	O	tryptophan	nn	15	SENT_239	[p14l727t2227r1119b2316],
15	residue	NN	O	residue	dobj	11	SENT_239	[p14l1148t2227r1416b2293],
16	.	.	O	.	_	0	SENT_239	[p14l1148t2227r1416b2293],

1	Because	IN	O	because	mark	9	SENT_240	[p14l1450t2228r1731b2293],
2	this	DT	O	this	det	5	SENT_240	[p14l1761t2227r1888b2293],
3	amino	NN	O	amino	nn	5	SENT_240	[p14l1921t2230r2139b2293],
4	acid	NN	O	acid	nn	5	SENT_240	[p14l12t2333r152b2399],
5	substitution	NN	O	substitution	nsubjpass	9	SENT_240	[p14l188t2333r605b2399],
6	is	VBZ	O	be	auxpass	9	SENT_240	[p14l640t2336r690b2399],
7	in	IN	O	in	advmod	9	SENT_240	[p14l727t2336r794b2398],
8	a	DT	O	a	dep	7	SENT_240	[p14l830t2359r865b2399],
9	predicted	VBN	O	predict	advcl	23	SENT_240	[p14l897t2333r1229b2422],
10	coiled	VBN	O	coil	dep	9	SENT_240	[p14l1263t2333r1635b2399],
11	—	CD	NUMBER	—	num	13	SENT_240	[p14l1263t2333r1635b2399],
12	coil	NN	O	coil	nn	13	SENT_240	[p14l1263t2333r1635b2399],
13	region	NN	O	region	dobj	10	SENT_240	[p14l1669t2336r1892b2422],
14	of	IN	O	of	_	0	SENT_240	[p14l1928t2333r2007b2399],
15	the	DT	O	the	det	18	SENT_240	[p14l2029t2333r2140b2399],
16	KIF	NN	ORGANIZATION	kif	nn	18	SENT_240	[p14l9t2442r165b2504],
17	6	CD	NUMBER	6	num	18	SENT_240	[p14l163t2445r199b2505],
18	protein	NN	O	protein	prep_of	13	SENT_240	[p14l228t2442r503b2528],
19	,	,	O	,	_	0	SENT_240	[p14l228t2442r503b2528],
20	the	DT	O	the	det	21	SENT_240	[p14l536t2439r646b2505],
21	change	NN	O	change	nsubj	23	SENT_240	[p14l678t2439r923b2528],
22	might	MD	O	might	aux	23	SENT_240	[p14l955t2439r1167b2528],
23	affect	VB	O	affect	_	0	SENT_240	[p14l1197t2439r1382b2505],
24	the	DT	O	the	det	26	SENT_240	[p14l1410t2439r1520b2505],
25	cargo	NN	O	cargo	nn	26	SENT_240	[p14l1551t2465r1738b2528],
26	binding	NN	O	binding	dobj	23	SENT_240	[p14l1767t2439r2044b2528],
27	of	IN	O	of	_	0	SENT_240	[p14l2073t2439r2153b2505],
28	the	DT	O	the	det	32	SENT_240	[p14l10t2545r120b2611],
29	kinesin	NN	O	kinesin	nn	32	SENT_240	[p14l159t2545r411b2611],
30	(	NN	O	(	nn	32	SENT_240	[p14l453t2543r612b2625],
31	22	CD	NUMBER	22	num	32	SENT_240	[p14l453t2543r612b2625],
32	)	NN	O	)	prep_of	26	SENT_240	[p14l453t2543r612b2625],
33	.	.	O	.	_	0	SENT_240	[p14l453t2543r612b2625],

1	Several	JJ	O	several	amod	2	SENT_241	[p14l658t2545r906b2611],
2	kinesins	NNS	O	kinesin	nsubjpass	5	SENT_241	[p14l943t2545r1225b2611],
3	have	VBP	O	have	aux	5	SENT_241	[p14l1264t2545r1423b2611],
4	been	VBN	O	be	auxpass	5	SENT_241	[p14l1460t2545r1626b2611],
5	implicated	VBN	O	implicate	_	0	SENT_241	[p14l1664t2545r2036b2634],
6	in	IN	O	in	_	0	SENT_241	[p14l2073t2548r2141b2610],
7	the	DT	O	the	det	8	SENT_241	[p14l10t2652r120b2718],
8	pathogenesis	NN	O	pathogenesis	prep_in	5	SENT_241	[p14l146t2652r599b2741],
9	of	IN	O	of	_	0	SENT_241	[p14l628t2652r707b2718],
10	chronic	JJ	O	chronic	amod	11	SENT_241	[p14l722t2652r984b2718],
11	diseases	NNS	O	disease	prep_of	8	SENT_241	[p14l1010t2652r1304b2733],
12	,	,	O	,	_	0	SENT_241	[p14l1010t2652r1304b2733],
13	including	VBG	O	include	_	0	SENT_241	[p14l1333t2652r1667b2741],
14	neurodegenerative	JJ	O	neurodegenerative	amod	15	SENT_241	[p14l1692t2652r2138b2741, p14l11t2761r241b2824],
15	diseases	NNS	O	disease	prep_including	8	SENT_241	[p14l287t2758r581b2839],
16	,	,	O	,	_	0	SENT_241	[p14l287t2758r581b2839],
17	type	NN	O	type	nn	19	SENT_241	[p14l629t2775r775b2847],
18	2	CD	NUMBER	2	num	19	SENT_241	[p14l819t2761r860b2825],
19	diabetes	NN	O	diabetes	prep_including	8	SENT_241	[p14l907t2758r1210b2839],
20	,	,	O	,	_	0	SENT_241	[p14l907t2758r1210b2839],
21	and	CC	O	and	_	0	SENT_241	[p14l1260t2758r1387b2824],
22	Alzheimer	NN	O	alzheimer	poss	27	SENT_241	[p14l1429t2756r1851b2824],
23	’s	POS	O	’s	_	0	SENT_241	[p14l1429t2756r1851b2824],
24	disease	NN	O	disease	nn	27	SENT_241	[p14l1898t2758r2140b2824],
25	(	NN	O	(	nn	27	SENT_241	[p14l13t2862r173b2944],
26	23	CD	NUMBER	23	num	27	SENT_241	[p14l13t2862r173b2944],
27	)	NN	O	)	conj_and	15	SENT_241	[p14l13t2862r173b2944],
28	.	.	O	.	_	0	SENT_241	[p14l13t2862r173b2944],

1	We	PRP	O	we	nsubj	2	SENT_242	[p14l218t2865r348b2931],
2	believe	VBP	O	believe	_	0	SENT_242	[p14l391t2864r632b2930],
3	that	IN	O	that	complm	24	SENT_242	[p14l677t2864r818b2930],
4	functional	JJ	O	functional	amod	5	SENT_242	[p14l861t2864r1219b2930],
5	studies	NNS	O	study	nsubj	24	SENT_242	[p14l1264t2864r1502b2930],
6	that	WDT	O	that	nsubj	7	SENT_242	[p14l1547t2864r1689b2930],
7	explore	VBP	O	explore	rcmod	5	SENT_242	[p14l1732t2864r1985b2953],
8	the	DT	O	the	det	9	SENT_242	[p14l2030t2864r2140b2930],
9	mechanism	NN	O	mechanism	dobj	7	SENT_242	[p14l11t2970r413b3036],
10	by	IN	O	by	_	0	SENT_242	[p14l458t2970r544b3059],
11	which	WDT	O	which	rel	22	SENT_242	[p14l583t2970r801b3036],
12	the	DT	O	the	det	14	SENT_242	[p14l847t2970r957b3036],
13	KIF6	NN	O	kif6	nn	14	SENT_242	[p14l1003t2973r1194b3036],
14	kinesin	NN	O	kinesin	nsubj	22	SENT_242	[p14l1240t2970r1492b3036],
15	and	CC	O	and	_	0	SENT_242	[p14l1541t2970r1668b3036],
16	the	DT	O	the	det	19	SENT_242	[p14l1714t2970r1824b3036],
17	719Arg	NN	O	719arg	nn	19	SENT_242	[p14l1873t2968r2142b3059],
18	variant	JJ	O	variant	amod	19	SENT_242	[p14l7t3079r253b3142],
19	affect	NN	O	affect	nsubj	22	SENT_242	[p14l309t3076r494b3141],
20	cardiovascular	JJ	O	cardiovascular	amod	21	SENT_242	[p14l549t3076r1046b3142],
21	disease	NN	O	disease	dep	19	SENT_242	[p14l1101t3076r1343b3141],
22	are	VBP	O	be	rcmod	9	SENT_242	[p14l1402t3101r1502b3141],
23	now	RB	DATE	now	advmod	22	SENT_242	[p14l1560t3102r1712b3142],
24	warranted	VBN	O	warrant	ccomp	2	SENT_242	[p14l1760t3076r2138b3156],
25	,	,	O	,	_	0	SENT_242	[p14l1760t3076r2138b3156],

1	given	VBN	O	give	_	0	SENT_243	[p14l9t3186r198b3272],
2	the	DT	O	the	det	3	SENT_243	[p14l222t3183r333b3249],
3	consistency	NN	O	consistency	dobj	1	SENT_243	[p14l360t3186r763b3272],
4	of	IN	O	of	_	0	SENT_243	[p14l785t3183r865b3249],
5	the	DT	O	the	det	6	SENT_243	[p14l878t3183r988b3249],
6	association	NN	O	association	prep_of	3	SENT_243	[p14l1016t3186r1398b3249],
7	in	IN	O	in	_	0	SENT_243	[p14l1423t3186r1491b3248],
8	multiple	JJ	O	multiple	amod	10	SENT_243	[p14l1517t3183r1810b3272],
9	prospective	JJ	O	prospective	amod	10	SENT_243	[p14l1835t3209r2138b3272, p14l10t3292r135b3355],
10	cohorts	NNS	O	cohort	prep_in	6	SENT_243	[p14l166t3289r443b3355],
11	.	.	O	.	_	0	SENT_243	[p14l166t3289r443b3355],

1	Such	JJ	O	such	amod	2	SENT_244	[p14l480t3289r651b3355],
2	studies	NNS	O	study	nsubj	5	SENT_244	[p14l682t3289r919b3355],
3	are	VBP	O	be	cop	5	SENT_244	[p14l952t3315r1052b3355],
4	particularly	RB	O	particularly	advmod	5	SENT_244	[p14l1081t3289r1483b3378],
5	important	JJ	O	important	_	0	SENT_244	[p14l1508t3292r1864b3378],
6	to	TO	O	to	aux	7	SENT_244	[p14l1891t3306r1959b3355],
7	help	VB	O	help	xcomp	5	SENT_244	[p14l1990t3289r2139b3378],
8	explain	VB	O	explain	dep	7	SENT_244	[p14l11t3395r261b3484],
9	why	WRB	O	why	advmod	26	SENT_244	[p14l300t3395r452b3484],
10	the	DT	O	the	det	11	SENT_244	[p14l490t3395r600b3461],
11	beneﬁt	NN	O	beneﬁt	dep	9	SENT_244	[p14l641t3395r886b3461],
12	from	IN	O	from	_	0	SENT_244	[p14l926t3395r1096b3461],
13	atorvastatin	NN	O	atorvastatin	prep_from	11	SENT_244	[p14l1141t3398r1551b3461],
14	(	CD	NUMBER	(	num	13	SENT_244	[p14l1596t3393r1707b3475],
15	80	CD	NUMBER	80	num	17	SENT_244	[p14l1596t3393r1707b3475],
16	mg	NN	O	mg	nn	17	SENT_244	[p14l1751t3393r1910b3484],
17	)	NN	O	)	nsubj	26	SENT_244	[p14l1751t3393r1910b3484],
18	,	,	O	,	_	0	SENT_244	[p14l1751t3393r1910b3484],
19	compared	VBN	O	compare	_	0	SENT_244	[p14l1957t3421r2138b3461, p14l9t3501r206b3590],
20	with	IN	O	with	prepc_compared_with	26	SENT_244	[p14l226t3501r388b3567],
21	pravastatin	NN	O	pravastatin	pobj	26	SENT_244	[p14l411t3504r796b3590],
22	(	CD	NUMBER	(	num	21	SENT_244	[p14l824t3499r935b3581],
23	40	CD	NUMBER	40	num	25	SENT_244	[p14l824t3499r935b3581],
24	mg	NN	O	mg	nn	25	SENT_244	[p14l961t3499r1097b3590],
25	)	NN	O	)	nsubj	26	SENT_244	[p14l961t3499r1097b3590],
26	differed	VBD	O	differ	advcl	8	SENT_244	[p14l1127t3501r1393b3567],
27	between	IN	O	between	_	0	SENT_244	[p14l1415t3501r1708b3567],
28	carriers	NNS	O	carrier	prep_between	26	SENT_244	[p14l1734t3504r1986b3567],
29	and	CC	O	and	_	0	SENT_244	[p14l2014t3501r2141b3567],
30	noncarriers	NNS	O	noncarrier	prep_between	26	SENT_244	[p14l11t3610r403b3673],
31	despite	IN	O	despite	_	0	SENT_244	[p14l439t3607r685b3696],
32	similar	JJ	O	similar	amod	37	SENT_244	[p14l720t3607r959b3673],
33	on	IN	O	on	_	0	SENT_244	[p14l991t3607r1385b3696],
34	—	NN	O	—	nn	35	SENT_244	[p14l991t3607r1385b3696],
35	therapy	NN	O	therapy	prep_on	32	SENT_244	[p14l991t3607r1385b3696],
36	plasma	NN	O	plasma	nn	37	SENT_244	[p14l1413t3607r1659b3696],
37	LDL	NN	O	ldl	prep_despite	26	SENT_244	[p14l1692t3607r1977b3673],
38	.	.	O	.	_	0	SENT_244	[p14l1692t3607r1977b3673],

1	—	NN	O	—	_	0	SENT_245	[p14l1692t3607r1977b3673],
2	.	.	O	.	_	0	SENT_245	[p14l1692t3607r1977b3673],

1	C	NN	O	c	_	0	SENT_246	[p14l1692t3607r1977b3673],
2	and	CC	O	and	_	0	SENT_246	[p14l2014t3607r2141b3673],
3	CRP	NN	O	crp	conj_and	1	SENT_246	[p14l12t3714r189b3780],
4	levels	NNS	O	level	dep	1	SENT_246	[p14l221t3714r428b3779],
5	.	.	O	.	_	0	SENT_246	[p14l221t3714r428b3779],

1	Study	NNP	O	Study	_	0	SENT_247	[p15l13t27r228b117],
2	limitations	NNS	O	limitation	dep	1	SENT_247	[p15l248t27r678b94],
3	.	.	O	.	_	0	SENT_247	[p15l248t27r678b94],

1	This	DT	O	this	det	3	SENT_248	[p15l726t26r890b94],
2	genetic	JJ	O	genetic	amod	3	SENT_248	[p15l917t31r1170b117],
3	study	NN	O	study	nsubj	7	SENT_248	[p15l1198t28r1387b117],
4	was	VBD	O	be	cop	7	SENT_248	[p15l1406t54r1536b94],
5	not	RB	O	not	neg	7	SENT_248	[p15l1565t45r1682b94],
6	a	DT	O	a	det	7	SENT_248	[p15l1709t54r1743b94],
7	part	NN	O	part	_	0	SENT_248	[p15l1768t45r1910b117],
8	of	IN	O	of	_	0	SENT_248	[p15l1935t28r2015b94],
9	the	DT	O	the	det	11	SENT_248	[p15l2030t28r2140b94],
10	study	NN	O	study	nn	11	SENT_248	[p15l12t134r201b223],
11	protocol	NN	O	protocol	prep_of	7	SENT_248	[p15l233t134r528b223],
12	for	IN	O	for	_	0	SENT_248	[p15l563t134r664b200],
13	the	DT	O	the	det	16	SENT_248	[p15l698t134r809b200],
14	original	JJ	O	original	amod	16	SENT_248	[p15l847t134r1117b223],
15	PROVE	NNP	O	PROVE	nn	16	SENT_248	[p15l1153t134r1461b201],
16	IT	NNP	O	IT	prep_for	11	SENT_248	[p15l1498t132r1840b199],
17	.	.	O	.	_	0	SENT_248	[p15l1498t132r1840b199],

1	—	NN	O	—	_	0	SENT_249	[p15l1498t132r1840b199],
2	.	.	O	.	_	0	SENT_249	[p15l1498t132r1840b199],

1	TIMI	NNP	ORGANIZATION	TIMI	nsubj	5	SENT_250	[p15l1498t132r1840b199],
2	22	CD	NUMBER	22	num	1	SENT_250	[p15l1877t137r1962b201],
3	trial	NN	O	trial	_	0	SENT_250	[p15l2000t134r2142b200],
4	and	CC	O	and	_	0	SENT_250	[p15l12t240r139b306],
5	included	VBD	O	include	conj_and	3	SENT_250	[p15l179t240r482b306],
6	only	RB	O	only	advmod	9	SENT_250	[p15l522t240r675b329],
7	the	DT	O	the	det	9	SENT_250	[p15l711t240r821b306],
8	white	JJ	O	white	amod	9	SENT_250	[p15l858t240r1057b306],
9	patients	NNS	O	patient	dobj	5	SENT_250	[p15l1096t243r1373b329],
10	who	WP	O	who	nsubj	16	SENT_250	[p15l1411t240r1563b306],
11	were	VBD	O	be	cop	16	SENT_250	[p15l1601t266r1767b306],
12	predominantly	RB	O	predominantly	advmod	13	SENT_250	[p15l1807t240r2138b329, p15l12t346r233b435],
13	middle	JJ	O	middle	amod	16	SENT_250	[p15l263t346r709b435],
14	—	JJ	O	—	amod	16	SENT_250	[p15l263t346r709b435],
15	aged	JJ	O	aged	amod	16	SENT_250	[p15l263t346r709b435],
16	men	NNS	O	man	rcmod	9	SENT_250	[p15l741t372r913b427],
17	;	:	O	;	_	0	SENT_250	[p15l741t372r913b427],
18	therefore	RB	O	therefore	advmod	39	SENT_250	[p15l948t346r1286b427],
19	,	,	O	,	_	0	SENT_250	[p15l948t346r1286b427],
20	the	DT	O	the	det	21	SENT_250	[p15l1321t346r1431b412],
21	eﬂect	NN	O	eﬂect	nsubjpass	39	SENT_250	[p15l1465t346r1650b412],
22	of	IN	O	of	_	0	SENT_250	[p15l1681t346r1761b412],
23	the	DT	O	the	det	26	SENT_250	[p15l1781t346r1891b412],
24	intensive	JJ	O	intensive	amod	26	SENT_250	[p15l1924t349r2138b412, p15l12t455r138b518],
25	statin	NN	O	statin	nn	26	SENT_250	[p15l177t455r370b518],
26	therapy	NN	O	therapy	prep_of	21	SENT_250	[p15l406t452r674b541],
27	in	IN	O	in	_	0	SENT_250	[p15l707t455r774b517],
28	carriers	NNS	O	carrier	prep_in	26	SENT_250	[p15l812t455r1064b518],
29	and	CC	O	and	_	0	SENT_250	[p15l1105t452r1232b518],
30	noncarriers	NNS	O	noncarrier	conj_and	28	SENT_250	[p15l1270t455r1660b518],
31	of	IN	O	of	_	0	SENT_250	[p15l1700t452r1780b518],
32	the	DT	O	the	det	35	SENT_250	[p15l1804t452r1914b518],
33	KIF6	NN	O	kif6	nn	35	SENT_250	[p15l1950t455r2141b518],
34	719Arg	NN	O	719arg	nn	35	SENT_250	[p15l12t556r281b647],
35	variant	NN	O	variant	prep_of	28	SENT_250	[p15l308t561r553b624],
36	should	MD	O	should	aux	39	SENT_250	[p15l584t558r818b624],
37	be	VB	O	be	auxpass	39	SENT_250	[p15l846t558r927b624],
38	further	RB	O	further	advmod	39	SENT_250	[p15l959t558r1205b624],
39	investigated	VBN	O	investigate	parataxis	3	SENT_250	[p15l1234t558r1656b647],
40	in	IN	O	in	_	0	SENT_250	[p15l1686t561r1754b623],
41	additional	JJ	O	additional	amod	43	SENT_250	[p15l1787t558r2142b624],
42	ethnic	JJ	O	ethnic	amod	43	SENT_250	[p15l11t665r230b731],
43	groups	NNS	O	group	prep_in	39	SENT_250	[p15l260t691r517b754],
44	,	,	O	,	_	0	SENT_250	[p15l260t691r517b754],
45	women	NNS	O	woman	prep_in	39	SENT_250	[p15l549t691r831b746],
46	,	,	O	,	_	0	SENT_250	[p15l549t691r831b746],
47	and	CC	O	and	_	0	SENT_250	[p15l868t665r995b731],
48	older	JJR	O	older	amod	49	SENT_250	[p15l1028t665r1207b731],
49	patients	NNS	O	patient	prep_in	39	SENT_250	[p15l1236t668r1513b754],
50	after	IN	O	after	_	0	SENT_250	[p15l1549t665r1707b731],
51	acute	JJ	O	acute	amod	53	SENT_250	[p15l1740t682r1920b731],
52	coronary	JJ	O	coronary	amod	53	SENT_250	[p15l1954t690r2138b731, p15l11t797r165b860],
53	syndromes	NNS	O	syndrome	prep_after	39	SENT_250	[p15l200t771r593b860],
54	.	.	O	.	_	0	SENT_250	[p15l200t771r593b860],

1	Although	IN	O	although	mark	3	SENT_251	[p15l631t769r976b860],
2	genetic	JJ	O	genetic	amod	3	SENT_251	[p15l1012t774r1265b860],
3	studies	NNS	O	study	_	0	SENT_251	[p15l1302t771r1540b837],
4	of	IN	O	of	_	0	SENT_251	[p15l1579t771r1659b837],
5	the	DT	O	the	det	7	SENT_251	[p15l1683t771r1794b837],
6	PROVE	NNP	O	PROVE	nn	7	SENT_251	[p15l1832t771r2139b838],
7	IT	NNP	O	IT	prep_of	3	SENT_251	[p15l10t876r352b943],
8	.	.	O	.	_	0	SENT_251	[p15l10t876r352b943],

1	—	NN	O	—	_	0	SENT_252	[p15l10t876r352b943],
2	.	.	O	.	_	0	SENT_252	[p15l10t876r352b943],

1	TIMI	NNP	ORGANIZATION	TIMI	_	0	SENT_253	[p15l10t876r352b943],
2	22	CD	NUMBER	22	num	1	SENT_253	[p15l390t881r497b959],
3	,	,	O	,	_	0	SENT_253	[p15l390t881r497b959],
4	WOSCOPS	NNP	O	WOSCOPS	appos	1	SENT_253	[p15l534t878r1011b959],
5	,	,	O	,	_	0	SENT_253	[p15l534t878r1011b959],
6	and	CC	O	and	_	0	SENT_253	[p15l1053t878r1180b944],
7	CARE	NNP	O	CARE	nn	8	SENT_253	[p15l1219t876r1468b944],
8	trials	NNS	O	trial	conj_and	1	SENT_253	[p15l1507t878r1677b944],
9	(	CD	NUMBER	(	dep	8	SENT_253	[p15l1720t876r2142b967],
10	comprising	VBG	O	comprise	partmod	1	SENT_253	[p15l1720t876r2142b967],

1	454	CD	NUMBER	454	num	2	SENT_254	[p15l42t1042r96b1067],
2	lakoubova	NN	O	lakoubova	_	0	SENT_254	[p15l194t1042r328b1067],
3	et	FW	O	et	nn	4	SENT_254	[p15l338t1043r365b1067],
4	al.	FW	O	al.	dep	2	SENT_254	[p15l372t1042r404b1067],
5	.	.	O	.	_	0	SENT_254	[p15l372t1042r404b1067],

1	JACC	NNP	O	JACC	nn	2	SENT_255	[p15l1823t1043r1877b1067],
2	Vol	NNP	O	Vol	_	0	SENT_255	[p15l1886t1043r1925b1067],
3	.	.	O	.	_	0	SENT_255	[p15l1886t1043r1925b1067],

1	51	CD	NUMBER	51	_	0	SENT_256	[p15l1936t1043r1971b1071],
2	,	,	O	,	_	0	SENT_256	[p15l1936t1043r1971b1071],
3	No.	NN	O	no.	amod	1	SENT_256	[p15l1983t1043r2017b1067],
4	4	CD	NUMBER	4	number	3	SENT_256	[p15l2028t1043r2048b1071],
5	,	,	O	,	_	0	SENT_256	[p15l2028t1043r2048b1071],
6	2008	CD	DATE	2008	num	8	SENT_256	[p15l2059t1043r2117b1067],
7	KIF6	NN	O	kif6	nn	8	SENT_256	[p15l194t1083r256b1108],
8	Trp719Arg	NN	O	trp719arg	appos	1	SENT_256	[p15l262t1083r407b1113],
9	in	IN	O	in	_	0	SENT_256	[p15l416t1083r438b1108],
10	the	DT	O	the	det	12	SENT_256	[p15l447t1083r490b1108],
11	PROVE	NNP	O	PROVE	nn	12	SENT_256	[p15l500t1083r589b1108],
12	IT-TIMI	NN	O	it-timus	prep_in	8	SENT_256	[p15l599t1083r691b1108],
13	22	CD	NUMBER	22	num	12	SENT_256	[p15l701t1083r736b1108],
14	Trial	NNP	O	Trial	nn	15	SENT_256	[p15l744t1083r804b1108],
15	January	NNP	DATE	January	dep	1	SENT_256	[p15l1823t1084r1906b1114],
16	29	CD	DATE	29	num	15	SENT_256	[p15l1915t1084r1950b1112],
17	,	,	O	,	_	0	SENT_256	[p15l1915t1084r1950b1112],
18	2008:449	CD	NUMBER	2008:449	num	15	SENT_256	[p15l1961t1084r2117b1108],
19	—	CD	NUMBER	—	number	20	SENT_256	[p15l1961t1084r2117b1108],
20	55	CD	NUMBER	55	dep	15	SENT_256	[p15l1961t1084r2117b1108],

1	C	NN	O	c	nn	3	SENT_257	[p15l1333t1240r1350b1260],
2	ulaiive	JJ	O	ulaiive	amod	3	SENT_257	[p15l1393t1240r1478b1260],
3	Incidence	NN	O	incidence	nsubj	7	SENT_257	[p15l1486t1240r1609b1260],
4	of	IN	O	of	_	0	SENT_257	[p15l1617t1240r1642b1260],
5	ronary	JJ	O	ronary	amod	6	SENT_257	[p15l1394t1269r1476b1292],
6	Events	NNS	O	event	prep_of	3	SENT_257	[p15l1485t1266r1571b1286],
7	(	VBP	O	(	_	0	SENT_257	[p15l1580t1264r1621b1291],
8	79	CD	NUMBER	79	num	9	SENT_257	[p15l1580t1264r1621b1291],
9	)	CD	NUMBER	)	dobj	7	SENT_257	[p15l1580t1264r1621b1291],
10	censoring	VBG	O	censor	xcomp	7	SENT_257	[p15l534t1320r652b1344],
11	11me	JJ	O	11me	amod	17	SENT_257	[p15l659t1320r715b1338],
12	Hazard	NN	O	hazard	nn	17	SENT_257	[p15l799t1320r876b1338],
13	Fla1io	NN	O	fla1io	nn	17	SENT_257	[p15l885t1318r1006b1343],
14	(	CD	PERCENT	(	num	17	SENT_257	[p15l885t1318r1006b1343],
15	95	CD	PERCENT	95	num	17	SENT_257	[p15l885t1318r1006b1343],
16	%	NN	PERCENT	%	nn	17	SENT_257	[p15l885t1318r1006b1343],
17	Cl	NN	O	cl	dobj	10	SENT_257	[p15l1014t1318r1044b1343],
18	)	CD	NUMBER	)	num	19	SENT_257	[p15l1014t1318r1044b1343],
19	Risk	NN	O	risk	rcmod	17	SENT_257	[p15l1209t1319r1258b1338],
20	80	CD	NUMBER	80	num	21	SENT_257	[p15l1371t1320r1397b1338],
21	mg	NN	O	mg	dep	19	SENT_257	[p15l1405t1324r1439b1343],
22	of	IN	O	of	dep	19	SENT_257	[p15l1446t1320r1469b1338],
23	40	CD	NUMBER	40	num	24	SENT_257	[p15l1543t1320r1569b1338],
24	mg	NN	O	mg	pobj	22	SENT_257	[p15l1577t1324r1611b1343],
25	of	IN	O	of	_	0	SENT_257	[p15l1619t1320r1642b1338],
26	Reduction	NN	O	reduction	nn	27	SENT_257	[p15l1153t1342r1268b1362],
27	(	NN	O	(	prep_of	24	SENT_257	[p15l1276t1342r1313b1367],
28	7	CD	NUMBER	7	num	27	SENT_257	[p15l1276t1342r1313b1367],
29	.	.	O	.	_	0	SENT_257	[p15l1276t1342r1313b1367],
30	)	SYM	O	)	dep	17	SENT_257	[p15l1276t1342r1313b1367],

1	Atorvastatin	NNP	O	Atorvastatin	nn	2	SENT_258	[p15l1350t1343r1489b1362],
2	Pravaslatln	NNP	O	Pravaslatln	_	0	SENT_258	[p15l1529t1343r1655b1362],

1	30	CD	DURATION	30	num	2	SENT_259	[p15l534t1428r563b1449],
2	Days	NNS	DURATION	day	nsubj	3	SENT_259	[p15l573t1428r635b1454],
3	|	VBP	O	|	_	0	SENT_259	[p15l647t1429r988b1449],
4	E	NN	O	e	num	9	SENT_259	[p15l1015t1425r1018b1463],
5	82	CD	NUMBER	82	number	4	SENT_259	[p15l1221t1428r1250b1449],
6	0.39	CD	NUMBER	0.39	number	4	SENT_259	[p15l1408t1428r1460b1448],
7	2.12	CD	NUMBER	2.12	number	4	SENT_259	[p15l1575t1426r1627b1446],
8	|	NN	O	|	nn	9	SENT_259	[p15l929t1458r1134b1493],
9	ji	NN	O	jus	dobj	3	SENT_259	[p15l929t1458r1134b1493],
10	.	.	O	.	_	0	SENT_259	[p15l929t1458r1134b1493],

1	—	NN	O	—	_	0	SENT_260	[p15l929t1458r1134b1493],
2	.	.	O	.	_	0	SENT_260	[p15l929t1458r1134b1493],

1	A	DT	O	a	det	3	SENT_261	[p15l929t1458r1134b1493],
2	-36	CD	NUMBER	-36	num	3	SENT_261	[p15l1212t1456r1250b1476],
3	3.01	CD	NUMBER	3.01	nsubj	7	SENT_261	[p15l1408t1455r1456b1475],
4	2.22	CD	NUMBER	2.22	num	6	SENT_261	[p15l1577t1454r1628b1475],
5	90	CD	DURATION	90	num	6	SENT_261	[p15l534t1512r563b1532],
6	Days	NNS	DURATION	day	dep	3	SENT_261	[p15l573t1511r635b1538],
7	iéozi	VBP	O	iéozi	_	0	SENT_261	[p15l799t1515r982b1533],
8	p	NN	O	p	dobj	7	SENT_261	[p15l1015t1494r1018b1542],
9	*	CD	NUMBER	*	number	10	SENT_261	[p15l1015t1494r1018b1542],
10	59	CD	NUMBER	59	num	12	SENT_261	[p15l1221t1512r1250b1532],
11	2.73	CD	NUMBER	2.73	number	12	SENT_261	[p15l1408t1511r1460b1532],
12	6.41	CD	NUMBER	6.41	dep	8	SENT_261	[p15l1575t1511r1624b1532],
13	I	PRP	O	I	dep	12	SENT_261	[p15l924t1542r1083b1592],
14	.	.	O	.	_	0	SENT_261	[p15l924t1542r1083b1592],

1	—	NN	O	—	_	0	SENT_262	[p15l924t1542r1083b1592],
2	.	.	O	.	_	0	SENT_262	[p15l924t1542r1083b1592],

1	.	.	O	.	_	0	SENT_263	[p15l924t1542r1083b1592],

1	—	NN	O	—	_	0	SENT_264	[p15l924t1542r1083b1592],
2	.	.	O	.	_	0	SENT_264	[p15l924t1542r1083b1592],

1	-	:	O	-	_	0	SENT_265	[p15l924t1542r1083b1592],
2	‘	NN	O	‘	nn	3	SENT_265	[p15l924t1542r1083b1592],
3	T	NN	O	t	_	0	SENT_265	[p15l924t1542r1083b1592],
4	-	:	O	-	_	0	SENT_265	[p15l924t1542r1083b1592],
5	.	.	O	.	_	0	SENT_265	[p15l924t1542r1083b1592],

1	—	NN	O	—	_	0	SENT_266	[p15l924t1542r1083b1592],
2	.	.	O	.	_	0	SENT_266	[p15l924t1542r1083b1592],

1	i	LS	O	i	dep	3	SENT_267	[p15l924t1542r1083b1592],
2	9	CD	NUMBER	9	number	3	SENT_267	[p15l1236t1539r1250b1560],
3	6.88	CD	NUMBER	6.88	num	4	SENT_267	[p15l1408t1538r1460b1559],
4	7.60	CD	NUMBER	7.60	_	0	SENT_267	[p15l1576t1539r1628b1560],
5	180	CD	DURATION	180	num	6	SENT_267	[p15l534t1596r578b1617],
6	Days	NNS	DURATION	day	dep	4	SENT_267	[p15l587t1596r650b1622],
7	I	PRP	O	I	dep	6	SENT_267	[p15l898t1593r1018b1619],
8	.	.	O	.	_	0	SENT_267	[p15l898t1593r1018b1619],

1	—	NN	O	—	_	0	SENT_268	[p15l898t1593r1018b1619],
2	.	.	O	.	_	0	SENT_268	[p15l898t1593r1018b1619],

1	O	NN	O	o	_	0	SENT_269	[p15l898t1593r1018b1619],
2	.	.	O	.	_	0	SENT_269	[p15l898t1593r1018b1619],

1	—	NN	O	—	_	0	SENT_270	[p15l898t1593r1018b1619],
2	.	.	O	.	_	0	SENT_270	[p15l898t1593r1018b1619],

1	Ii	NN	O	ii	_	0	SENT_271	[p15l898t1593r1018b1619],
2	36	CD	NUMBER	36	dep	1	SENT_271	[p15l1221t1596r1250b1617],
3	.	.	O	.	_	0	SENT_271	[p15l1424t1611r1429b1617],

1	6	CD	NUMBER	6	num	2	SENT_272	[p15l1446t1596r1460b1617],
2	12.92	CD	NUMBER	12.92	nsubj	3	SENT_272	[p15l1563t1594r1628b1616],
3	i	LS	O	i	_	0	SENT_272	[p15l953t1612r1075b1651],
4	.	.	O	.	_	0	SENT_272	[p15l953t1612r1075b1651],

1	—	NN	O	—	_	0	SENT_273	[p15l953t1612r1075b1651],
2	.	.	O	.	_	0	SENT_273	[p15l953t1612r1075b1651],

1	J	NN	O	j	_	0	SENT_274	[p15l953t1612r1075b1651],
2	.	.	O	.	_	0	SENT_274	[p15l953t1612r1075b1651],

1	—	NN	O	—	_	0	SENT_275	[p15l953t1612r1075b1651],
2	.	.	O	.	_	0	SENT_275	[p15l953t1612r1075b1651],

1	-4	CD	NUMBER	-4	num	2	SENT_276	[p15l953t1612r1075b1651],
2	2	CD	NUMBER	2	_	0	SENT_276	[p15l1236t1625r1250b1645],
3	.	.	O	.	_	0	SENT_276	[p15l1424t1640r1429b1645],

1	3	CD	NUMBER	3	num	2	SENT_277	[p15l1446t1625r1460b1645],
2	12.47	CD	NUMBER	12.47	_	0	SENT_277	[p15l1563t1623r1628b1643],

1	I	PRP	O	I	_	0	SENT_278	[p15l1015t1652r1018b1670],

1	2	CD	DURATION	2	num	2	SENT_279	[p15l536t1682r550b1702],
2	Years	NNS	DURATION	year	_	0	SENT_279	[p15l557t1681r631b1702],
3	I	PRP	O	I	dep	2	SENT_279	[p15l898t1683r983b1703],
4	.	.	O	.	_	0	SENT_279	[p15l898t1683r983b1703],

1	—	NN	O	—	_	0	SENT_280	[p15l898t1683r983b1703],
2	.	.	O	.	_	0	SENT_280	[p15l898t1683r983b1703],

1	O	NN	O	o	_	0	SENT_281	[p15l898t1683r983b1703],
2	.	.	O	.	_	0	SENT_281	[p15l898t1683r983b1703],

1	—	NN	O	—	_	0	SENT_282	[p15l898t1683r983b1703],
2	.	.	O	.	_	0	SENT_282	[p15l898t1683r983b1703],

1	l	NN	O	l	_	0	SENT_283	[p15l898t1683r983b1703],
2	!	.	O	!	_	0	SENT_283	[p15l1015t1671r1019b1709],

1	41	CD	NUMBER	41	num	2	SENT_284	[p15l1221t1685r1247b1706],
2	15_os	NNS	O	15_os	_	0	SENT_284	[p15l1395t1685r1460b1706],
3	25.03	CD	NUMBER	25.03	num	4	SENT_284	[p15l1562t1680r1628b1702],
4	|	NN	O	|	dep	2	SENT_284	[p15l970t1710r1062b1759],
5	.	.	O	.	_	0	SENT_284	[p15l970t1710r1062b1759],

1	—	NN	O	—	_	0	SENT_285	[p15l970t1710r1062b1759],
2	.	.	O	.	_	0	SENT_285	[p15l970t1710r1062b1759],

1	T	NN	O	t	_	0	SENT_286	[p15l970t1710r1062b1759],
2	.	.	O	.	_	0	SENT_286	[p15l970t1710r1062b1759],

1	—	NN	O	—	_	0	SENT_287	[p15l970t1710r1062b1759],
2	.	.	O	.	_	0	SENT_287	[p15l970t1710r1062b1759],

1	i	LS	O	i	dep	2	SENT_288	[p15l970t1710r1062b1759],
2	1	CD	NUMBER	1	dep	13	SENT_288	[p15l1237t1709r1247b1729],
3	23.88	CD	NUMBER	23.88	number	4	SENT_288	[p15l1394t1709r1460b1730],
4	24.72	CD	NUMBER	24.72	num	8	SENT_288	[p15l1562t1708r1628b1729],
5	End	NN	O	end	nn	8	SENT_288	[p15l535t1764r583b1786],
6	ol	NN	O	ol	nn	8	SENT_288	[p15l592t1765r617b1786],
7	follow-up	NN	O	follow-up	nn	8	SENT_288	[p15l625t1764r744b1792],
8	n	NN	O	n	dep	2	SENT_288	[p15l903t1769r983b1787],
9	—	CD	NUMBER	—	dep	8	SENT_288	[p15l903t1769r983b1787],
10	o	NN	O	o	dep	13	SENT_288	[p15l903t1769r983b1787],
11	—	CD	NUMBER	—	num	10	SENT_288	[p15l903t1769r983b1787],
12	i	FW	O	i	nn	13	SENT_288	[p15l903t1769r983b1787],
13	i	FW	O	i	dep	17	SENT_288	[p15l1015t1760r1019b1789],
14	41	CD	NUMBER	41	number	15	SENT_288	[p15l1221t1768r1247b1789],
15	20.46	CD	NUMBER	20.46	dep	13	SENT_288	[p15l1394t1768r1460b1789],
16	30.16	CD	NUMBER	30.16	dep	15	SENT_288	[p15l1562t1764r1628b1786],
17	¢	NN	O	¢	dep	20	SENT_288	[p15l970t1790r1057b1838],
18	3	CD	NUMBER	3	num	17	SENT_288	[p15l1236t1793r1251b1814],
19	24.97	CD	NUMBER	24.97	num	20	SENT_288	[p15l1394t1794r1460b1814],
20	27.29	CD	NUMBER	27.29	_	0	SENT_288	[p15l1563t1793r1630b1813],

1	High-Dose	JJ	MISC	high-dose	amod	6	SENT_289	[p15l776t1883r915b1909],
2	Standard-Dose	NNP	MISC	Standard-Dose	nn	6	SENT_289	[p15l1072t1883r1253b1903],
3	Atorvastatin	NNP	MISC	Atorvastatin	nn	6	SENT_289	[p15l718t1916r880b1936],
4	Better	NNP	MISC	Better	nn	6	SENT_289	[p15l891t1916r970b1936],
5	Pravastatln	NNP	MISC	Pravastatln	nn	6	SENT_289	[p15l1055t1916r1190b1936],
6	Better	NNP	MISC	Better	_	0	SENT_289	[p15l1199t1916r1272b1936],

1	o	NN	O	o	nn	3	SENT_290	[p15l504t1974r529b1998],
2	719Arg	NN	O	719arg	nn	3	SENT_290	[p15l540t1976r631b2002],
3	carriers	NNS	O	carrier	_	0	SENT_290	[p15l639t1976r737b1997],
4	A	DT	O	a	det	5	SENT_290	[p15l503t2009r529b2029],
5	Noncarriers	NNS	O	noncarrier	dep	3	SENT_290	[p15l539t2008r688b2029],

1	Time	NNP	O	Time	nsubj	3	SENT_291	[p15l241t2096r312b2120],
2	to	TO	O	to	aux	3	SENT_291	[p15l324t2097r354b2120],
3	Benefit	VB	O	benefit	_	0	SENT_291	[p15l368t2096r473b2120],
4	According	VBG	O	accord	_	0	SENT_291	[p15l484t2096r635b2126],
5	to	TO	O	to	prepc_according_to	3	SENT_291	[p15l645t2097r675b2120],
6	KlF6	NN	O	klf6	nn	11	SENT_291	[p15l689t2096r759b2120],
7	719Arg	NN	O	719arg	nn	11	SENT_291	[p15l770t2096r879b2126],
8	carrier	NN	O	carrier	nn	11	SENT_291	[p15l891t2096r991b2120],
9	status	NN	O	status	nn	11	SENT_291	[p15l1002t2096r1099b2120],
10	Hazard	NN	O	hazard	nn	11	SENT_291	[p15l69t2180r148b2199],
11	ratio	NN	O	ratio	pobj	3	SENT_291	[p15l160t2180r210b2199],
12	for	IN	O	for	_	0	SENT_291	[p15l220t2180r252b2199],
13	death	NN	O	death	prep_for	11	SENT_291	[p15l261t2180r326b2199],
14	or	CC	O	or	_	0	SENT_291	[p15l338t2185r360b2199],
15	major	JJ	O	major	amod	17	SENT_291	[p15l371t2180r435b2204],
16	cardiovascular	JJ	O	cardiovascular	amod	17	SENT_291	[p15l445t2180r615b2199],
17	events	NNS	O	event	conj_or	11	SENT_291	[p15l624t2181r701b2199],
18	at	IN	O	at	_	0	SENT_291	[p15l712t2181r734b2199],
19	30	CD	NUMBER	30	prep_at	17	SENT_291	[p15l744t2180r782b2203],
20	,	,	O	,	_	0	SENT_291	[p15l744t2180r782b2203],
21	90	CD	NUMBER	90	conj_and	19	SENT_291	[p15l794t2180r831b2203],
22	,	,	O	,	_	0	SENT_291	[p15l794t2180r831b2203],
23	and	CC	DURATION	and	_	0	SENT_291	[p15l844t2180r885b2199],
24	180	CD	DURATION	180	num	25	SENT_291	[p15l897t2180r943b2199],
25	days	NNS	NUMBER	day	conj_and	19	SENT_291	[p15l954t2180r1014b2204],
26	,	,	O	,	_	0	SENT_291	[p15l954t2180r1014b2204],
27	2	CD	DURATION	2	num	28	SENT_291	[p15l1026t2180r1040b2199],
28	years	NNS	NUMBER	year	appos	25	SENT_291	[p15l1050t2185r1120b2204],
29	,	,	O	,	_	0	SENT_291	[p15l1050t2185r1120b2204],
30	and	CC	O	and	_	0	SENT_291	[p15l1132t2180r1173b2199],
31	at	IN	O	at	_	0	SENT_291	[p15l1185t2181r1207b2199],
32	the	DT	O	the	det	33	SENT_291	[p15l1216t2180r1253b2199],
33	end	NN	O	end	prep_at	17	SENT_291	[p15l1264t2180r1305b2199],
34	of	IN	O	of	_	0	SENT_291	[p15l1317t2180r1340b2199],
35	follow-up	NN	O	follow-up	prep_of	33	SENT_291	[p15l1348t2180r1457b2204],
36	.	.	O	.	_	0	SENT_291	[p15l1348t2180r1457b2204],

1	High-dose	JJ	O	high-dose	amod	3	SENT_292	[p15l1470t2180r1584b2204],
2	atorvastatin	NN	O	atorvastatin	nn	3	SENT_292	[p15l1595t2180r1732b2199],
3	therapy	NN	O	therapy	nsubjpass	5	SENT_292	[p15l1743t2180r1831b2204],
4	was	VBD	O	be	auxpass	5	SENT_292	[p15l1839t2185r1885b2199],
5	compared	VBN	O	compare	_	0	SENT_292	[p15l1896t2180r2010b2204],
6	with	IN	O	with	_	0	SENT_292	[p15l2021t2180r2067b2199],
7	standard-dose	JJ	O	standard-dose	amod	9	SENT_292	[p15l68t2218r235b2237],
8	pravastatin	NN	O	pravastatin	nn	9	SENT_292	[p15l247t2218r375b2241],
9	therapy	NN	O	therapy	prep_with	5	SENT_292	[p15l385t2218r473b2242],
10	according	VBG	O	accord	_	0	SENT_292	[p15l483t2218r595b2242],
11	to	TO	O	to	prepc_according_to	5	SENT_292	[p15l604t2219r626b2237],
12	KIF6	NN	O	kif6	nn	15	SENT_292	[p15l638t2217r691b2237],
13	719Arg	NN	O	719arg	nn	15	SENT_292	[p15l700t2217r785b2242],
14	carrier	NN	O	carrier	nn	15	SENT_292	[p15l794t2218r868b2237],
15	status	NN	O	status	pobj	5	SENT_292	[p15l878t2219r958b2237],
16	.	.	O	.	_	0	SENT_292	[p15l878t2219r958b2237],

1	The	DT	O	the	det	3	SENT_293	[p15l969t2218r1011b2237],
2	cumulative	JJ	O	cumulative	amod	3	SENT_293	[p15l1022t2218r1147b2237],
3	incidence	NN	O	incidence	nsubjpass	11	SENT_293	[p15l1159t2218r1268b2237],
4	of	IN	O	of	_	0	SENT_293	[p15l1279t2217r1302b2237],
5	death	NN	O	death	nn	9	SENT_293	[p15l1311t2218r1376b2237],
6	or	CC	O	or	_	0	SENT_293	[p15l1387t2222r1410b2237],
7	major	JJ	O	major	nn	9	SENT_293	[p15l1420t2218r1485b2242],
8	cardiovascular	JJ	O	cardiovascular	amod	9	SENT_293	[p15l1495t2218r1664b2237],
9	events	NNS	O	event	prep_of	3	SENT_293	[p15l1674t2219r1750b2237],
10	was	VBD	O	be	auxpass	11	SENT_293	[p15l1761t2222r1806b2237],
11	estimated	VBN	O	estimate	_	0	SENT_293	[p15l1817t2218r1933b2237],
12	by	IN	O	by	_	0	SENT_293	[p15l1945t2218r1970b2242],
13	the	DT	O	the	det	15	SENT_293	[p15l1979t2218r2016b2237],
14	Kaplan-Meier	NN	O	kaplan-meier	nn	15	SENT_293	[p15l69t2255r222b2279],
15	method	NN	O	method	agent	11	SENT_293	[p15l232t2255r326b2274],
16	.	.	O	.	_	0	SENT_293	[p15l232t2255r326b2274],

1	CI	NN	O	ci	_	0	SENT_294	[p15l338t2255r359b2274],
2	=	JJ	O	=	amod	4	SENT_294	[p15l373t2262r390b2269],
3	confidence	NN	O	confidence	nn	4	SENT_294	[p15l402t2255r528b2274],
4	interval	NN	O	interval	dep	1	SENT_294	[p15l540t2255r630b2274],
5	.	.	O	.	_	0	SENT_294	[p15l540t2255r630b2274],

1	about	IN	O	about	_	0	SENT_295	[p15l12t2468r210b2534],
2	6,000	CD	NUMBER	6,000	num	3	SENT_295	[p15l260t2471r455b2549],
3	patients	NNS	O	patient	prep_about	5	SENT_295	[p15l506t2466r812b2557],
4	)	RB	O	)	advmod	5	SENT_295	[p15l506t2466r812b2557],
5	showed	VBD	O	show	_	0	SENT_295	[p15l867t2468r1133b2534],
6	that	IN	O	that	complm	13	SENT_295	[p15l1183t2468r1324b2534],
7	carriers	NNS	O	carrier	nsubj	13	SENT_295	[p15l1374t2471r1627b2534],
8	of	IN	O	of	_	0	SENT_295	[p15l1680t2468r1761b2534],
9	the	DT	O	the	det	12	SENT_295	[p15l1799t2468r1910b2534],
10	KIF6	NN	O	kif6	nn	12	SENT_295	[p15l1959t2471r2151b2534],
11	719Arg	NN	O	719arg	nn	12	SENT_295	[p15l12t2572r283b2663],
12	allele	NN	O	allele	prep_of	7	SENT_295	[p15l318t2574r495b2640],
13	receive	VBP	O	receive	ccomp	5	SENT_295	[p15l531t2577r770b2640],
14	significant	JJ	O	significant	amod	16	SENT_295	[p15l808t2574r1175b2663],
15	clinical	JJ	O	clinical	amod	16	SENT_295	[p15l1209t2574r1458b2640],
16	beneﬁt	NN	O	beneﬁt	dobj	13	SENT_295	[p15l1490t2574r1736b2640],
17	from	IN	O	from	_	0	SENT_295	[p15l1769t2574r1940b2640],
18	ator	NN	O	ator	nn	20	SENT_295	[p15l1978t2591r2147b2640],
19	—	NN	O	—	nn	20	SENT_295	[p15l1978t2591r2147b2640],
20	vastatin	NN	O	vastatin	prep_from	13	SENT_295	[p15l7t2683r282b2746],
21	(	CD	NUMBER	(	number	22	SENT_295	[p15l324t2678r435b2760],
22	80	CD	NUMBER	80	num	24	SENT_295	[p15l324t2678r435b2760],
23	mg	NN	O	mg	nn	24	SENT_295	[p15l476t2678r613b2769],
24	)	NN	O	)	nsubj	5	SENT_295	[p15l476t2678r613b2769],
25	compared	VBN	O	compare	prep	24	SENT_295	[p15l656t2680r1005b2769],
26	with	IN	O	with	pcomp	25	SENT_295	[p15l1039t2680r1201b2746],
27	pravastatin	NN	O	pravastatin	pobj	26	SENT_295	[p15l1239t2683r1626b2769],
28	(	CD	NUMBER	(	number	29	SENT_295	[p15l1668t2678r1779b2760],
29	40	CD	NUMBER	40	num	31	SENT_295	[p15l1668t2678r1779b2760],
30	mg	NN	O	mg	nn	31	SENT_295	[p15l1820t2678r1980b2769],
31	)	NN	O	)	dep	27	SENT_295	[p15l1820t2678r1980b2769],
32	,	,	O	,	_	0	SENT_295	[p15l1820t2678r1980b2769],
33	and	CC	O	and	_	0	SENT_295	[p15l2023t2680r2151b2746],
34	from	IN	O	from	_	0	SENT_295	[p15l10t2786r181b2852],
35	pravastatin	NN	O	pravastatin	prep_from	39	SENT_295	[p15l242t2789r629b2875],
36	(	CD	NUMBER	(	num	35	SENT_295	[p15l693t2784r804b2866],
37	40	CD	NUMBER	40	num	39	SENT_295	[p15l693t2784r804b2866],
38	mg	NN	O	mg	nn	39	SENT_295	[p15l867t2784r1004b2875],
39	)	NN	O	)	pobj	26	SENT_295	[p15l867t2784r1004b2875],
40	compared	VBN	O	compare	_	0	SENT_295	[p15l1070t2786r1419b2875],
41	with	IN	O	with	prepc_compared_with	39	SENT_295	[p15l1476t2786r1638b2852],
42	placebo	NN	O	placebo	pobj	39	SENT_295	[p15l1698t2786r1965b2875],
43	(	CD	NUMBER	(	number	44	SENT_295	[p15l2031t2784r2148b2867],
44	8	CD	NUMBER	8	num	45	SENT_295	[p15l2031t2784r2148b2867],
45	)	NN	O	)	dep	42	SENT_295	[p15l2031t2784r2148b2867],
46	,	,	O	,	_	0	SENT_295	[p15l2031t2784r2148b2867],

1	study	NN	O	study	_	0	SENT_296	[p16l169t182r336b240],
2	No.	NN	O	no.	dep	1	SENT_296	[p16l587t182r677b228],
3	of	IN	O	of	prep	2	SENT_296	[p16l696t182r754b228],
4	Patients	NNS	O	patient	dep	3	SENT_296	[p16l773t182r1005b228],
5	ﬁt	NN	O	ﬁt	dep	4	SENT_296	[p16l1024t182r1114b240],
6	.	.	O	.	_	0	SENT_296	[p16l1024t182r1114b240],
7	)	SYM	O	)	dep	2	SENT_296	[p16l1024t182r1114b240],

1	Adjusted	VBN	O	adjust	_	0	SENT_297	[p16l1274t182r1529b240],
2	Risk	NN	O	risk	nn	3	SENT_297	[p16l1551t182r1676b228],
3	Ratio	NN	O	ratio	dobj	1	SENT_297	[p16l1695t182r1844b228],
4	(	CD	PERCENT	(	num	6	SENT_297	[p16l1862t182r2001b240],
5	95	CD	PERCENT	95	num	6	SENT_297	[p16l1862t182r2001b240],
6	%	NN	PERCENT	%	tmod	1	SENT_297	[p16l1862t182r2001b240],
7	CI	NN	O	ci	nn	8	SENT_297	[p16l2020t182r2098b240],
8	)	NN	O	)	dep	6	SENT_297	[p16l2020t182r2098b240],

1	Pravastaﬁn	NNP	O	Pravastaﬁn	nsubj	11	SENT_298	[p16l63t269r356b317],
2	versus	CC	O	versus	prep	1	SENT_298	[p16l377t279r554b317],
3	placebo	NN	O	placebo	nn	4	SENT_298	[p16l574t269r780b327],
4	woscops	NNS	O	woscop	dep	2	SENT_298	[p16l169t391r484b440],
5	are	VBP	O	be	cop	11	SENT_298	[p16l638t391r738b437],
6	(	CD	NUMBER	(	number	7	SENT_298	[p16l754t388r860b449],
7	57	CD	NUMBER	57	num	11	SENT_298	[p16l754t388r860b449],
8	)	NN	O	)	nn	11	SENT_298	[p16l754t388r860b449],
9	n	NN	O	n	nn	11	SENT_298	[p16l1114t388r1509b439],
10	*	CD	NUMBER	*	num	11	SENT_298	[p16l1114t388r1509b439],
11	n	NN	O	n	_	0	SENT_298	[p16l1750t388r1757b455],
12	*	CD	NUMBER	*	dep	11	SENT_298	[p16l1750t388r1757b455],

1	654143	CD	NUMBER	654143	_	0	SENT_299	[p16l638t532r860b591],
2	)	CD	NUMBER	)	num	3	SENT_299	[p16l638t532r860b591],
3	n	NN	O	n	dep	1	SENT_299	[p16l1499t497r1898b594],
4	*	CD	NUMBER	*	dep	1	SENT_299	[p16l1499t497r1898b594],

1	CARE	NNP	O	CARE	nn	2	SENT_300	[p16l169t845r336b893],
2	1E01	NN	O	1e01	nsubj	6	SENT_300	[p16l606t835r860b896],
3	(	CD	NUMBER	(	num	4	SENT_300	[p16l606t835r860b896],
4	59l	NN	O	59l	dep	2	SENT_300	[p16l606t835r860b896],
5	I	PRP	O	I	dep	2	SENT_300	[p16l1255t842r1670b893],
6	—	VBP	O	—	_	0	SENT_300	[p16l1255t842r1670b893],
7	o	NN	O	o	dobj	6	SENT_300	[p16l1255t842r1670b893],
8	—	CD	NUMBER	—	num	9	SENT_300	[p16l1255t842r1670b893],
9	l	NN	O	l	tmod	7	SENT_300	[p16l1255t842r1670b893],
10	`	``	O	`	_	0	SENT_300	[p16l1750t816r1757b909],
11	)	NN	O	)	tmod	6	SENT_300	[p16l1750t816r1757b909],
12	n	NN	O	n	dep	11	SENT_300	[p16l1750t816r1757b909],
13	*	CD	NUMBER	*	num	12	SENT_300	[p16l1750t816r1757b909],

1	1l	NN	O	1l	nn	2	SENT_301	[p16l606t986r628b1031],
2	use	NN	O	use	_	0	SENT_301	[p16l638t986r738b1031],
3	(	CD	NUMBER	(	number	4	SENT_301	[p16l754t986r860b1044],
4	41	CD	NUMBER	41	num	5	SENT_301	[p16l754t986r860b1044],
5	)	CD	NUMBER	)	dep	2	SENT_301	[p16l754t986r860b1044],
6	`	``	O	`	_	0	SENT_301	[p16l1383t950r1885b1047],
7	(	NN	O	(	nn	8	SENT_301	[p16l1383t950r1885b1047],
8	n	NN	O	n	dep	5	SENT_301	[p16l1383t950r1885b1047],
9	*	CD	NUMBER	*	dep	8	SENT_301	[p16l1383t950r1885b1047],

1	Atorvastatin	NNP	O	Atorvastatin	nsubj	8	SENT_302	[p16l59t1169r375b1218],
2	versus	CC	O	versus	prep	1	SENT_302	[p16l394t1182r571b1218],
3	pravastatin	NN	O	pravastatin	dep	4	SENT_302	[p16l590t1169r882b1227],
4	>	JJR	O	>	dep	2	SENT_302	[p16l1753t1137r1757b1245],
5	)	CD	NUMBER	)	num	6	SENT_302	[p16l1753t1137r1757b1245],
6	n	NN	O	n	dep	4	SENT_302	[p16l1753t1137r1757b1245],
7	*	CD	NUMBER	*	dep	6	SENT_302	[p16l1753t1137r1757b1245],
8	PROVE	VBP	O	prove	_	0	SENT_302	[p16l169t1291r375b1340],
9	IT	PRP	O	it	nsubj	12	SENT_302	[p16l397t1294r449b1340],
10	104359	CD	NUMBER	104359	num	12	SENT_302	[p16l606t1288r860b1346],
11	)	CD	NUMBER	)	num	12	SENT_302	[p16l606t1288r860b1346],
12	l	NN	O	l	xcomp	8	SENT_302	[p16l1304t1295r1615b1346],
13	l	NN	O	l	prep	12	SENT_302	[p16l1304t1295r1615b1346],
14	o	NN	O	o	nn	15	SENT_302	[p16l1750t1272r1757b1365],
15	n	NN	O	n	dep	13	SENT_302	[p16l1750t1272r1757b1365],
16	*	CD	NUMBER	*	num	15	SENT_302	[p16l1750t1272r1757b1365],

1	730	CD	PERCENT	730	number	2	SENT_303	[p16l638t1439r738b1487],
2	(	CD	PERCENT	(	_	0	SENT_303	[p16l754t1439r860b1497],
3	41	CD	PERCENT	41	num	5	SENT_303	[p16l754t1439r860b1497],
4	)	CD	PERCENT	)	num	5	SENT_303	[p16l754t1439r860b1497],
5	%	NN	PERCENT	%	dep	2	SENT_303	[p16l1551t1404r1892b1500],
6	n	NN	O	n	dep	2	SENT_303	[p16l1551t1404r1892b1500],
7	*	CD	NUMBER	*	num	6	SENT_303	[p16l1551t1404r1892b1500],

1	I	PRP	O	I	_	0	SENT_304	[p16l146t1545r194b1591],
2	?	.	O	?	_	0	SENT_304	[p16l223t1545r426b1606],

1	19Arg	NN	O	19arg	nn	2	SENT_305	[p16l223t1545r426b1606],
2	carriers	NNS	O	carrier	nsubj	4	SENT_305	[p16l445t1545r667b1594],
3	I	PRP	O	I	nsubj	4	SENT_305	[p16l853t1542r892b1605],
4	_	VBP	O	_	_	0	SENT_305	[p16l853t1542r892b1605],
5	I	PRP	O	I	nsubj	9	SENT_305	[p16l1239t1542r1249b1600],
6	II	CD	NUMBER	ii	num	7	SENT_305	[p16l1464t1542r1474b1600],
7	l	NN	O	l	tmod	9	SENT_305	[p16l1599t1542r1635b1605],
8	I	PRP	O	I	nsubj	9	SENT_305	[p16l1753t1539r1760b1600],
9	I1	VBP	O	i1	ccomp	4	SENT_305	[p16l1940t1542r1949b1600],
10	_	CD	NUMBER	_	num	12	SENT_305	[p16l363t1658r365b1660],
11	0.2	CD	NUMBER	0.2	num	12	SENT_305	[p16l815t1603r902b1651],
12	ﬂI	NN	O	ﬂi	dobj	9	SENT_305	[p16l1204t1603r1287b1651],
13	.	.	O	.	_	0	SENT_305	[p16l1204t1603r1287b1651],

1	.4	NN	NUMBER	.4	_	0	SENT_306	[p16l1204t1603r1287b1651],
2	0.6	CD	NUMBER	0.6	num	3	SENT_306	[p16l1429t1603r1512b1651],
3	0.8	CD	NUMBER	0.8	dep	1	SENT_306	[p16l1589t1603r1670b1651],
4	1.0	CD	NUMBER	1.0	number	5	SENT_306	[p16l1718t1603r1799b1651],
5	1.4	CD	NUMBER	1.4	dep	3	SENT_306	[p16l1907t1603r1985b1648],

1	A	DT	O	a	det	2	SENT_307	[p16l140t1638r201b1693],
2	Nam	NNP	O	Nam	_	0	SENT_307	[p16l220t1645r555b1693],
3	:	:	O	:	_	0	SENT_307	[p16l220t1645r555b1693],
4	-	:	O	-	_	0	SENT_307	[p16l220t1645r555b1693],
5	arriers	NNS	O	arrier	dep	2	SENT_307	[p16l220t1645r555b1693],

1	Effect	NN	O	effect	_	0	SENT_308	[p16l438t1825r621b1876],
2	of	IN	O	of	_	0	SENT_308	[p16l648t1825r708b1876],
3	Statin	NN	O	statin	nn	4	SENT_308	[p16l731t1825r920b1877],
4	Therapy	NN	O	therapy	prep_of	1	SENT_308	[p16l948t1826r1198b1888],
5	According	VBG	O	accord	_	0	SENT_308	[p16l434t1905r756b1969],
6	to	TO	O	to	prepc_according_to	1	SENT_308	[p16l779t1908r844b1957],
7	KIF6	NN	O	kif6	nn	8	SENT_308	[p16l874t1906r1022b1957],
8	Trp719Arg	NN	O	trp719arg	pobj	1	SENT_308	[p16l1042t1906r1382b1969],
9	in	IN	O	in	_	0	SENT_308	[p16l1408t1905r1459b1956],
10	3	CD	NUMBER	3	num	11	SENT_308	[p16l1487t1905r1526b1957],
11	Studies	NNS	O	study	prep_in	8	SENT_308	[p16l1553t1905r1791b1957],

1	Effect	NN	O	effect	_	0	SENT_309	[p16l67t2067r207b2108],
2	of	IN	O	of	_	0	SENT_309	[p16l229t2067r277b2108],
3	statin	NN	O	statin	nn	4	SENT_309	[p16l297t2067r435b2108],
4	therapy	NN	O	therapy	prep_of	1	SENT_309	[p16l457t2067r645b2119],
5	on	IN	O	on	_	0	SENT_309	[p16l666t2077r723b2108],
6	fatal	JJ	O	fatal	amod	9	SENT_309	[p16l746t2067r854b2108],
7	coronary	JJ	O	coronary	amod	9	SENT_309	[p16l879t2077r1093b2119],
8	heart	NN	O	heart	nn	9	SENT_309	[p16l1116t2067r1243b2108],
9	disease	NN	O	disease	prep_on	1	SENT_309	[p16l1264t2067r1459b2109],
10	or	CC	O	or	_	0	SENT_309	[p16l1483t2077r1532b2108],
11	nonfatal	JJ	O	nonfatal	amod	13	SENT_309	[p16l1554t2067r1753b2109],
12	myocardial	JJ	O	myocardial	amod	13	SENT_309	[p16l1780t2067r2044b2119],
13	infarction	NN	O	infarction	prep_on	1	SENT_309	[p16l66t2147r294b2189],
14	in	IN	O	in	_	0	SENT_309	[p16l321t2148r359b2188],
15	the	DT	O	the	det	17	SENT_309	[p16l382t2148r460b2189],
16	CARE	NNP	O	CARE	nn	17	SENT_309	[p16l484t2147r618b2189],
17	trial	NN	O	trial	prep_in	13	SENT_309	[p16l638t2148r748b2196],
18	,	,	O	,	_	0	SENT_309	[p16l638t2148r748b2196],
19	coronary	JJ	O	coronary	amod	21	SENT_309	[p16l773t2157r986b2199],
20	heart	NN	O	heart	nn	21	SENT_309	[p16l1009t2148r1137b2189],
21	disease	NN	O	disease	conj_or	9	SENT_309	[p16l1158t2148r1353b2189],
22	in	IN	O	in	_	0	SENT_309	[p16l1379t2148r1416b2188],
23	the	DT	O	the	det	25	SENT_309	[p16l1439t2148r1518b2189],
24	WOSCOPS	JJ	O	woscops	amod	25	SENT_309	[p16l1541t2147r1802b2189],
25	trial	NN	O	trial	prep_in	21	SENT_309	[p16l1824t2148r1933b2196],
26	,	,	O	,	_	0	SENT_309	[p16l1824t2148r1933b2196],
27	and	CC	O	and	_	0	SENT_309	[p16l1960t2148r2047b2189],
28	death	NN	O	death	prep_on	1	SENT_309	[p16l64t2228r202b2269],
29	or	CC	O	or	_	0	SENT_309	[p16l227t2238r276b2269],
30	major	JJ	O	major	amod	32	SENT_309	[p16l298t2228r437b2279],
31	cardiovascular	JJ	O	cardiovascular	amod	32	SENT_309	[p16l457t2228r820b2269],
32	events	NNS	O	event	conj_or	28	SENT_309	[p16l841t2231r1005b2269],
33	in	IN	O	in	_	0	SENT_309	[p16l1031t2228r1068b2269],
34	the	DT	O	the	det	38	SENT_309	[p16l1091t2228r1170b2269],
35	PROVE	NNP	O	PROVE	nn	38	SENT_309	[p16l1195t2228r1362b2269],
36	IT-TIMI	NN	O	it-timus	nn	38	SENT_309	[p16l1388t2228r1542b2269],
37	22	CD	NUMBER	22	num	38	SENT_309	[p16l1569t2228r1633b2269],
38	trial	NN	O	trial	prep_in	1	SENT_309	[p16l1655t2228r1747b2269],
39	according	VBG	O	accord	_	0	SENT_309	[p16l1774t2228r2013b2280],
40	to	TO	O	to	prepc_according_to	38	SENT_309	[p16l2032t2231r2080b2269],
41	KIF6	NN	O	kif6	nn	44	SENT_309	[p16l67t2308r179b2350],
42	719Arg	NN	O	719arg	nn	44	SENT_309	[p16l199t2308r380b2360],
43	carrier	NN	O	carrier	nn	44	SENT_309	[p16l401t2308r560b2350],
44	status	NN	O	status	pobj	38	SENT_309	[p16l581t2311r751b2350],
45	.	.	O	.	_	0	SENT_309	[p16l581t2311r751b2350],

1	In	IN	O	in	_	0	SENT_310	[p16l780t2308r818b2349],
2	both	CC	O	both	dep	5	SENT_310	[p16l844t2308r950b2350],
3	the	DT	O	the	det	5	SENT_310	[p16l973t2308r1052b2350],
4	CARE	NNP	O	CARE	nn	5	SENT_310	[p16l1076t2308r1209b2350],
5	trial	NN	O	trial	prep_in	33	SENT_310	[p16l1229t2308r1339b2357],
6	,	,	O	,	_	0	SENT_310	[p16l1229t2308r1339b2357],
7	a	DT	O	a	det	10	SENT_310	[p16l1366t2318r1392b2350],
8	secondary	JJ	O	secondary	amod	10	SENT_310	[p16l1416t2308r1671b2360],
9	prevention	NN	O	prevention	nn	10	SENT_310	[p16l1694t2308r1952b2359],
10	study	NN	O	study	conj_and	5	SENT_310	[p16l64t2389r211b2440],
11	,	,	O	,	_	0	SENT_310	[p16l64t2389r211b2440],
12	and	CC	O	and	_	0	SENT_310	[p16l237t2389r325b2430],
13	the	DT	O	the	det	15	SENT_310	[p16l348t2389r427b2430],
14	WOSCOPS	JJ	O	woscops	amod	15	SENT_310	[p16l449t2388r711b2430],
15	trial	NN	O	trial	conj_and	5	SENT_310	[p16l732t2389r842b2437],
16	,	,	O	,	_	0	SENT_310	[p16l732t2389r842b2437],
17	a	DT	O	a	det	20	SENT_310	[p16l868t2398r894b2430],
18	primary	JJ	O	primary	amod	20	SENT_310	[p16l920t2389r1102b2440],
19	prevention	NN	O	prevention	nn	20	SENT_310	[p16l1125t2389r1382b2439],
20	study	NN	O	study	nsubjpass	33	SENT_310	[p16l1407t2389r1553b2440],
21	,	,	O	,	_	0	SENT_310	[p16l1407t2389r1553b2440],
22	the	DT	O	the	det	23	SENT_310	[p16l1577t2389r1656b2430],
23	effect	NN	O	effect	appos	20	SENT_310	[p16l1680t2388r1822b2430],
24	of	IN	O	of	_	0	SENT_310	[p16l1843t2388r1892b2430],
25	prava	NN	O	prava	nn	27	SENT_310	[p16l1914t2398r2060b2439],
26	—	CD	NUMBER	—	num	27	SENT_310	[p16l1914t2398r2060b2439],
27	statin	NN	O	statin	prep_of	23	SENT_310	[p16l64t2469r202b2510],
28	(	CD	NUMBER	(	num	27	SENT_310	[p16l228t2469r310b2520],
29	40	CD	NUMBER	40	num	31	SENT_310	[p16l228t2469r310b2520],
30	mg	NN	O	mg	nn	31	SENT_310	[p16l335t2469r423b2521],
31	)	NN	O	)	dep	23	SENT_310	[p16l335t2469r423b2521],
32	was	VBD	O	be	auxpass	33	SENT_310	[p16l445t2479r543b2510],
33	compared	VBN	O	compare	_	0	SENT_310	[p16l566t2469r811b2519],
34	with	IN	O	with	_	0	SENT_310	[p16l834t2469r933b2510],
35	placebo	NN	O	placebo	prep_with	33	SENT_310	[p16l959t2469r1166b2519],
36	.	.	O	.	_	0	SENT_310	[p16l959t2469r1166b2519],

1	In	IN	O	in	_	0	SENT_311	[p16l1195t2469r1233b2510],
2	the	DT	O	the	det	6	SENT_311	[p16l1256t2469r1336b2510],
3	PROVE	NNP	O	PROVE	nn	6	SENT_311	[p16l1360t2469r1527b2510],
4	IT-TIMI	NN	O	it-timus	nn	6	SENT_311	[p16l1553t2469r1707b2510],
5	22	CD	NUMBER	22	num	6	SENT_311	[p16l1734t2469r1798b2510],
6	trial	NN	O	trial	prep_in	22	SENT_311	[p16l1820t2469r1929b2517],
7	,	,	O	,	_	0	SENT_311	[p16l1820t2469r1929b2517],
8	a	DT	O	a	det	11	SENT_311	[p16l1956t2479r1982b2510],
9	secondary	JJ	O	secondary	amod	11	SENT_311	[p16l65t2549r320b2600],
10	prevention	NN	O	prevention	nn	11	SENT_311	[p16l343t2549r600b2600],
11	study	NN	O	study	nsubjpass	22	SENT_311	[p16l625t2549r771b2600],
12	,	,	O	,	_	0	SENT_311	[p16l625t2549r771b2600],
13	the	DT	O	the	det	14	SENT_311	[p16l795t2549r874b2590],
14	effect	NN	O	effect	appos	11	SENT_311	[p16l898t2549r1040b2590],
15	of	IN	O	of	_	0	SENT_311	[p16l1061t2549r1110b2590],
16	atorvastatin	NN	O	atorvastatin	prep_of	14	SENT_311	[p16l1130t2549r1424b2590],
17	(	CD	NUMBER	(	number	18	SENT_311	[p16l1450t2549r1532b2600],
18	80	CD	NUMBER	80	num	20	SENT_311	[p16l1450t2549r1532b2600],
19	mg	NN	O	mg	nn	20	SENT_311	[p16l1557t2549r1645b2601],
20	)	NN	O	)	dep	14	SENT_311	[p16l1557t2549r1645b2601],
21	was	VBD	O	be	auxpass	22	SENT_311	[p16l1667t2559r1764b2590],
22	compared	VBN	O	compare	_	0	SENT_311	[p16l1788t2549r2033b2600],
23	with	IN	O	with	_	0	SENT_311	[p16l62t2630r160b2671],
24	pravastatin	NN	O	pravastatin	prep_with	22	SENT_311	[p16l188t2630r462b2680],
25	(	CD	NUMBER	(	number	26	SENT_311	[p16l487t2629r570b2680],
26	40	CD	NUMBER	40	num	28	SENT_311	[p16l487t2629r570b2680],
27	mg	NN	O	mg	nn	28	SENT_311	[p16l595t2630r698b2681],
28	)	NN	O	)	dep	22	SENT_311	[p16l595t2630r698b2681],
29	.	.	O	.	_	0	SENT_311	[p16l595t2630r698b2681],

1	We	PRP	O	we	nsubj	2	SENT_312	[p16l723t2630r798b2671],
2	used	VBD	O	use	_	0	SENT_312	[p16l824t2630r941b2671],
3	Cox	NN	O	cox	prep	2	SENT_312	[p16l966t2629r1056b2671],
4	proportional	JJ	O	proportional	amod	6	SENT_312	[p16l1080t2630r1374b2680],
5	hazards	NNS	O	hazard	nn	6	SENT_312	[p16l1402t2630r1594b2671],
6	models	NNS	O	model	dep	3	SENT_312	[p16l1619t2630r1799b2671],
7	in	IN	O	in	_	0	SENT_312	[p16l1825t2630r1863b2670],
8	the	DT	O	the	det	9	SENT_312	[p16l1885t2630r1964b2671],
9	CARE	NNP	O	CARE	prep_in	2	SENT_312	[p16l64t2710r198b2751],
10	and	CC	O	and	_	0	SENT_312	[p16l221t2710r309b2751],
11	PROVE	VBP	O	prove	conj_and	2	SENT_312	[p16l335t2710r502b2751],
12	IT-TIMI	NN	O	it-timus	dobj	11	SENT_312	[p16l527t2710r682b2751],
13	22	CD	NUMBER	22	num	14	SENT_312	[p16l709t2710r772b2751],
14	trials	NNS	O	trial	dep	12	SENT_312	[p16l794t2710r919b2751],
15	and	CC	O	and	_	0	SENT_312	[p16l943t2710r1031b2751],
16	conditional	JJ	O	conditional	amod	18	SENT_312	[p16l1056t2710r1326b2751],
17	logistic	JJ	O	logistic	amod	18	SENT_312	[p16l1354t2710r1526b2762],
18	regression	NN	O	regression	conj_and	12	SENT_312	[p16l1551t2710r1809b2762],
19	in	IN	O	in	_	0	SENT_312	[p16l1837t2710r1874b2751],
20	the	DT	O	the	det	25	SENT_312	[p16l1897t2710r1976b2751],
21	nested	JJ	O	nested	amod	25	SENT_312	[p16l66t2790r232b2831],
22	case	NN	O	case	nn	25	SENT_312	[p16l257t2790r558b2831],
23	—	CD	NUMBER	—	num	25	SENT_312	[p16l257t2790r558b2831],
24	control	NN	O	control	nn	25	SENT_312	[p16l257t2790r558b2831],
25	study	NN	O	study	prep_in	18	SENT_312	[p16l583t2790r718b2842],
26	of	IN	O	of	_	0	SENT_312	[p16l738t2790r787b2831],
27	the	DT	O	the	det	29	SENT_312	[p16l804t2790r883b2831],
28	WOSCOPS	JJ	O	woscops	amod	29	SENT_312	[p16l906t2790r1167b2831],
29	trial	NN	O	trial	prep_of	25	SENT_312	[p16l1189t2790r1298b2831],
30	.	.	O	.	_	0	SENT_312	[p16l1189t2790r1298b2831],

1	CI	NN	O	ci	_	0	SENT_313	[p16l1324t2790r1368b2831],
2	=	JJ	O	=	amod	4	SENT_313	[p16l1399t2805r1434b2819],
3	confidence	NN	O	confidence	nn	4	SENT_313	[p16l1462t2790r1730b2831],
4	interval	NN	O	interval	dep	1	SENT_313	[p16l1756t2790r1949b2831],
5	.	.	O	.	_	0	SENT_313	[p16l1756t2790r1949b2831],

1	Whereas	IN	O	whereas	mark	3	SENT_314	[p16l7t3080r291b3146],
2	noncarriers	NNS	O	noncarrier	nsubj	3	SENT_314	[p16l337t3083r730b3145],
3	do	VBP	O	do	advcl	10	SENT_314	[p16l775t3080r860b3145],
4	not	RB	O	not	neg	3	SENT_314	[p16l906t3097r1041b3160],
5	,	,	O	,	_	0	SENT_314	[p16l906t3097r1041b3160],
6	these	DT	O	these	det	7	SENT_314	[p16l1087t3080r1267b3145],
7	observations	NNS	O	observation	nsubjpass	10	SENT_314	[p16l1312t3080r1748b3146],
8	should	MD	O	should	aux	10	SENT_314	[p16l1794t3080r2029b3145],
9	be	VB	O	be	auxpass	10	SENT_314	[p16l2068t3080r2149b3145],
10	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_314	[p16l11t3186r372b3252],
11	in	IN	O	in	_	0	SENT_314	[p16l410t3189r478b3251],
12	other	JJ	O	other	amod	14	SENT_314	[p16l517t3186r704b3252],
13	larger	JJR	O	larger	amod	14	SENT_314	[p16l740t3186r943b3275],
14	studies	NNS	O	study	prep_in	10	SENT_314	[p16l981t3186r1240b3252],
15	.	.	O	.	_	0	SENT_314	[p16l981t3186r1240b3252],

1	In	IN	O	in	_	0	SENT_315	[p16l1282t3187r1360b3251],
2	addition	NN	O	addition	prep_in	15	SENT_315	[p16l1400t3186r1714b3267],
3	,	,	O	,	_	0	SENT_315	[p16l1400t3186r1714b3267],
4	although	IN	O	although	mark	9	SENT_315	[p16l1757t3186r2071b3275],
5	2	CD	NUMBER	2	num	7	SENT_315	[p16l2107t3189r2149b3253],
6	different	JJ	O	different	amod	7	SENT_315	[p16l11t3292r309b3358],
7	statins	NNS	O	statin	nsubjpass	9	SENT_315	[p16l343t3295r566b3358],
8	were	VBD	O	be	auxpass	9	SENT_315	[p16l598t3318r766b3358],
9	studied	VBN	O	study	advcl	15	SENT_315	[p16l802t3292r1077b3373],
10	,	,	O	,	_	0	SENT_315	[p16l802t3292r1077b3373],
11	our	PRP$	O	we	poss	12	SENT_315	[p16l1115t3318r1233b3358],
12	findings	NNS	O	finding	nsubj	15	SENT_315	[p16l1265t3292r1549b3381],
13	may	MD	O	may	aux	15	SENT_315	[p16l1586t3318r1734b3381],
14	not	RB	O	not	neg	15	SENT_315	[p16l1766t3309r1883b3358],
15	extend	VB	O	extend	_	0	SENT_315	[p16l1917t3292r2151b3358],
16	to	TO	O	to	_	0	SENT_315	[p16l10t3414r79b3462],
17	other	JJ	O	other	amod	18	SENT_315	[p16l130t3397r317b3462],
18	statins	NNS	O	statin	prep_to	15	SENT_315	[p16l366t3400r609b3462],
19	.	.	O	.	_	0	SENT_315	[p16l366t3400r609b3462],

1	It	PRP	O	it	nsubjpass	40	SENT_316	[p16l661t3398r722b3462],
2	is	VBZ	O	be	cop	5	SENT_316	[p16l769t3400r820b3462],
3	also	RB	O	also	advmod	5	SENT_316	[p16l872t3397r1003b3462],
4	not	RB	O	not	neg	5	SENT_316	[p16l1054t3414r1172b3462],
5	clear	JJ	O	clear	_	0	SENT_316	[p16l1220t3397r1384b3462],
6	Whether	IN	O	whether	complm	22	SENT_316	[p16l1427t3397r1721b3462],
7	differential	JJ	O	differential	amod	8	SENT_316	[p16l1769t3397r2151b3462],
8	beneﬁt	NN	O	beneﬁt	nsubj	22	SENT_316	[p16l8t3502r255b3567],
9	between	IN	O	between	_	0	SENT_316	[p16l307t3502r602b3568],
10	carriers	NNS	O	carrier	prep_between	8	SENT_316	[p16l659t3505r913b3567],
11	and	CC	O	and	_	0	SENT_316	[p16l973t3502r1101b3567],
12	noncarriers	NNS	O	noncarrier	conj_and	10	SENT_316	[p16l1158t3505r1551b3567],
13	from	IN	O	from	_	0	SENT_316	[p16l1609t3502r1779b3567],
14	intensive	JJ	O	intensive	amod	16	SENT_316	[p16l1836t3505r2150b3568],
15	statin	NN	O	statin	nn	16	SENT_316	[p17l12t30r205b93],
16	therapy	NN	O	therapy	prep_from	10	SENT_316	[p17l258t27r527b116],
17	compared	VBN	O	compare	prep	16	SENT_316	[p17l577t27r925b116],
18	with	IN	O	with	pcomp	17	SENT_316	[p17l973t27r1135b93],
19	standard	JJ	O	standard	amod	20	SENT_316	[p17l1190t27r1493b93],
20	treatment	NN	O	treatment	pobj	18	SENT_316	[p17l1545t44r1893b93],
21	is	VBZ	O	be	cop	22	SENT_316	[p17l1944t30r1995b93],
22	restricted	JJ	O	restricted	ccomp	5	SENT_316	[p17l2049t53r2147b93, p17l12t133r272b199],
23	only	RB	O	only	advmod	22	SENT_316	[p17l313t133r467b222],
24	to	TO	O	to	_	0	SENT_316	[p17l504t150r573b199],
25	beneﬁt	JJ	O	beneﬁt	prep_to	22	SENT_316	[p17l613t133r860b199],
26	from	IN	O	from	_	0	SENT_316	[p17l899t133r1070b199],
27	high	JJ	O	high	amod	30	SENT_316	[p17l1112t133r1468b222],
28	—	NN	O	—	nn	30	SENT_316	[p17l1112t133r1468b222],
29	dose	NN	O	dose	nn	30	SENT_316	[p17l1112t133r1468b222],
30	atorvastatin	NN	O	atorvastatin	prep_from	22	SENT_316	[p17l1512t136r1923b199],
31	compared	VBN	O	compare	_	0	SENT_316	[p17l1965t159r2147b199, p17l9t239r207b328],
32	with	IN	O	with	prepc_compared_with	30	SENT_316	[p17l230t239r392b305],
33	standard	JJ	O	standard	amod	36	SENT_316	[p17l421t239r920b305],
34	—	NN	O	—	nn	36	SENT_316	[p17l421t239r920b305],
35	dose	NN	O	dose	nn	36	SENT_316	[p17l421t239r920b305],
36	pravastatin	NN	O	pravastatin	pobj	30	SENT_316	[p17l947t242r1335b328],
37	or	CC	O	or	_	0	SENT_316	[p17l1363t265r1435b305],
38	can	MD	O	can	aux	40	SENT_316	[p17l1462t265r1580b305],
39	be	VB	O	be	auxpass	40	SENT_316	[p17l1606t239r1687b305],
40	extrapolated	VBN	O	extrapolate	conj_or	5	SENT_316	[p17l1716t239r2151b328],
41	to	TO	O	to	_	0	SENT_316	[p17l10t362r79b411],
42	different	JJ	O	different	amod	43	SENT_316	[p17l109t345r406b411],
43	doses	NNS	O	dose	prep_to	40	SENT_316	[p17l432t345r619b411],
44	of	IN	O	of	_	0	SENT_316	[p17l649t345r729b411],
45	the	DT	O	the	det	47	SENT_316	[p17l744t345r855b411],
46	same	JJ	O	same	amod	47	SENT_316	[p17l884t371r1059b411],
47	statin	NN	O	statin	prep_of	43	SENT_316	[p17l1089t348r1300b411],
48	.	.	O	.	_	0	SENT_316	[p17l1089t348r1300b411],

1	This	DT	O	this	det	2	SENT_317	[p17l1329t343r1493b411],
2	question	NN	O	question	nsubjpass	5	SENT_317	[p17l1523t348r1823b434],
3	could	MD	O	could	aux	5	SENT_317	[p17l1852t345r2044b411],
4	be	VB	O	be	auxpass	5	SENT_317	[p17l2069t345r2150b411],
5	addressed	VBN	O	address	_	0	SENT_317	[p17l12t451r381b517],
6	by	IN	O	by	_	0	SENT_317	[p17l447t451r537b540],
7	conducting	VBG	O	conduct	agent	5	SENT_317	[p17l603t451r1030b540],
8	a	DT	O	a	det	10	SENT_317	[p17l1099t477r1133b517],
9	genetic	JJ	O	genetic	amod	10	SENT_317	[p17l1199t454r1473b540],
10	study	NN	O	study	dobj	7	SENT_317	[p17l1543t451r1745b540],
11	of	IN	O	of	_	0	SENT_317	[p17l1811t451r1895b517],
12	KIF6	NN	O	kif6	nn	14	SENT_317	[p17l1950t454r2151b517],
13	Trp719Arg	NN	O	trp719arg	nn	14	SENT_317	[p17l8t555r422b646],
14	polymorphism	NN	O	polymorphism	prep_of	10	SENT_317	[p17l466t557r983b646],
15	in	IN	O	in	_	0	SENT_317	[p17l1031t560r1099b622],
16	clinical	JJ	O	clinical	amod	17	SENT_317	[p17l1147t557r1397b623],
17	trials	NNS	O	trial	prep_in	14	SENT_317	[p17l1442t557r1612b623],
18	that	WDT	O	that	nsubj	19	SENT_317	[p17l1661t557r1803b623],
19	compare	VBP	O	compare	rcmod	10	SENT_317	[p17l1849t583r2150b646],
20	different	JJ	O	different	amod	21	SENT_317	[p17l11t663r309b728],
21	doses	NNS	O	dose	dobj	19	SENT_317	[p17l341t663r528b728],
22	of	IN	O	of	_	0	SENT_317	[p17l564t663r644b728],
23	the	DT	O	the	det	25	SENT_317	[p17l665t663r775b728],
24	same	JJ	O	same	amod	25	SENT_317	[p17l810t689r984b728],
25	statin	NN	O	statin	prep_of	21	SENT_317	[p17l1020t666r1232b728],
26	.	.	O	.	_	0	SENT_317	[p17l1020t666r1232b728],

1	Conclusions	NNS	O	conclusion	_	0	SENT_318	[p17l10t889r530b952],

1	Carriers	NNS	O	carrier	nsubj	6	SENT_319	[p17l12t1060r295b1126],
2	of	IN	O	of	_	0	SENT_319	[p17l326t1060r406b1126],
3	the	DT	O	the	det	5	SENT_319	[p17l422t1060r532b1126],
4	719Arg	NNP	O	719Arg	nn	5	SENT_319	[p17l563t1058r834b1149],
5	allele	NN	O	allele	prep_of	1	SENT_319	[p17l862t1060r1039b1126],
6	are	VBP	O	be	_	0	SENT_319	[p17l1069t1086r1170b1126],
7	at	IN	O	at	_	0	SENT_319	[p17l1201t1077r1264b1126],
8	increased	VBN	O	increase	amod	9	SENT_319	[p17l1290t1060r1619b1126],
9	risk	NN	O	risk	prep_at	6	SENT_319	[p17l1646t1060r1777b1126],
10	of	IN	O	of	_	0	SENT_319	[p17l1803t1060r1882b1126],
11	fatal	JJ	O	fatal	amod	15	SENT_319	[p17l1898t1060r2052b1126],
12	or	CC	O	or	_	0	SENT_319	[p17l2079t1086r2152b1126],
13	nonfatal	JJ	O	nonfatal	amod	15	SENT_319	[p17l12t1166r303b1232],
14	coronary	JJ	O	coronary	amod	15	SENT_319	[p17l357t1192r668b1255],
15	events	NNS	O	event	prep_of	9	SENT_319	[p17l720t1183r936b1232],
16	when	WRB	O	when	advmod	21	SENT_319	[p17l989t1166r1185b1232],
17	not	RB	O	not	neg	18	SENT_319	[p17l1240t1183r1358b1232],
18	treated	VBN	O	treat	csubj	21	SENT_319	[p17l1411t1166r1656b1232],
19	with	IN	O	with	_	0	SENT_319	[p17l1707t1166r1869b1232],
20	statins	NNS	O	statin	prep_with	18	SENT_319	[p17l1925t1169r2149b1232],
21	(	VBP	O	(	dep	9	SENT_319	[p17l13t1270r78b1352],
22	8	CD	NUMBER	8	num	24	SENT_319	[p17l13t1270r78b1352],
23	-10	CD	NUMBER	-10	num	24	SENT_319	[p17l93t1270r275b1353],
24	)	NN	O	)	dobj	21	SENT_319	[p17l93t1270r275b1353],
25	,	,	O	,	_	0	SENT_319	[p17l93t1270r275b1353],
26	and	CC	O	and	_	0	SENT_319	[p17l303t1272r430b1338],
27	they	PRP	O	they	dep	29	SENT_319	[p17l453t1272r607b1361],
28	clearly	RB	O	clearly	advmod	29	SENT_319	[p17l627t1272r855b1361],
29	beneﬁt	NN	O	beneﬁt	conj_and	6	SENT_319	[p17l871t1272r1118b1338],
30	from	IN	O	from	_	0	SENT_319	[p17l1139t1272r1310b1338],
31	statin	NN	O	statin	nn	32	SENT_319	[p17l1334t1275r1528b1338],
32	therapy	NN	O	therapy	prep_from	29	SENT_319	[p17l1551t1272r1835b1361],
33	,	,	O	,	_	0	SENT_319	[p17l1551t1272r1835b1361],
34	Whether	IN	O	whether	complm	40	SENT_319	[p17l1858t1272r2152b1338],
35	it	PRP	O	it	nsubj	40	SENT_319	[p17l10t1381r61b1444],
36	be	VB	O	be	cop	40	SENT_319	[p17l93t1378r174b1444],
37	standard	JJ	O	standard	amod	40	SENT_319	[p17l212t1378r711b1444],
38	—	NN	O	—	nn	40	SENT_319	[p17l212t1378r711b1444],
39	dose	NN	O	dose	nn	40	SENT_319	[p17l212t1378r711b1444],
40	pravastatin	NN	O	pravastatin	dep	6	SENT_319	[p17l746t1381r1133b1467],
41	compared	VBN	O	compare	prep	40	SENT_319	[p17l1170t1378r1518b1467],
42	with	IN	O	with	pcomp	41	SENT_319	[p17l1549t1378r1711b1444],
43	placebo	NN	O	placebo	pobj	42	SENT_319	[p17l1746t1378r2013b1467],
44	(	CD	NUMBER	(	number	45	SENT_319	[p17l2053t1376r2147b1458],
45	8	CD	NUMBER	8	num	46	SENT_319	[p17l2053t1376r2147b1458],
46	)	NN	O	)	dep	43	SENT_319	[p17l2053t1376r2147b1458],
47	or	CC	O	or	_	0	SENT_319	[p17l11t1510r84b1550],
48	high	JJ	O	high	amod	52	SENT_319	[p17l113t1484r469b1573],
49	—	NN	O	—	nn	52	SENT_319	[p17l113t1484r469b1573],
50	dose	NN	O	dose	nn	52	SENT_319	[p17l113t1484r469b1573],
51	atorvastatin	NN	O	atorvastatin	nn	52	SENT_319	[p17l503t1487r914b1550],
52	therapy	NN	O	therapy	conj_or	43	SENT_319	[p17l945t1484r1214b1573],
53	compared	VBN	O	compare	_	0	SENT_319	[p17l1242t1484r1590b1573],
54	with	IN	O	with	prepc_compared_with	52	SENT_319	[p17l1617t1484r1779b1550],
55	standarddose	NN	O	standarddose	nn	56	SENT_319	[p17l1811t1484r2147b1550, p17l11t1591r167b1657],
56	pravastatin	NN	O	pravastatin	pobj	52	SENT_319	[p17l204t1594r610b1680],
57	.	.	O	.	_	0	SENT_319	[p17l204t1594r610b1680],

1	In	IN	O	in	_	0	SENT_320	[p17l651t1592r729b1656],
2	contrast	NN	O	contrast	prep_in	4	SENT_320	[p17l768t1608r1069b1672],
3	,	,	O	,	_	0	SENT_320	[p17l768t1608r1069b1672],
4	noncarriers	NNS	O	noncarrier	_	0	SENT_320	[p17l1110t1594r1504b1657],
5	not	RB	O	not	neg	6	SENT_320	[p17l1544t1608r1661b1657],
6	only	RB	O	only	dep	4	SENT_320	[p17l1698t1591r1851b1680],
7	were	VBD	O	be	conj_and	7	SENT_320	[p17l1882t1617r2049b1657],
8	at	IN	O	at	_	0	SENT_320	[p17l2089t1608r2152b1657],
9	lower	JJR	O	lower	amod	10	SENT_320	[p17l9t1697r206b1764],
10	risk	NN	O	risk	prep_at	7	SENT_320	[p17l230t1697r361b1763],
11	than	IN	O	than	_	0	SENT_320	[p17l383t1697r542b1763],
12	carriers	NNS	O	carrier	prep_than	10	SENT_320	[p17l569t1700r823b1763],
13	in	IN	O	in	_	0	SENT_320	[p17l851t1700r919b1763],
14	the	DT	O	the	det	18	SENT_320	[p17l945t1697r1055b1763],
15	ARIC	NN	ORGANIZATION	aric	nn	18	SENT_320	[p17l1080t1695r1305b1764],
16	and	CC	O	and	_	0	SENT_320	[p17l1334t1697r1462b1763],
17	WHS	NN	O	wh	nn	18	SENT_320	[p17l1484t1697r1700b1764],
18	trials	NNS	O	trial	prep_in	12	SENT_320	[p17l1729t1697r1899b1763],
19	and	CC	O	and	_	0	SENT_320	[p17l1929t1697r2057b1763],
20	in	IN	O	in	_	0	SENT_320	[p17l2082t1700r2150b1763],
21	the	DT	O	the	det	23	SENT_320	[p17l10t1804r121b1870],
22	placebo	NN	O	placebo	nn	23	SENT_320	[p17l159t1804r427b1893],
23	groups	NNS	O	group	prep_in	7	SENT_320	[p17l466t1830r703b1893],
24	of	IN	O	of	_	0	SENT_320	[p17l745t1804r825b1870],
25	the	DT	O	the	det	29	SENT_320	[p17l851t1804r962b1870],
26	CARE	NNP	O	CARE	nn	29	SENT_320	[p17l1003t1802r1253b1870],
27	and	CC	O	and	_	0	SENT_320	[p17l1296t1804r1423b1870],
28	WOSCOPS	NNP	O	WOSCOPS	nn	29	SENT_320	[p17l1458t1804r1913b1871],
29	trials	NNS	O	trial	prep_of	23	SENT_320	[p17l1955t1804r2147b1885],
30	,	,	O	,	_	0	SENT_320	[p17l1955t1804r2147b1885],
31	but	CC	O	but	_	0	SENT_320	[p17l8t1909r127b1974],
32	noncarriers	NNS	O	noncarrier	nsubj	34	SENT_320	[p17l162t1912r555b1974],
33	also	RB	O	also	advmod	34	SENT_320	[p17l594t1909r724b1974],
34	received	VBD	O	receive	conj_but	4	SENT_320	[p17l761t1909r1049b1974],
35	less	JJR	O	less	amod	36	SENT_320	[p17l1082t1909r1203b1974],
36	beneﬁt	NN	O	beneﬁt	dobj	34	SENT_320	[p17l1238t1909r1484b1974],
37	from	IN	O	from	_	0	SENT_320	[p17l1518t1909r1688b1974],
38	statin	NN	O	statin	nn	39	SENT_320	[p17l1725t1912r1919b1974],
39	treatment	NN	O	treatment	prep_from	34	SENT_320	[p17l1954t1926r2147b1974, p17l11t2032r195b2081],
40	than	IN	O	than	mark	41	SENT_320	[p17l239t2015r398b2081],
41	did	VBD	O	do	advcl	34	SENT_320	[p17l445t2015r558b2081],
42	carriers	NNS	O	carrier	dobj	41	SENT_320	[p17l604t2018r858b2081],
43	in	IN	O	in	_	0	SENT_320	[p17l905t2018r973b2081],
44	the	DT	O	the	det	45	SENT_320	[p17l1019t2015r1129b2081],
45	CARE	NNP	O	CARE	prep_in	41	SENT_320	[p17l1178t2013r1449b2096],
46	,	,	O	,	_	0	SENT_320	[p17l1178t2013r1449b2096],
47	WOSCOPS	NNP	O	WOSCOPS	appos	45	SENT_320	[p17l1494t2015r1973b2096],
48	,	,	O	,	_	0	SENT_320	[p17l1494t2015r1973b2096],
49	and	CC	O	and	_	0	SENT_320	[p17l2023t2015r2151b2081],
50	PROVE	VB	O	prove	conj_and	41	SENT_320	[p17l11t2123r320b2190],
51	IT	PRP	O	it	dobj	50	SENT_320	[p17l371t2121r714b2188],
52	.	.	O	.	_	0	SENT_320	[p17l371t2121r714b2188],

1	—	NN	O	—	_	0	SENT_321	[p17l371t2121r714b2188],
2	.	.	O	.	_	0	SENT_321	[p17l371t2121r714b2188],

1	TIMI	NNP	ORGANIZATION	TIMI	_	0	SENT_322	[p17l371t2121r714b2188],
2	22	CD	NUMBER	22	num	3	SENT_322	[p17l765t2126r851b2190],
3	trials	NNS	O	trial	dep	1	SENT_322	[p17l902t2123r1093b2189],
4	.	.	O	.	_	0	SENT_322	[p17l902t2123r1093b2189],

1	The	DT	O	the	det	2	SENT_323	[p17l1145t2121r1292b2189],
2	absence	NN	O	absence	nsubj	14	SENT_323	[p17l1345t2123r1614b2189],
3	of	IN	O	of	_	0	SENT_323	[p17l1666t2123r1746b2189],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_323	[p17l1785t2123r2152b2212],
5	beneﬁt	NN	O	beneﬁt	prep_of	2	SENT_323	[p17l8t2229r255b2295],
6	from	IN	O	from	_	0	SENT_323	[p17l279t2229r450b2295],
7	intensive	JJ	O	intensive	amod	9	SENT_323	[p17l477t2232r791b2295],
8	statin	NN	O	statin	nn	9	SENT_323	[p17l820t2232r1013b2295],
9	therapy	NN	O	therapy	prep_from	5	SENT_323	[p17l1040t2229r1309b2318],
10	in	IN	O	in	_	0	SENT_323	[p17l1332t2232r1400b2294],
11	noncarriers	NNS	O	noncarrier	prep_in	9	SENT_323	[p17l1428t2232r1821b2295],
12	does	VBZ	O	do	aux	14	SENT_323	[p17l1850t2229r2005b2295],
13	not	RB	O	not	neg	14	SENT_323	[p17l2034t2246r2152b2295],
14	preclude	VB	O	preclude	_	0	SENT_323	[p17l9t2335r310b2424],
15	the	DT	O	the	det	16	SENT_323	[p17l358t2335r469b2401],
16	possibility	NN	O	possibility	dobj	14	SENT_323	[p17l517t2335r879b2424],
17	that	IN	O	that	complm	22	SENT_323	[p17l923t2335r1065b2401],
18	a	DT	O	a	det	19	SENT_323	[p17l1112t2361r1146b2401],
19	portion	NN	O	portion	nsubj	22	SENT_323	[p17l1192t2338r1455b2424],
20	of	IN	O	of	_	0	SENT_323	[p17l1503t2335r1583b2401],
21	noncarriers	NNS	O	noncarrier	prep_of	19	SENT_323	[p17l1620t2338r2013b2401],
22	do	VBP	O	do	ccomp	14	SENT_323	[p17l2064t2335r2149b2401],
23	beneﬁt	NN	O	beneﬁt	dobj	22	SENT_323	[p17l8t2441r255b2507],
24	from	IN	O	from	_	0	SENT_323	[p17l280t2441r451b2507],
25	statin	NN	O	statin	nn	26	SENT_323	[p17l480t2444r674b2507],
26	therapy	NN	O	therapy	prep_from	22	SENT_323	[p17l701t2441r985b2530],
27	,	,	O	,	_	0	SENT_323	[p17l701t2441r985b2530],
28	but	CC	O	but	_	0	SENT_323	[p17l1014t2441r1133b2507],
29	it	PRP	O	it	nsubj	31	SENT_323	[p17l1159t2444r1209b2507],
30	does	VBZ	O	do	aux	31	SENT_323	[p17l1236t2441r1390b2507],
31	suggest	VB	O	suggest	conj_or	31	SENT_323	[p17l1421t2458r1680b2530],
32	that	IN	O	that	complm	36	SENT_323	[p17l1705t2441r1847b2507],
33	noncarriers	NNS	O	noncarrier	nsubjpass	36	SENT_323	[p17l1874t2467r2147b2507, p17l10t2550r160b2613],
34	may	MD	O	may	aux	36	SENT_323	[p17l200t2573r348b2636],
35	be	VB	O	be	auxpass	36	SENT_323	[p17l380t2547r460b2613],
36	treated	VBN	O	treat	ccomp	31	SENT_323	[p17l498t2547r744b2613],
37	With	IN	O	with	dep	36	SENT_323	[p17l777t2547r938b2613],
38	standard	JJ	O	standard	amod	40	SENT_323	[p17l977t2547r1280b2613],
39	statin	NN	O	statin	nn	40	SENT_323	[p17l1318t2550r1512b2613],
40	therapy	NN	O	therapy	pobj	37	SENT_323	[p17l1549t2547r1817b2636],
41	and	CC	O	and	_	0	SENT_323	[p17l1852t2547r1980b2613],
42	also	RB	O	also	conj_and	37	SENT_323	[p17l2018t2547r2149b2613],
43	with	IN	O	with	_	0	SENT_323	[p17l7t2653r169b2719],
44	other	JJ	O	other	amod	46	SENT_323	[p17l196t2653r383b2719],
45	lipid	NN	O	lipid	nn	46	SENT_323	[p17l407t2653r974b2742],
46	—	NN	O	—	prep_with	31	SENT_323	[p17l407t2653r974b2742],
47	modifying	VBG	O	modify	partmod	46	SENT_323	[p17l407t2653r974b2742],
48	drugs	NNS	O	drug	dobj	47	SENT_323	[p17l1000t2653r1191b2742],
49	or	CC	O	or	_	0	SENT_323	[p17l1220t2679r1293b2719],
50	by	IN	O	by	_	0	SENT_323	[p17l1315t2653r1402b2742],
51	strategies	NNS	O	strategy	prep_by	31	SENT_323	[p17l1426t2656r1752b2742],
52	that	WDT	O	that	nsubj	53	SENT_323	[p17l1780t2653r1922b2719],
53	target	VBP	O	target	rcmod	51	SENT_323	[p17l1946t2670r2152b2742],
54	other	JJ	O	other	amod	56	SENT_323	[p17l11t2759r198b2825],
55	risk	NN	O	risk	nn	56	SENT_323	[p17l232t2759r363b2825],
56	factors	NNS	O	factor	dobj	53	SENT_323	[p17l393t2759r626b2825],
57	such	JJ	O	such	_	0	SENT_323	[p17l664t2759r821b2825],
58	as	IN	O	as	_	0	SENT_323	[p17l858t2785r921b2825],
59	hypertension	NN	O	hypertension	nn	61	SENT_323	[p17l957t2759r1437b2848],
60	,	,	O	,	_	0	SENT_323	[p17l957t2759r1437b2848],
61	diabetes	NN	O	diabetes	prep_such_as	56	SENT_323	[p17l1476t2759r1781b2840],
62	,	,	O	,	_	0	SENT_323	[p17l1476t2759r1781b2840],
63	or	CC	O	or	_	0	SENT_323	[p17l1820t2785r1892b2825],
64	smokJACC	NN	O	smokjacc	nn	65	SENT_323	[p17l1927t2759r2148b2825, p17l11t2864r125b2915],
65	Vol	NN	O	vol	prep_such_as	56	SENT_323	[p17l152t2864r234b2915],
66	.	.	O	.	_	0	SENT_323	[p17l152t2864r234b2915],

1	51	CD	NUMBER	51	_	0	SENT_324	[p17l265t2864r338b2923],
2	,	,	O	,	_	0	SENT_324	[p17l265t2864r338b2923],
3	No.	NN	O	no.	amod	1	SENT_324	[p17l370t2864r442b2915],
4	4	CD	NUMBER	4	number	3	SENT_324	[p17l471t2864r513b2923],
5	,	,	O	,	_	0	SENT_324	[p17l471t2864r513b2923],
6	2008	CD	DATE	2008	appos	1	SENT_324	[p17l544t2864r667b2915],
7	January	NNP	DATE	January	tmod	6	SENT_324	[p17l11t2952r187b3015],
8	29	CD	DATE	29	num	7	SENT_324	[p17l213t2952r285b3011],
9	,	,	O	,	_	0	SENT_324	[p17l213t2952r285b3011],
10	2008:449	CD	NUMBER	2008:449	num	7	SENT_324	[p17l316t2952r648b3002],
11	—	CD	NUMBER	—	num	12	SENT_324	[p17l316t2952r648b3002],
12	55	CD	NUMBER	55	dep	1	SENT_324	[p17l316t2952r648b3002],

1	ing	NN	O	ing	_	0	SENT_325	[p18l12t89r141b175],
2	.	.	O	.	_	0	SENT_325	[p18l12t89r141b175],

1	The	DT	O	the	det	3	SENT_326	[p18l173t84r320b152],
2	biological	JJ	O	biological	amod	3	SENT_326	[p18l349t86r692b175],
3	explanations	NNS	O	explanation	nsubj	54	SENT_326	[p18l722t86r1159b175],
4	for	IN	O	for	_	0	SENT_326	[p18l1191t86r1292b152],
5	the	DT	O	the	det	7	SENT_326	[p18l1320t86r1430b152],
6	observed	VBN	O	observe	amod	7	SENT_326	[p18l1462t86r1769b152],
7	difference	NN	O	difference	prep_for	3	SENT_326	[p18l1800t86r2139b152],
8	in	IN	O	in	_	0	SENT_326	[p18l12t194r80b256],
9	treatment	NN	O	treatment	nn	10	SENT_326	[p18l139t208r485b256],
10	beneﬁt	NN	O	beneﬁt	prep_in	7	SENT_326	[p18l541t191r786b256],
11	should	MD	O	should	aux	13	SENT_326	[p18l845t191r1078b256],
12	be	VB	O	be	auxpass	13	SENT_326	[p18l1135t191r1215b256],
13	provided	VBN	O	provide	_	0	SENT_326	[p18l1274t191r1585b279],
14	by	IN	O	by	_	0	SENT_326	[p18l1641t191r1727b279],
15	functional	JJ	O	functional	amod	16	SENT_326	[p18l1783t191r2141b256],
16	studies	NNS	O	study	agent	13	SENT_326	[p18l14t296r252b361],
17	of	IN	O	of	_	0	SENT_326	[p18l292t296r372b361],
18	this	DT	O	this	det	21	SENT_326	[p18l397t296r524b361],
19	kinesin	NN	O	kinesin	nn	21	SENT_326	[p18l563t296r815b361],
20	motor	NN	O	motor	nn	21	SENT_326	[p18l853t313r1069b361],
21	protein	NN	O	protein	prep_of	16	SENT_326	[p18l1104t299r1378b384],
22	,	,	O	,	_	0	SENT_326	[p18l1104t299r1378b384],
23	studies	NNS	O	study	conj_and	21	SENT_326	[p18l1420t296r1658b361],
24	which	WDT	O	which	nsubj	27	SENT_326	[p18l1694t296r1911b361],
25	could	MD	O	could	aux	27	SENT_326	[p18l1950t296r2140b361],
26	also	RB	O	also	advmod	27	SENT_326	[p18l14t401r144b466],
27	offer	VB	O	offer	rcmod	23	SENT_326	[p18l181t401r338b466],
28	important	JJ	O	important	amod	30	SENT_326	[p18l371t404r726b489],
29	additional	JJ	O	additional	amod	30	SENT_326	[p18l761t401r1116b466],
30	insights	NNS	O	insight	dobj	27	SENT_326	[p18l1150t401r1421b489],
31	into	IN	O	into	_	0	SENT_326	[p18l1458t404r1596b466],
32	the	DT	O	the	det	33	SENT_326	[p18l1633t401r1743b466],
33	biology	NN	O	biology	prep_into	27	SENT_326	[p18l1776t401r2040b489],
34	of	IN	O	of	_	0	SENT_326	[p18l2072t401r2151b466],
35	lipid	NN	O	lipid	nn	36	SENT_326	[p18l11t506r172b594],
36	metabolism	NN	O	metabolism	prep_of	33	SENT_326	[p18l203t506r612b571],
37	and	CC	O	and	_	0	SENT_326	[p18l645t506r772b571],
38	acute	JJ	O	acute	amod	40	SENT_326	[p18l803t523r983b571],
39	coronary	JJ	O	coronary	amod	40	SENT_326	[p18l1015t531r1324b594],
40	syndromes	NNS	O	syndrome	prep_of	16	SENT_326	[p18l1352t506r1724b594],
41	that	WDT	O	that	nsubj	47	SENT_326	[p18l1757t506r1897b571],
42	could	MD	O	could	aux	47	SENT_326	[p18l1927t506r2137b586],
43	,	,	O	,	_	0	SENT_326	[p18l1927t506r2137b586],
44	in	IN	O	in	_	0	SENT_326	[p18l12t615r80b677],
45	turn	NN	O	turn	prep_in	47	SENT_326	[p18l115t629r282b692],
46	,	,	O	,	_	0	SENT_326	[p18l115t629r282b692],
47	generate	VBP	O	generate	rcmod	40	SENT_326	[p18l320t629r616b700],
48	novel	JJ	O	novel	amod	49	SENT_326	[p18l654t612r841b678],
49	targets	NNS	O	target	dobj	47	SENT_326	[p18l875t629r1107b700],
50	for	IN	O	for	_	0	SENT_326	[p18l1144t612r1244b677],
51	therapeutic	JJ	O	therapeutic	amod	52	SENT_326	[p18l1278t612r1674b700],
52	intervention	NN	O	intervention	prep_for	47	SENT_326	[p18l1709t615r2139b677],
53	and	CC	O	and	_	0	SENT_326	[p18l14t717r141b782],
54	lead	VB	O	lead	conj_and	13	SENT_326	[p18l172t717r315b782],
55	to	TO	O	to	_	0	SENT_326	[p18l348t734r415b782],
56	better	JJR	O	better	prep_to	54	SENT_326	[p18l448t717r961b782],
57	—	CD	NUMBER	—	num	59	SENT_326	[p18l448t717r961b782],
58	tailored	VBN	O	tailor	amod	59	SENT_326	[p18l448t717r961b782],
59	therapy	NN	O	therapy	dobj	54	SENT_326	[p18l993t717r1261b805],
60	for	IN	O	for	_	0	SENT_326	[p18l1289t717r1390b782],
61	patients	NNS	O	patient	prep_for	59	SENT_326	[p18l1420t720r1716b805],
62	.	.	O	.	_	0	SENT_326	[p18l1420t720r1716b805],

1	Acknowledgments	NNS	O	acknowledgment	nsubj	4	SENT_327	[p18l7t925r632b1007],
2	The	DT	O	the	det	3	SENT_327	[p18l10t1025r156b1093],
3	authors	NNS	O	author	dep	1	SENT_327	[p18l205t1027r464b1093],
4	express	VBP	O	express	_	0	SENT_327	[p18l513t1052r760b1116],
5	their	PRP$	O	they	poss	6	SENT_327	[p18l809t1027r975b1093],
6	gratitude	NN	O	gratitude	dobj	4	SENT_327	[p18l1019t1027r1336b1116],
7	to	TO	O	to	_	0	SENT_327	[p18l1383t1044r1451b1093],
8	the	DT	O	the	det	13	SENT_327	[p18l1499t1027r1609b1093],
9	PROVE	NNP	O	PROVE	nn	13	SENT_327	[p18l1657t1027r1964b1094],
10	ITTIMI	NNP	O	ITTIMI	nn	13	SENT_327	[p18l2011t1025r2137b1092, p18l10t1131r222b1198],
11	22	CD	NUMBER	22	num	13	SENT_327	[p18l262t1136r348b1200],
12	trial	NN	O	trial	nn	13	SENT_327	[p18l389t1133r530b1199],
13	patients	NNS	O	patient	prep_to	4	SENT_327	[p18l567t1136r865b1222],
14	;	:	O	;	_	0	SENT_327	[p18l567t1136r865b1222],
15	to	TO	O	to	_	0	SENT_327	[p18l907t1150r975b1199],
16	Drs.	NNP	O	Drs.	nn	18	SENT_327	[p18l1016t1134r1165b1199],
17	Thomas	NNP	PERSON	Thomas	nn	18	SENT_327	[p18l1206t1131r1499b1199],
18	White	NNP	PERSON	White	prep_to	13	SENT_327	[p18l1536t1133r1767b1200],
19	and	CC	O	and	_	0	SENT_327	[p18l1808t1133r1936b1199],
20	John	NNP	PERSON	John	nn	21	SENT_327	[p18l1965t1133r2140b1217],
21	Sninsky	NNP	PERSON	Sninsky	conj_and	18	SENT_327	[p18l16t1238r294b1326],
22	for	IN	O	for	_	0	SENT_327	[p18l333t1238r434b1303],
23	helpful	JJ	O	helpful	amod	24	SENT_327	[p18l475t1238r722b1326],
24	comments	NNS	O	comment	prep_for	18	SENT_327	[p18l765t1255r1128b1303],
25	on	IN	O	on	_	0	SENT_327	[p18l1173t1263r1261b1303],
26	the	DT	O	the	det	27	SENT_327	[p18l1303t1238r1413b1303],
27	manuscript	NN	O	manuscript	prep_on	24	SENT_327	[p18l1458t1241r1871b1326],
28	;	:	O	;	_	0	SENT_327	[p18l1458t1241r1871b1326],
29	to	TO	O	to	_	0	SENT_327	[p18l1917t1255r1985b1303],
30	the	DT	O	the	det	34	SENT_327	[p18l2029t1238r2139b1303],
31	Celera	NNP	ORGANIZATION	Celera	nn	34	SENT_327	[p18l14t1344r243b1409],
32	high	JJ	O	high	amod	34	SENT_327	[p18l276t1344r435b1432],
33	throughput	NN	O	throughput	nn	34	SENT_327	[p18l469t1344r872b1432],
34	group	NN	O	group	prep_to	24	SENT_327	[p18l904t1369r1107b1432],
35	for	IN	O	for	_	0	SENT_327	[p18l1143t1344r1244b1409],
36	genotyping	VBG	O	genotype	amod	37	SENT_327	[p18l1274t1347r1673b1432],
37	data	NNS	O	datum	prep_for	34	SENT_327	[p18l1706t1344r1872b1424],
38	;	:	O	;	_	0	SENT_327	[p18l1706t1344r1872b1424],
39	and	CC	O	and	_	0	SENT_327	[p18l1910t1344r2037b1409],
40	to	TO	O	to	_	0	SENT_327	[p18l2070t1361r2138b1409],
41	Dr.	NNP	O	Dr.	nn	43	SENT_327	[p18l13t1450r130b1514],
42	David	NNP	PERSON	David	nn	43	SENT_327	[p18l167t1449r382b1514],
43	Ross	NNP	PERSON	Ross	conj_and	18	SENT_327	[p18l417t1450r600b1529],
44	,	,	O	,	_	0	SENT_327	[p18l417t1450r600b1529],
45	Dr.	NNP	O	Dr.	nn	47	SENT_327	[p18l636t1450r753b1514],
46	Goran	NNP	PERSON	Goran	nn	47	SENT_327	[p18l792t1449r1018b1514],
47	Gogic	NNP	PERSON	Gogic	conj_and	18	SENT_327	[p18l1053t1449r1287b1537],
48	,	,	O	,	_	0	SENT_327	[p18l1053t1449r1287b1537],
49	Joel	NNP	PERSON	Joel	nn	50	SENT_327	[p18l1314t1449r1455b1532],
50	Bolonick	NNP	PERSON	Bolonick	conj_and	43	SENT_327	[p18l1486t1449r1823b1529],
51	,	,	O	,	_	0	SENT_327	[p18l1486t1449r1823b1529],
52	Migdad	NNP	PERSON	Migdad	nn	53	SENT_327	[p18l1857t1449r2140b1537],
53	Machrus	NNP	PERSON	Machrus	conj_and	43	SENT_327	[p18l11t1555r345b1636],
54	,	,	O	,	_	0	SENT_327	[p18l11t1555r345b1636],
55	Daniel	NNP	PERSON	Daniel	nn	56	SENT_327	[p18l372t1555r611b1621],
56	Civello	NNP	PERSON	Civello	conj_and	43	SENT_327	[p18l635t1555r905b1636],
57	,	,	O	,	_	0	SENT_327	[p18l635t1555r905b1636],
58	Alla	NNP	PERSON	Alla	nn	59	SENT_327	[p18l929t1553r1079b1621],
59	Smolgovsky	NNP	PERSON	Smolgovsky	conj_and	43	SENT_327	[p18l1105t1555r1545b1644],
60	,	,	O	,	_	0	SENT_327	[p18l1105t1555r1545b1644],
61	David	NNP	PERSON	David	nn	62	SENT_327	[p18l1572t1555r1787b1621],
62	Wolfson	NNP	PERSON	Wolfson	conj_and	18	SENT_327	[p18l1806t1555r2137b1636],
63	,	,	O	,	_	0	SENT_327	[p18l1806t1555r2137b1636],
64	and	CC	O	and	_	0	SENT_327	[p18l14t1662r141b1728],
65	Kevin	NNP	PERSON	Kevin	nn	66	SENT_327	[p18l176t1663r380b1728],
66	Tsai	NNP	PERSON	Tsai	conj_and	18	SENT_327	[p18l411t1660r565b1728],
67	for	IN	O	for	_	0	SENT_327	[p18l598t1662r699b1728],
68	computational	JJ	O	computational	amod	70	SENT_327	[p18l731t1662r1241b1751],
69	biology	NN	O	biology	nn	70	SENT_327	[p18l1271t1662r1534b1751],
70	support	NN	O	support	prep_for	13	SENT_327	[p18l1565t1679r1849b1751],
71	.	.	O	.	_	0	SENT_327	[p18l1565t1679r1849b1751],

1	Reprint	JJ	MISC	reprint	amod	2	SENT_328	[p18l14t1896r274b1975],
2	requests	NNS	O	request	_	0	SENT_328	[p18l304t1910r578b1975],
3	and	CC	O	and	_	0	SENT_328	[p18l613t1894r736b1955],
4	correspondence	NN	O	correspondence	conj_and	2	SENT_328	[p18l768t1894r1311b1975],
5	:	:	O	:	_	0	SENT_328	[p18l768t1894r1311b1975],
6	Dr.	NNP	O	Dr.	nn	9	SENT_328	[p18l1348t1896r1453b1955],
7	Olga	NNP	PERSON	Olga	nn	9	SENT_328	[p18l1493t1895r1648b1975],
8	A.	NNP	PERSON	A.	nn	9	SENT_328	[p18l1678t1894r1753b1955],
9	Iakoubova	NNP	PERSON	Iakoubova	dep	2	SENT_328	[p18l1790t1895r2137b1968],
10	,	,	O	,	_	0	SENT_328	[p18l1790t1895r2137b1968],
11	Celera	NNP	ORGANIZATION	Celera	appos	9	SENT_328	[p18l14t1994r236b2066],
12	,	,	ORGANIZATION	,	_	0	SENT_328	[p18l14t1994r236b2066],
13	Inc.	NNP	ORGANIZATION	Inc.	appos	9	SENT_328	[p18l286t1995r426b2066],
14	,	,	O	,	_	0	SENT_328	[p18l286t1995r426b2066],
15	1401	CD	DATE	1401	num	18	SENT_328	[p18l480t1997r628b2053],
16	Harbor	NNP	LOCATION	Harbor	nn	18	SENT_328	[p18l681t1994r916b2053],
17	Bay	NNP	LOCATION	Bay	nn	18	SENT_328	[p18l962t1995r1084b2074],
18	Parkway	NNP	LOCATION	Parkway	appos	9	SENT_328	[p18l1128t1994r1415b2074],
19	,	,	O	,	_	0	SENT_328	[p18l1128t1994r1415b2074],
20	Alameda	NNP	LOCATION	Alameda	appos	9	SENT_328	[p18l1463t1993r1768b2066],
21	,	,	O	,	_	0	SENT_328	[p18l1463t1993r1768b2066],
22	California	NNP	LOCATION	California	appos	9	SENT_328	[p18l1820t1994r2141b2053],
23	94502	CD	NUMBER	94502	num	22	SENT_328	[p18l14t2092r225b2152],
24	.	.	O	.	_	0	SENT_328	[p18l14t2092r225b2152],

1	E	NN	O	e	nn	3	SENT_329	[p18l260t2092r500b2151],
2	—	CD	NUMBER	—	num	3	SENT_329	[p18l260t2092r500b2151],
3	mai1	NN	O	mai1	_	0	SENT_329	[p18l260t2092r500b2151],
4	:	:	O	:	_	0	SENT_329	[p18l260t2092r500b2151],
5	olga.iakoubova@celera.com	NNP	O	olga.iakoubova@celera.com	dep	3	SENT_329	[p18l534t2092r1427b2172],
6	.	.	O	.	_	0	SENT_329	[p18l534t2092r1427b2172],

1	REFERENCES	NNS	O	reference	_	0	SENT_330	[p18l13t2332r401b2376],

1	1	LS	NUMBER	1	_	0	SENT_331	[p18l51t2486r95b2535],
2	.	.	O	.	_	0	SENT_331	[p18l51t2486r95b2535],

1	Chen	NNP	O	Chen	nn	2	SENT_332	[p18l138t2483r294b2536],
2	Q	NNP	O	Q	_	0	SENT_332	[p18l323t2483r401b2549],
3	,	,	O	,	_	0	SENT_332	[p18l323t2483r401b2549],
4	Reis	NNP	PERSON	Reis	nn	5	SENT_332	[p18l424t2484r543b2535],
5	SE	NN	O	se	appos	2	SENT_332	[p18l575t2483r673b2547],
6	,	,	O	,	_	0	SENT_332	[p18l575t2483r673b2547],
7	Kammerer	NNP	PERSON	Kammerer	nn	8	SENT_332	[p18l705t2484r1006b2535],
8	CM	NN	O	cm	appos	2	SENT_332	[p18l1035t2483r1169b2547],
9	,	,	O	,	_	0	SENT_332	[p18l1035t2483r1169b2547],
10	et	FW	O	et	nn	11	SENT_332	[p18l1200t2497r1251b2535],
11	al.	FW	O	al.	appos	2	SENT_332	[p18l1279t2483r1338b2535],
12	.	.	O	.	_	0	SENT_332	[p18l1279t2483r1338b2535],

1	APOE	NNP	ORGANIZATION	APOE	nn	2	SENT_333	[p18l1368t2482r1569b2536],
2	polymorphism	NN	O	polymorphism	_	0	SENT_333	[p18l1597t2483r2009b2554],
3	and	CC	O	and	_	0	SENT_333	[p18l2039t2483r2141b2535],
4	angiographic	JJ	O	angiographic	amod	6	SENT_333	[p18l138t2562r503b2633],
5	coronary	JJ	O	coronary	amod	6	SENT_333	[p18l523t2582r771b2633],
6	artery	NN	O	artery	conj_and	2	SENT_333	[p18l789t2576r951b2633],
7	disease	NN	O	disease	nn	8	SENT_333	[p18l968t2562r1162b2614],
8	severity	NN	O	severity	dep	2	SENT_333	[p18l1184t2564r1396b2633],
9	in	IN	O	in	_	0	SENT_333	[p18l1413t2564r1467b2614],
10	the	DT	O	the	det	11	SENT_333	[p18l1487t2562r1575b2614],
11	Women	NNS	O	woman	poss	14	SENT_333	[p18l1593t2562r1865b2615],
12	’s	POS	O	’s	_	0	SENT_333	[p18l1593t2562r1865b2615],
13	Ischemia	NN	O	ischemia	nn	14	SENT_333	[p18l1886t2562r2141b2614],
14	Syndrome	NN	O	syndrome	prep_in	8	SENT_333	[p18l139t2640r430b2711],
15	Evaluation	NN	O	evaluation	nn	17	SENT_333	[p18l483t2640r796b2692],
16	(	CD	NUMBER	(	num	17	SENT_333	[p18l849t2639r1081b2704],
17	VVISE	NNP	O	VVISE	dep	2	SENT_333	[p18l849t2639r1081b2704],
18	)	CD	NUMBER	)	num	19	SENT_333	[p18l849t2639r1081b2704],
19	study	NN	O	study	dep	17	SENT_333	[p18l1136t2640r1302b2711],
20	.	.	O	.	_	0	SENT_333	[p18l1136t2640r1302b2711],

1	Atherosclerosis	NNP	O	Atherosclerosis	_	0	SENT_334	[p18l1354t2639r1799b2692],
2	2003	CD	DATE	2003	num	1	SENT_334	[p18l1849t2643r2136b2704],
3	;	:	O	;	_	0	SENT_334	[p18l1849t2643r2136b2704],
4	169	CD	NUMBER	169	num	6	SENT_334	[p18l1849t2643r2136b2704],
5	:	:	O	:	_	0	SENT_334	[p18l1849t2643r2136b2704],
6	159-67	CD	NUMBER	159-67	dep	1	SENT_334	[p18l140t2719r379b2772],
7	.	.	O	.	_	0	SENT_334	[p18l140t2719r379b2772],

1	2	LS	NUMBER	2	_	0	SENT_335	[p18l46t2800r95b2850],
2	.	.	O	.	_	0	SENT_335	[p18l46t2800r95b2850],

1	Cohen	NNP	PERSON	Cohen	nn	2	SENT_336	[p18l138t2797r329b2850],
2	JC	NNP	PERSON	JC	_	0	SENT_336	[p18l359t2797r456b2864],
3	,	,	O	,	_	0	SENT_336	[p18l359t2797r456b2864],
4	Boerwinkle	NNP	PERSON	Boerwinkle	nn	5	SENT_336	[p18l497t2797r819b2850],
5	E	NNP	O	E	appos	2	SENT_336	[p18l860t2798r920b2861],
6	,	,	O	,	_	0	SENT_336	[p18l860t2798r920b2861],
7	Mosley	NNP	PERSON	Mosley	nn	8	SENT_336	[p18l959t2797r1171b2868],
8	TH	NN	O	th	appos	2	SENT_336	[p18l1204t2796r1313b2849],
9	]	CD	NUMBER	]	num	10	SENT_336	[p18l1345t2798r1431b2864],
10	r.	NN	O	r.	dep	8	SENT_336	[p18l1345t2798r1431b2864],
11	,	,	O	,	_	0	SENT_336	[p18l1345t2798r1431b2864],
12	Hobbs	NNP	PERSON	Hobbs	nn	13	SENT_336	[p18l1471t2797r1660b2849],
13	HH	NNP	O	HH	appos	2	SENT_336	[p18l1700t2798r1833b2849],
14	.	.	O	.	_	0	SENT_336	[p18l1700t2798r1833b2849],

1	Sequence	NN	O	sequence	nn	2	SENT_337	[p18l1877t2797r2139b2868],
2	variations	NNS	O	variation	_	0	SENT_337	[p18l134t2877r407b2927],
3	in	IN	O	in	_	0	SENT_337	[p18l430t2877r484b2927],
4	PCSK9	NN	O	pcsk9	prep_in	2	SENT_337	[p18l506t2875r740b2939],
5	,	,	O	,	_	0	SENT_337	[p18l506t2875r740b2939],
6	low	JJ	O	low	amod	7	SENT_337	[p18l763t2875r867b2927],
7	LDL	NN	O	ldl	prep_in	2	SENT_337	[p18l887t2876r1051b2939],
8	,	,	O	,	_	0	SENT_337	[p18l887t2876r1051b2939],
9	and	CC	O	and	_	0	SENT_337	[p18l1076t2875r1178b2927],
10	protection	NN	O	protection	prep_in	2	SENT_337	[p18l1198t2877r1490b2946],
11	against	IN	O	against	_	0	SENT_337	[p18l1512t2877r1710b2946],
12	coronary	JJ	O	coronary	amod	14	SENT_337	[p18l1731t2895r1978b2946],
13	heart	NN	O	heart	nn	14	SENT_337	[p18l1996t2875r2141b2927],
14	disease	NN	O	disease	prep_against	2	SENT_337	[p18l137t2953r346b3005],
15	.	.	O	.	_	0	SENT_337	[p18l137t2953r346b3005],

1	N	NN	O	n	nn	3	SENT_338	[p18l375t2954r428b3005],
2	Engl	NNP	O	Engl	nn	3	SENT_338	[p18l457t2953r640b3024],
3	]	NNP	O	]	nsubj	4	SENT_338	[p18l457t2953r640b3024],
4	Med	VBD	O	med	_	0	SENT_338	[p18l665t2953r801b3005],
5	2006	CD	DATE	2006	dobj	4	SENT_338	[p18l825t2953r1380b3017],
6	;	:	O	;	_	0	SENT_338	[p18l825t2953r1380b3017],
7	354:1264	CD	NUMBER	354:1264	num	8	SENT_338	[p18l825t2953r1380b3017],
8	-72	CD	NUMBER	-72	dep	5	SENT_338	[p18l825t2953r1380b3017],
9	.	.	O	.	_	0	SENT_338	[p18l825t2953r1380b3017],

1	3	LS	NUMBER	3	_	0	SENT_339	[p18l48t3034r95b3084],
2	.	.	O	.	_	0	SENT_339	[p18l48t3034r95b3084],

1	Florez	NNP	ORGANIZATION	Florez	nn	2	SENT_340	[p18l137t3031r317b3083],
2	JC	NNP	ORGANIZATION	JC	_	0	SENT_340	[p18l326t3031r424b3098],
3	,	,	O	,	_	0	SENT_340	[p18l326t3031r424b3098],
4	Jablonski	NNP	PERSON	Jablonski	nn	5	SENT_340	[p18l437t3031r702b3098],
5	KA	NN	O	ka	appos	2	SENT_340	[p18l723t3030r837b3095],
6	,	,	O	,	_	0	SENT_340	[p18l723t3030r837b3095],
7	Bayley	NNP	PERSON	Bayley	nn	8	SENT_340	[p18l858t3031r1046b3102],
8	N	NNP	O	N	appos	2	SENT_340	[p18l1061t3032r1131b3095],
9	,	,	O	,	_	0	SENT_340	[p18l1061t3032r1131b3095],
10	et	FW	O	et	nn	11	SENT_340	[p18l1153t3045r1203b3083],
11	al.	FW	O	al.	appos	2	SENT_340	[p18l1222t3031r1281b3083],
12	.	.	O	.	_	0	SENT_340	[p18l1222t3031r1281b3083],

1	TCF7L2	NN	O	tcf7l2	nn	2	SENT_341	[p18l1301t3030r1562b3084],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_341	[p18l1581t3031r2017b3102],
3	and	CC	O	and	_	0	SENT_341	[p18l2039t3031r2140b3083],
4	progression	NN	O	progression	conj_and	2	SENT_341	[p18l136t3111r462b3180],
5	to	TO	O	to	_	0	SENT_341	[p18l488t3123r543b3161],
6	diabetes	NN	O	diabetes	prep_to	2	SENT_341	[p18l571t3109r797b3161],
7	in	IN	O	in	_	0	SENT_341	[p18l825t3111r879b3161],
8	the	DT	O	the	det	11	SENT_341	[p18l906t3109r993b3161],
9	Diabetes	NNP	O	Diabetes	nn	11	SENT_341	[p18l1021t3109r1268b3161],
10	Prevention	NNP	O	Prevention	nn	11	SENT_341	[p18l1297t3110r1605b3161],
11	Program	NNP	O	Program	prep_in	2	SENT_341	[p18l1632t3110r1892b3180],
12	.	.	O	.	_	0	SENT_341	[p18l1632t3110r1892b3180],

1	N	NN	O	n	nn	3	SENT_342	[p18l1922t3110r1975b3161],
2	Engl	NNP	O	Engl	nn	3	SENT_342	[p18l2004t3109r2141b3180],
3	J	NNP	O	J	nsubj	4	SENT_342	[p18l129t3189r158b3255],
4	Med	VBD	O	med	_	0	SENT_342	[p18l183t3188r319b3240],
5	2006	CD	DATE	2006	dobj	4	SENT_342	[p18l343t3188r854b3252],
6	;	:	O	;	_	0	SENT_342	[p18l343t3188r854b3252],
7	355:241	CD	NUMBER	355:241	number	8	SENT_342	[p18l343t3188r854b3252],
8	—	CD	NUMBER	—	dep	5	SENT_342	[p18l343t3188r854b3252],
9	50	CD	NUMBER	50	dep	8	SENT_342	[p18l343t3188r854b3252],
10	.	.	O	.	_	0	SENT_342	[p18l343t3188r854b3252],

1	4	LS	NUMBER	4	_	0	SENT_343	[p18l47t3270r95b3320],
2	.	.	O	.	_	0	SENT_343	[p18l47t3270r95b3320],

1	Gibbons	NNP	PERSON	Gibbons	nn	2	SENT_344	[p18l138t3267r380b3320],
2	GH	NN	O	gh	_	0	SENT_344	[p18l424t3267r554b3331],
3	,	,	O	,	_	0	SENT_344	[p18l424t3267r554b3331],
4	Liew	NNP	ORGANIZATION	Liew	nn	5	SENT_344	[p18l598t3268r742b3320],
5	CC	NN	ORGANIZATION	cc	appos	2	SENT_344	[p18l782t3267r900b3331],
6	,	,	O	,	_	0	SENT_344	[p18l782t3267r900b3331],
7	Goodarzi	NNP	O	Goodarzi	nn	8	SENT_344	[p18l944t3267r1211b3320],
8	MC	NNP	O	MC	appos	2	SENT_344	[p18l1250t3267r1393b3331],
9	,	,	O	,	_	0	SENT_344	[p18l1250t3267r1393b3331],
10	et	FW	O	et	nn	11	SENT_344	[p18l1437t3281r1488b3320],
11	al.	FW	O	al.	appos	2	SENT_344	[p18l1528t3267r1588b3320],
12	.	.	O	.	_	0	SENT_344	[p18l1528t3267r1588b3320],

1	Genetic	JJ	O	genetic	amod	2	SENT_345	[p18l1634t3267r1857b3320],
2	markers	NNS	O	marker	_	0	SENT_345	[p18l1898t3267r2136b3320],
3	:	:	O	:	_	0	SENT_345	[p18l1898t3267r2136b3320],
4	progress	NN	O	progress	dep	2	SENT_345	[p18l136t3365r368b3416],
5	and	CC	O	and	_	0	SENT_345	[p18l406t3345r508b3397],
6	potential	NN	O	potential	dep	2	SENT_345	[p18l543t3345r794b3416],
7	for	IN	O	for	_	0	SENT_345	[p18l829t3345r910b3397],
8	cardiovascular	JJ	O	cardiovascular	amod	9	SENT_345	[p18l945t3345r1342b3397],
9	disease	NN	O	disease	prep_for	4	SENT_345	[p18l1377t3345r1586b3397],
10	.	.	O	.	_	0	SENT_345	[p18l1377t3345r1586b3397],

1	Circulation	NN	O	circulation	_	0	SENT_346	[p18l1627t3345r1947b3398],
2	2004	CD	DATE	2004	num	1	SENT_346	[p18l1981t3348r2137b3409],
3	;	:	O	;	_	0	SENT_346	[p18l1981t3348r2137b3409],
4	109	CD	NUMBER	109	dep	1	SENT_346	[p18l140t3424r527b3477],
5	:	:	O	:	_	0	SENT_346	[p18l140t3424r527b3477],
6	IV47-58	NN	O	iv47-58	dep	4	SENT_346	[p18l140t3424r527b3477],
7	.	.	O	.	_	0	SENT_346	[p18l140t3424r527b3477],

1	5	CD	NUMBER	5	_	0	SENT_347	[p18l48t3502r95b3555],
2	.	.	O	.	_	0	SENT_347	[p18l48t3502r95b3555],

1	Arnett	NNP	PERSON	Arnett	nn	2	SENT_348	[p18l135t3501r326b3554],
2	DK	NNP	O	DK	_	0	SENT_348	[p18l353t3503r474b3566],
3	,	,	O	,	_	0	SENT_348	[p18l353t3503r474b3566],
4	Baird	NNP	ORGANIZATION	Baird	nn	5	SENT_348	[p18l504t3502r659b3554],
5	AE	NNP	ORGANIZATION	AE	appos	2	SENT_348	[p18l685t3501r802b3566],
6	,	,	O	,	_	0	SENT_348	[p18l685t3501r802b3566],
7	Barkley	NNP	PERSON	Barkley	nn	8	SENT_348	[p18l832t3502r1048b3573],
8	RA	NN	O	ra	appos	2	SENT_348	[p18l1075t3501r1188b3566],
9	,	,	O	,	_	0	SENT_348	[p18l1075t3501r1188b3566],
10	et	FW	O	et	nn	11	SENT_348	[p18l1220t3516r1270b3554],
11	al.	FW	O	al.	appos	2	SENT_348	[p18l1298t3502r1358b3554],
12	.	.	O	.	_	0	SENT_348	[p18l1298t3502r1358b3554],

1	Relevance	NN	O	relevance	_	0	SENT_349	[p18l1390t3502r1672b3554],
2	of	IN	O	of	_	0	SENT_349	[p18l1701t3502r1765b3554],
3	genetics	NNS	O	genetics	prep_of	1	SENT_349	[p18l1782t3504r2008b3573],
4	and	CC	O	and	_	0	SENT_349	[p18l2039t3502r2140b3554],
5	genomics	NNS	O	genomic	conj_and	3	SENT_349	[p18l136t3582r401b3651],
6	for	IN	O	for	dep	1	SENT_349	[p18l438t3580r519b3632],
7	prevention	NN	O	prevention	pobj	6	SENT_349	[p18l552t3582r855b3651],
8	and	CC	O	and	_	0	SENT_349	[p18l892t3580r994b3632],
9	treatment	NN	O	treatment	pobj	6	SENT_349	[p18l1029t3594r1306b3632],
10	of	IN	O	of	dep	1	SENT_349	[p18l1341t3580r1405b3632],
11	cardiovascular	JJ	O	cardiovascular	amod	12	SENT_349	[p18l1432t3580r1829b3632],
12	disease	NN	O	disease	pobj	10	SENT_349	[p18l1864t3580r2072b3632],
13	:	:	O	:	_	0	SENT_349	[p18l1864t3580r2072b3632],
14	a	DT	O	a	det	16	SENT_349	[p18l2113t3601r2141b3632],
15	scientiﬁc	NN	O	scientiﬁc	nn	16	SENT_349	[p18l138t3658r385b3710],
16	statement	NN	O	statement	dep	1	SENT_349	[p18l409t3672r686b3710],
17	from	IN	O	from	dep	16	SENT_349	[p18l708t3658r843b3710],
18	the	DT	O	the	det	22	SENT_349	[p18l867t3658r955b3710],
19	American	JJ	O	american	amod	22	SENT_349	[p18l977t3657r1256b3710],
20	Heart	NNP	ORGANIZATION	Heart	nn	22	SENT_349	[p18l1280t3659r1446b3710],
21	Association	NNP	ORGANIZATION	Association	nn	22	SENT_349	[p18l1466t3657r1798b3710],
22	Council	NNP	ORGANIZATION	Council	pobj	17	SENT_349	[p18l1822t3658r2047b3711],
23	on	IN	O	on	dep	16	SENT_349	[p18l2070t3679r2140b3710],

1	Epidemiology	NNP	O	Epidemiology	_	0	SENT_350	[p19l138t19r539b90],
2	and	CC	O	and	_	0	SENT_350	[p19l558t19r659b71],
3	Prevention	NNP	O	Prevention	conj_and	1	SENT_350	[p19l679t20r1003b83],
4	,	,	O	,	_	0	SENT_350	[p19l679t20r1003b83],
5	the	DT	O	the	det	7	SENT_350	[p19l1026t19r1114b71],
6	Stroke	NNP	ORGANIZATION	Stroke	nn	7	SENT_350	[p19l1137t19r1317b72],
7	Council	NNP	ORGANIZATION	Council	conj_and	1	SENT_350	[p19l1340t19r1580b83],
8	,	,	O	,	_	0	SENT_350	[p19l1340t19r1580b83],
9	and	CC	O	and	_	0	SENT_350	[p19l1603t19r1705b71],
10	the	DT	O	the	det	12	SENT_350	[p19l1725t19r1813b71],
11	Functional	JJ	ORGANIZATION	functional	amod	12	SENT_350	[p19l1834t19r2141b71],
12	Genomics	NNS	ORGANIZATION	genomic	conj_and	1	SENT_350	[p19l138t97r431b150],
13	and	CC	ORGANIZATION	and	_	0	SENT_350	[p19l484t97r588b149],
14	Translational	JJ	ORGANIZATION	translational	amod	18	SENT_350	[p19l636t96r1025b149],
15	Biology	NNP	ORGANIZATION	Biology	nn	18	SENT_350	[p19l1075t97r1300b168],
16	Interdisciplinary	NNP	ORGANIZATION	Interdisciplinary	nn	18	SENT_350	[p19l1348t97r1829b168],
17	Working	NNP	ORGANIZATION	Working	nn	18	SENT_350	[p19l1874t97r2141b168],
18	Group	NNP	ORGANIZATION	Group	conj_and	12	SENT_350	[p19l138t175r339b246],
19	.	.	O	.	_	0	SENT_350	[p19l138t175r339b246],

1	Circulation	NN	O	circulation	_	0	SENT_351	[p19l370t175r690b228],
2	2007	CD	DATE	2007	num	1	SENT_351	[p19l715t175r1138b239],
3	;	:	O	;	_	0	SENT_351	[p19l715t175r1138b239],
4	115:2878	CD	NUMBER	115:2878	number	5	SENT_351	[p19l715t175r1138b239],
5	-901	CD	NUMBER	-901	dep	1	SENT_351	[p19l1150t178r1305b228],
6	.	.	O	.	_	0	SENT_351	[p19l1150t178r1305b228],

1	lakoubova	NN	O	lakoubova	_	0	SENT_352	[p19l1367t264r1655b317],
2	et	FW	O	et	nn	3	SENT_352	[p19l1684t267r1741b317],
3	al.	FW	O	al.	dep	1	SENT_352	[p19l1762t265r1830b317],
4	.	.	O	.	_	0	SENT_352	[p19l1762t265r1830b317],

1	KlF6	NN	O	klf6	nn	2	SENT_353	[p19l477t352r612b405],
2	Trp719Arg	NN	O	trp719arg	_	0	SENT_353	[p19l631t352r942b415],
3	in	IN	O	in	_	0	SENT_353	[p19l967t353r1014b404],
4	the	DT	O	the	det	6	SENT_353	[p19l1040t353r1132b405],
5	PROVE	NNP	O	PROVE	nn	6	SENT_353	[p19l1160t352r1350b405],
6	IT-TIMI	NN	O	it-timus	prep_in	2	SENT_353	[p19l1377t353r1575b404],
7	22	CD	NUMBER	22	num	8	SENT_353	[p19l1603t352r1677b404],
8	Trial	NN	O	trial	dep	2	SENT_353	[p19l1701t353r1829b405],

1	.	.	O	.	_	0	SENT_354	[p19l81t619r90b628],

1	Hirokawa	NNP	PERSON	Hirokawa	nn	2	SENT_355	[p19l133t575r416b628],
2	N.	NNP	PERSON	N.	_	0	SENT_355	[p19l465t575r534b628],
3	Kinesin	NNP	PERSON	Kinesin	nn	7	SENT_355	[p19l590t575r806b628],
4	and	CC	O	and	_	0	SENT_355	[p19l857t574r959b628],
5	dynein	NN	O	dynein	nn	7	SENT_355	[p19l1009t574r1200b646],
6	superfamily	NN	O	superfamily	nn	7	SENT_355	[p19l1251t574r1583b646],
7	proteins	NNS	O	protein	dep	2	SENT_355	[p19l1628t577r1858b646],
8	and	CC	O	and	_	0	SENT_355	[p19l1910t574r2013b628],
9	the	DT	O	the	det	10	SENT_355	[p19l2062t575r2151b628],
10	mechanism	NN	O	mechanism	dep	2	SENT_355	[p19l133t657r456b710],
11	of	IN	O	of	_	0	SENT_355	[p19l484t656r548b710],
12	organelle	NN	O	organelle	nn	13	SENT_355	[p19l565t656r823b728],
13	transport	NN	O	transport	prep_of	2	SENT_355	[p19l850t670r1123b728],
14	.	.	O	.	_	0	SENT_355	[p19l850t670r1123b728],

1	Science	NN	O	science	_	0	SENT_356	[p19l1156t656r1366b710],
2	1998	CD	DATE	1998	num	1	SENT_356	[p19l1396t657r1915b722],
3	;	:	O	;	_	0	SENT_356	[p19l1396t657r1915b722],
4	279:519	CD	NUMBER	279:519	number	5	SENT_356	[p19l1396t657r1915b722],
5	-26	CD	NUMBER	-26	dep	1	SENT_356	[p19l1396t657r1915b722],
6	.	.	O	.	_	0	SENT_356	[p19l1396t657r1915b722],

1	Miki	NNP	PERSON	Miki	nn	2	SENT_357	[p19l131t739r274b791],
2	H	NNP	PERSON	H	_	0	SENT_357	[p19l300t739r374b803],
3	,	,	O	,	_	0	SENT_357	[p19l300t739r374b803],
4	Okada	NNP	PERSON	Okada	nn	5	SENT_357	[p19l403t738r593b792],
5	Y	NN	PERSON	y	appos	2	SENT_357	[p19l614t739r678b804],
6	,	,	O	,	_	0	SENT_357	[p19l614t739r678b804],
7	Hirokawa	NNP	PERSON	Hirokawa	nn	9	SENT_357	[p19l707t739r991b792],
8	N.	NNP	PERSON	N.	nn	9	SENT_357	[p19l1015t739r1084b792],
9	Analysis	NN	PERSON	analysis	appos	2	SENT_357	[p19l1112t737r1351b810],
10	of	IN	O	of	_	0	SENT_357	[p19l1379t738r1443b792],
11	the	DT	O	the	det	13	SENT_357	[p19l1459t739r1548b792],
12	kinesin	NN	O	kinesin	nn	13	SENT_357	[p19l1574t739r1777b792],
13	superfamily	NN	O	superfamily	prep_of	9	SENT_357	[p19l1804t738r2148b810],
14	:	:	O	:	_	0	SENT_357	[p19l1804t738r2148b810],
15	insights	NNS	O	insight	dep	2	SENT_357	[p19l132t821r352b892],
16	into	IN	O	into	_	0	SENT_357	[p19l373t823r484b874],
17	structure	NN	O	structure	prep_into	15	SENT_357	[p19l506t834r754b874],
18	and	CC	O	and	_	0	SENT_357	[p19l775t820r878b874],
19	function	NN	O	function	prep_into	15	SENT_357	[p19l897t820r1150b874],
20	.	.	O	.	_	0	SENT_357	[p19l897t820r1150b874],

1	Trends	NNS	O	trend	nn	2	SENT_358	[p19l1171t819r1375b874],
2	Cell	NN	O	cell	_	0	SENT_358	[p19l1397t820r1515b874],
3	Biol	NNP	O	Biol	dep	2	SENT_358	[p19l1533t821r1652b874],
4	2005	CD	DATE	2005	num	3	SENT_358	[p19l1669t820r2148b886],
5	;	:	O	;	_	0	SENT_358	[p19l1669t820r2148b886],
6	15:467	CD	NUMBER	15:467	number	7	SENT_358	[p19l1669t820r2148b886],
7	—	CD	NUMBER	—	dep	2	SENT_358	[p19l1669t820r2148b886],
8	76	CD	NUMBER	76	dep	7	SENT_358	[p19l1669t820r2148b886],
9	.	.	O	.	_	0	SENT_358	[p19l1669t820r2148b886],

1	.	.	O	.	_	0	SENT_359	[p19l81t947r90b956],

1	lakoubova	NN	O	lakoubova	nn	2	SENT_360	[p19l132t903r428b956],
2	OA	NN	O	oa	_	0	SENT_360	[p19l461t901r585b968],
3	,	,	O	,	_	0	SENT_360	[p19l461t901r585b968],
4	Tong	NNP	PERSON	Tong	nn	5	SENT_360	[p19l618t901r777b974],
5	CH	NN	O	ch	appos	2	SENT_360	[p19l810t902r936b968],
6	,	,	O	,	_	0	SENT_360	[p19l810t902r936b968],
7	Rowland	NNP	ORGANIZATION	Rowland	nn	8	SENT_360	[p19l972t902r1227b956],
8	CM	NN	ORGANIZATION	cm	appos	2	SENT_360	[p19l1261t902r1395b968],
9	,	,	O	,	_	0	SENT_360	[p19l1261t902r1395b968],
10	et	FW	O	et	nn	11	SENT_360	[p19l1431t916r1482b956],
11	al.	FW	O	al.	appos	2	SENT_360	[p19l1515t903r1574b956],
12	.	.	O	.	_	0	SENT_360	[p19l1515t903r1574b956],

1	Association	NNP	O	Association	_	0	SENT_361	[p19l1608t901r1942b956],
2	of	IN	O	of	_	0	SENT_361	[p19l1975t902r2039b956],
3	the	DT	O	the	det	5	SENT_361	[p19l2062t903r2150b956],
4	Trp719Arg	NN	O	trp719arg	nn	5	SENT_361	[p19l130t983r462b1056],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_361	[p19l490t984r905b1056],
6	in	IN	O	in	_	0	SENT_361	[p19l935t987r990b1037],
7	kinesin	NN	O	kinesin	prep_in	5	SENT_361	[p19l1020t984r1354b1038],
8	—	CD	NUMBER	—	num	7	SENT_361	[p19l1020t984r1354b1038],
9	like	IN	O	like	_	0	SENT_361	[p19l1020t984r1354b1038],
10	protein	NN	O	protein	prep_like	7	SENT_361	[p19l1384t987r1590b1056],
11	6	CD	NUMBER	6	num	10	SENT_361	[p19l1621t987r1651b1038],
12	with	IN	O	with	_	0	SENT_361	[p19l1680t985r1810b1038],
13	myocardial	JJ	O	myocardial	amod	14	SENT_361	[p19l1840t984r2152b1056],
14	infarction	NN	O	infarction	prep_with	10	SENT_361	[p19l132t1066r409b1119],
15	and	CC	O	and	_	0	SENT_361	[p19l430t1066r532b1120],
16	coronary	JJ	O	coronary	amod	18	SENT_361	[p19l552t1087r802b1138],
17	heart	NN	O	heart	nn	18	SENT_361	[p19l818t1066r964b1119],
18	disease	NN	O	disease	prep_with	10	SENT_361	[p19l983t1066r1177b1119],
19	in	IN	O	in	_	0	SENT_361	[p19l1197t1069r1252b1119],
20	2	CD	NUMBER	2	num	22	SENT_361	[p19l1270t1069r1304b1120],
21	prospective	JJ	O	prospective	amod	22	SENT_361	[p19l1324t1069r1643b1138],
22	trials	NNS	O	trial	prep_in	14	SENT_361	[p19l1663t1066r1817b1119],
23	:	:	O	:	_	0	SENT_361	[p19l1663t1066r1817b1119],
24	the	DT	O	the	det	28	SENT_361	[p19l1839t1066r1928b1119],
25	CARE	NNP	O	CARE	nn	28	SENT_361	[p19l1950t1065r2151b1120],
26	and	CC	O	and	_	0	SENT_361	[p19l134t1148r236b1202],
27	WOSCOPS	NNP	O	WOSCOPS	nn	28	SENT_361	[p19l259t1148r625b1202],
28	trials	NNS	O	trial	dep	1	SENT_361	[p19l653t1148r806b1202],
29	.	.	O	.	_	0	SENT_361	[p19l653t1148r806b1202],

1	J	NNP	O	J	nn	4	SENT_362	[p19l829t1149r858b1216],
2	Am	NNP	O	Am	nn	4	SENT_362	[p19l882t1147r992b1201],
3	Coll	NNP	O	Coll	nn	4	SENT_362	[p19l1020t1148r1143b1202],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_362	[p19l1169t1148r1385b1202],
5	2008	CD	DATE	2008	num	4	SENT_362	[p19l1409t1148r1897b1214],
6	;	:	O	;	_	0	SENT_362	[p19l1409t1148r1897b1214],
7	51:435	CD	NUMBER	51:435	number	8	SENT_362	[p19l1409t1148r1897b1214],
8	-43	CD	NUMBER	-43	dep	4	SENT_362	[p19l1409t1148r1897b1214],
9	.	.	O	.	_	0	SENT_362	[p19l1409t1148r1897b1214],

1	.	.	O	.	_	0	SENT_363	[p19l81t1275r90b1283],

1	Morrison	NNP	ORGANIZATION	Morrison	nn	2	SENT_364	[p19l131t1231r403b1283],
2	AC	NN	ORGANIZATION	ac	_	0	SENT_364	[p19l425t1229r546b1295],
3	,	,	O	,	_	0	SENT_364	[p19l425t1229r546b1295],
4	Bare	JJ	O	bare	amod	5	SENT_364	[p19l573t1231r702b1283],
5	LA	NNP	O	LA	appos	2	SENT_364	[p19l728t1229r840b1295],
6	,	,	O	,	_	0	SENT_364	[p19l728t1229r840b1295],
7	Chambless	NNP	ORGANIZATION	Chambless	nn	8	SENT_364	[p19l869t1230r1179b1284],
8	LE	NNP	ORGANIZATION	LE	appos	2	SENT_364	[p19l1205t1231r1315b1295],
9	,	,	O	,	_	0	SENT_364	[p19l1205t1231r1315b1295],
10	et	FW	O	et	nn	11	SENT_364	[p19l1341t1244r1393b1283],
11	al.	FW	O	al.	appos	2	SENT_364	[p19l1417t1230r1477b1284],
12	.	.	O	.	_	0	SENT_364	[p19l1417t1230r1477b1284],

1	Prediction	NN	O	prediction	_	0	SENT_365	[p19l1504t1230r1801b1283],
2	of	IN	O	of	_	0	SENT_365	[p19l1826t1230r1890b1283],
3	coronary	JJ	O	coronary	amod	6	SENT_365	[p19l1905t1251r2154b1302],
4	heart	NN	O	heart	nn	6	SENT_365	[p19l132t1312r278b1365],
5	disease	NN	O	disease	nn	6	SENT_365	[p19l298t1312r493b1365],
6	risk	NN	O	risk	prep_of	1	SENT_365	[p19l514t1312r619b1365],
7	using	VBG	O	use	partmod	6	SENT_365	[p19l635t1315r789b1384],
8	a	DT	O	a	det	11	SENT_365	[p19l809t1333r836b1365],
9	genetic	JJ	O	genetic	amod	11	SENT_365	[p19l855t1315r1059b1384],
10	risk	NN	O	risk	nn	11	SENT_365	[p19l1078t1312r1184b1365],
11	score	NN	NUMBER	score	dobj	7	SENT_365	[p19l1202t1333r1359b1365],
12	:	:	O	:	_	0	SENT_365	[p19l1202t1333r1359b1365],
13	the	DT	O	the	det	15	SENT_365	[p19l1382t1312r1471b1365],
14	Atherosclerosis	NNP	O	Atherosclerosis	nn	15	SENT_365	[p19l1490t1311r1927b1365],
15	Risk	NN	O	risk	dep	1	SENT_365	[p19l1951t1312r2079b1365],
16	in	IN	O	in	_	0	SENT_365	[p19l2097t1315r2151b1365],
17	Communities	NNP	O	Communities	nn	18	SENT_365	[p19l134t1394r524b1448],
18	Study	NNP	O	Study	prep_in	15	SENT_365	[p19l555t1394r731b1466],
19	.	.	O	.	_	0	SENT_365	[p19l555t1394r731b1466],

1	AmJ	NN	O	amj	nn	2	SENT_366	[p19l759t1393r917b1462],
2	Epidemiol	NN	O	epidemiol	_	0	SENT_366	[p19l944t1394r1245b1466],
3	2007	CD	DATE	2007	dep	2	SENT_366	[p19l1269t1394r1757b1459],
4	;	:	O	;	_	0	SENT_366	[p19l1269t1394r1757b1459],
5	166:28	CD	NUMBER	166:28	number	6	SENT_366	[p19l1269t1394r1757b1459],
6	—	CD	NUMBER	—	dep	2	SENT_366	[p19l1269t1394r1757b1459],
7	35	CD	NUMBER	35	dep	6	SENT_366	[p19l1269t1394r1757b1459],
8	.	.	O	.	_	0	SENT_366	[p19l1269t1394r1757b1459],

1	Shilfman	NN	O	shilfman	nn	2	SENT_367	[p19l136t1476r391b1530],
2	D	NN	O	d	_	0	SENT_367	[p19l416t1477r487b1541],
3	,	,	O	,	_	0	SENT_367	[p19l416t1477r487b1541],
4	Chasman	NNP	PERSON	Chasman	nn	5	SENT_367	[p19l515t1476r785b1530],
5	DI	NNP	O	DI	appos	2	SENT_367	[p19l809t1477r907b1541],
6	,	,	O	,	_	0	SENT_367	[p19l809t1477r907b1541],
7	Zee	NNP	O	Zee	nn	8	SENT_367	[p19l935t1477r1042b1530],
8	RYL	NNP	O	RYL	appos	2	SENT_367	[p19l1068t1477r1225b1541],
9	,	,	O	,	_	0	SENT_367	[p19l1068t1477r1225b1541],
10	et	FW	O	et	nn	11	SENT_367	[p19l1252t1490r1303b1529],
11	al.	FW	O	al.	appos	2	SENT_367	[p19l1327t1476r1387b1529],
12	.	.	O	.	_	0	SENT_367	[p19l1327t1476r1387b1529],

1	A	DT	O	a	det	7	SENT_368	[p19l1413t1475r1467b1529],
2	kinesin	NN	O	kinesin	nn	7	SENT_368	[p19l1489t1476r1693b1529],
3	family	NN	O	family	nn	7	SENT_368	[p19l1717t1476r1896b1548],
4	member	NN	O	member	nn	7	SENT_368	[p19l1918t1476r2153b1529],
5	6	CD	NUMBER	6	num	7	SENT_368	[p19l134t1561r164b1612],
6	(	NN	O	(	nn	7	SENT_368	[p19l209t1557r403b1623],
7	KIF6	NN	O	kif6	nsubjpass	11	SENT_368	[p19l209t1557r403b1623],
8	)	CD	NUMBER	)	num	9	SENT_368	[p19l209t1557r403b1623],
9	variant	NN	O	variant	dep	7	SENT_368	[p19l444t1561r642b1612],
10	is	VBZ	O	be	auxpass	11	SENT_368	[p19l681t1561r722b1611],
11	associated	VBN	O	associate	_	0	SENT_368	[p19l765t1558r1049b1611],
12	with	IN	O	with	_	0	SENT_368	[p19l1086t1558r1216b1612],
13	coronary	JJ	O	coronary	amod	15	SENT_368	[p19l1258t1579r1507b1630],
14	heart	NN	O	heart	nn	15	SENT_368	[p19l1544t1558r1690b1611],
15	disease	NN	O	disease	prep_with	11	SENT_368	[p19l1730t1558r1926b1611],
16	in	IN	O	in	_	0	SENT_368	[p19l1967t1561r2021b1611],
17	the	DT	O	the	det	18	SENT_368	[p19l2062t1558r2151b1611],
18	Women	NNS	O	woman	poss	21	SENT_368	[p19l129t1640r404b1694],
19	’s	POS	O	’s	_	0	SENT_368	[p19l129t1640r404b1694],
20	Health	NNP	O	Health	nn	21	SENT_368	[p19l433t1640r631b1694],
21	Study	NNP	O	Study	prep_in	15	SENT_368	[p19l661t1640r836b1712],
22	.	.	O	.	_	0	SENT_368	[p19l661t1640r836b1712],

1	J	NNP	O	J	nn	4	SENT_369	[p19l859t1641r888b1708],
2	Am	NNP	O	Am	nn	4	SENT_369	[p19l912t1639r1022b1693],
3	Coll	NNP	O	Coll	nn	4	SENT_369	[p19l1050t1640r1173b1694],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_369	[p19l1200t1640r1415b1694],
5	2008	CD	DATE	2008	num	4	SENT_369	[p19l1439t1640r1900b1705],
6	;	:	O	;	_	0	SENT_369	[p19l1439t1640r1900b1705],
7	51:444	CD	NUMBER	51:444	number	8	SENT_369	[p19l1439t1640r1900b1705],
8	-8	CD	NUMBER	-8	dep	4	SENT_369	[p19l1439t1640r1900b1705],
9	.	.	O	.	_	0	SENT_369	[p19l1439t1640r1900b1705],

1	Kajinami	NNP	LOCATION	Kajinami	nn	13	SENT_370	[p19l135t1723r394b1794],
2	K	NNP	LOCATION	K	nn	13	SENT_370	[p19l422t1723r484b1787],
3	,	,	O	,	_	0	SENT_370	[p19l422t1723r484b1787],
4	Okabayashi	NNP	O	Okabayashi	nn	5	SENT_370	[p19l514t1722r846b1794],
5	M	NNP	O	M	dep	13	SENT_370	[p19l871t1723r955b1787],
6	,	,	O	,	_	0	SENT_370	[p19l871t1723r955b1787],
7	Sato	NNP	PERSON	Sato	nn	8	SENT_370	[p19l987t1722r1108b1776],
8	R	NNP	PERSON	R	appos	5	SENT_370	[p19l1137t1723r1199b1787],
9	,	,	O	,	_	0	SENT_370	[p19l1137t1723r1199b1787],
10	Polisecki	NNP	PERSON	Polisecki	nn	11	SENT_370	[p19l1227t1722r1481b1775],
11	E	NNP	PERSON	E	appos	5	SENT_370	[p19l1509t1723r1569b1787],
12	,	,	O	,	_	0	SENT_370	[p19l1509t1723r1569b1787],
13	Schaefer	NNP	PERSON	Schaefer	_	0	SENT_370	[p19l1601t1722r1842b1776],
14	`	``	O	`	_	0	SENT_370	[p19l1868t1723r1952b1790],
15	`	``	O	`	_	0	SENT_370	[p19l1868t1723r1952b1790],
16	E	NN	O	e	dep	13	SENT_370	[p19l1868t1723r1952b1790],
17	*	CD	NUMBER	*	num	16	SENT_370	[p19l1868t1723r1952b1790],
18	Statin	NN	O	statin	nn	19	SENT_370	[p19l1984t1722r2152b1776],
19	pharmacogenomics	NNS	O	pharmacogenomic	dep	16	SENT_370	[p19l131t1804r699b1876],
20	:	:	O	:	_	0	SENT_370	[p19l131t1804r699b1876],
21	what	WP	O	what	nsubj	22	SENT_370	[p19l730t1804r873b1858],
22	have	VBP	O	have	rcmod	13	SENT_370	[p19l902t1804r1030b1858],
23	we	PRP	O	we	nsubj	24	SENT_370	[p19l1058t1825r1138b1858],
24	learned	VBD	O	learn	ccomp	22	SENT_370	[p19l1168t1804r1392b1869],
25	,	,	O	,	_	0	SENT_370	[p19l1168t1804r1392b1869],
26	and	CC	O	and	_	0	SENT_370	[p19l1426t1804r1528b1857],
27	what	WP	O	what	nsubj	29	SENT_370	[p19l1556t1804r1699b1858],
28	remains	VBZ	O	remain	cop	29	SENT_370	[p19l1728t1807r1950b1857],
29	unanswered	JJ	O	unanswered	conj_and	22	SENT_370	[p19l1981t1825r2149b1857, p19l134t1886r352b1940],
30	?	.	O	?	_	0	SENT_370	[p19l1981t1825r2149b1857, p19l134t1886r352b1940],

1	Curr	NNP	O	Curr	nn	3	SENT_371	[p19l382t1886r517b1940],
2	Opin	NNP	O	Opin	nn	3	SENT_371	[p19l544t1886r692b1958],
3	Lipidol	NNP	O	Lipidol	_	0	SENT_371	[p19l720t1886r931b1958],
4	2005	CD	DATE	2005	num	3	SENT_371	[p19l955t1886r1310b1951],
5	;	:	O	;	_	0	SENT_371	[p19l955t1886r1310b1951],
6	16:606	CD	NUMBER	16:606	number	7	SENT_371	[p19l955t1886r1310b1951],
7	-13	CD	NUMBER	-13	dep	3	SENT_371	[p19l1321t1889r1442b1940],
8	.	.	O	.	_	0	SENT_371	[p19l1321t1889r1442b1940],

1	Schmitz	NNP	PERSON	Schmitz	nn	2	SENT_372	[p19l136t1968r370b2022],
2	G	NNP	PERSON	G	_	0	SENT_372	[p19l391t1968r461b2033],
3	,	,	O	,	_	0	SENT_372	[p19l391t1968r461b2033],
4	Langmann	NNP	PERSON	Langmann	nn	6	SENT_372	[p19l487t1969r798b2040],
5	T.	NNP	O	T.	nn	6	SENT_372	[p19l818t1967r883b2021],
6	Pharmacogenomics	NNP	O	Pharmacogenomics	appos	2	SENT_372	[p19l909t1968r1465b2040],
7	of	IN	O	of	_	0	SENT_372	[p19l1489t1968r1554b2021],
8	cholesterol	NN	O	cholesterol	nn	11	SENT_372	[p19l1567t1968r2153b2040],
9	—	CD	NUMBER	—	num	11	SENT_372	[p19l1567t1968r2153b2040],
10	lowering	NN	O	lowering	nn	11	SENT_372	[p19l1567t1968r2153b2040],
11	therapy	NN	O	therapy	prep_of	6	SENT_372	[p19l132t2050r359b2122],
12	.	.	O	.	_	0	SENT_372	[p19l132t2050r359b2122],

1	Vascul	NNP	O	Vascul	nn	2	SENT_373	[p19l389t2050r578b2104],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_373	[p19l604t2050r910b2103],
3	2006	CD	DATE	2006	num	2	SENT_373	[p19l935t2050r1293b2115],
4	;	:	O	;	_	0	SENT_373	[p19l935t2050r1293b2115],
5	44:75	CD	NUMBER	44:75	num	7	SENT_373	[p19l935t2050r1293b2115],
6	-	:	O	-	_	0	SENT_373	[p19l935t2050r1293b2115],
7	89	CD	DATE	89	dep	2	SENT_373	[p19l1306t2053r1387b2104],
8	.	.	O	.	_	0	SENT_373	[p19l1306t2053r1387b2104],

1	Schmitz	NNP	PERSON	Schmitz	nn	2	SENT_374	[p19l136t2132r370b2186],
2	G	NNP	O	G	_	0	SENT_374	[p19l409t2132r479b2197],
3	,	,	O	,	_	0	SENT_374	[p19l409t2132r479b2197],
4	Schmitz	NNP	PERSON	Schmitz	appos	2	SENT_374	[p19l524t2132r982b2204],
5	.	.	O	.	_	0	SENT_374	[p19l524t2132r982b2204],

1	—	NN	O	—	_	0	SENT_375	[p19l524t2132r982b2204],
2	.	.	O	.	_	0	SENT_375	[p19l524t2132r982b2204],

1	Madry	NNP	PERSON	Madry	nn	2	SENT_376	[p19l524t2132r982b2204],
2	A	NNP	O	A	_	0	SENT_376	[p19l1016t2131r1085b2197],
3	,	,	O	,	_	0	SENT_376	[p19l1016t2131r1085b2197],
4	Ugocsai	NNP	PERSON	Ugocsai	nn	6	SENT_376	[p19l1125t2133r1352b2204],
5	P.	NNP	PERSON	P.	nn	6	SENT_376	[p19l1392t2133r1447b2185],
6	Pharmacogenetics	NNP	PERSON	Pharmacogenetics	appos	2	SENT_376	[p19l1490t2132r2007b2204],
7	and	CC	O	and	_	0	SENT_376	[p19l2049t2132r2152b2185],
8	pharmacogenomics	NNS	O	pharmacogenomic	appos	2	SENT_376	[p19l131t2215r682b2287],
9	of	IN	O	of	_	0	SENT_376	[p19l711t2215r776b2268],
10	cholesterol	NN	O	cholesterol	nn	13	SENT_376	[p19l794t2215r1380b2287],
11	—	CD	NUMBER	—	num	13	SENT_376	[p19l794t2215r1380b2287],
12	lowering	NN	O	lowering	nn	13	SENT_376	[p19l794t2215r1380b2287],
13	therapy	NN	O	therapy	prep_of	8	SENT_376	[p19l1406t2215r1632b2287],
14	.	.	O	.	_	0	SENT_376	[p19l1406t2215r1632b2287],

1	Curr	NNP	O	Curr	nn	3	SENT_377	[p19l1664t2215r1800b2269],
2	Opin	NNP	O	Opin	nn	3	SENT_377	[p19l1827t2215r1976b2287],
3	Lipidol	NNP	O	Lipidol	_	0	SENT_377	[p19l2004t2216r2149b2287, p19l133t2298r222b2351],
4	2007	CD	DATE	2007	num	3	SENT_377	[p19l246t2299r734b2362],
5	;	:	O	;	_	0	SENT_377	[p19l246t2299r734b2362],
6	18:164	CD	NUMBER	18:164	number	7	SENT_377	[p19l246t2299r734b2362],
7	—	CD	NUMBER	—	dep	3	SENT_377	[p19l246t2299r734b2362],
8	73	CD	NUMBER	73	dep	7	SENT_377	[p19l246t2299r734b2362],
9	.	.	O	.	_	0	SENT_377	[p19l246t2299r734b2362],

1	Cannon	NNP	O	Cannon	nn	2	SENT_378	[p19l134t2379r364b2432],
2	CP	NNP	O	CP	_	0	SENT_378	[p19l407t2379r516b2443],
3	,	,	O	,	_	0	SENT_378	[p19l407t2379r516b2443],
4	Braunwald	NNP	PERSON	Braunwald	nn	5	SENT_378	[p19l561t2379r870b2432],
5	E	NNP	O	E	appos	2	SENT_378	[p19l913t2380r974b2443],
6	,	,	O	,	_	0	SENT_378	[p19l913t2380r974b2443],
7	McCabe	NNP	PERSON	McCabe	nn	8	SENT_378	[p19l1017t2379r1265b2432],
8	CH	NN	O	ch	appos	2	SENT_378	[p19l1310t2379r1436b2443],
9	,	,	O	,	_	0	SENT_378	[p19l1310t2379r1436b2443],
10	et	FW	O	et	nn	11	SENT_378	[p19l1481t2393r1532b2432],
11	al.	FW	O	al.	appos	2	SENT_378	[p19l1574t2379r1634b2432],
12	.	.	O	.	_	0	SENT_378	[p19l1574t2379r1634b2432],

1	Intensive	JJ	O	intensive	_	0	SENT_379	[p19l1679t2380r1938b2432],
2	versus	CC	O	versus	prep	1	SENT_379	[p19l1979t2399r2150b2432],
3	moderate	JJ	O	moderate	amod	4	SENT_379	[p19l133t2460r399b2513],
4	lipid	NN	O	lipid	dep	2	SENT_379	[p19l427t2460r556b2532],
5	lowering	VBG	O	lower	partmod	1	SENT_379	[p19l582t2460r832b2532],
6	with	IN	O	with	_	0	SENT_379	[p19l856t2460r986b2513],
7	statins	NNS	O	statin	prep_with	5	SENT_379	[p19l1015t2462r1195b2513],
8	after	IN	O	after	_	0	SENT_379	[p19l1225t2460r1353b2513],
9	acute	JJ	O	acute	amod	11	SENT_379	[p19l1381t2474r1527b2513],
10	coronary	JJ	O	coronary	amod	11	SENT_379	[p19l1556t2480r1805b2532],
11	syndromes	NNS	O	syndrome	prep_after	5	SENT_379	[p19l1832t2460r2148b2532],
12	.	.	O	.	_	0	SENT_379	[p19l1832t2460r2148b2532],

1	N	NN	O	n	nn	2	SENT_380	[p19l132t2544r185b2596],
2	EnglJ	NN	O	englj	nsubj	3	SENT_380	[p19l215t2543r399b2615],
3	Med	VBD	O	med	_	0	SENT_380	[p19l424t2543r561b2596],
4	2004	CD	DATE	2004	dobj	3	SENT_380	[p19l585t2543r1172b2608],
5	;	:	O	;	_	0	SENT_380	[p19l585t2543r1172b2608],
6	350:1495	CD	NUMBER	350:1495	num	7	SENT_380	[p19l585t2543r1172b2608],
7	—	NN	O	—	dep	4	SENT_380	[p19l585t2543r1172b2608],
8	504	CD	NUMBER	504	dep	7	SENT_380	[p19l585t2543r1172b2608],
9	.	.	O	.	_	0	SENT_380	[p19l585t2543r1172b2608],

1	Germer	NNP	PERSON	Germer	nn	2	SENT_381	[p19l134t2625r357b2678],
2	S	NNP	O	S	_	0	SENT_381	[p19l393t2625r443b2690],
3	,	,	O	,	_	0	SENT_381	[p19l393t2625r443b2690],
4	Holland	NNP	ORGANIZATION	Holland	nn	5	SENT_381	[p19l480t2625r717b2678],
5	MJ	NNP	ORGANIZATION	MJ	appos	2	SENT_381	[p19l750t2626r858b2693],
6	,	,	O	,	_	0	SENT_381	[p19l750t2626r858b2693],
7	Higuchi	NNP	PERSON	Higuchi	nn	14	SENT_381	[p19l896t2625r1131b2697],
8	R.	NNP	PERSON	R.	nn	14	SENT_381	[p19l1167t2626r1228b2678],
9	High	NNP	PERSON	High	nn	14	SENT_381	[p19l1266t2625r1774b2697],
10	—	NN	O	—	nn	14	SENT_381	[p19l1266t2625r1774b2697],
11	throughput	NN	O	throughput	nn	14	SENT_381	[p19l1266t2625r1774b2697],
12	SNP	NN	O	snp	nn	14	SENT_381	[p19l1810t2625r1944b2678],
13	allelefrequency	NN	O	allelefrequency	nn	14	SENT_381	[p19l1980t2625r2149b2678, p19l132t2707r412b2779],
14	determination	NN	O	determination	appos	2	SENT_381	[p19l445t2707r848b2760],
15	in	IN	O	in	_	0	SENT_381	[p19l884t2709r939b2760],
16	pooled	JJ	O	pooled	amod	18	SENT_381	[p19l973t2707r1166b2779],
17	DNA	NN	O	dna	nn	18	SENT_381	[p19l1202t2706r1369b2760],
18	samples	NNS	O	sample	prep_in	14	SENT_381	[p19l1404t2707r1624b2779],
19	by	IN	O	by	_	0	SENT_381	[p19l1659t2707r1729b2779],
20	kinetic	JJ	O	kinetic	amod	21	SENT_381	[p19l1762t2707r1954b2760],
21	PCR	NN	O	pcr	prep_by	18	SENT_381	[p19l1989t2707r2148b2760],
22	.	.	O	.	_	0	SENT_381	[p19l1989t2707r2148b2760],

1	Genome	NNP	O	Genome	nn	2	SENT_382	[p19l134t2789r380b2842],
2	Res	NNP	O	Res	_	0	SENT_382	[p19l409t2790r509b2842],
3	2000	CD	DATE	2000	num	2	SENT_382	[p19l535t2789r1032b2853],
4	;	:	O	;	_	0	SENT_382	[p19l535t2789r1032b2853],
5	10:258	CD	NUMBER	10:258	number	6	SENT_382	[p19l535t2789r1032b2853],
6	—	CD	NUMBER	—	dep	2	SENT_382	[p19l535t2789r1032b2853],
7	66	CD	NUMBER	66	dep	6	SENT_382	[p19l535t2789r1032b2853],
8	.	.	O	.	_	0	SENT_382	[p19l535t2789r1032b2853],

1	Iannone	NNP	PERSON	Iannone	nn	2	SENT_383	[p19l132t2871r367b2923],
2	MA	NNP	PERSON	MA	_	0	SENT_383	[p19l390t2869r528b2935],
3	,	,	O	,	_	0	SENT_383	[p19l390t2869r528b2935],
4	Taylor	NNP	PERSON	Taylor	nn	5	SENT_383	[p19l552t2869r743b2942],
5	JD	NNP	O	JD	appos	2	SENT_383	[p19l759t2871r861b2938],
6	,	,	O	,	_	0	SENT_383	[p19l759t2871r861b2938],
7	Chen	NNP	PERSON	Chen	nn	8	SENT_383	[p19l889t2870r1045b2923],
8	J	NNP	PERSON	J	appos	2	SENT_383	[p19l1062t2871r1106b2938],
9	,	,	O	,	_	0	SENT_383	[p19l1062t2871r1106b2938],
10	et	FW	O	et	nn	11	SENT_383	[p19l1134t2884r1185b2923],
11	al.	FW	O	al.	appos	2	SENT_383	[p19l1209t2870r1268b2923],
12	.	.	O	.	_	0	SENT_383	[p19l1209t2870r1268b2923],

1	Multiplexed	JJ	O	multiplexed	amod	3	SENT_384	[p19l1295t2870r1645b2942],
2	single	JJ	O	single	amod	3	SENT_384	[p19l1670t2870r1832b2942],
3	nucleotide	NN	O	nucleotide	_	0	SENT_384	[p19l1857t2870r2151b2923],
4	polymorphism	NN	O	polymorphism	nn	5	SENT_384	[p19l131t2952r547b3024],
5	genotyping	NN	O	genotyping	dep	3	SENT_384	[p19l566t2954r887b3024],
6	by	IN	O	by	_	0	SENT_384	[p19l904t2952r973b3023],
7	oligonucleotide	NN	O	oligonucleotide	nn	8	SENT_384	[p19l991t2952r1428b3023],
8	ligation	NN	O	ligation	prep_by	5	SENT_384	[p19l1448t2952r1665b3024],
9	and	CC	O	and	_	0	SENT_384	[p19l1686t2952r1788b3005],
10	ﬂow	NN	O	ﬂow	nn	11	SENT_384	[p19l1807t2952r1932b3005],
11	cytometry	NN	O	cytometry	conj_and	8	SENT_384	[p19l1949t2966r2149b3023, p19l133t3048r253b3105],
12	.	.	O	.	_	0	SENT_384	[p19l1949t2966r2149b3023, p19l133t3048r253b3105],

1	Cytometry	NN	O	cytometry	_	0	SENT_385	[p19l285t3034r593b3105],
2	2000	CD	DATE	2000	num	1	SENT_385	[p19l616t3037r1103b3099],
3	;	:	O	;	_	0	SENT_385	[p19l616t3037r1103b3099],
4	39:131	CD	NUMBER	39:131	number	5	SENT_385	[p19l616t3037r1103b3099],
5	—	CD	NUMBER	—	dep	1	SENT_385	[p19l616t3037r1103b3099],
6	40	CD	NUMBER	40	dep	5	SENT_385	[p19l616t3037r1103b3099],
7	.	.	O	.	_	0	SENT_385	[p19l616t3037r1103b3099],

1	Weir	NNP	O	Weir	nn	2	SENT_386	[p19l129t3117r280b3170],
2	BS	NNP	O	BS	_	0	SENT_386	[p19l309t3117r407b3170],
3	.	.	O	.	_	0	SENT_386	[p19l309t3117r407b3170],

1	Genetic	NNP	O	Genetic	nn	2	SENT_387	[p19l443t3117r668b3170],
2	Data	NNP	O	Data	_	0	SENT_387	[p19l698t3117r838b3170],
3	Analysis	NN	O	analysis	dep	2	SENT_387	[p19l866t3116r1105b3188],
4	II	CD	NUMBER	ii	num	3	SENT_387	[p19l1136t3117r1201b3170],
5	.	.	O	.	_	0	SENT_387	[p19l1136t3117r1201b3170],

1	Sunderland	NNP	LOCATION	Sunderland	_	0	SENT_388	[p19l1238t3117r1577b3170],
2	:	:	O	:	_	0	SENT_388	[p19l1238t3117r1577b3170],
3	Sinauer	NNP	ORGANIZATION	Sinauer	nn	5	SENT_388	[p19l1614t3117r1828b3170],
4	Associates	NNPS	ORGANIZATION	Associates	nn	5	SENT_388	[p19l1855t3116r2150b3170],
5	Inc.	NNP	ORGANIZATION	Inc.	dep	1	SENT_388	[p19l132t3199r258b3263],
6	,	,	O	,	_	0	SENT_388	[p19l132t3199r258b3263],
7	1996	CD	DATE	1996	appos	5	SENT_388	[p19l290t3201r442b3251],
8	.	.	O	.	_	0	SENT_388	[p19l290t3201r442b3251],

1	Ridker	NNP	PERSON	Ridker	nn	2	SENT_389	[p19l135t3279r328b3333],
2	PM	NNP	O	PM	_	0	SENT_389	[p19l351t3280r478b3344],
3	,	,	O	,	_	0	SENT_389	[p19l351t3280r478b3344],
4	Cannon	NNP	O	Cannon	nn	5	SENT_389	[p19l507t3279r736b3333],
5	CP	NNP	O	CP	appos	2	SENT_389	[p19l763t3279r871b3345],
6	,	,	O	,	_	0	SENT_389	[p19l763t3279r871b3345],
7	Morrow	NNP	PERSON	Morrow	nn	8	SENT_389	[p19l897t3280r1138b3333],
8	D	NNP	O	D	appos	2	SENT_389	[p19l1160t3280r1231b3345],
9	,	,	O	,	_	0	SENT_389	[p19l1160t3280r1231b3345],
10	et	FW	O	et	nn	11	SENT_389	[p19l1259t3293r1310b3333],
11	al.	FW	O	al.	appos	2	SENT_389	[p19l1335t3280r1394b3333],
12	.	.	O	.	_	0	SENT_389	[p19l1335t3280r1394b3333],

1	C-Reactive	JJ	O	c-reactive	amod	3	SENT_390	[p19l1424t3279r1745b3333],
2	protein	NN	O	protein	nn	3	SENT_390	[p19l1770t3282r1976b3351],
3	levels	NNS	O	level	_	0	SENT_390	[p19l1999t3280r2150b3333],
4	and	CC	O	and	_	0	SENT_390	[p19l134t3361r236b3415],
5	outcomes	NNS	O	outcome	conj_and	3	SENT_390	[p19l263t3375r532b3415],
6	after	IN	O	after	_	0	SENT_390	[p19l561t3361r689b3415],
7	statin	NN	O	statin	nn	8	SENT_390	[p19l715t3364r870b3415],
8	therapy	NN	O	therapy	prep_after	3	SENT_390	[p19l896t3362r1123b3433],
9	.	.	O	.	_	0	SENT_390	[p19l896t3362r1123b3433],

1	N	NN	O	n	nn	2	SENT_391	[p19l1153t3362r1206b3414],
2	EnglJ	NN	O	englj	nsubj	3	SENT_391	[p19l1235t3362r1420b3433],
3	Med	VBD	O	med	_	0	SENT_391	[p19l1444t3362r1582b3415],
4	2005	CD	DATE	2005	dobj	3	SENT_391	[p19l1606t3361r2067b3426],
5	;	:	O	;	_	0	SENT_391	[p19l1606t3361r2067b3426],
6	352:20	CD	NUMBER	352:20	number	7	SENT_391	[p19l1606t3361r2067b3426],
7	—	CD	NUMBER	—	dep	4	SENT_391	[p19l1606t3361r2067b3426],
8	8	CD	NUMBER	8	dep	7	SENT_391	[p19l1606t3361r2067b3426],
9	.	.	O	.	_	0	SENT_391	[p19l1606t3361r2067b3426],

1	LaRosa	NNP	ORGANIZATION	LaRosa	nn	2	SENT_392	[p19l134t3444r350b3496],
2	JC	NNP	ORGANIZATION	JC	_	0	SENT_392	[p19l369t3443r467b3511],
3	,	,	O	,	_	0	SENT_392	[p19l369t3443r467b3511],
4	Grundy	NNP	PERSON	Grundy	nn	5	SENT_392	[p19l499t3443r723b3515],
5	SM	NNP	O	SM	appos	2	SENT_392	[p19l750t3443r870b3508],
6	,	,	O	,	_	0	SENT_392	[p19l750t3443r870b3508],
7	Waters	NNP	O	Waters	nn	8	SENT_392	[p19l897t3444r1104b3497],
8	DD	NNP	O	DD	appos	2	SENT_392	[p19l1133t3444r1262b3508],
9	,	,	O	,	_	0	SENT_392	[p19l1133t3444r1262b3508],
10	et	FW	O	et	nn	11	SENT_392	[p19l1293t3457r1344b3497],
11	al.	FW	O	al.	appos	2	SENT_392	[p19l1371t3443r1431b3496],
12	.	.	O	.	_	0	SENT_392	[p19l1371t3443r1431b3496],

1	Intensive	JJ	O	intensive	amod	2	SENT_393	[p19l1462t3444r1721b3497],
2	lipid	NN	O	lipid	_	0	SENT_393	[p19l1748t3443r1877b3515],
3	lowering	VBG	O	lower	partmod	2	SENT_393	[p19l1904t3443r2153b3515],
4	with	IN	O	with	_	0	SENT_393	[p19l129t3525r260b3579],
5	atorvastatin	NN	O	atorvastatin	prep_with	3	SENT_393	[p19l299t3528r629b3578],
6	in	IN	O	in	_	0	SENT_393	[p19l667t3528r721b3578],
7	patients	NNS	O	patient	prep_in	3	SENT_393	[p19l758t3528r981b3597],
8	with	IN	O	with	_	0	SENT_393	[p19l1018t3525r1148b3579],
9	stable	JJ	O	stable	amod	11	SENT_393	[p19l1187t3525r1346b3578],
10	coronary	JJ	O	coronary	amod	11	SENT_393	[p19l1385t3546r1635b3597],
11	disease	NN	O	disease	prep_with	7	SENT_393	[p19l1670t3525r1880b3578],
12	.	.	O	.	_	0	SENT_393	[p19l1670t3525r1880b3578],

1	N	NN	O	n	nn	3	SENT_394	[p19l1921t3526r1975b3578],
2	Engl	NNP	O	Engl	nn	3	SENT_394	[p19l2015t3525r2153b3597],
3	J	NNP	O	J	nsubj	4	SENT_394	[p19l125t3609r154b3676],
4	Med	VBD	O	med	_	0	SENT_394	[p19l179t3608r316b3661],
5	2005	CD	DATE	2005	dobj	4	SENT_394	[p19l341t3608r891b3673],
6	;	:	O	;	_	0	SENT_394	[p19l341t3608r891b3673],
7	352:1425	CD	NUMBER	352:1425	num	8	SENT_394	[p19l341t3608r891b3673],
8	-35	CD	NUMBER	-35	dep	5	SENT_394	[p19l341t3608r891b3673],
9	.	.	O	.	_	0	SENT_394	[p19l341t3608r891b3673],

1	Schwartz	NNP	PERSON	Schwartz	nn	2	SENT_395	[p19l136t3690r397b3743],
2	GG	NNS	O	gg	_	0	SENT_395	[p19l420t3690r549b3755],
3	,	,	O	,	_	0	SENT_395	[p19l420t3690r549b3755],
4	Olsson	NNP	ORGANIZATION	Olsson	nn	5	SENT_395	[p19l577t3690r775b3743],
5	AG	NNP	ORGANIZATION	AG	appos	2	SENT_395	[p19l797t3689r922b3743],
6	.	.	O	.	_	0	SENT_395	[p19l797t3689r922b3743],

1	The	DT	O	the	det	2	SENT_396	[p19l947t3689r1066b3743],
2	case	NN	O	case	_	0	SENT_396	[p19l1091t3711r1203b3743],
3	for	IN	O	for	_	0	SENT_396	[p19l1227t3690r1308b3743],
4	intensive	JJ	O	intensive	amod	6	SENT_396	[p19l1331t3692r1583b3743],
5	statin	NN	O	statin	nn	6	SENT_396	[p19l1608t3692r1763b3743],
6	therapy	NN	O	therapy	prep_for	2	SENT_396	[p19l1787t3690r2003b3762],
7	after	IN	O	after	_	0	SENT_396	[p19l2025t3690r2153b3743],
8	acute	JJ	O	acute	amod	10	SENT_396	[p20l134t26r279b65],
9	coronary	JJ	O	coronary	amod	10	SENT_396	[p20l306t32r556b83],
10	syndromes	NNS	O	syndrome	prep_after	2	SENT_396	[p20l580t12r896b83],
11	.	.	O	.	_	0	SENT_396	[p20l580t12r896b83],

1	Am	VBP	O	be	dep	3	SENT_397	[p20l925t11r1083b80],
2	]	CD	NUMBER	]	num	3	SENT_397	[p20l925t11r1083b80],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_397	[p20l1110t12r1326b65],
4	2005	CD	DATE	2005	num	3	SENT_397	[p20l1350t12r1490b66],
5	;	:	O	;	_	0	SENT_397	[p20l1497t12r1879b77],
6	96:45	CD	NUMBER	96:45	num	7	SENT_397	[p20l1497t12r1879b77],
7	F	NN	O	f	dep	3	SENT_397	[p20l1497t12r1879b77],
8	—	CD	NUMBER	—	num	9	SENT_397	[p20l1497t12r1879b77],
9	53F	NN	O	53f	dep	7	SENT_397	[p20l1497t12r1879b77],
10	.	.	O	.	_	0	SENT_397	[p20l1497t12r1879b77],

1	Halcox	NNP	O	Halcox	nn	2	SENT_398	[p20l133t94r338b147],
2	JP	NNP	O	JP	_	0	SENT_398	[p20l354t95r442b162],
3	,	,	O	,	_	0	SENT_398	[p20l354t95r442b162],
4	Deanﬁeld	NNP	PERSON	Deanﬁeld	rcmod	2	SENT_398	[p20l470t94r750b147],
5	(	CD	NUMBER	(	num	7	SENT_398	[p20l768t95r860b162],
6	c	NN	O	c	nn	7	SENT_398	[p20l768t95r860b162],
7	*	NN	O	*	dep	4	SENT_398	[p20l768t95r860b162],
8	Beyond	IN	O	beyond	dep	4	SENT_398	[p20l889t94r1107b165],
9	the	DT	O	the	det	10	SENT_398	[p20l1132t94r1220b147],
10	laboratory	NN	O	laboratory	pobj	8	SENT_398	[p20l1245t94r1548b165],
11	:	:	O	:	_	0	SENT_398	[p20l1245t94r1548b165],
12	clinical	JJ	O	clinical	amod	13	SENT_398	[p20l1578t94r1778b147],
13	implications	NNS	O	implication	dep	2	SENT_398	[p20l1802t94r2150b166],
14	for	IN	O	for	_	0	SENT_398	[p20l132t177r213b230],
15	statin	NN	O	statin	nn	16	SENT_398	[p20l240t179r395b230],
16	pleiotropy	NN	O	pleiotropy	prep_for	13	SENT_398	[p20l420t177r724b249],
17	.	.	O	.	_	0	SENT_398	[p20l420t177r724b249],

1	Circulation	NN	O	circulation	_	0	SENT_399	[p20l756t177r1079b230],
2	2004	CD	DATE	2004	num	1	SENT_399	[p20l1104t177r1609b242],
3	;	:	O	;	_	0	SENT_399	[p20l1104t177r1609b242],
4	109	CD	NUMBER	109	dep	1	SENT_399	[p20l1104t177r1609b242],
5	:	:	O	:	_	0	SENT_399	[p20l1104t177r1609b242],
6	II42	NN	O	ii42	dep	4	SENT_399	[p20l1104t177r1609b242],
7	—	CD	NUMBER	—	number	8	SENT_399	[p20l1104t177r1609b242],
8	8	CD	NUMBER	8	dep	6	SENT_399	[p20l1104t177r1609b242],
9	.	.	O	.	_	0	SENT_399	[p20l1104t177r1609b242],

1	Seiler	NNP	PERSON	Seiler	nn	2	SENT_400	[p20l136t259r293b312],
2	S	NNP	O	S	_	0	SENT_400	[p20l316t259r366b324],
3	,	,	O	,	_	0	SENT_400	[p20l316t259r366b324],
4	Kirchner	NNP	PERSON	Kirchner	nn	5	SENT_400	[p20l392t259r701b327],
5	]	NNP	O	]	appos	2	SENT_400	[p20l392t259r701b327],
6	,	,	O	,	_	0	SENT_400	[p20l392t259r701b327],
7	Horn	NNP	ORGANIZATION	Horn	nn	8	SENT_400	[p20l725t259r881b312],
8	C	NNP	ORGANIZATION	C	appos	2	SENT_400	[p20l904t259r969b324],
9	,	,	O	,	_	0	SENT_400	[p20l904t259r969b324],
10	Kallipolitou	NNP	MISC	Kallipolitou	nn	11	SENT_400	[p20l995t259r1333b331],
11	A	NNP	MISC	A	appos	2	SENT_400	[p20l1352t258r1420b324],
12	,	,	O	,	_	0	SENT_400	[p20l1352t258r1420b324],
13	Woehlke	NNP	O	Woehlke	nn	14	SENT_400	[p20l1441t259r1704b312],
14	G	NNP	O	G	appos	2	SENT_400	[p20l1729t259r1799b324],
15	,	,	O	,	_	0	SENT_400	[p20l1729t259r1799b324],
16	Schliwa	NNP	O	Schliwa	nn	19	SENT_400	[p20l1825t259r2045b312],
17	M.	NNP	O	M.	nn	19	SENT_400	[p20l2064t259r2148b312],
18	Cargo	NNP	O	Cargo	dep	19	SENT_400	[p20l134t340r307b412],
19	binding	NN	O	binding	appos	2	SENT_400	[p20l335t340r558b412],
20	and	CC	O	and	_	0	SENT_400	[p20l586t340r689b394],
21	regulatory	JJ	O	regulatory	amod	22	SENT_400	[p20l716t340r1006b412],
22	sites	NNS	O	site	conj_and	19	SENT_400	[p20l1032t343r1151b394],
23	in	IN	O	in	_	0	SENT_400	[p20l1180t343r1235b393],
24	the	DT	O	the	det	25	SENT_400	[p20l1263t341r1352b394],
25	tail	NN	O	tail	prep_in	19	SENT_400	[p20l1381t340r1470b394],
26	of	IN	O	of	_	0	SENT_400	[p20l1498t340r1563b394],
27	fungal	JJ	O	fungal	amod	29	SENT_400	[p20l1581t340r1760b412],
28	conventional	JJ	O	conventional	amod	29	SENT_400	[p20l1788t341r2153b394],
29	kinesin	NN	O	kinesin	prep_of	25	SENT_400	[p20l133t422r350b475],
30	.	.	O	.	_	0	SENT_400	[p20l133t422r350b475],

1	Nat	NNP	MISC	Nat	nn	3	SENT_401	[p20l380t423r489b475],
2	Cell	NNP	MISC	Cell	nn	3	SENT_401	[p20l516t422r633b475],
3	Biol	NNP	MISC	Biol	_	0	SENT_401	[p20l659t422r778b475],
4	2000	CD	DATE	2000	num	3	SENT_401	[p20l801t425r1218b487],
5	;	:	O	;	_	0	SENT_401	[p20l801t425r1218b487],
6	2:333	CD	NUMBER	2:333	number	7	SENT_401	[p20l801t425r1218b487],
7	—	CD	NUMBER	—	dep	3	SENT_401	[p20l801t425r1218b487],
8	8	CD	NUMBER	8	dep	7	SENT_401	[p20l801t425r1218b487],
9	.	.	O	.	_	0	SENT_401	[p20l801t425r1218b487],

1	Seog	NNP	O	Seog	nn	2	SENT_402	[p20l136t503r271b575],
2	DH	NNP	O	DH	_	0	SENT_402	[p20l293t504r425b568],
3	,	,	O	,	_	0	SENT_402	[p20l293t504r425b568],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_402	[p20l451t504r556b556],
5	DH	NNP	O	DH	appos	2	SENT_402	[p20l579t504r711b568],
6	,	,	O	,	_	0	SENT_402	[p20l579t504r711b568],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_402	[p20l738t504r842b556],
8	SK	NNP	O	SK	appos	5	SENT_402	[p20l869t503r968b557],
9	.	.	O	.	_	0	SENT_402	[p20l869t503r968b557],

1	Molecular	JJ	O	molecular	amod	3	SENT_403	[p20l993t503r1287b556],
2	motor	NN	O	motor	nn	3	SENT_403	[p20l1309t517r1483b556],
3	proteins	NNS	O	protein	nsubj	9	SENT_403	[p20l1504t506r1733b575],
4	of	IN	O	of	_	0	SENT_403	[p20l1759t503r1823b556],
5	the	DT	O	the	det	8	SENT_403	[p20l1836t503r1925b556],
6	kinesin	NN	O	kinesin	nn	8	SENT_403	[p20l1948t503r2151b556],
7	superfamily	NN	O	superfamily	nn	8	SENT_403	[p20l134t585r466b657],
8	proteins	NNS	O	protein	prep_of	3	SENT_403	[p20l497t588r726b657],
9	(	VBP	O	(	_	0	SENT_403	[p20l766t583r968b650],
10	KIFS	NNS	O	kif	dobj	9	SENT_403	[p20l766t583r968b650],
11	)	CD	NUMBER	)	tmod	9	SENT_403	[p20l766t583r968b650],
12	:	:	O	:	_	0	SENT_403	[p20l766t583r968b650],
13	structure	NN	O	structure	dobj	9	SENT_403	[p20l1009t599r1273b650],
14	,	,	O	,	_	0	SENT_403	[p20l1009t599r1273b650],
15	cargo	NN	O	cargo	dobj	9	SENT_403	[p20l1312t606r1462b657],
16	and	CC	O	and	_	0	SENT_403	[p20l1500t585r1602b638],
17	disease	NN	O	disease	dobj	9	SENT_403	[p20l1638t585r1848b638],
18	.	.	O	.	_	0	SENT_403	[p20l1638t585r1848b638],

1	J	NN	O	j	_	0	SENT_404	[p20l1880t586r1909b653],
2	Korean	JJ	O	korean	amod	3	SENT_404	[p20l1946t586r2151b638],
3	Med	JJ	O	med	amod	1	SENT_404	[p20l131t684r268b737],
4	Sci	NNP	O	Sci	dep	1	SENT_404	[p20l297t684r380b737],
5	2004	CD	DATE	2004	num	4	SENT_404	[p20l404t685r776b747],
6	;	:	O	;	_	0	SENT_404	[p20l404t685r776b747],
7	19:1	CD	NUMBER	19:1	num	8	SENT_404	[p20l404t685r776b747],
8	—	NN	O	—	dep	1	SENT_404	[p20l404t685r776b747],
9	7	CD	NUMBER	7	dep	8	SENT_404	[p20l404t685r776b747],
10	.	.	O	.	_	0	SENT_404	[p20l404t685r776b747],

